,Biomarker,Relations,Cluster
0,11C-(R)-PK11195,"[{'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",369
1,11C-DAA1106,"[{'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",369
2,11C-DED,"[{'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Astrocytosis in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Astrocytosis in early stages of Alzheimer's Disease""}]",369
3,11C-PBR28,"[{'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",369
4,11C-PiB,"[{'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Aβ deposition in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Aβ plaque deposition in Alzheimer's Disease""}]",5
5,11C-Pittsburgh compound B (PiB) PET uptake,"[{'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",683
6,11β-HSD1,"[{'article': 'PMC5301048.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Treatment: UE2343 (Xanamem™) for Alzheimer's Disease""}]",682
7,11β‐HSD1,"[{'article': 'PMC5301048.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of cognitive impairment in early‐stage Alzheimer's Disease""}, {'article': 'PMC5301048.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive improvement in memory'}, {'article': 'PMC5301048.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Therapeutic strategy for Alzheimer's Disease""}]",682
8,123iodine-metaiodobenzylguanidine (MIBG) myocardial scintigraphy,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dementia with Lewy Bodies (DLB), which is often misdiagnosed as Alzheimer's Disease""}]",564
9,129Xe,"[{'article': 'PMC6023430.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Disease state and progression'}]",614
10,129Xe retention parameter,"[{'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",3
11,129Xe signal in gray matter,"[{'article': 'PMC9314594.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",350
12,129Xe washout half-life,"[{'article': 'PMC9314594.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",461
13,129Xe-GM,"[{'article': 'PMC6023430.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cerebral perfusion changes in Alzheimer's Disease""}]",614
14,13-cis-retinoic acid,"[{'article': 'PMC2765081.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]",225
15,18F-AV-1451,"[{'article': 'PMC4995360.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4995360.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Tau pathology in Alzheimer's Disease""}, {'article': 'PMC4995360.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4995360.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau pathology'}, {'article': 'PMC4995360.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Tau pathology in Alzheimer's Disease""}, {'article': 'PMC4995360.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Tau aggregates in Alzheimer's Disease""}, {'article': 'PMC5209394.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",692
16,18F-AV-1451 (tau),"[{'article': 'PMC4995360.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Tau pathology in Alzheimer's Disease""}]",692
17,18F-AV45 SUVR,"[{'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",552
18,18F-FDG,"[{'article': 'PMC3467226.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early detection of Alzheimer's Disease""}, {'article': 'PMC4995360.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Hypometabolism in Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early posterior hypometabolism in Alzheimer's Disease""}]",43
19,18F-FDG (glucose metabolism),"[{'article': 'PMC4995360.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Glucose metabolism abnormalities in Alzheimer's Disease""}]",357
20,18F-FDG PET,"[{'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Decline in relative CMRgl in Alzheimer disease–associated region'}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES', 'object': 'Functional impairment of neurons'}, {'article': 'PMC9011335.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease progression""}]",43
21,18F-FDG uptake,"[{'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",593
22,18F-FDG-PET,"[{'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9011335.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9011335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild mesial temporal hypometabolism in Alzheimer's Disease""}]",43
23,18F-Florbetaben,"[{'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",689
24,18F-Florbetaben SUVR,"[{'article': 'PMC8570037.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease progression""}]",689
25,18F-Florbetapir,"[{'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",689
26,18F-Flortaucipir (18F-AV1451),"[{'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",689
27,18F-PI-2620,"[{'article': 'PMC9327167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Tau deposition in early Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early tau deposition in Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau buildup in Alzheimer's Disease""}]",552
28,18F-PI-2620 SUVR,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau load'}, {'article': 'PMC9327167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Tau positivity'}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid p-tau'}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid t-tau'}, {'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reduced hippocampal volume'}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}, {'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",552
29,18F-PI-2620 SUVR in fusiform gyrus,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau deposition in Alzheimer's Disease""}]",552
30,18F-PI-2620 SUVR in inferior temporal cortex,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau deposition in Alzheimer's Disease""}]",655
31,18F-PI-2620 SUVR in mesial temporal cortex,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau deposition in Alzheimer's Disease""}]",655
32,18F-PI-2620 SUVR in occipital cortex,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau deposition in Alzheimer's Disease""}]",655
33,18F-PI-2620 SUVR in superior temporal cortex,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau deposition in Alzheimer's Disease""}]",655
34,18F-florbetaben PET,"[{'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Aβ deposition'}]",362
35,18F-florbetapir,"[{'article': 'PMC8905724.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid accumulation in Alzheimer’s disease'}]",689
36,18F-flortaucipir,"[{'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Tau deposition in Alzheimer's Disease""}]",689
37,18F-fluorodeoxyglucose,"[{'article': 'PMC8905724.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain metabolism in Alzheimer’s disease'}]",43
38,18F-flutemetamol (amyloid-β),"[{'article': 'PMC4995360.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Amyloid-β pathology in Alzheimer's Disease""}]",8
39,18F-flutemetamol PET,"[{'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",393
40,18FDG,"[{'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Disease progression in Alzheimer's Disease""}]",43
41,18FDG-PET,"[{'article': 'PMC9606044.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring functional changes in the brain during PE treatment'}, {'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Metabolic deficits associated with neuronal damage in Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts: Rapid progression to more severe Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'response to PE treatment in AD patients'}]",43
42,18Q,"[{'article': 'PMC4899632.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Associated with better motor coordination and extended survival in Alzheimer's Disease models.""}]",111
43,2'-deoxyguanosine,"[{'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease through oxidative stress and cognitive decline""}]",591
44,2-deoxy-D-glucose (2DG),"[{'article': 'PMC6015016.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",586
45,200 kDa neurofilament,"[{'article': 'PMC3978916.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuronal damage in Alzheimer's Disease""}]",281
46,23Q,"[{'article': 'PMC4899632.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Used to diagnose and study disease progression in Alzheimer's Disease models.""}]",111
47,24HC,"[{'article': 'PMC9797897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'CYP46A1 activation in early Alzheimer’s disease'}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to Efavirenz treatment in Alzheimer's Disease""}]",230
48,24OH,"[{'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3712995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Better spatial memory retention in aged female mice, indicating potential for better prognosis in Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}]",594
49,25-hydroxyvitamin D (25OHD),"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3212921.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",553
50,25OHD,"[{'article': 'PMC3212921.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Hypovitaminosis D in Alzheimer's Disease Patients""}]",594
51,2D T2-weighted FLAIR MRI,"[{'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",158
52,2D T2-weighted GRE MRI,"[{'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",158
53,2DG,"[{'article': 'PMC6015016.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6015016.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain metabolism impairment in Alzheimer's Disease mouse models""}, {'article': 'PMC6015016.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Glucose metabolism in Alzheimer's Disease""}]",136
54,2DG uptake,"[{'article': 'PMC6015016.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain metabolism deficits in Alzheimer's Disease""}]",593
55,2DG6P,"[{'article': 'PMC6015016.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",136
56,2HG,"[{'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",0
57,3-Hydroxybutyrate,"[{'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Mild Cognitive Impairment'}]",361
58,3-hydroxybutyrate,"[{'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive function through ketogenesis'}]",361
59,30-second chair stand test (CST),"[{'article': 'PMC4431827.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in lower limb strength and function after exercise'}]",291
60,30CST,"[{'article': 'PMC10475546.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower-body strength in older adults with cognitive decline'}]",122
61,390-gene co-expression module,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",638
62,3D T1-weighted MRI,"[{'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",158
63,3MS,"[{'article': 'PMC4324943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Global cognitive function in Alzheimer's Disease""}, {'article': 'PMC4324943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",348
64,4-HNE,"[{'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]",0
65,4-hydroxyhexenal (4HHE),"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Oxidative stress in AD'}]",591
66,4-item Instrumental Activities of Daily Living scale (IADL-PAQUID) score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Disability in instrumental activities'}]",419
67,48Q,"[{'article': 'PMC4899632.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Associated with impaired motor coordination and reduced survival in Alzheimer's Disease models.""}]",111
68,4G8,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Assessing Aβ levels in biopsy samples'}]",348
69,4G8 antibody,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of amyloid-beta plaques'}]",25
70,4SBT,"[{'article': 'PMC10475546.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Balance in older adults with cognitive decline'}]",348
71,5 LOX,"[{'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of pro-inflammatory enzyme in AD mice'}]",695
72,5-HT6 receptor antagonist,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",688
73,5-LOX,"[{'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Inflammatory response: Reduced to control levels by J147'}]",695
74,6-CN-PiB,"[{'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",545
75,67-kDa laminin receptor,"[{'article': 'PMC4675859.txt', 'relationship': 'TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",120
76,6MWT,"[{'article': 'PMC6406356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Global cognitive and physical function in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better brain health and cognition'}]",348
77,73Q,"[{'article': 'PMC4899632.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of neuronal hyperexcitability in Alzheimer's Disease models.""}]",111
78,"8,12-isoiPF(2alpha)-VI","[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiating AD-MCA; biomarkers of AD progression'}]",431
79,8-OHDG,"[{'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]",594
80,8-OHdG,"[{'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""DNA and RNA oxidation in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Differentiating Alzheimer's Disease from healthy controls""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",594
81,8-hydroxy-2′-deoxyguanosine (8-OHdG),"[{'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}]",591
82,8-hydroxydeoxyguanosine (8-OHdG),"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Oxidative stress in AD'}]",591
83,8-oxoGuo,"[{'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'oxidative RNA damage'}]",585
84,8-oxodG,"[{'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'oxidative DNA damage'}]",585
85,8-oxodG/8-oxoGuo,"[{'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress linked to Alzheimer's Disease""}]",585
86,A,"[{'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",113
87,A+T+ profile,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",122
88,A/T/N system,"[{'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",122
89,A1 astrocyte phenotype,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",339
90,A2 astrocyte phenotype,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",339
91,A2m,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Amyloid-β clearance'}]",312
92,A673T,"[{'article': 'PMC4304279.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",144
93,A673T mutation in APP,"[{'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",100
94,AAB-003,"[{'article': 'PMC4772335.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Completed Phase I trials'}]",222
95,AAB-003 levels,"[{'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Treatment response'}]",222
96,AADvac-1,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",222
97,AADvac1,"[{'article': 'PMC6201586.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Active immunotherapy for Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Slower brain atrophy and less cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Patients with higher antibody titres'}]",222
98,AB,"[{'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",304
99,AB 42/40 ratio,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",304
100,ABCA7,"[{'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'RESPONDED_TO_TREATMENT', 'object': 'Exercise-induced cognitive benefits'}, {'article': 'PMC10710152.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4107377.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ accumulation in Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease inflammation""}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8066440.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Late-Onset Alzheimer's Disease (LOAD)""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",478
101,ABCA7 genotype,"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive performance and Alzheimer's disease risk""}]",478
102,ABCA7 rs3764650,"[{'article': 'PMC10710152.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease genetic risk factor""}]",478
103,ABeta42,"[{'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",560
104,ABeta42/40,"[{'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",560
105,ACC,"[{'article': 'PMC7735856.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Item memory gains'}]",222
106,ACC-001,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Discontinued in Phase II trials due to autoimmune response'}]",222
107,ACE category fluency,"[{'article': 'PMC4811920.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Disease progression in amild cognitive impairment group'}]",394
108,ACE total score,"[{'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline associated with Alzheimer's Disease""}]",1
109,ACTH,"[{'article': 'PMC5301048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': '11β-HSD1 inhibition'}]",661
110,ACh,"[{'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher ACh levels in intervention groups'}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease through increased ACh levels""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Slowing of cognitive function loss'}, {'article': 'PMC6130053.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Facilitating neuronal plasticity and cognitive functions in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improved ACh concentration after tDCS therapy'}]",687
111,AChE,"[{'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4936020.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cholinergic activity in Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cholinergic Neuron Loss'}, {'article': 'PMC9202553.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's disease-related neuropathological features""}]",455
112,AChE activity,"[{'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Correlated with cognitive changes in Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",455
113,AChE protein levels,"[{'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",455
114,AD,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Gait characteristics in the same way as MD'}]",170
115,AD (Axial Diffusivity),"[{'article': 'PMC8760674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",224
116,AD pathology,"[{'article': 'PMC6110931.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",18
117,AD-GRS,"[{'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Dementia prediction in Non-Hispanic populations'}]",170
118,AD-GRS (Alzheimer's Disease Genetic Risk Score),"[{'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""dementia probability and memory functioning in Alzheimer's Disease""}]",18
119,AD8,"[{'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease presence""}]",170
120,AD8-slefd,"[{'article': 'PMC9354045.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia'}]",170
121,ADAM10,"[{'article': 'PMC2765081.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2765081.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease risk""}, {'article': 'PMC7389451.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",293
122,ADAS,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease-specific symptoms""}, {'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5016950.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",106
123,ADAS-Cog,"[{'article': 'PMC2731764.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Cognitive performance in Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Changes in cognitive function'}, {'article': 'PMC2949590.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive and non-cognitive AD-specific symptoms'}, {'article': 'PMC3226277.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3226277.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to masitinib treatment in Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Primary endpoint for assessing cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive decline in response to cycling intervention'}, {'article': 'PMC4380493.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4380493.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Assessment in Alzheimer's Disease""}, {'article': 'PMC8386362.txt', 'relationship': 'RESPONDED_TO', 'object': ""rTMS treatment response in Alzheimer's Disease patients""}, {'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Global cognition in Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4764002.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive Functioning in Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5546604.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to rivastigmine patch therapy in Alzheimer's Disease patients""}, {'article': 'PMC5546604.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive decline in Alzheimer's Disease patients""}, {'article': 'PMC6225735.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6225735.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Clinical improvement in Alzheimer's Disease""}, {'article': 'PMC6225735.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Clinical improvement in Alzheimer's Disease""}, {'article': 'PMC6260857.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7106668.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Slow gait speed in Alzheimer's Disease patients""}, {'article': 'PMC7106668.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Slow gait speed in Alzheimer's Disease patients""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Effectiveness of intervention in Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to rTMS treatment in Alzheimer's Disease""}, {'article': 'PMC9309357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function changes in Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in cognition in participants with mild to moderate Alzheimer's disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9539040.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",106
124,ADAS-Cog (Alzheimer's Disease Assessment Scale-Cognitive subscale),"[{'article': 'PMC8564955.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline predicts functional decline'}]",485
125,ADAS-Cog 11,"[{'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",106
126,ADAS-Cog 13,"[{'article': 'PMC9204250.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}]",106
127,ADAS-Cog 13-item total score,"[{'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improvement in cognitive function in Alzheimer's Disease""}]",531
128,ADAS-Cog score,"[{'article': 'PMC6074058.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",531
129,ADAS-Cog scores,"[{'article': 'PMC6074058.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",531
130,ADAS-Cog-11,"[{'article': 'PMC7364345.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7364345.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",106
131,ADAS-Cog11,"[{'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Decline in Alzheimer's Disease""}]",106
132,ADAS-Cog13 scores,"[{'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Change in cognitive decline over 12 months'}]",531
133,ADAS-Cog14,"[{'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease clinical decline""}]",106
134,ADAS-cog,"[{'article': 'PMC2194921.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive Progression in Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Assessment of cognitive performance in AD'}, {'article': 'PMC4324943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC4324943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4353453.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Clinically relevant improvement in Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4712287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4712287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement in AD patients after rTMS treatment'}, {'article': 'PMC5464918.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5496421.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5496421.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Continuous non-significant decline in cognitive function.'}, {'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and assessment of Alzheimer's Disease""}, {'article': 'PMC7930223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7930223.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Cognitive benefits in Alzheimer's Disease treatment""}, {'article': 'PMC9389745.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Worsening dementia'}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease cognitive decline""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive deterioration in Alzheimer's Disease""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",106
135,ADAS-cog scores,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5546604.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No significant differences in ADAS-cog scores between patients with minimal and moderate WMHs'}, {'article': 'PMC6130053.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]",531
136,ADAS-cog-13,"[{'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",106
137,ADAS-cog11,"[{'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",106
138,ADAS-cog12,"[{'article': 'PMC7489025.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive improvement in Alzheimer's Disease""}, {'article': 'PMC7489025.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive improvement in Alzheimer's Disease""}]",106
139,ADAS-mem,"[{'article': 'PMC6130053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Non-significant progressive improvement of the ADAS-mem values.'}]",106
140,ADAScog11,"[{'article': 'PMC4461930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",106
141,ADCOMS,"[{'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease clinical decline""}, {'article': 'PMC7067750.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",170
142,ADCS ADL total score,"[{'article': 'PMC4401690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Activities of daily living performance in Alzheimer's Disease patients""}]",121
143,ADCS-ADL,"[{'article': 'PMC3226277.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4324943.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Functional status in Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8386362.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment efficacy in Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5496421.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Daily living activities in Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Activities of Daily Living in Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7364345.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment with rotigotine in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess managing finances in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-care in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess gait in Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Improvement in activities of daily living in patients with Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9389745.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Functional decline'}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease functional decline""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Functional decline in Alzheimer's Disease""}]",540
144,ADCS-ADL scores,"[{'article': 'PMC8500065.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",121
145,ADCS-ADL23,"[{'article': 'PMC6260857.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional impairment in Alzheimer's Disease""}]",540
146,ADCS-CGIC,"[{'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",540
147,ADCS-IADL,"[{'article': 'PMC4353453.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Functional response in Alzheimer's Disease""}]",540
148,ADL,"[{'article': 'PMC8316394.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Personal Independence in Alzheimer's Disease""}, {'article': 'PMC8316394.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Lower ADL Scores Indicate Poor Prognosis'}, {'article': 'PMC8436545.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Functional impairment in Alzheimer’s Disease'}, {'article': 'PMC7745768.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Functional independence in Alzheimer's Disease""}, {'article': 'PMC9513684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",540
149,ADL (Activities of Daily Living),"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",419
150,ADL (activities of daily living),"[{'article': 'PMC3382377.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Functional status in Alzheimer's Disease""}]",419
151,ADL decline,"[{'article': 'PMC5359367.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in people with Down Syndrome""}, {'article': 'PMC5359367.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}]",540
152,ADLs,"[{'article': 'PMC3382377.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Wii-Fit intervention'}, {'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease or related dementia""}, {'article': 'PMC9395831.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Functional decline in Alzheimer's Disease""}]",540
153,ADNC scores,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",121
154,ADRD,"[{'article': 'PMC7031904.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease and Related Dementias""}]",170
155,ADS score,"[{'article': 'PMC5442667.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",121
156,AFF1,"[{'article': 'PMC4857621.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Targeting α-syn for Alzheimer's Disease treatment""}]",349
157,AGEs,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",372
158,AIS,"[{'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Insomnia Disorder in Alzheimer's Disease""}]",22
159,AKAP9,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",561
160,AKT,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",358
161,AKT1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",358
162,AKT3,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease neuropathology""}]",358
163,ALA,"[{'article': 'PMC5223628.txt', 'relationship': 'PREDICTS_BETTER_OUTCOME', 'object': 'Predicts improved or stabilised ADAS-Cog at 12 months'}]",578
164,ALB,"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS', 'object': ""Change in body mass (∆BM) in women with Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Involuntary weight loss in AD patients'}]",644
165,ALCAR,"[{'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive and neurodegenerative disorders in the elderly'}]",644
166,ALFF,"[{'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease-related neurodegeneration""}, {'article': 'PMC6306691.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease progression in Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia of Alzheimer’s disease'}, {'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Dementia of Alzheimer’s disease'}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to Alzheimer's Disease treatment""}, {'article': 'PMC6668217.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",592
167,ALFF combined with ASL in PCC/PCu,"[{'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}]",533
168,ALFF/fALFF,"[{'article': 'PMC6306691.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease diagnosis and staging""}]",592
169,ALFF/fALFF levels,"[{'article': 'PMC6306691.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",592
170,ALK,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]",644
171,ALT,"[{'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Liver enzyme levels during atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment response to atabecestat'}, {'article': 'PMC7227237.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Liver enzyme elevations in Alzheimer's Disease treatment""}]",314
172,ALZ-801,"[{'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: Inhibition of Aβ oligomers'}]",222
173,AMP-activated protein kinase,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Inflammation in Alzheimer's Disease""}]",399
174,AMPA,"[{'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related synaptic changes""}]",676
175,AMPK,"[{'article': 'PMC4615808.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'RESPONDED_TO', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Metformin'}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",676
176,AN-1792,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Discontinued in Phase II due to meningoencephalitis'}]",141
177,AN1792,"[{'article': 'PMC6916654.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Active immunotherapy targeting Aβ'}]",144
178,ANAPC5,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",233
179,ANGP-2,"[{'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Vascular survival and memory restoration in Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Changes in MoCA scores over 2 weeks'}]",584
180,ANGPT1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",584
181,ANU-ADRI risk,"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}]",146
182,ANU-ADRI total,"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}]",146
183,APLP1,"[{'article': 'PMC4780148.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",429
184,APLP1β17,"[{'article': 'PMC4780148.txt', 'relationship': 'RESPONDED_TO', 'object': 'Semagacestat treatment'}]",429
185,APO E,"[{'article': 'PMC4679337.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",527
186,APOE,"[{'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive response to ketosis in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease mortality and outcomes""}, {'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease groups""}, {'article': 'PMC4311425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4311425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk of Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4983010.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility for PREADVISE study'}, {'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s disease'}, {'article': 'PMC8066440.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8201462.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Genetic risk factor for Alzheimer's Disease""}, {'article': 'PMC8201462.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease risk assessment""}, {'article': 'PMC8302739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease risk""}, {'article': 'PMC8302739.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease clinical trials""}, {'article': 'PMC8302739.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved prediction accuracy for Alzheimer's Disease diagnosis""}, {'article': 'PMC8302739.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Identify individuals at higher risk of developing Alzheimer's Disease or dementia""}, {'article': 'PMC8507171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk of Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5067903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5496518.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6547570.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Cortical morphometry changes in SCD related to Alzheimer's Disease""}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Higher abundance of Firmicutes and Clostridiales in APOE2/E3 genotype'}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Lower abundance of Prevotellaceae in APOE2/E3 genotype compared to other APOE genotypes'}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Higher abundance of Ruminococcaceae in APOE2/E3 compared to APOE3/E3, APOE3/E4, or apoe4/E4'}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Higher abundance of Gemmiger in APOE2/E3 compared to APOE3/E3 and APOE3/E4'}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Higher abundance of Roseburia in APOE3/E3 compared to other APOE genotypes'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Disease-Associated Microglia (DAM) phenotype in Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7648990.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Late-onset Alzheimer's Disease (LOAD)""}, {'article': 'PMC7822120.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9644639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Tauopathies and Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'PSD95 levels in superior temporal cortex in AD'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'LDL cholesterol levels'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'GlycA, isoleucine, LDL-TG, VLDL-TG, and M-VLDL'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'CRP, ApoB, IL-13, and CXCL9 levels'}, {'article': 'PMC9644639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for therapeutic interventions in Alzheimer's Disease""}]",142
187,APOE e4,"[{'article': 'PMC7364345.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Higher genetic risk for Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",142
188,APOE e4 allele,"[{'article': 'PMC6565843.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",396
189,APOE fragments,"[{'article': 'PMC7223540.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Alzheimer's Disease treatment with COR388""}]",142
190,APOE genotype,"[{'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline and Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': ""Alzheimer's Disease dementia""}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Risk assessment for Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive performance and Alzheimer's disease risk""}, {'article': 'PMC6004911.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Age of dementia onset in individuals with Down Syndrome and Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive changes in response to physical activity'}, {'article': 'PMC9644639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment selection: Bexarotene treatment'}]",403
191,APOE status,"[{'article': 'PMC6004911.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",142
192,APOE ɛ4,"[{'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'High plasma tau in APOE ɛ4 carriers'}]",142
193,APOE ε2,"[{'article': 'PMC6439956.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Shows protective influence on dementia risk'}]",142
194,APOE ε2 allele,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Decreased Alzheimer's Disease pathology""}]",396
195,APOE ε3 genotype,"[{'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",403
196,APOE ε4,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced MTL activation in Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poorer memory performance and increased risk for Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Reduced hippocampal volume and activation in elderly carriers'}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4311425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Behavior changes: mental activities and diet at 6 weeks among self-referred participants'}, {'article': 'PMC4311425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Associated with prognosis in Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased intra-individual variability (IIV) in cognitive performance'}, {'article': 'PMC4481070.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4481070.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4503593.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased functional connectivity in default mode network (DMN) regions'}, {'article': 'PMC4503593.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Decreased functional connectivity in cerebellar tonsils and retrosplenial regions'}, {'article': 'PMC4503593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4503593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4503593.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline and functional connectivity changes in brain regions'}, {'article': 'PMC4503593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4503593.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster decline in cognitive scores'}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4746584.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease in APOE ε4 carriers with more severe Aβ amyloid angiopathy and capillary amyloid accumulation""}, {'article': 'PMC4835514.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""greater volume of white matter hyperintensities in Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased risk of Aβ amyloid angiopathy-associated lobar haemorrhage'}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in carriers""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Lower baseline cerebral spinal fluid Aβ42 levels'}, {'article': 'PMC4928349.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced delivery of DHA to the brain'}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive improvements in non-carriers'}, {'article': 'PMC4928349.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Subjective Cognitive Decline (SCD)'}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8074126.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8074126.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Diagnosis and treatment selection for Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Behavioral changes in health and insurance'}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8570373.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8570373.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Eligibility for: Alzheimer's Disease treatment""}, {'article': 'PMC8843023.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4607601.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4862247.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease pathology and progression""}, {'article': 'PMC5067903.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Higher plasma tau levels in Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased risk of developing Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Anxiety and depression in FDRs of AD patients'}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Test-related distress in ε4-positive participants'}, {'article': 'PMC5103503.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Behavioral changes in insurance uptake and health-related behavior'}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Memory functioning differences in ε4-positive participants'}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Elevated test-related distress and depressive symptoms'}, {'article': 'PMC5103503.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Changes in health-related behavior and subjective memory functioning'}, {'article': 'PMC5315443.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5399035.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Early functional connectivity alterations in preclinical Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Risk of Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Treatment: Atabecestat'}, {'article': 'PMC6106931.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Therapy: Alzheimer's Disease treatment""}, {'article': 'PMC6152871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6260857.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6260857.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Late-onset Alzheimer's Disease, particularly in European and Asian populations""}, {'article': 'PMC6374283.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6439956.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of death and dementia in adults with Down syndrome'}, {'article': 'PMC6439956.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predicts earlier dementia diagnosis and higher mortality risk'}, {'article': 'PMC6439956.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased mortality risk'}, {'article': 'PMC6439956.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Earlier dementia diagnosis'}, {'article': 'PMC6547570.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Reduction in right cortical surface area in Alzheimer's Disease""}, {'article': 'PMC6547570.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cortical surface area reduction in the right hemisphere'}, {'article': 'PMC6547570.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cortical surface area reduction in the right hemisphere'}, {'article': 'PMC6547570.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical surface area decline in Alzheimer's Disease""}, {'article': 'PMC6547570.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk factor for early-stage Alzheimer's Disease""}, {'article': 'PMC6547570.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predicts cognitive decline in SCD individuals'}, {'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'DIAGNOSITC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of dementia'}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease prognosis'}, {'article': 'PMC6646979.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease Prognosis""}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Prognosis""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk of late-life dementia'}, {'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia incidence'}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'AD'}]",142
197,APOE ε4 allele,"[{'article': 'PMC1325254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1325254.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC1373642.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Functional decline in the medial temporal lobe (MTL) in individuals with a family history of AD'}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased production of β-amyloid, reduced synaptic plasticity, and impaired hippocampus-dependent spatial memory'}, {'article': 'PMC1373642.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Greater longitudinal age-related decline in episodic memory functions in older ε4 carriers'}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced hippocampal activation during a novel-picture encoding task in ε3/4 heterozygotes'}, {'article': 'PMC2194921.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with: Modification of cognitive functioning and GM reduction in AD patients'}, {'article': 'PMC4346122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased incidence of amyloid-related imaging abnormalities with edema or effusions (ARIA-E)'}, {'article': 'PMC4928349.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased amyloid-beta deposition and neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased anxiety and depression in ε4-positive group'}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'cognitive function'}, {'article': 'PMC6174237.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Progression of Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Clinical trials for Alzheimer's Disease""}, {'article': 'PMC6439956.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': 'Increased mortality risk in individuals with dementia'}, {'article': 'PMC6439956.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of developing dementia'}, {'article': 'PMC6547570.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Progression of sporadic Alzheimer's Disease""}, {'article': 'PMC6547570.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk of developing Alzheimer's Disease in individuals with Subjective Cognitive Decline (SCD)""}, {'article': 'PMC6910674.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7364345.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}]",396
198,APOE ε4 allele carriers,"[{'article': 'PMC6152871.txt', 'relationship': 'RESPONDED_TO', 'object': 'Nilvadipine treatment'}, {'article': 'PMC6152871.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Differential effects in Alzheimer's Disease treatment""}]",78
199,APOE ε4 genotype,"[{'article': 'PMC10013957.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk in individuals with Subjective Cognitive Decline (SCD)'}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease risk assessment""}]",403
200,APOE ε4-allele,"[{'article': 'PMC6174237.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",396
201,APOE-4,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased risk of Alzheimer's Disease diagnosis""}]",142
202,APOE-ɛ4,"[{'article': 'PMC8351379.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8351379.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",142
203,APOE-ɛ4 genotype,"[{'article': 'PMC8351379.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's disease genetic risk""}]",403
204,APOE-ε4,"[{'article': 'PMC4107377.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC546007.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC546007.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC546007.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC546007.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC546007.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC546007.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Higher risk of Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Therapy: Oligogenic risk score for Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased risk for Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Higher risk for Alzheimer's Disease with lower burden of common AD risk alleles""}, {'article': 'PMC8302739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dementia (Alzheimer's Disease)""}, {'article': 'PMC8302739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prevalence of low Aβ pathology burden in Alzheimer's Disease""}, {'article': 'PMC8351379.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4820235.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk of cognitive decline'}, {'article': 'PMC4820235.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Greater response to physical activity'}, {'article': 'PMC4820235.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4820235.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4820235.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5301048.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Higher cerebral spinal fluid cortisol and worse prognosis in Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Genetic risk for Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9204250.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Progression from mild cognitive impairment to Alzheimer's Disease""}]",142
205,APOE2,"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased levels of PSD95 in superior temporal cortex'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Most phospholipids'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased HDL, CRP, vitamin D, CysC, ApoA, creatinine, and alkaline phosphatase'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced LDL, IGF-1, bilirubin, and ApoB'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced total cholesterol, LDL, lipoprotein A, and ApoB'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased apoA1'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced Aβ burden'}]",142
206,APOE3,"[{'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",142
207,APOE3-Christchurch (APOE3-Ch),"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Resistance against aggressive familial AD'}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduced tau pathology and neurodegeneration'}]",78
208,APOE3-Jacksonville (APOE3-Jac),"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Healthy brain aging and decreased amyloid deposition'}, {'article': 'PMC9644639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Reduction of apoE self-association and increased lipidation'}]",78
209,APOE3-R145C,"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for lipid disorders and cardiovascular diseases'}]",78
210,APOE4,"[{'article': 'PMC10001958.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC10002844.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Reduced risk of Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in APOE ε4 carriers""}, {'article': 'PMC10233712.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Prognosis""}, {'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10306194.txt', 'relationship': 'RESPONDED_TO', 'object': 'Response to INI therapy in AD patients'}, {'article': 'PMC10306194.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'No cognitive benefits or decline in memory in APOE-ε4+ subjects'}, {'article': 'PMC1325254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1325254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Episodic memory deficits in Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'DIAGNOSITC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC1373642.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive performance in Alzheimer's Disease patients""}, {'article': 'PMC2731764.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Efficacy of AC-1202 treatment'}, {'article': 'PMC2731764.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC2731764.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC2731764.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility for memantine treatment'}, {'article': 'PMC2731764.txt', 'relationship': 'PREDICTS_RESPONSE_TO_TREATMENT', 'object': ""Response to AC-1202 treatment in Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline as measured by ADAS-Cog scores'}, {'article': 'PMC2731764.txt', 'relationship': 'PREDICTS_RESPONSE_TO', 'object': 'Treatment: AC-1202'}, {'article': 'PMC2731764.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection based on APOE4 status for Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'PREDICTS_RESPONSE_TO_TREATMENT', 'object': ""Predicts response to AC-1202 treatment in Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Significant improvement in ADAS-Cog scores in APOE4(-) subjects at Day 45'}, {'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Significant improvement in ADAS-Cog scores in APOE4(-) subjects at Day 90'}, {'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Significant improvement in MMSE scores in APOE4(+) subjects at Day 104'}, {'article': 'PMC2731764.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved MMSE scores in APOE4(+) subjects at Day 104'}, {'article': 'PMC2731764.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Guiding selection based on APOE4 status'}, {'article': 'PMC2731764.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive improvement in Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'RESPONDED_TO', 'object': 'Response to AC-1202 therapy in E4(-) subjects'}, {'article': 'PMC2731764.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Treatment eligibility in E4(-) AD patients'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Response to AC-1202 treatment in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment using AC-1202""}, {'article': 'PMC3213220.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Determine eligibility for MCT treatment in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Early functional signs of emerging Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Learning and Memory Deficits'}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Age-dependent Impairments of Hilar GABAergic Interneurons'}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3767625.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of conversion to mild cognitive impairment'}, {'article': 'PMC3767625.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk for future cognitive decline'}, {'article': 'PMC4055052.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4107377.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Worse memory score in older NHW individuals'}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': ""PREDICTS_CONVERSION_TO_ALZHEIMER'S_DISEASE"", 'object': ""Conversion from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Related prognosis: Alzheimer's Disease progression""}, {'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive improvement in Alzheimer's Disease patients without APOE4""}, {'article': 'PMC4311425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Genetic risk for Alzheimer's Disease""}, {'article': 'PMC4311425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Genetic susceptibility testing for Alzheimer's Disease""}, {'article': 'PMC4311425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4333880.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4333880.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-related imaging abnormalities-edema (ARIA-E)'}, {'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4410460.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Age at onset (AAO) of Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Determine treatment response based on APOE4 carrier status'}, {'article': 'PMC4731943.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved MMSE scores in APOE4 noncarriers'}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction of Aβ on composite measure in APOE4 noncarriers'}, {'article': 'PMC4731943.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'No significant difference in Aβ measures among APOE4 carriers'}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'ARIA-E'}, {'article': 'PMC4886210.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased Alzheimer's Disease risk and decreased brain clearance of Aβ""}, {'article': 'PMC4888851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection for Alzheimer's Disease based on carrier status""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Alzheimer’s disease'}, {'article': 'PMC8053280.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment Eligibility and Allocation in Clinical Trial'}, {'article': 'PMC8053280.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Discontinuation of lecanemab treatment'}, {'article': 'PMC8053280.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher incidence of ARIA-E'}, {'article': 'PMC8053280.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Lecanemab dose adjustment for APOE4 carriers'}, {'article': 'PMC8053280.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility: APOE4 carriers for lecanemab treatment'}, {'article': 'PMC8201462.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC8211849.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Late-onset Alzheimer's Disease""}, {'article': 'PMC8211849.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Genetic risk for Alzheimer's Disease""}, {'article': 'PMC8211849.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Indicates treatment eligibility for study participation in Alzheimer's Disease research""}, {'article': 'PMC8211849.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8211849.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8287201.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8302739.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Prognosis""}, {'article': 'PMC8364310.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8500065.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}, {'article': 'PMC8502814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease eligibility""}, {'article': 'PMC8502814.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8570037.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poorer prognosis in Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_AD_PROGRESSION', 'object': 'Progression to AD dementia (trend level contribution)'}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased risk of converting to Alzheimer's Disease dementia""}, {'article': 'PMC4153084.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC4923754.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease risk assessment""}, {'article': 'PMC5103503.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Decrease in CES-D at 12 months'}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Memory functioning in participants'}, {'article': 'PMC5103503.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5103503.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Behavioral changes and lifestyle modifications'}, {'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Psychological effects such as anxiety and depression'}, {'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Late-onset sporadic Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6004911.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Age at onset of Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease risk""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6126036.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6152871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6152871.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Micro-haemorrhages and haemosiderin detection in AD patients'}, {'article': 'PMC6208946.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6225735.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6260857.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6292112.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC6374283.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC6439956.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': 'Mortality in individuals with Down syndrome and dementia'}, {'article': 'PMC6439956.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Dementia in Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC6448216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6448216.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC6593891.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6593891.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease risk""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cerebral amyloid angiopathy'}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of typical or limbic predominant AD'}, {'article': 'PMC6679855.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC6685277.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Dose-titration scheme based on APOE genotype'}, {'article': 'PMC6909550.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Eligibility: Alzheimer's Disease clinical trials""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Sporadic Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Response to Nilvadipine treatment in Alzheimer's Disease""}, {'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline in middle-aged adults'}, {'article': 'PMC7274941.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis and response to physical activity intervention""}, {'article': 'PMC7364345.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7364345.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7414752.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better outcome in clinical response to ALZ-801'}, {'article': 'PMC7424995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Higher risk of early AD progression'}, {'article': 'PMC7653537.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC7662091.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7662091.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline and amyloid accumulation in Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7822120.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Late-onset Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Late-onset Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Late-onset Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of developing Late-onset Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9204250.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC9269742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cerebral blood flow regulation'}, {'article': 'PMC9269742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Sporadic Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC9269742.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Exercise intervention'}, {'article': 'PMC9269742.txt', 'relationship': 'RESPONDED_TO', 'object': 'Exercise'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral blood flow response to exercise'}, {'article': 'PMC9289357.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Early-stage preclinical Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for other dementia'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lewy body pathology'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Parkinson’s disease dementia'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Greater cognitive impairment in vascular dementia'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline and neurodegeneration'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased tau aggregation and neurotoxicity'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced retinal capillary density'}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Decreased cholesterol transport capacity and increased lipid droplet accumulation'}, {'article': 'PMC9644639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Long-term treatment with angiotensin receptor blockers'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'LysoPE and acylcarnitine species'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'PE(O), PE(P), ceramides, and triglycerides'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced levels of phosphatidylinositol'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced levels of CAR, LPC, LPE, PA, PC, PE, PI, PS, SM, and ST'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced hyperlipidemia'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased VLDL-cholesterol and reduced HDL-cholesterol levels'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced LysoPC(18:1), LysoPC(P-18:0), and Cardiolipin'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Higher levels of cholesterol'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased LDL, IGF-1, SHBG, bilirubin, triphosphate, ApoB, and total cholesterol'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased SNAP-25 in cognitively normal patients'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased Aβ burden and tau burden'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased VILIP-1 in preclinical AD'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased levels of CDH6 and HAGH in AD patients'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased NP1 levels'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease (AD)""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid accumulation in the vasculature'}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression and pathogenesis'}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: CRISPR/Cas9 genome-editing'}, {'article': 'PMC9644639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Associated with poor outcome in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Higher baseline amyloid levels in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Higher baseline PET SUVr levels in APOE4 carriers'}, {'article': 'PMC9797897.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",142
211,APOE4 allele,"[{'article': 'PMC6521224.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",396
212,APOE4 genotype,"[{'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6236893.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk for Alzheimer's Disease""}]",403
213,APOE4-R251G,"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Protection against AD risk'}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Potential changes in apoE structure and lipidation capability'}]",78
214,APOEε4,"[{'article': 'PMC10013957.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased lifetime risk of developing AD dementia'}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reflects: Disease progression and prognosis'}, {'article': 'PMC5450399.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Stratification based on APOEε4 genotype for treatment response'}, {'article': 'PMC6146627.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Higher proportion in amyloid-positive group'}, {'article': 'PMC6909550.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Gantenerumab dose-titration'}, {'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7505369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early identification of Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in preclinical Familial Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Early increased hippocampal volume in cognitive normal carriers'}, {'article': 'PMC9972804.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Decreased FC of frontostriatal pathway, potentially indicating lower capacity for adaptation and higher chance of disease progression'}]",142
215,APOEε4 allele,"[{'article': 'PMC6208946.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of progressing to dementia'}]",396
216,APOε4,"[{'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk for late-onset Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Treatment effect in Alzheimer's Disease""}]",142
217,APOε4 carriers,"[{'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced glucose metabolism in posterior cortical areas'}]",78
218,APP,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Increased Aβ Production'}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ generation'}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease therapy""}, {'article': 'PMC2765081.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s disease'}, {'article': 'PMC3397527.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid production in Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Inhibition of γ-secretase cleavage of APP associated with adverse cognitive effects'}, {'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal Dominant Alzheimer's Disease""}, {'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal Dominant Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Amyloid pathway manipulation for reducing AD incidence'}, {'article': 'PMC4659639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostic model""}, {'article': 'PMC4675859.txt', 'relationship': 'PROMOTES', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4780148.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid plaques in AD brain'}, {'article': 'PMC4876682.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Increased Aβ levels and Aβ42/Aβ40 ratio'}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC4939696.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5100351.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal dominant Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6004911.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in Down Syndrome""}, {'article': 'PMC6004911.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid deposits in the brain'}, {'article': 'PMC6145937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Aβ production and synapse stability'}, {'article': 'PMC6145937.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Familial Alzheimer's Disease""}, {'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Familial Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaques formation'}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early identification of Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in preclinical Familial Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",402
219,APP CTFs,"[{'article': 'PMC2880593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",420
220,APP and Aβ,"[{'article': 'PMC4485995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurotoxicity in Alzheimer's Disease""}]",8
221,APP fragments,"[{'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",402
222,APP gene,"[{'article': 'PMC6374283.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",100
223,APP gene mutation,"[{'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Familial Alzheimer’s disease'}]",100
224,APP levels,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",402
225,APP mRNA,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",100
226,APP mutation,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Myelin integrity loss in frontostriatal circuits'}]",100
227,APP p.A673T,"[{'article': 'PMC4617238.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Protective effect in Alzheimer's Disease""}]",402
228,APP palmitoylation,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",273
229,APP-FL,"[{'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",402
230,APP/PS1 mutation carriers,"[{'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]",378
231,APP23,"[{'article': 'PMC4674770.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",402
232,APPSwe,"[{'article': 'PMC6145937.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Synapse loss and reduced synapse stability'}]",402
233,APPsw,"[{'article': 'PMC3338462.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved performance in Y-maze task with EMF treatment'}]",402
234,AQ4,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Decreased Aβ clearance and cognitive impairment'}]",441
235,AQP4,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Glymphatic function and amyloid clearance in Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Regulation of glymphatic clearance in Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target for AAV5-GFAP-EGFP-shAqp4 therapy'}, {'article': 'PMC10917684.txt', 'relationship': 'RESPONDED_TO', 'object': 'TGN020 modulation'}, {'article': 'PMC10917684.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Therapy choice in Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'shAQP4 strategy to attenuate AQP4 function'}, {'article': 'PMC10917684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Astrocytic endfeet polarization'}, {'article': 'PMC4939696.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Impaired glymphatic clearance in Alzheimer's disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Impaired glymphatic clearance and amyloid-beta accumulation'}, {'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Impaired glymphatic function contributes to Alzheimer's disease progression""}, {'article': 'PMC7698404.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Loss of AQP4 polarization and reduced glymphatic clearance'}, {'article': 'PMC7698404.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Impaired glymphatic function in Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Decreased amyloid-beta clearance in Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced glymphatic clearance in older individuals'}, {'article': 'PMC7698404.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': 'Glymphatic activity and clearance'}, {'article': 'PMC9527145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",441
236,AQP4 polarization,"[{'article': 'PMC10917684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Glymphatic clearance and amyloid beta clearance in Alzheimer's Disease""}]",441
237,AR global telemetry variance,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",235
238,AR object place and find telemetry variance,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",235
239,AR object placement fast Fourier transform (FFT),"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",235
240,ARIA,"[{'article': 'PMC6685277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-related imaging abnormality'}]",398
241,ARIA-E,"[{'article': 'PMC4772335.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Adverse outcome in Alzheimer's Disease treatment""}, {'article': 'PMC4772335.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Incidence of ARIA-E as a treatment-related adverse event'}, {'article': 'PMC4866415.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid-related imaging abnormalities'}, {'article': 'PMC4918115.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-related imaging abnormalities with edema or effusions'}, {'article': 'PMC4918115.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-related imaging abnormalities in Alzheimer's Disease""}]",398
242,ARIA-H,"[{'article': 'PMC4772335.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4822297.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Alzheimer's Disease progression""}, {'article': 'PMC4822297.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Treatment efficacy in Alzheimer's Disease""}]",398
243,AS,"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",647
244,ASC,"[{'article': 'PMC11274940.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Amyloid burden'}]",647
245,AST,"[{'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Liver enzyme levels during atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment response to atabecestat'}]",647
246,ASV_19,"[{'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-β-positive status in cognitively normal participants'}]",108
247,ASV_9,"[{'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-β-positive status in cognitively normal participants'}]",108
248,AT,"[{'article': 'PMC4227681.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuroprotection against Aβ42-induced toxicity in Alzheimer's Disease""}]",176
249,AT profile,"[{'article': 'PMC7890889.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",176
250,AT8,"[{'article': 'PMC3978916.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4774258.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4774258.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",176
251,AT8 (Ser(P)202/Thr(P)205)-positive Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",40
252,AT8-positive Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
253,ATF3,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",176
254,ATF4,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",176
255,ATP,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Synaptic alteration in Alzheimer's Disease""}]",618
256,ATP content,"[{'article': 'PMC4707222.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Increased ATP content in Alzheimer's Disease""}]",618
257,AV-1451,"[{'article': 'PMC5209394.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6204612.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiate PSP patients from controls'}, {'article': 'PMC6204612.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}, {'article': 'PMC6204612.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6204612.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Tau pathology in Alzheimer's Disease""}]",692
258,AV-1451 PET,"[{'article': 'PMC6204612.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Monitoring disease progression in Progressive Supranuclear Palsy (PSP)'}]",692
259,AV-45,"[{'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cortical amyloid load in Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral amyloid load in Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early, pre-demential diagnosis of Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Memory performance decline in prodromal AD patients'}, {'article': 'PMC3733998.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Amyloid load correlating with memory decline'}, {'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaques associated with Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Amyloid burden in Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3978219.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': 'Therapy Choice: PET template-based quantification for clinical diagnosis'}]",301
260,AV-45 Uptake,"[{'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid Pathology in Alzheimer's Disease""}]",301
261,AV45-PET,"[{'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': ""Conversion to Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Conversion into dementia in mild cognitive impairment subjects'}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease progression""}, {'article': 'PMC4506984.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': ""Predicts conversion from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",301
262,AV45-PET SUVR,"[{'article': 'PMC7814451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Aβ burden in Alzheimer's Disease""}]",301
263,AV45-SUVR,"[{'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities (WMH) in splenium and body of corpus callosum'}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Aβ deposition'}]",301
264,AVLT,"[{'article': 'PMC5326769.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Memory function in Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Memory impairment in Alzheimer's Disease""}, {'article': 'PMC9539040.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Related prognosis: Memory impairment in Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in APP group""}]",535
265,AVLT scores,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",535
266,AVLT-DR,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",535
267,AVLT-IR,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",535
268,AVLT-LDR,"[{'article': 'PMC10439779.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",535
269,AVLT-SDR,"[{'article': 'PMC10439779.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",535
270,AVLT-learning,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",535
271,AXL,"[{'article': 'PMC6879435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",356
272,AZD0530,"[{'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Efficacy in Alzheimer's Disease treatment""}]",602
273,AZD3293,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Phase III clinical trials for Alzheimer's Disease""}]",602
274,Ab,"[{'article': 'PMC4487699.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",304
275,Ab274,"[{'article': 'PMC4857621.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Targeting α-syn for Alzheimer's Disease treatment""}]",304
276,Ab42,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depression in Alzheimer's Disease""}]",304
277,Ab42/40 ratio,"[{'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",304
278,Aberrant motor activity,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",218
279,Abeta,"[{'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Predicts AD dementia'}]",560
280,Abeta-42,"[{'article': 'PMC9295361.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Normal levels in prodromal DLB patients, distinguishing from prodromal Alzheimer's disease""}]",560
281,Acarbose,"[{'article': 'PMC6074058.txt', 'relationship': 'USED_TO_TREAT', 'object': 'Neurodegeneration with diabetes-related cognitive dysfunction'}]",48
282,Acceleration variance,"[{'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Sex differences in Alzheimer's Disease""}]",55
283,Acetate,"[{'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaque deposition in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased amyloid plaque load in Alzheimer's Disease""}]",186
284,Acetic acid,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anti-inflammatory response in Alzheimer's Disease""}]",186
285,Acetylcholine,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Reduced levels in Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'RESPONDED_TO', 'object': ""rTMS treatment in Alzheimer's Disease""}, {'article': 'PMC8048550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cortical activation and maintenance of wakefulness'}]",253
286,Acetylcholine (ACh),"[{'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Cognitive function improvement in Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Acetylcholinesterase inhibitors (donepezil, galantamine, rivastigmine)'}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",253
287,Acetylcholine (Ach) level,"[{'article': 'PMC4159858.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No significant alteration in AD-like mice'}]",253
288,Acetylcholine level,"[{'article': 'PMC9011335.txt', 'relationship': 'RESPONDED_TO', 'object': 'Nucleus basalis of Meynert (NBM) deep brain stimulation (DBS)'}]",253
289,Acetylcholinesterase (AChE),"[{'article': 'PMC3097009.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",253
290,Acetylcholinesterase (AChE) activity,"[{'article': 'PMC4397698.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",253
291,Acetylcholinesterase ([11C]PMP) PET,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cholinergic deficit associated with Alzheimer's Disease""}]",253
292,Acetylcholinesterase inhibitors,"[{'article': 'PMC5648830.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",253
293,Ach,"[{'article': 'PMC4659639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Ach release from NBM affects the neocortical environment, potentially guiding treatment for Alzheimer's Disease.""}]",687
294,Acid phosphatase,"[{'article': 'PMC4489713.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Autophagy-lysosomal cascade functionality'}]",209
295,Acoustic features,"[{'article': 'PMC9171270.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",167
296,Across-domain IIV,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Early Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Cognitive decline in Alzheimer's Disease""}]",445
297,Actigraphy,"[{'article': 'PMC8500065.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Sleep disturbances in Alzheimer's Disease patients""}]",612
298,Actigraphy measurements,"[{'article': 'PMC8500065.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",612
299,Actin,"[{'article': 'PMC8581408.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'BBB permeability and integrity'}]",661
300,Actinobacteria,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",331
301,Activated Caspase 3,"[{'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",86
302,Activated microglia,"[{'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}]",423
303,Active durations,"[{'article': 'PMC8500065.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC8500065.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]",168
304,Activin A,"[{'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Enhanced endogenous adult neurogenesis and synaptic activity'}]",661
305,Activities of Daily Living (ADL) scale score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Dependence in daily living activities'}]",419
306,Activities of Daily Living (ADLs),"[{'article': 'PMC4666316.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",419
307,Activities of Daily Living Questionnaire,"[{'article': 'PMC6343283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Functional impairment in Alzheimer's Disease""}]",117
308,Activity,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",130
309,Activity Levels,"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",130
310,Acylcarnitines,"[{'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Mitochondrial β-oxidation defects in Alzheimer's Disease""}]",484
311,Adalimumab,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Lower risk of Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced risk for Alzheimer's Disease""}]",106
312,Adamts1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Basement membrane interaction'}]",293
313,Addenbrooke's Cognitive Examination (ACE) VL/OM ratio,"[{'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",41
314,Adiponectin levels,"[{'article': 'PMC4153084.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]",528
315,Adjusted Flow Index (AFI),"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",494
316,Adjusted flow index (AFI),"[{'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease""}]",494
317,Aducanumab,"[{'article': 'PMC4888851.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Phase III trials in early AD'}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",146
318,Aerobic exercise,"[{'article': 'PMC5504954.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Larger hippocampal regions and increased gray and white matter volume'}]",260
319,Affitope AD02,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Phase II clinical investigation'}]",222
320,AgRP,"[{'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction of Aβ levels in AD mouse models'}]",31
321,Age,"[{'article': 'PMC6945608.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}]",372
322,Age at diagnosis,"[{'article': 'PMC6004911.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': ""Survival time in Alzheimer's Disease""}]",372
323,Aggregated Aβ,"[{'article': 'PMC4054967.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",8
324,Agitation,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",282
325,Akkermansia,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced Aβ42 levels'}]",15
326,Akt,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",358
327,Alanine Transaminase (ALT),"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",153
328,Alanine aminotransferase (ALT),"[{'article': 'PMC2194921.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Liver function during indomethacin treatment'}]",153
329,Albumin,"[{'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to: Semagacestat treatment'}, {'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Reduction in body mass in women with Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Used in plasma exchange to remove pathogenic Aβ elements'}, {'article': 'PMC7274941.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Plasma exchange with albumin replacement'}, {'article': 'PMC9606044.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of Plasma Exchange (PE) treatment with albumin replacement'}, {'article': 'PMC9606044.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",363
330,Albumin (ALB),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Antioxidant capacity in Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",363
331,Albuminemia,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Weight loss in female Alzheimer's Disease patients""}]",363
332,All-trans-retinoic acid (RA),"[{'article': 'PMC2765081.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]",225
333,Allobaculum,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",33
334,Alpha band,"[{'article': 'PMC3914466.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",42
335,Alpha oscillations,"[{'article': 'PMC3682121.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Transcranial alternating current stimulation (tACS)'}]",42
336,Alpha oscillatory power,"[{'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",42
337,Alpha power,"[{'article': 'PMC3914466.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Probable Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",42
338,Alpha-2 macroglobulin,"[{'article': 'PMC7274941.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",88
339,Alpha-syn,"[{'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Correlation with tau levels and neurodegeneration'}]",501
340,Alpha-synuclein,"[{'article': 'PMC4890804.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7171193.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",395
341,Alternate-key tapping test,"[{'article': 'PMC10916999.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]",76
342,Altoida DNS,"[{'article': 'PMC8225898.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': ""Predicts conversion from mild cognitive impairment to Alzheimer's Disease 6–8 months prior to the event""}, {'article': 'PMC8225898.txt', 'relationship': 'MONITORS_DISEASE_PROGRESSION', 'object': ""Monitors disease progression in Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'PREDICTS_DISEASE_PROGRESSION', 'object': ""Predicts disease progression in Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'USED_AS_CLINICAL_TRIAL_ENDPOINT', 'object': ""Used as a clinical trial endpoint for Alzheimer's Disease""}]",408
343,Altoida Digital Neuro Signature (DNS),"[{'article': 'PMC8225898.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Predicts risk of developing mild cognitive impairment due to Alzheimer's Disease""}]",408
344,Aluminum,"[{'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease Progression""}]",244
345,Aluminum (Al) concentration,"[{'article': 'PMC4397698.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",244
346,Aluminum concentration,"[{'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",244
347,Aluminum levels,"[{'article': 'PMC4159858.txt', 'relationship': 'RESPONDED_TO', 'object': 'Sulforaphane treatment'}]",244
348,Alzheimer Disease Assessment Scale–Cognitive Subscale (ADAS-Cog),"[{'article': 'PMC7364345.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive change in Alzheimer's Disease""}]",485
349,Alzheimer Disease Cooperative Study–Activities of Daily Living (ADCS-ADL),"[{'article': 'PMC7364345.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Functional impairment reduction'}]",18
350,Alzheimer Disease Related Quality of Life (ADRQL),"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Quality of life in Alzheimer's Disease""}]",480
351,Alzheimer type neuropathologic change,"[{'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",18
352,Alzheimer's Disease Assessment Scale (ADAS-Cog),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",485
353,Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog),"[{'article': 'PMC9412195.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Evaluating cognitive changes in mild Alzheimer's disease""}]",485
354,Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog),"[{'article': 'PMC2500042.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]",485
355,Alzheimer's Mood Scale,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Mood changes in Alzheimer's Disease""}]",21
356,Alzheimer’s Disease Assessment Scale,"[{'article': 'PMC3407718.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}]",21
357,Alzheimer’s Disease Assessment Scale-13 (ADAS-Cog 13),"[{'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",485
358,Alzheimer’s Disease Assessment Scale-Cognitive Behavior section (ADAS-Cog),"[{'article': 'PMC3394709.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}]",485
359,Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-cog),"[{'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}]",485
360,Alzheimer’s Disease Co-operative Study – Activities of Daily Living Inventory,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in activities of daily living in participants with mild to moderate Alzheimer's disease""}]",18
361,Alzheimer’s Disease Cooperative Study—Activity of Daily Living total score,"[{'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improvement in daily living activities in Alzheimer's Disease""}]",18
362,Alzheimer’s disease,"[{'article': 'PMC8436545.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}]",18
363,Alzheimer’s disease Assessment Scale-Cognition (ADAS-Cog),"[{'article': 'PMC4283145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic exercise intervention'}]",485
364,Amino acid levels,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",153
365,"Amino acids (phenylalanine, isoleucine, histidine)","[{'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""GV-971 treatment in Alzheimer's Disease""}]",153
366,Ammonia,"[{'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",105
367,Ampicillin,"[{'article': 'PMC6530014.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased anxiety-like behavior and memory impairment'}]",211
368,Amplitude Low Frequency Fluctuation (ALFF),"[{'article': 'PMC6668217.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",276
369,Amsterdam IADL,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess managing finances in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-care in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess use of technology/devices in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess driving difficulties in Alzheimer's Disease""}]",505
370,Amygdala,"[{'article': 'PMC10439779.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor sleep quality in AD spectrum patients with ID'}]",182
371,Amygdala volume,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}, {'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4175156.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""emotional memory in patients with Alzheimer's Disease""}]",182
372,Amygdalar volume,"[{'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3767625.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis of mild cognitive impairment'}]",182
373,Amygdale atrophy,"[{'article': 'PMC4200223.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aberrant motor behaviour, anxiety, and irritability'}]",182
374,Amylin (IAPP),"[{'article': 'PMC6679855.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease pathology""}]",79
375,Amyloid,"[{'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral amyloidosis'}, {'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Glymphatic clearance in Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': ""PREDICTS_CONVERSION_TO_ALZHEIMER'S_DISEASE"", 'object': ""Conversion from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8502814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8502814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8502814.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8502814.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8905724.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Decreased amyloid burden in tissue proximal to the implant'}, {'article': 'PMC8905724.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduction of amyloid burden in mild Alzheimer's Disease patients.""}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease.""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Clinical benefit in early symptomatic Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Gantenerumab treatment'}, {'article': 'PMC6909550.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Clinical benefit in early symptomatic Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7074941.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7074941.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Aerobic exercise intervention'}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9438329.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9438329.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild cognitive impairment to major neurocognitive disorder'}, {'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",8
376,Amyloid (Aβ oligomers),"[{'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}]",8
377,Amyloid (D54D2),"[{'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Amyloid clearance in deep cervical lymph nodes'}]",8
378,Amyloid Beta (Aβ),"[{'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
379,Amyloid Beta Peptides Burden,"[{'article': 'PMC6565843.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
380,Amyloid Beta Peptides and Phosphorylated Tau,"[{'article': 'PMC9373273.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Brain Pathologies""}]",8
381,Amyloid Centiloid,"[{'article': 'PMC9768996.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
382,Amyloid PET,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Amyloid deposition in the brain, a hallmark of Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Disease-modifying therapies, specifically anti-amyloid drugs'}, {'article': 'PMC4054967.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain amyloid load in Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild cognitive impairment subtypes'}, {'article': 'PMC4346122.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Future diagnostic algorithms for CBS due to AD'}, {'article': 'PMC4606063.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease characteristics in clinically normal subjects""}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive decline risk'}, {'article': 'PMC8005243.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Anti-amyloid interventional trials'}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Reduction in brain amyloid levels over 18 months'}, {'article': 'PMC8502814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cerebral amyloid burden'}, {'article': 'PMC8507171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8507171.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Behavioral changes in health'}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Disease progression in mild cognitive impairment'}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced amyloid accumulation'}, {'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaques in Alzheimer's Disease""}, {'article': 'PMC6236893.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease with amyloid plaques""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Detecting amyloid deposits in preclinical Alzheimer's Disease and monitoring progressive amyloid burden""}, {'article': 'PMC9011335.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid deposition in Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",8
383,Amyloid PET SUVr,"[{'article': 'PMC8053280.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid pathology'}, {'article': 'PMC9768996.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Slowing of clinical decline in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid negativity and clinical decline in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid accumulation and clinical decline in Alzheimer's Disease""}]",637
384,Amyloid PET biomarkers,"[{'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early amyloid deposition in Alzheimer's Disease""}]",8
385,Amyloid PET imaging,"[{'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of prodromal Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Target engagement and amyloid accumulation'}]",8
386,Amyloid PET imaging with 18F–FDDNP,"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease in individuals with Down Syndrome""}]",8
387,Amyloid PET positivity,"[{'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
388,Amyloid PET scan,"[{'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical stage of Alzheimer's Disease""}]",8
389,Amyloid PET testing,"[{'article': 'PMC8507171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Identify individuals at higher risk of developing Alzheimer's Disease or dementia""}]",8
390,Amyloid PET-CT,"[{'article': 'PMC9011335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaques in Alzheimer's Disease""}]",8
391,Amyloid Plaques (Aβ),"[{'article': 'PMC9527145.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Reduction of cerebral Aβ burden in Alzheimer's Disease""}]",8
392,Amyloid Precursor Protein (APP),"[{'article': 'PMC4890804.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4939696.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
393,Amyloid SUVR,"[{'article': 'PMC8502814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",637
394,Amyloid SUVr,"[{'article': 'PMC6615169.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",637
395,Amyloid accumulation,"[{'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
396,Amyloid and tau,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Motor performance in Alzheimer's Disease""}]",8
397,Amyloid beta (Aβ),"[{'article': 'PMC10001958.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in brain amyloid levels'}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",8
398,Amyloid beta (Aβ) peptides,"[{'article': 'PMC4780148.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to γ-secretase inhibitor semagacestat treatment'}]",8
399,Amyloid beta peptides,"[{'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10787596.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC3389343.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5504954.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC5504954.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced amyloid beta plaques in Alzheimer's Disease models""}, {'article': 'PMC5504954.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Improved spatial memory in Alzheimer's Disease models""}, {'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6547570.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Gait velocity in Alzheimer's Disease""}, {'article': 'PMC7364345.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced amyloid burden in Alzheimer's Disease""}]",8
400,Amyloid beta peptides (Aβ),"[{'article': 'PMC3097009.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3216294.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
401,Amyloid beta peptides (Aβ) plaques,"[{'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
402,Amyloid beta peptides (abeta 40 and 42),"[{'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
403,Amyloid beta peptides40,"[{'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
404,Amyloid beta peptides42,"[{'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
405,Amyloid biomarkers,"[{'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Prodromal Alzheimer's Disease""}]",8
406,Amyloid burden,"[{'article': 'PMC8905724.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC4750048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Worse cognitive outcomes in Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s disease'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid plaques in the brain'}, {'article': 'PMC6146627.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reduction in accumulation with high-dose IV crenezumab treatment'}, {'article': 'PMC6146627.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target engagement in the central nervous system'}, {'article': 'PMC6565843.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cognitive reserve dysfunction'}]",8
407,Amyloid burden (SUVR),"[{'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",637
408,Amyloid deposition,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
409,Amyloid deposits,"[{'article': 'PMC4150993.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
410,Amyloid levels,"[{'article': 'PMC6448216.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]",8
411,Amyloid neuropathology,"[{'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]",8
412,Amyloid oligomers,"[{'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",8
413,Amyloid peptide,"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
414,Amyloid plaque deposition,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
415,Amyloid plaques,"[{'article': 'PMC10704137.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Pre-AD'}, {'article': 'PMC8043748.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4826954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Reduction of amyloid plaques in AD'}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9527145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
416,Amyloid plaques (Aβ1–42),"[{'article': 'PMC4659639.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Increased amyloid plaques with age in transgenic mice'}]",8
417,Amyloid positivity,"[{'article': 'PMC4750048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
418,Amyloid precursor protein (APP),"[{'article': 'PMC8470960.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Familial Alzheimer's Disease""}, {'article': 'PMC6015016.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",8
419,Amyloid scan,"[{'article': 'PMC7171193.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
420,Amyloid status,"[{'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
421,Amyloid tracer uptake,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
422,Amyloid β,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
423,Amyloid β (Aβ),"[{'article': 'PMC2194921.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to indomethacin treatment in Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4826954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5301048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",8
424,Amyloid β (Aβ) plaques,"[{'article': 'PMC6937673.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
425,Amyloid β peptide (Aβ),"[{'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s disease'}]",8
426,Amyloid β precursor protein,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflammatory endothelial dysfunction and risk of cognitive decline'}]",8
427,Amyloid β-protein (Aβ),"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
428,Amyloid β42,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
429,Amyloid-PET,"[{'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
430,Amyloid-beta,"[{'article': 'PMC10758173.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Beneficial changes in plasma amyloid levels'}, {'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8287201.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Central nervous system amyloid deposition'}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Gantenerumab treatment'}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Impaired fluid movement and decreased glymphatic clearance in Alzheimer's disease""}, {'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease progression in Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9327167.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Anti-amyloid therapies in Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment: Genistein'}]",8
431,Amyloid-beta (Aβ),"[{'article': 'PMC4054967.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target: Amyloid-beta (Aβ) protofibrils in Alzheimer’s disease'}, {'article': 'PMC4095696.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Disease-modifying therapies in Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease pathology in cognitively normal older adults""}, {'article': 'PMC5315443.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Faster cognitive decline and progression to mild cognitive impairment or Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",8
432,Amyloid-beta (Aβ) levels,"[{'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
433,Amyloid-beta (Aβ) peptides,"[{'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and treatment of Alzheimer's Disease""}]",8
434,Amyloid-beta (Aβ) plaques,"[{'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",8
435,Amyloid-beta (Aβ42),"[{'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
436,Amyloid-beta load,"[{'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",8
437,Amyloid-beta load (CL values),"[{'article': 'PMC9327167.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Higher tau deposition in Alzheimer's Disease""}]",8
438,Amyloid-beta plaques,"[{'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease treatment response""}]",8
439,Amyloid-related imaging abnormalities with edema or effusions (ARIA-E),"[{'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Presence of edema or effusions in Alzheimer's Disease patients""}]",8
440,Amyloid-β,"[{'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurotoxic effects and memory inhibition'}, {'article': 'PMC9539040.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Reduction of amyloid levels through 40-Hz auditory stimulation'}, {'article': 'PMC9539040.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved cognitive function in patients with AD'}]",8
441,Amyloid-β (Aβ),"[{'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2765081.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline in executive/speed functions'}, {'article': 'PMC4519341.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Faster decline in executive/speed cognitive functions'}, {'article': 'PMC4675859.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's disease (AD) neuropathology in Down syndrome individuals""}, {'article': 'PMC8500065.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8500065.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: 40 Hz gamma oscillation therapy'}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Passive immunotherapy (crenezumab, gantenerumab, aducanumab)'}, {'article': 'PMC5648830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6110931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
442,Amyloid-β (Aβ) plaques,"[{'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
443,Amyloid-β (Aβ) protofibrils,"[{'article': 'PMC4013077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",8
444,Amyloid-β 42,"[{'article': 'PMC7551340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
445,Amyloid-β PET,"[{'article': 'PMC9011335.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",8
446,Amyloid-β peptide (Aβ),"[{'article': 'PMC6646979.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
447,Amyloid-β plaques,"[{'article': 'PMC4503593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Slowing of clinical decline in Alzheimer's Disease""}]",8
448,Amyloid-β protein,"[{'article': 'PMC9539040.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in content in the visual cortex of mice after 40-Hz light stimulation'}]",8
449,Amyloid-β1–42,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
450,Amyloid-β42,"[{'article': 'PMC4750048.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
451,Angiopoietin,"[{'article': 'PMC5427593.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Associated with enhanced migratory activity of MSCs in Alzheimer's Disease treatment""}]",584
452,Ankylosing Spondylitis,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",606
453,Annexin A2,"[{'article': 'PMC3835777.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",120
454,Anomia,"[{'article': 'PMC9171270.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",527
455,Anterior Cingulate Cortex (ACC),"[{'article': 'PMC7735856.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",448
456,Anterior cingulate cortex,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anxiety and Depression in Alzheimer's Disease""}]",448
457,Anti-dementia drugs,"[{'article': 'PMC6004911.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': ""Survival advantage in Alzheimer's Disease""}]",18
458,Antibiotics,"[{'article': 'PMC6530014.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction of neuroinflammation and cognitive improvement in AD'}]",211
459,Anxiety,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",270
460,Anxious-Depressive-Like Behavior,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early signs of Alzheimer's Disease""}]",270
461,Apathy,"[{'article': 'PMC4174765.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",663
462,Apathy (NPI),"[{'article': 'PMC4431827.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to exercise intervention in Alzheimer's Disease""}]",663
463,Apathy Inventory,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC4798753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Apathy in participants with dementia'}]",663
464,Apathy Scale (AS),"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}]",663
465,Apo A-I,"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced HDL anti-inflammatory activity'}]",527
466,ApoB,"[{'article': 'PMC10236460.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",527
467,ApoE,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3764973.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Increased Aβ plaque deposition in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Microglial-mediated Aβ deposition in early stages of amyloidogenesis'}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ plaques'}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ plaque deposition in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'PREDICTS_AD_PROGRESSION', 'object': 'ApoE expression levels predict AD progression'}, {'article': 'PMC8088704.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Brain amyloidosis'}, {'article': 'PMC8088704.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease Outcome""}, {'article': 'PMC8088704.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection for Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6126036.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7389451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Associated with: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Aβ detection and clearance'}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7648990.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Prodromal Alzheimer's Disease""}]",142
468,ApoE genotype,"[{'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",403
469,ApoE genotyping,"[{'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",403
470,ApoE proteotype,"[{'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",403
471,ApoE status,"[{'article': 'PMC6201586.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",142
472,ApoE ε4,"[{'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Carrier status for ApoE ε4 allele'}, {'article': 'PMC4866415.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Increased risk of Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis in carriers vs. noncarriers""}, {'article': 'PMC4918115.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lack of clinical efficacy in treatment response'}, {'article': 'PMC4918115.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Lower MMSE scores and longer duration of Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Bapineuzumab treatment response'}, {'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6353871.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Presence of dementia'}, {'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk factor for Alzheimer's Disease""}, {'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease-related dementia""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Increased risk of Alzheimer's Disease progression""}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment (MCI)'}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of conversion to Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Conversion to Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Higher rate of conversion to Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Progression to Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression in dyslipidemic patients""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher proportion of progression to AD'}, {'article': 'PMC7354597.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",142
473,ApoE ε4 allele,"[{'article': 'PMC4013077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: No benefit from DHA supplementation in carriers'}, {'article': 'PMC7830228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease Co-pathology""}]",396
474,ApoE-4,"[{'article': 'PMC6530014.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'AD conversion risk'}]",142
475,ApoE-E4 gene,"[{'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Pre-AD'}]",403
476,ApoE-E4 genotype,"[{'article': 'PMC4846650.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Earlier emergence of clinical symptoms'}, {'article': 'PMC4846650.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Specific brain region atrophy'}]",403
477,ApoE4,"[{'article': 'PMC2764863.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive dysfunction and spatial learning deficits in Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Increased seizure susceptibility in female mice'}, {'article': 'PMC3733998.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Presence of PIB-negativity in Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Genotype-specific response to bexarotene treatment in Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher prevalence of ApoE4 carriers in amyloid positive group'}, {'article': 'PMC8088704.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease risk and amyloid positivity""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Therapy Choice: Alzheimer's Disease""}, {'article': 'PMC8325256.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC5223628.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with higher neurogranin values'}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Worse outcomes in Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Cognitive Training Benefits'}]",142
478,ApoE4 allele,"[{'article': 'PMC2731764.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",396
479,ApoE4 genotype,"[{'article': 'PMC4731943.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",403
480,ApoEε4,"[{'article': 'PMC4615808.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurofibrillary tangles formation in Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",142
481,Apold1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Endothelial cell signaling and BBB integrity'}]",429
482,Apolipoprotein 4,"[{'article': 'PMC8154928.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",189
483,Apolipoprotein C 2 (APOC2),"[{'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",189
484,Apolipoprotein E (APOE),"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",189
485,Apolipoprotein E (APOE) ε4,"[{'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Faster memory decline'}, {'article': 'PMC4519341.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Faster cognitive decline in memory'}]",189
486,Apolipoprotein E (APOE) ε4 allele,"[{'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Greater accumulation of Aβ plaques and earlier age of onset of dementia'}]",189
487,Apolipoprotein E (ApoE) ε4,"[{'article': 'PMC7830228.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",189
488,Apolipoprotein E (ApoE) ε4 allele,"[{'article': 'PMC3849204.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Alzheimer’s Disease'}]",189
489,Apolipoprotein E genotype,"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease through brain structural changes""}]",189
490,Apolipoprotein E genotyping,"[{'article': 'PMC7995588.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",189
491,Apolipoprotein E ε4 (APOE4),"[{'article': 'PMC4153084.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",189
492,Apoptosis regulation,"[{'article': 'PMC2432467.txt', 'relationship': 'RELATED_TO', 'object': 'Cellular response to stress and inflammation'}]",209
493,Appetite/eating abnormalities,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",126
494,Aquaporin-4,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",632
495,Arc,"[{'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",110
496,Argyrophilic grain disease (AGD),"[{'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Amnestic cognitive impairment in Alzheimer's Disease""}]",126
497,Arterial Pulsatility,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",252
498,Arterial Spin Labelling (ASL),"[{'article': 'PMC9373273.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",252
499,Asiatic acid,"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Centella asiatica product (CAP) administration'}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuroprotective effects in Alzheimer's Disease""}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Bioavailability in brain'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Centella asiatica treatment in cognitively impaired older adults'}]",389
500,Asiatic acid (AA),"[{'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Centella asiatica water extract treatment in cognitively impaired older adults'}]",389
501,Asiaticoside,"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Centella asiatica product (CAP) administration'}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuroprotective effects in Alzheimer's Disease""}]",389
502,Aspartate Transaminase (AST),"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",153
503,Aspartate aminotransferase (AST),"[{'article': 'PMC2194921.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Normalized within four weeks after treatment discontinuation'}]",153
504,Asthma,"[{'article': 'PMC5389824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",69
505,Astrocytes,"[{'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",339
506,Astrocytic insulin,"[{'article': 'PMC10001958.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment Selection: Targeting astrocytes for AD therapy'}]",202
507,Astrocytic insulin signalling,"[{'article': 'PMC10001958.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Cognitive performance and synaptic integrity in AD'}]",202
508,Atabecestat,"[{'article': 'PMC6106931.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",450
509,Atrophy (global and local),"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Predict disease course in AD and MCI'}]",286
510,Atrophy in Temporal and Parietal Cortices,"[{'article': 'PMC5372150.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Reflects progression of Alzheimer's Disease pathology""}]",184
511,Atrophy on MRI,"[{'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",651
512,Atrophy progression,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Cognitive decline in SCD-clinic group'}]",286
513,Attention,"[{'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Positive change in brain activity'}, {'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",407
514,Attention deficits,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",516
515,Auditory cortex,"[{'article': 'PMC10439779.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in verbal memory in AD spectrum with ID patients'}]",220
516,Auditory network,"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Acupuncture treatment response in Alzheimer's Disease""}]",220
517,Automated parcellation,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Assess atrophy and predict conversion from MCI to AD'}]",323
518,Autophagy,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Improvement in Alzheimer's Disease treatment""}]",126
519,Avagacestat,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Discontinued in Phase II clinical trials due to adverse events'}]",450
520,AxD (axial diffusivity),"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Axonal integrity damage in hippocampus-PCC tract'}]",224
521,Axial Diffusivity (AD),"[{'article': 'PMC8760674.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Decreased AD in motor and somatosensory ROIs after TPS stimulation'}]",224
522,Axial Diffusivity (AxD),"[{'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",224
523,Axial diffusivity (AD),"[{'article': 'PMC8760674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved axonal status in the sensorimotor network'}]",224
524,Axl,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Microglia recognition and phagocytosis of amyloid plaques in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Pathogenesis of AD'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Microglial Neurodegenerative Phenotype (MGnD) in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'AD-associated microglial activation'}]",356
525,Axon Peptide 108,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",308
526,Axona,"[{'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]",356
527,Aß amyloid deposits,"[{'article': 'PMC6236893.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
528,AΒ1-42,"[{'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cortical dysfunction in Alzheimer's Disease""}]",8
529,Aβ,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10758173.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10758173.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC10758173.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Mild Cognitive Impairment/Alzheimer's Disease""}, {'article': 'PMC10758173.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC11493878.txt', 'relationship': 'PREDICTS_RESPONSE', 'object': ""Response: Alzheimer's Disease""}, {'article': 'PMC11493878.txt', 'relationship': 'RESPONDED_TO', 'object': 'Treatment: PLAS intervention'}, {'article': 'PMC11493878.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive decline mitigation'}, {'article': 'PMC11493878.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Cognitive improvement'}, {'article': 'PMC11493878.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive function'}, {'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2868024.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2868024.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid Plaques'}, {'article': 'PMC2868024.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC2868024.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive deficits in Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC3216294.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Cognitive benefit and reversal of brain Aβ deposition'}, {'article': 'PMC3338462.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive improvement in Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""EMF treatment for Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Greater Aβ burdens in Tg mice'}, {'article': 'PMC3338462.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Prevention and reversal of brain Aβ aggregation/deposition'}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Vasoconstriction and reduced cerebral blood flow (CBF)'}, {'article': 'PMC3338462.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target: Enhanced Aβ removal/efflux from the brain'}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Neuronal loss and cognitive impairment'}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Synaptic dysfunction and neuronal loss'}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Impaired insulin receptor function'}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Oxidative stress and apoptosis'}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive deficits and synaptic pathology'}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory responses and neuronal death in Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuronal death and neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Disease progression and neurodegeneration'}, {'article': 'PMC3741576.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Mild cognitive impairment'}, {'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid plaques in neocortex and hippocampus'}, {'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to Near-infrared light treatment in Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring disease progression in Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathogenesis""}, {'article': 'PMC4054967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Immunotherapy for Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'GSK933776 treatment in mild AD and mild cognitive impairment'}, {'article': 'PMC4095696.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reduction in Aβ levels and amyloid plaques'}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive deficits in Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""SS treatment for Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE_TO_TREATMENT', 'object': 'Reduction in soluble Aβ levels after SS treatment'}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'GSK933776 treatment'}, {'article': 'PMC4366075.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment with GSK933776'}, {'article': 'PMC4366075.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Changes in plasma and CSF levels during treatment with GSK933776'}, {'article': 'PMC4366075.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'CAD106 treatment'}, {'article': 'PMC4410460.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for CAD106 immunotherapy in Alzheimer's Disease treatment""}, {'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Amyloid-beta deposits in the brain'}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}, {'article': 'PMC4519341.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster cognitive decline in APOE ε4 carriers'}, {'article': 'PMC4519341.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster cognitive decline in African-Americans'}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Memory decline'}, {'article': 'PMC4519341.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster decline in executive/speed functions'}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Greater hippocampal atrophy'}, {'article': 'PMC4568340.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Inverse relationship with regional glucose metabolism'}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Preclinical treatment of AD in adults with DS'}, {'article': 'PMC4615808.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis of Aβ amyloid angiopathy according to the Boston criteria'}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities, an indicator of the severity of white matter ischaemia'}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurofibrillary pathology around Aβ-laden parenchymal arterioles in AD'}, {'article': 'PMC4835514.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Impaired blood–brain barrier (BBB) function'}, {'article': 'PMC4835514.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau deposition'}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau hyperphosphorylation'}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau pathology'}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment monitoring""}, {'article': 'PMC4888851.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for Alzheimer's Disease therapies""}, {'article': 'PMC4918115.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Anti-Aβ therapies'}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloidosis'}, {'article': 'PMC4956742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid Plaque Burden'}, {'article': 'PMC4956742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amyloid plaque deposition and soluble Aβ levels'}, {'article': 'PMC4956742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Early detection of amyloid load using 18F-florbetaben PET'}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Aβ pathology in Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Established Alzheimer's Disease pathology""}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Progression to AD dementia'}, {'article': 'PMC8005243.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early stages of Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Early detection of amyloid pathology'}, {'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s disease'}, {'article': 'PMC8043748.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'PREDICTS_AD_PROGRESSION', 'object': 'Aβ plaque load predicts AD progression'}, {'article': 'PMC8053280.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease progression in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better functional outcomes in Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline and AD pathogenesis in mice'}, {'article': 'PMC8480485.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of AD pathology'}, {'article': 'PMC8500065.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: 40 Hz light stimulation'}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Advanced clinical diagnosis of Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Personalized tACS stimulation based on individual Aβ accumulation maps'}, {'article': 'PMC8690894.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Targeting cortical areas for tACS stimulation in Alzheimer's Disease treatment""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection and diagnosis of cognitive impairment'}, {'article': 'PMC4267230.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4471648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4826954.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: Ultrasound therapy to remove Aβ and restore memory in AD mouse model'}, {'article': 'PMC4857621.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-beta aggregates'}, {'article': 'PMC5297247.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral Amyloidosis'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: Episodic memory impairment (r = -0.12)'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: Executive function impairment (r = 0.08)'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Episodic memory impairment'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Visuospatial function impairment'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Semantic memory impairment'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Global cognition impairment'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: episodic memory'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: semantic memory'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: visuospatial function'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: global cognition'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment: Episodic memory decline'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment: Executive function decline'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment: Processing speed decline'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment: Visuospatial function decline'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment: Global cognition decline'}, {'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment: Semantic memory decline'}, {'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amyloid-beta burden in cortex and hippocampus'}, {'article': 'PMC5342482.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-beta deposits in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaques in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'LEVELS_ARE_NEGATIVELY_ASSOCIATED_WITH', 'object': 'Plasma leptin concentration'}, {'article': 'PMC5496518.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5496518.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Amyloid Beta'}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reduction of Aβ levels in the brain'}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for therapeutic interventions in Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Wnt-β-catenin signalling activity'}, {'article': 'PMC6145937.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Wnt-PCP signalling activity'}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6145937.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced gait velocity'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased stance time variability, reduced cadence, and increased double support time'}, {'article': 'PMC6565843.txt', 'relationship': 'NOT_ASSOCIATED_WITH', 'object': 'Step length'}, {'article': 'PMC6668217.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral amyloid angiopathy'}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6685277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis of: Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target of immunotherapy for Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Therapies targeting amyloid cascade'}, {'article': 'PMC6966425.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of combination treatments with cromolyn and ibuprofen'}, {'article': 'PMC6966425.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Clearance via albumin in plasma exchange'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts presence of: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of treatment: Aducanumab (BIIB037), BAN2401 (mAb158)'}, {'article': 'PMC6977279.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment response of crenezumab'}, {'article': 'PMC7001626.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaques'}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to: Antibiotic treatment (ABX)'}, {'article': 'PMC7389451.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Microglial Aβ phagocytosis'}, {'article': 'PMC7389451.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Microglial Aβ phagocytosis'}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7489025.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: GV-971 (Sodium oligomannate)'}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of TEMT treatment to disaggregate toxic oligomers'}, {'article': 'PMC9389745.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Acupuncture treatment reduces Aβ deposition.'}, {'article': 'PMC9527145.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Worse memory and decreased cerebral blood flow in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduces the levels of Aβ1-40 and Aβ1-42'}, {'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Slowed decline in cognitive, functional, and neuropsychological outcomes in AD patients'}, {'article': 'PMC9635167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid β deposition in the brain'}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduced Aβ accumulation and improved cognitive impairment in Aβ1-42-infused mouse model'}, {'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC9755275.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: Amyloid-clearing drugs'}, {'article': 'PMC9755275.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC9768996.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",8
530,Aβ (Amyloid Beta),"[{'article': 'PMC4366075.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
531,Aβ (amyloid beta peptides),"[{'article': 'PMC9289357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]",8
532,Aβ (amyloid deposition),"[{'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
533,Aβ (amyloid-beta),"[{'article': 'PMC7067577.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
534,Aβ 1-40,"[{'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
535,Aβ 1-42,"[{'article': 'PMC4174765.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
536,Aβ 42/40,"[{'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",166
537,Aβ PET,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
538,Aβ Protein,"[{'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid Accumulation in Alzheimer's Disease""}]",8
539,Aβ SUVR,"[{'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
540,Aβ accumulation,"[{'article': 'PMC5399035.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
541,Aβ amyloid angiopathy,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease, present in over 90% of patients""}]",8
542,Aβ amyloid beta peptides,"[{'article': 'PMC6937673.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",8
543,Aβ amyloid fibrils,"[{'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal damage associated with Neurofibrillary tangles and NT'}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Promotion of neuronal damage'}]",8
544,Aβ and tau oligomers,"[{'article': 'PMC8500065.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Sleep dysfunction in Alzheimer's Disease""}]",473
545,Aβ biomarkers,"[{'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
546,Aβ burden,"[{'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",8
547,Aβ deposition,"[{'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Pre-AD symptoms'}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tauopathy'}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Increased risk of cognitive decline'}, {'article': 'PMC4981900.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Preclinical Alzheimer's Disease intervention""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
548,Aβ deposition on PET,"[{'article': 'PMC4970664.txt', 'relationship': 'DIAGNOSITIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]",8
549,Aβ depositions,"[{'article': 'PMC8690894.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8690894.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]",8
550,Aβ deposits,"[{'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk of AD-type dementia'}, {'article': 'PMC5450399.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
551,Aβ levels,"[{'article': 'PMC4174765.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Cognitive compromise in Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased plasma Aβ levels with bapineuzumab treatment'}, {'article': 'PMC4866415.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Dynamics: Significant increases in plasma Aβ levels observed with bapineuzumab'}, {'article': 'PMC4875639.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring response to Aβ-targeting treatments'}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]",8
552,Aβ levels (Aβ1−40 and Aβ1−42),"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",8
553,Aβ load,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Reduction in Alzheimer's Disease""}]",8
554,Aβ oligomers,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Decrease in levels due to J147 treatment'}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s disease'}, {'article': 'PMC4003513.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Synaptic plasticity impairment and neuronal death'}, {'article': 'PMC4174765.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Early stages of Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress and mitochondrial dysfunction in Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease changes""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Synaptic dysfunction and structural impairment'}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease patients""}, {'article': 'PMC4981900.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Progression of cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""synaptic impairment and neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression'}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Aducanumab, gantenerumab, BAN2401, and ALZ-801'}, {'article': 'PMC7424995.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Clinical trials'}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",8
555,Aβ oligomers (AβOs),"[{'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dementia in Alzheimer's Disease""}]",8
556,Aβ pathology,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Memory performance and RI'}]",8
557,Aβ peptide,"[{'article': 'PMC3978916.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid plaques in Alzheimer's Disease""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
558,Aβ peptides,"[{'article': 'PMC3226277.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction in plasma Aβ peptides associated with drug exposure'}, {'article': 'PMC4780148.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4875639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Therapeutic interventions'}, {'article': 'PMC4875639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Amyloid-lowering therapies'}, {'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""amyloid plaques in Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurotoxic effects leading to neuronal death'}]",8
559,Aβ plaque,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",8
560,Aβ plaque deposition,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduced Aβ plaque deposition in Alzheimer's Disease mice treated with GV-971""}]",8
561,Aβ plaques,"[{'article': 'PMC2868024.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Alzheimer's Disease progression""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Synaptic stripping in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Disease progression in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'REDUCES', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8868383.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduced Aβ plaque formation in AD animal models'}]",8
562,Aβ polymers,"[{'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in Aβ polymers in the hippocampus'}]",8
563,Aβ positivity,"[{'article': 'PMC7995588.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",8
564,Aβ protein,"[{'article': 'PMC3226277.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4095696.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4095696.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",8
565,Aβ protein precursor (AβPP),"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",8
566,Aβ proteins,"[{'article': 'PMC5372260.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
567,Aβ protofibrils,"[{'article': 'PMC4054967.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Immunotherapy for Alzheimer's Disease""}, {'article': 'PMC4822297.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'BAN2401 treatment'}, {'article': 'PMC4822297.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: BAN2401 dosing based on lowering of Aβ protofibrils'}]",8
568,Aβ seeding activity,"[{'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s disease'}, {'article': 'PMC8808989.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s disease'}, {'article': 'PMC8808989.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive performance and conventional AD biomarkers'}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",8
569,Aβ(1-40),"[{'article': 'PMC4822297.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4822297.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
570,Aβ(1–40),"[{'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased plasma concentrations after crenezumab treatment'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Crenezumab treatment'}, {'article': 'PMC6977279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild-to-moderate Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'MEASURED_IN', 'object': 'Plasma'}, {'article': 'PMC6977279.txt', 'relationship': 'INFLUENCED_BY', 'object': 'Baseline patient characteristics such as age and renal function'}, {'article': 'PMC6977279.txt', 'relationship': 'USED_IN_MODEL', 'object': 'TMDD model to simulate free plasma Aβ concentrations'}, {'article': 'PMC6977279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Crenezumab Treatment'}, {'article': 'PMC6977279.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Crenezumab Treatment'}]",8
571,Aβ(1–42),"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to crenezumab treatment in Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased plasma concentrations after crenezumab treatment'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Crenezumab treatment'}, {'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment response'}, {'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to crenezumab treatment'}, {'article': 'PMC6977279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild-to-moderate Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'MEASURED_IN', 'object': 'Plasma'}, {'article': 'PMC6977279.txt', 'relationship': 'INFLUENCED_BY', 'object': 'Baseline patient characteristics such as age and renal function'}, {'article': 'PMC6977279.txt', 'relationship': 'USED_IN_MODEL', 'object': 'TMDD model to simulate free plasma Aβ concentrations'}, {'article': 'PMC6977279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6977279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Crenezumab Treatment'}, {'article': 'PMC6977279.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Crenezumab Treatment'}]",8
572,"Aβ(1–42), total tau (t-tau), and phosphorylated tau (p-tau)","[{'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",473
573,Aβ+,"[{'article': 'PMC5315443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in preclinical Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Episodic memory decline in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
574,Aβ-IgG,"[{'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",534
575,Aβ-PET,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Volumes of CA1, subiculum, and transentorhinal cortex/BA35'}, {'article': 'PMC6937673.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",8
576,Aβ-degrading enzymes,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",85
577,Aβ-immunoglobulin G (IgG),"[{'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Immune response to CAD106 in Alzheimer's Disease""}]",534
578,Aβ-specific IgG,"[{'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Antibody response to CAD106 treatment'}]",534
579,Aβ-specific IgGs,"[{'article': 'PMC4410460.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to CAD106 treatment'}]",534
580,Aβ-specific antibody titers,"[{'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
581,Aβ/tau level ratios,"[{'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Decline to CDR>0 in normal individuals with CDR=0'}]",473
582,Aβ1-14,"[{'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to γ-secretase inhibitor treatment in Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to γ-secretase inhibitor treatment'}, {'article': 'PMC2876785.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Effect of γ-secretase inhibitor LY450139'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Effect of γ-secretase inhibitor treatment in AD patients'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Detect biochemical effects of γ-secretase inhibitor treatment in AD patients'}]",8
583,Aβ1-15,"[{'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to γ-secretase inhibitor treatment in Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to γ-secretase inhibitor treatment'}, {'article': 'PMC2876785.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Effect of γ-secretase inhibitor LY450139'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Effect of γ-secretase inhibitor treatment in AD patients'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Detect biochemical effects of γ-secretase inhibitor treatment in AD patients'}, {'article': 'PMC4780148.txt', 'relationship': 'RESPONDED_TO', 'object': 'Chronic semagacestat treatment'}]",8
584,Aβ1-16,"[{'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to γ-secretase inhibitor treatment in Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to γ-secretase inhibitor treatment'}, {'article': 'PMC2876785.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Effect of γ-secretase inhibitor LY450139'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Effect of γ-secretase inhibitor treatment in AD patients'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Detect biochemical effects of γ-secretase inhibitor treatment in AD patients'}, {'article': 'PMC4780148.txt', 'relationship': 'RESPONDED_TO', 'object': 'Chronic semagacestat treatment'}]",8
585,Aβ1-34,"[{'article': 'PMC2876785.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to γ-secretase inhibitor treatment'}, {'article': 'PMC2876785.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Effect of γ-secretase inhibitor LY450139'}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Effect of γ-secretase inhibitor treatment in AD patients'}, {'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to BACbche gene gene inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Target engagement of BACbche gene gene inhibitors'}, {'article': 'PMC4233234.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to BACE inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'BACE inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'BACE inhibition in clinical trials'}, {'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'BACE inhibition in humans'}]",8
586,Aβ1-37,"[{'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differentiate AD from FTD or DLB'}]",8
587,Aβ1-38,"[{'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differentiate AD from FTD or DLB'}]",8
588,Aβ1-40,"[{'article': 'PMC2876785.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""No significant change during γ-secretase inhibitor treatment in Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Rescue of cognitive deficits in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'LY2811376 treatment'}, {'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased Soluble Aβ Levels'}, {'article': 'PMC4956742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
589,Aβ1-42,"[{'article': 'PMC2876785.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""No significant change during γ-secretase inhibitor treatment in Alzheimer's Disease""}, {'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Rescue of cognitive deficits in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'p-Tau levels'}, {'article': 'PMC4247762.txt', 'relationship': 'RESPONDED_TO', 'object': 'Nilotinib treatment'}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Autophagic clearance'}, {'article': 'PMC4247762.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Nilotinib treatment'}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Extracellular plaque deposition and dementia'}, {'article': 'PMC4247762.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased Soluble Aβ Levels'}, {'article': 'PMC4956742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early disease progression'}, {'article': 'PMC8416781.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Brain amyloid pathology'}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Intermediate to high Thal amyloid phases in Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Pathology-confirmed Alzheimer's Disease dementia""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Lower levels associated with poor outcomes in Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early diagnosis of Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-β (Aβ) deposition'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease in its prodromal stage""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Pre-clinical Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnostic of: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differential diagnosis between AD and non-AD dementia'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Prodromal AD in case of mild cognitive impairment'}, {'article': 'PMC5565643.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Select subjects for clinical trials with potentially disease-modifying drugs against AD'}, {'article': 'PMC5565643.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Identify asymptomatic subjects at risk to develop symptoms of AD'}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Amyloid'}, {'article': 'PMC6764494.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid deposition'}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroinflammation and neurodegeneration in AD'}]",8
590,Aβ1-42 expression,"[{'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
591,Aβ1-42/1-40,"[{'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
592,Aβ1-42/1-40 (blood-based),"[{'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",8
593,Aβ1-42/Aβ1-40,"[{'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Amyloid'}]",8
594,Aβ1-42/Aβ1-40 ratio,"[{'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid deposition'}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of amyloid'}]",8
595,Aβ1-42/t-tau ratio,"[{'article': 'PMC9108275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",473
596,Aβ1-43,"[{'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early disease progression'}, {'article': 'PMC8416781.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Greater propensity to aggregate and more neurotoxic'}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'DIFFERENTIATE', 'object': 'Amnestic mild cognitive impairment patients who progress to AD'}]",8
597,Aβ1-x,"[{'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",8
598,Aβ11-42,"[{'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",166
599,Aβ18–35,"[{'article': 'PMC4055052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to GSK933776 treatment in mild AD and mild cognitive impairment'}, {'article': 'PMC4055052.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Plasma levels increased following GSK933776 treatment'}]",166
600,Aβ1–37,"[{'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in cerebral spinal fluid levels in response to atabecestat treatment'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to atabecestat treatment in Alzheimer's Disease patients""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Atabecestat'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}]",8
601,Aβ1–38,"[{'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amyloid-positive individuals'}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in cerebral spinal fluid levels in response to atabecestat treatment'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to atabecestat treatment in Alzheimer's Disease patients""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Atabecestat'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}]",8
602,Aβ1–40,"[{'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Decrease in levels due to J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in soluble Aβ levels in the hippocampus'}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Alzheimer's Disease progression""}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decreased levels in cerebral spinal fluid following administration of GSK933776'}, {'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amyloid-positive individuals'}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Nonpathological cerebral spinal fluid profile'}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid deposits in Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in cerebral spinal fluid levels in response to atabecestat treatment'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to atabecestat treatment in Alzheimer's Disease patients""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC6106931.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment monitoring in Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Atabecestat'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}]",8
603,Aβ1–40 and Aβ1–42,"[{'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}]",8
604,Aβ1–40 and Aβ1–42 serum levels,"[{'article': 'PMC4731943.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}]",8
605,Aβ1–42,"[{'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Decrease in levels due to J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in soluble Aβ levels in the hippocampus'}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Alzheimer's Disease progression""}, {'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s disease'}, {'article': 'PMC4055052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to GSK933776 treatment in mild AD and mild cognitive impairment'}, {'article': 'PMC4055052.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to GSK933776 treatment in Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebrospinal fluid levels decreased following GSK933776 administration'}, {'article': 'PMC4055052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Dose-dependent reductions in cerebrospinal fluid Aβ1–42 levels'}, {'article': 'PMC4366075.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Increased levels in cerebral spinal fluid following administration of GSK933776'}, {'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-beta pathology in Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target: Anti-Aβ therapy'}, {'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-positive individuals'}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amyloid-positive individuals'}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction in brain amyloid in apoe4 noncarriers'}, {'article': 'PMC4731943.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Biomarker for amyloid burden in Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced cortical amyloid burden in apoe4 noncarriers'}, {'article': 'PMC4875639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4979550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment response to lecanemab'}, {'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Nonpathological cerebral spinal fluid profile'}, {'article': 'PMC8866346.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid deposits in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaque formation'}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in cerebral spinal fluid levels in response to atabecestat treatment'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cerebral amyloid plaque deposition'}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to atabecestat treatment in Alzheimer's Disease patients""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'NOT_USED_TO_DIAGNOSE', 'object': 'No significant changes in levels'}, {'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'P. gingivalis infection'}, {'article': 'PMC6357742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to P. gingivalis brain infection treatment'}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Atabecestat'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC7648990.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid pathology'}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
606,Aβ1–42/Aβ1–40,"[{'article': 'PMC7648990.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
607,Aβ1–42/Aβ1–40 ratio,"[{'article': 'PMC8866346.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Nonpathological (A−/T−/N−) cerebral spinal fluid profile'}, {'article': 'PMC8866346.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Non-pathological cerebral spinal fluid profiles'}, {'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid cerebral spinal fluid profiles'}]",8
608,Aβ22-28,"[{'article': 'PMC4780148.txt', 'relationship': 'RESPONDED_TO', 'object': 'Semagacestat treatment'}]",166
609,Aβ28–42,"[{'article': 'PMC4055052.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Plasma levels increased following GSK933776 treatment'}]",166
610,Aβ38,"[{'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased white matter lesions (WML)'}, {'article': 'PMC4746584.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased White Matter Lesions (WML) volume'}, {'article': 'PMC4746584.txt', 'relationship': 'MEASURED USING', 'object': 'EUROIMMUN ELISAs'}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower risk of AD-related cognitive decline and dementia'}, {'article': 'PMC8901176.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of γ-secretase modulators for disease-altering therapy'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Risk of developing AD dementia and cognitive decline'}, {'article': 'PMC8901176.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Longitudinal change in cognition as measured by the MMSE scale'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to AD dementia'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Less decline in MMSE score over time'}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower risk of AD dementia'}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Less decline in MMSE score and lower risk of developing AD dementia'}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower risk of AD-related changes'}, {'article': 'PMC8901176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease progression""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral Aβ amyloidosis'}, {'article': 'PMC5297247.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection in Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",166
611,Aβ40,"[{'article': 'PMC10075195.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Vessel wall damage and pericyte damage'}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC2868024.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2868024.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'MRIgFUS treatment'}, {'article': 'PMC2868024.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'RP reduces Aβ generation'}, {'article': 'PMC4227681.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'SS reduces Aβ generation'}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cerebral spinal fluid biomarker levels'}, {'article': 'PMC4461930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased white matter lesions (WML)'}, {'article': 'PMC4746584.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased White Matter Lesions (WML) volume'}, {'article': 'PMC4746584.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment, Alzheimer's Disease, and Cerebral Amyloid Angiopathy (CAA)""}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Microvascular dysfunction'}, {'article': 'PMC4746584.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: White matter lesions (WML) and cerebral amyloid angiopathy (CAA)'}, {'article': 'PMC4746584.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: White matter hyperintensity (WMH) in plasma'}, {'article': 'PMC4746584.txt', 'relationship': 'MEASURED USING', 'object': 'EUROIMMUN ELISAs'}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Vascular disease (e.g., white matter lesions, cerebral microbleeds, hypertension, diabetes, ischemic heart disease)'}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': 'Cardiovascular mortality in coronary heart disease'}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Hypertension, diabetes, and ischemic heart disease'}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease based on cerebrospinal fluid Aβ42/Aβ40 ratio""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pathologic cerebrospinal fluid signature in Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloidosis in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid fibrils'}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain amyloid plaques'}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amyloid-β-positive cognitively normal participants (CN+)'}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Less decline in MMSE score'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related amyloid production""}, {'article': 'PMC4267230.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ pathology'}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction after Nilotinib treatment'}, {'article': 'PMC5022094.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5022094.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Stabilization in resveratrol-treated AD patients'}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Reduction in cerebral spinal fluid levels indicates presence of Alzheimer's Disease.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral Aβ amyloidosis'}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid-beta pathology'}, {'article': 'PMC5297247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower levels in African Americans compared to Caucasians'}, {'article': 'PMC6152871.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Disease-Modifying Therapies (DMTs) in AD'}, {'article': 'PMC7067750.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'DIAGNOSITC_OF', 'object': 'Diagnose: Differential diagnosis between AD and DLB'}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",166
612,Aβ40 and Aβ42,"[{'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",166
613,Aβ40 levels,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",166
614,Aβ40 peptide,"[{'article': 'PMC8043748.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",8
615,Aβ40 ratio,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",166
616,Aβ40/Aβ42,"[{'article': 'PMC8733254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain amyloid-β burden'}]",166
617,Aβ42,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of AD pathology'}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease neuropathology""}, {'article': 'PMC10013957.txt', 'relationship': 'PREDICTS_PROGRESSION', 'object': ""Progression: Mild Cognitive Impairment to Alzheimer's Disease dementia""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'PREDICTS_DISEASE_PROGRESSION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Plaque formation and oligodendrocyte death'}, {'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in the ratio of t-tau to Aβ42 in cerebral spinal fluid'}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC2868024.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2868024.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'MRIgFUS treatment'}, {'article': 'PMC2868024.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3226277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid burden in Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Conversion from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive decline in non-demented subjects'}, {'article': 'PMC3523068.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early amyloidosis in Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Lower levels associated with higher risk of Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Amyloid plaques in Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment with Solanezumab in mild to moderate AD'}, {'article': 'PMC4054967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'RP reduces Aβ generation'}, {'article': 'PMC4227681.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'SS reduces Aβ generation'}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid deposition in Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with GSK933776'}, {'article': 'PMC4366075.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cerebral spinal fluid biomarker levels'}, {'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Increase in Aβ42 levels in blood at low concentrations of semagacestat'}, {'article': 'PMC4461930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaques and Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early diagnosis of Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Subjects with increased PET amyloid load'}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""White matter lesions (WML) mainly in Alzheimer's Disease (AD)""}, {'article': 'PMC4746584.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid deposition in Alzheimer's Disease via PET imaging""}, {'article': 'PMC4746584.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Increased risk for Alzheimer's Disease development""}, {'article': 'PMC4746584.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: White matter lesions (WML) in AD dementia'}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Association with white matter lesions (WML) in the temporal lobes in Alzheimer's Disease""}, {'article': 'PMC4746584.txt', 'relationship': 'MEASURED USING', 'object': 'INNOTEST ELISAs'}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Plaque density'}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Vascular disease (e.g., white matter lesions, cerebral microbleeds, hypertension, diabetes, ischemic heart disease)'}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Amyloid deposition in the brain'}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease based on cerebrospinal fluid Aβ42/Aβ40 ratio""}, {'article': 'PMC4886210.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pathologic cerebrospinal fluid signature in Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target of Aβ antibodies (solanezumab, crenezumab, and aducanumab)'}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early AD-related changes'}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid deposition in mid-life'}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced delivery of DHA to cerebral spinal fluid'}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'PREDICTS_RESPONSE', 'object': 'Change in DHA levels after supplementation'}, {'article': 'PMC4928349.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Correlation with DHA levels in cerebral spinal fluid'}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloidosis in Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid-beta pathology in Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain amyloid plaques'}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to neflamapimod treatment'}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Therapeutic effects of hUCB-MSC injection'}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Preclinical Alzheimer's Disease identification""}, {'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-β burden in Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amyloid-β-positive cognitively normal participants (CN+)'}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Brain amyloidosis in preclinical Alzheimer's Disease""}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Aβ38'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Brain Aβ buildup in Alzheimer's Disease""}, {'article': 'PMC8901176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4267230.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ pathology'}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to dementia'}, {'article': 'PMC4970664.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5022094.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5022094.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Decreases in Aβ42 levels over 2 years'}, {'article': 'PMC5089525.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Stabilization in resveratrol-treated AD patients'}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Reduction in cerebral spinal fluid levels indicates presence of Alzheimer's Disease.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral Aβ amyloidosis'}, {'article': 'PMC5297247.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6152871.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6158897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early-stage Alzheimer’s disease'}, {'article': 'PMC6158897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Diagnose: Early-stage Alzheimer’s disease'}, {'article': 'PMC6158897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6158897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6158897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid deposition in Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Higher levels of Aβ42 linked to cognitive impairment in AD'}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid depositions in Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Disease-Modifying Therapies (DMTs) in AD'}, {'article': 'PMC6966425.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Early detection of Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'DIAGNOSITC_OF', 'object': 'Diagnose: Differential diagnosis between AD and DLB'}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease (reduced levels considered pathological)""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cerebrospinal fluid Aβ biomarkers'}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Aerobic exercise reduced plasma Aβ42 by ~6%'}, {'article': 'PMC9716660.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Stretching increased plasma Aβ42 by 24%'}, {'article': 'PMC9797897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",166
618,Aβ42 levels,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease (cerebrospinal fluid Aβ42 levels ≤600 pg/mL)""}]",166
619,Aβ42 oligomers,"[{'article': 'PMC7424995.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with ALZ-801'}]",8
620,Aβ42/40,"[{'article': 'PMC10115176.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Alzheimer’s disease'}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Low burden of Aβ pathology'}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Brain Aβ pathology in early Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of abnormal brain Aβ status'}, {'article': 'PMC8453354.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease progression""}, {'article': 'PMC8453354.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'High risk of future conversion to Aβ-PET positivity'}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Abnormal brain Aβ burden in Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Accurate identification of abnormal brain Aβ burden in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",166
621,Aβ42/40 ratio,"[{'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Brain amyloid status'}, {'article': 'PMC8088704.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Presence of brain amyloidosis'}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Brain amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of amyloid pathology in Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC8088704.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for Treatment: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease via decreased ratio""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease continuum""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'PET amyloid load and cerebral spinal fluid Aβ42/40 ratio'}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Plasma biomarker measured using IP/LC-MS/MS technology platform (Precivity AD assay, C2N)'}, {'article': 'PMC9768996.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Slower cognitive decline in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to lecanemab treatment'}, {'article': 'PMC9768996.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid cascade in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment effects and disease state'}, {'article': 'PMC9768996.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Lecanemab treatment effects'}]",166
622,Aβ42/Aβ38,"[{'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease with better diagnostic performance""}]",166
623,Aβ42/Aβ38 ratio,"[{'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]",166
624,Aβ42/Aβ40,"[{'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10758173.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Worse SO/spindle coupling strength and higher dementia risk'}, {'article': 'PMC10758173.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Beneficial amyloid response to PLAS'}, {'article': 'PMC10758173.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Identifying individuals who may benefit most from PLAS'}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease with improved diagnostic accuracy""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amyloid-β-positive cognitively normal participants (CN+)'}, {'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Brain amyloidosis in preclinical Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_AD_PROGRESSION', 'object': 'Progression to AD dementia (minimal contribution)'}, {'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Improve performance in different stages of AD diagnosis'}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",166
625,Aβ42/Aβ40 ratio,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC10758173.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Relative memory increase at 1-week follow-up'}, {'article': 'PMC11493878.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive outcomes in older adults with cognitive impairment'}, {'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-β burden in Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'PREDICTS_PROGRESSION_TO', 'object': ""Alzheimer's Disease dementia""}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Brain amyloidosis'}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease Prognosis""}, {'article': 'PMC5297247.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease (reduced levels considered pathological)""}]",166
626,Aβ42/Aβ40 ratio in CSF,"[{'article': 'PMC7067750.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to Nilvadipine treatment in Alzheimer's Disease""}]",532
627,Aβ42/Aβ40 ratios,"[{'article': 'PMC5022094.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Lower risk of dementia'}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",166
628,Aβ42/P-Tau,"[{'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Lower ratios associated with higher risk of Alzheimer's Disease""}]",473
629,Aβ42/p-tau,"[{'article': 'PMC4607601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Early-stage Alzheimer's Disease""}]",473
630,Aβ42/t-tau,"[{'article': 'PMC4607601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Early-stage Alzheimer's Disease""}]",473
631,Aβ42/t-tau ratio,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",473
632,Aβ42/tau ratio,"[{'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",473
633,Aβ42/ttau,"[{'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease with high sensitivity at 95% specificity""}]",675
634,Aβ42/ttau ratio,"[{'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]",675
635,Aβ42EI,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",166
636,Aβ42EI/Aβ40EI,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",166
637,Aβ42IT,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",166
638,Aβ42IT/p-tauIT,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",473
639,Aβ42IT/t-tauEI,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",473
640,Aβ43,"[{'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",166
641,Aβ5-40,"[{'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to BACbche gene gene inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Target engagement of BACbche gene gene inhibitors'}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4233234.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to BACE inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'BACE inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",166
642,Aβ5-42,"[{'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",166
643,Aβ5-X,"[{'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to BACbche gene gene inhibitor treatment'}, {'article': 'PMC4233234.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Target engagement of BACbche gene gene inhibitors'}, {'article': 'PMC4233234.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'BACE inhibition'}]",166
644,AβPP,"[{'article': 'PMC6015016.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",8
645,AβX–38,"[{'article': 'PMC4366075.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Elevated levels in cerebral spinal fluid following administration of GSK933776'}]",166
646,AβX–42,"[{'article': 'PMC4366075.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Elevated levels in cerebral spinal fluid following administration of GSK933776'}, {'article': 'PMC4366075.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",166
647,Aβo (oligomeric amyloid beta),"[{'article': 'PMC4396171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
648,"Aβx-38, Aβx-40, and Aβx-42","[{'article': 'PMC4780148.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Semagacestat treatment'}]",166
649,Aβx-40,"[{'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'AAB-003 treatment'}, {'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",166
650,Aβx-42,"[{'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",166
651,Aβx–40 peptide levels,"[{'article': 'PMC4866415.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",8
652,Aβ−,"[{'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Lower likelihood of Alzheimer's Disease""}]",8
653,B Vitamins,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'brain atrophy'}]",231
654,B cells,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'chronic neuroinflammation and dementia'}, {'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease pathology""}]",231
655,B1 cells,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",231
656,B12,"[{'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Reversible causes of cognitive impairment'}]",231
657,B1N1,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",231
658,BA35 volume,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease pathology""}]",62
659,BA46,"[{'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",62
660,BA9,"[{'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",62
661,BACE,"[{'article': 'PMC3206445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid production in Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease through Aβ levels""}, {'article': 'PMC4304279.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Disease progression based on BACE levels and activity'}, {'article': 'PMC4304279.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: BACE inhibitors for Alzheimer's Disease prevention and treatment""}, {'article': 'PMC4304279.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: BACE inhibitor therapy in clinical trials for Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Slowing cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6685277.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Verubecestat treatment for Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': ""Prognosis: Alzheimer's Disease""}]",670
662,BACE (β-secretase),"[{'article': 'PMC5516350.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",617
663,BACE activity,"[{'article': 'PMC6966425.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment Monitoring: Alzheimer's Disease""}]",670
664,BACE enzyme,"[{'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",670
665,BACE1,"[{'article': 'PMC4304279.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Treatment: BACE1 inhibitor drugs for Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Clinical trials for Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]",670
666,BACE2,"[{'article': 'PMC4304279.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",670
667,BACbche gene,"[{'article': 'PMC4304279.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Amild cognitive impairment (aMCI) associated with Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Atabecestat'}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduced BACbche gene expression and improved cognitive impairment in Aβ1-42-infused mouse model'}]",481
668,BACbche gene gene,"[{'article': 'PMC7227237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",481
669,BACbche gene mRNA,"[{'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early biomarker for Alzheimer's Disease""}]",481
670,BAD,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",578
671,BAM-10,"[{'article': 'PMC2868024.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2868024.txt', 'relationship': 'TARGETS', 'object': 'Aβ plaques'}]",62
672,BAM-10 antibody,"[{'article': 'PMC2868024.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Aβ aggregates'}, {'article': 'PMC2868024.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Cognitive function rescue in Alzheimer's Disease mouse models""}]",62
673,BAN2401,"[{'article': 'PMC4054967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Disease progression and drug effects'}, {'article': 'PMC4054967.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Amyloid-beta species'}, {'article': 'PMC4822297.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased plasma Aβ(1-40)'}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Phase II trial in early AD'}]",144
674,BAVLT,"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",62
675,BAX,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",62
676,BBB disruption,"[{'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]",322
677,BBS,"[{'article': 'PMC3382377.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Wii-Fit intervention'}, {'article': 'PMC3382377.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Improvement in balance under Wii-Fit treatment'}]",322
678,BBS (Berg Balance Scale),"[{'article': 'PMC3382377.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Balance improvements in Alzheimer's Disease""}]",436
679,BC (Betweenness Centrality),"[{'article': 'PMC4545875.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increasing BC values in the lower alpha band in the anterior region with increasing disease severity'}]",437
680,BCAA,"[{'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease through increased oxidative stress and excitotoxicity""}]",376
681,BCAAs,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4694064.txt', 'relationship': 'RESPONDED_TO', 'object': 'J147 treatment'}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Improvement in mitochondrial function in Alzheimer's Disease""}]",376
682,BCG,"[{'article': 'PMC6837488.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced risk of Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Reduction of Alzheimer's Disease risk in bladder cancer patients""}, {'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved overall survival and disease-specific survival in patients'}, {'article': 'PMC7074941.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s disease'}, {'article': 'PMC7074941.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Alzheimer’s disease'}]",376
683,BCG therapy,"[{'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower incidence of Alzheimer’s disease'}]",376
684,BCL2,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",376
685,BDI-II,"[{'article': 'PMC4468784.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Depression in Alzheimer's Disease""}, {'article': 'PMC7930223.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Depression in Alzheimer's Disease patients""}]",312
686,BDNF,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1325254.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Protection against neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC2765081.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Memory and long-term potentiation'}, {'article': 'PMC3110111.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease: Brain function improvement through exercise""}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive enhancement and prevention of memory deficits in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved learning and memory in AD mice'}, {'article': 'PMC3581819.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive performance in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""J147 treatment in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive Function in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4150993.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes and protection against cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4333880.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4333880.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4401690.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Synaptic plasticity and memory improvement in Alzheimer's Disease""}, {'article': 'PMC4563885.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'INCREASES', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4747225.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved neurological outcomes in traumatic brain injury'}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal survival and differentiation'}, {'article': 'PMC4908397.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8201462.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Cognitive enhancement in Alzheimer's Disease""}, {'article': 'PMC8211849.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease through exercise-induced response""}, {'article': 'PMC8211849.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Exercise-induced neurotrophic responses'}, {'article': 'PMC8211849.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ' Promotion of mitochondrial biogenesis, synaptic plasticity, and cellular stress resistance'}, {'article': 'PMC8470960.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Improved cognitive functioning and neuroprotection in Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Promotes mitochondrial biogenesis, synaptic plasticity, and cellular stress resistance in Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Lower concentrations in Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Changes in MoCA scores over 2 weeks'}, {'article': 'PMC8645072.txt', 'relationship': 'RESPONDED_TO', 'object': 'Response to tDCS treatment'}, {'article': 'PMC8645072.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Individual responses to tDCS stimulation'}, {'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5348543.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroplasticity and cognitive improvements in Alzheimer's Disease""}, {'article': 'PMC5348543.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC5348543.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Neuroplasticity and cognitive function in elderly individuals'}, {'article': 'PMC5348543.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroplasticity in aging human brain'}, {'article': 'PMC5348543.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Prevention of gray matter and cognitive decline in elderly'}, {'article': 'PMC5427593.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognitive function in AD models'}, {'article': 'PMC5504954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5504954.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognitive function and reduced risk of dementia'}, {'article': 'PMC6040685.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Neuroplasticity in elderly'}, {'article': 'PMC6040685.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Increased plasma BDNF levels after dancing'}, {'article': 'PMC6040685.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved brain volume and cognitive function'}, {'article': 'PMC6040685.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of increased plasma BDNF levels after dance training'}, {'article': 'PMC6040685.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6040685.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive benefit in mild cognitive impairment'}, {'article': 'PMC6225735.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to treatment in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Synaptic plasticity and neurogenesis'}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognition and reduced Aβ plaque formation in AD animal models'}, {'article': 'PMC6893800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Elevated neurotrophin levels indicating improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC6893800.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive performance in Alzheimer's Disease""}, {'article': 'PMC6893800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6945614.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s disease progression'}, {'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline and functional abilities in Alzheimer’s disease'}, {'article': 'PMC6945614.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Aerobic exercise interventions'}, {'article': 'PMC6945614.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Neurogenesis and synaptic function in Alzheimer’s disease'}, {'article': 'PMC6945614.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to aerobic training in Alzheimer's Disease patients""}, {'article': 'PMC6945614.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease outcomes""}, {'article': 'PMC6945614.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to aerobic training in Alzheimer's Disease""}, {'article': 'PMC6945614.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to exercise training in Alzheimer's Disease patients""}, {'article': 'PMC6945614.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Exercise training response monitoring in Alzheimer's Disease""}, {'article': 'PMC6945614.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic training'}, {'article': 'PMC6945614.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Aerobic training'}, {'article': 'PMC6945614.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No significant change in plasma BDNF levels in response to training interventions.'}, {'article': 'PMC6945614.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC6945614.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945614.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7001626.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7648990.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Amelioration of brain network deficiencies and delayed disease progression'}, {'article': 'PMC7648990.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer Disease'}, {'article': 'PMC7822717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Improved synaptic plasticity and cognitive function in Alzheimer Disease'}, {'article': 'PMC7930223.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to rTMS treatment'}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-cognitive effects in Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Pro-cognitive effects in Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Exercise-induced response'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurotrophic Factor Levels'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9389745.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Acupuncture upregulates BDNF expression, promoting neurogenesis.'}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Enhances brain-derived neurotrophic factor (BDNF)/tropomyosin-related kinase B'}, {'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Neurotrophic support in cognitive recovery'}, {'article': 'PMC9962062.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Restoration of synaptic proteins and neuronal survival'}]",508
687,BDNF ApoE,"[{'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",508
688,BDNF Met-allele,"[{'article': 'PMC9373273.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive Decline in Episodic Memory and Executive Functions'}]",508
689,BDNF levels,"[{'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC5504954.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved cognitive functions and delayed onset of Alzheimer's Disease symptoms""}, {'article': 'PMC5504954.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive improvement in Alzheimer's Disease models""}]",508
690,BDNF plasma levels,"[{'article': 'PMC5348543.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dance intervention effectiveness'}]",508
691,BDNF-Val66Met polymorphism,"[{'article': 'PMC4487699.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",508
692,BDNF/TrkB,"[{'article': 'PMC9527145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]",183
693,BDS,"[{'article': 'PMC5326769.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive dysfunction in Alzheimer's Disease""}]",312
694,BEC 96 Total,"[{'article': 'PMC7928298.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}]",148
695,BEC96,"[{'article': 'PMC7928298.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",148
696,BEHAVE-AD,"[{'article': 'PMC4764002.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Behavioral Pathology in Alzheimer's Disease""}]",170
697,BGP,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive and functional characteristics'}]",522
698,BHB,"[{'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment with AC-1202'}, {'article': 'PMC2731764.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Ketone body levels post-dosing'}, {'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Cognitive improvement in E4(-) subjects'}, {'article': 'PMC2731764.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor: Serum BHB levels during treatment'}, {'article': 'PMC2731764.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Changes in serum β-hydroxybutyrate levels in Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Promotes mitochondrial biogenesis, synaptic plasticity, and cellular stress resistance in Alzheimer's Disease""}]",312
699,BHB levels,"[{'article': 'PMC2731764.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of ketosis in Alzheimer's Disease patients""}, {'article': 'PMC2731764.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cognitive performance improvement in E4(-) subjects'}, {'article': 'PMC2731764.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Correlation with improvement in ADAS-Cog score in E4(-) subjects'}]",312
700,BI,"[{'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Impairment in activities of daily living in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Assessment of functional performance in AD'}]",207
701,BI (Barthel Index),"[{'article': 'PMC8564955.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Scores reflect functional capacity and response to treatment'}]",131
702,BI 409306,"[{'article': 'PMC6371616.txt', 'relationship': 'RESPONDED_TO', 'object': 'Alzheimer’s Disease treatment'}]",602
703,BIN1,"[{'article': 'PMC4615808.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease age at onset""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5068716.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",555
704,BIN1 risk variant,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased tau loads in AD patients'}]",555
705,BMAL1,"[{'article': 'PMC8470960.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Circadian rhythm in Alzheimer's Disease""}, {'article': 'PMC5076443.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Circadian rhythm regulation in Alzheimer's Disease""}]",135
706,BMI,"[{'article': 'PMC10306194.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC10542675.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""No significant reduction in BMI-related risk for Alzheimer's Disease""}, {'article': 'PMC1325254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Brain Atrophy and Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC4987494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Behavior change and improved clinical outcomes in Alzheimer's Disease risk reduction""}, {'article': 'PMC4987494.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Reducing BMI can lower the risk of Alzheimer's Disease and other chronic diseases such as diabetes, heart disease, and stroke.""}, {'article': 'PMC4987494.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Addressing BMI as part of a multifactorial intervention improves overall health and reduces the risk of Alzheimer's Disease.""}, {'article': 'PMC4987494.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'BMI reduction during the study'}, {'article': 'PMC4987494.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Desirable lowering of BMI'}, {'article': 'PMC6208946.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6343283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Physical health indicators in Alzheimer's Disease""}, {'article': 'PMC7023686.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher BMI in the AHF group compared to the NGF group (22.7 ± 3.3 vs. 21.4 ± 3.6, p = 0.042)'}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline and dementia'}, {'article': 'PMC9246122.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",19
707,BMS,"[{'article': 'PMC10475546.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Exercise training for older adults with cognitive decline'}]",312
708,BNDF,"[{'article': 'PMC8470960.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved cognitive function in Alzheimer's Disease""}]",572
709,BORB,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",338
710,BPF (Brain Parenchymal Fraction),"[{'article': 'PMC9295361.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",236
711,BPSD,"[{'article': 'PMC5359367.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in people with Down Syndrome""}, {'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease in people with Down Syndrome""}, {'article': 'PMC7798342.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Behavioral and psychological symptoms in Alzheimer's Disease""}]",204
712,BPSD (Behavioral and Psychological Symptoms of Dementia),"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",215
713,BRAIN tap test,"[{'article': 'PMC10916999.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Early Alzheimer's Disease""}]",76
714,BVMT-R,"[{'article': 'PMC7729136.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Visuospatial memory in Alzheimer's Disease""}]",84
715,Bacteroides,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid Aβ42/Aβ40 ratio (lower levels reflect greater amyloid burden)'}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid p-tau (higher levels reflect greater neurofibrillary tangle pathology)'}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid p-tau/Aβ42 ratio (higher values imply greater AD pathology)'}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased cerebral spinal fluid YKL-40 levels (marker of astroglial and/or microglial activation)'}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Greater Alzheimer's Disease pathology""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Glial activation in AD'}, {'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Cognitive Impairment: Mild Cognitive Impairment in Alzheimer's Disease""}]",331
716,Bacteroides (enterotype I),"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}, {'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}]",331
717,Bacteroidetes,"[{'article': 'PMC8843023.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': 'Amyloid-β-positive status in cognitively normal participants'}, {'article': 'PMC8843023.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Exacerbation of AD pathology through inflammation'}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Greater Alzheimer's Disease pathology""}, {'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",331
718,Balance,"[{'article': 'PMC8795741.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Positive changes in balance'}]",91
719,Bapineuzumab,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Terminated in Phase III trials due to lack of efficacy'}]",268
720,Barcelona Test-Revised (TBR),"[{'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Language ability in Alzheimer's Disease""}]",291
721,Barthel Index,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Activities of daily life (ADL) in Alzheimer's Disease""}, {'article': 'PMC4722852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",131
722,Basal Ganglia Volume,"[{'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",558
723,Basal forebrain atrophy,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}]",360
724,Basal forebrain volume,"[{'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Progression to mild cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",360
725,Basal ganglia,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Gait in Alzheimer's Disease""}]",558
726,Basic fibroblast growth factor [BFGF],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",192
727,Bcl-2,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",376
728,Beck Depression Inventory (BDI),"[{'article': 'PMC7001626.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Depressive symptoms in Alzheimer's Disease patients""}]",270
729,Beclin-1,"[{'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Autophagy activation and amyloid clearance in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Restoration of mitochondrial dynamics and weakening of apoptosis'}]",241
730,Behavior Rating Scale for dementia,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Behavioral disturbances in Alzheimer's Disease""}]",21
731,Behavioral observations,"[{'article': 'PMC9412195.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Physical activity and exercise intensity in Alzheimer's Disease patients""}]",332
732,"Behaviors (e.g., getting out of bed at odd hours, going to bed earlier)","[{'article': 'PMC4666316.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}]",283
733,Behavioural and Psychological Symptoms of dementia (BPSD),"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease in people with Down Syndrome""}, {'article': 'PMC5359367.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Predicts more severe diagnosis of Alzheimer's Disease""}]",215
734,Benson Figure Copy,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection of amnestic mild cognitive impairment'}]",33
735,Benton Visual Retention Test (BVRT),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",334
736,Berberine,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Reduction of Aβ-induced inflammatory responses in Alzheimer's Disease""}]",309
737,Berg Balance Scale,"[{'article': 'PMC4722852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",436
738,Berg Balance Scale (BBS),"[{'article': 'PMC4431827.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor functional balance and increased risk of falling in Alzheimer's Disease patients""}, {'article': 'PMC4431827.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Balance ability and functional outcomes in Alzheimer's Disease""}]",436
739,Beta band,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early diagnosis of Alzheimer's Disease""}, {'article': 'PMC3914466.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Severe cognitive dysfunction in Alzheimer's Disease""}, {'article': 'PMC3914466.txt', 'relationship': 'PREDICTS', 'object': ""Development of Alzheimer's Disease""}]",42
740,Beta cell function,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved beta cell function in Alzheimer's Disease""}]",139
741,Beta power,"[{'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Sleep quality assessment'}]",42
742,Beta secretase-I,"[{'article': 'PMC6182869.txt', 'relationship': 'NOT_USED_TO_DIAGNOSE', 'object': 'No significant changes in levels'}]",617
743,Beta-amyloid (Aβ),"[{'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
744,Beta-secretase activity,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",617
745,Bexarotene,"[{'article': 'PMC4731943.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Reduction of brain amyloid levels in apoe4 noncarriers'}]",105
746,Bielschowsky,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",207
747,Bielschowsky silver,"[{'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",207
748,Bielschowsky silver stain,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",207
749,Bifidobacterium,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Less Alzheimer's Disease pathology""}]",331
750,Bilateral anterior fusiform gyrus (FG) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (svPPA variant)""}]",284
751,Bilateral anterior inferior temporal gyrus (ITG) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (svPPA variant)""}]",284
752,Bilophila,"[{'article': 'PMC8843023.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Contribution to AD pathology'}]",207
753,Biomarkers,"[{'article': 'PMC8507171.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predict incident dementia in individuals with subjective cognitive decline'}]",257
754,Blalock Alzheimer's Disease Up pathway,"[{'article': 'PMC4890804.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",387
755,Blalock Alzheimer’s Disease Down pathway,"[{'article': 'PMC4890804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",387
756,Blalock Alzheimer’s Disease Up pathway,"[{'article': 'PMC4890804.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4890804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",387
757,Blautia,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid Aβ42/Aβ40 ratio (lower levels reflect greater amyloid burden)'}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid p-tau (higher levels reflect greater neurofibrillary tangle pathology)'}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid p-tau/Aβ42 ratio (higher values imply greater AD pathology)'}]",312
758,Blessed ADL,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",327
759,Blessed Test,"[{'article': 'PMC3978714.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive impairment in Alzheimer's Disease""}]",327
760,Blessed score ADL,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",327
761,Blood Pressure (BP),"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",297
762,Blood biomarkers,"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease risk""}]",257
763,Blood cell count,"[{'article': 'PMC3849204.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",623
764,Blood cytokine levels,"[{'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive improvement in Alzheimer's Disease""}]",666
765,Blood glucose,"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",586
766,Blood neurofilament light (NfL),"[{'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",415
767,Blood pressure,"[{'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk for Alzheimer's Disease""}, {'article': 'PMC5123349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Monitoring health in Alzheimer's Disease patients""}, {'article': 'PMC6208946.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment and amyloid-β accumulation'}]",297
768,Blood samples,"[{'article': 'PMC3849204.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",623
769,Blood-Brain Barrier (BBB) Permeability,"[{'article': 'PMC4939696.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",311
770,Blood-based biomarkers,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",257
771,Blood-markers,"[{'article': 'PMC7934383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive function in Alzheimer's Disease""}]",623
772,Bluish BL with high CS level,"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Reduction in depressive symptoms in Alzheimer's Disease patients""}]",557
773,"Bluish color temperature (4,440–9,325 K)","[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Reduction in agitation in Alzheimer's Disease patients""}]",426
774,Body Mass (BM),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",19
775,Body weight,"[{'article': 'PMC4353453.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment response prediction in Alzheimer's Disease""}, {'article': 'PMC5123349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Monitoring health in Alzheimer's Disease patients""}]",19
776,Bone Mineral Density (BMD),"[{'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7505369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",51
777,Boston Naming Test,"[{'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Naming Impairment in Alzheimer's Disease""}, {'article': 'PMC5302785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Impairment in Alzheimer's Disease""}, {'article': 'PMC9204250.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Verbal fluency in Alzheimer's Disease""}]",185
778,Boston Naming Test (BNT),"[{'article': 'PMC8615710.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reflect treatment response in bilingual speakers with PPA'}]",185
779,Bowel Movements,"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",416
780,Braak stages,"[{'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",128
781,Bradykinin,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",64
782,Brain Amyloid Burden,"[{'article': 'PMC4351428.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to cognitive training in Alzheimer's Disease""}]",8
783,Brain Atrophy,"[{'article': 'PMC5372150.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",184
784,Brain Derived Neurotrophic Factor (BDNF),"[{'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotective and therapeutic effects of exercise on the brain'}]",234
785,"Brain MRI (regional atrophy in frontal, parietal, temporal structures)","[{'article': 'PMC4200223.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Specific BPSD symptoms (delusions, apathy, depressive symptoms)'}]",651
786,"Brain MRI findings (widening of sulci in fronto-insular, occipital, and olfactory sulci)","[{'article': 'PMC9295361.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",329
787,"Brain Rhythms (δ, θ, α1, α2, β1, β2, γ)","[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]",164
788,Brain Volume Loss,"[{'article': 'PMC5372150.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Associated with future cognitive deterioration and conversion to dementia'}]",430
789,Brain age,"[{'article': 'PMC9349172.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",82
790,Brain atrophy,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4200223.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",184
791,Brain atrophy rates,"[{'article': 'PMC8570373.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dementia and Alzheimer's Disease""}, {'article': 'PMC8570373.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",184
792,Brain free fraction (fND),"[{'article': 'PMC5209404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Brain penetration'}]",236
793,Brain glucose metabolism,"[{'article': 'PMC4153084.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to MSDC-0160 treatment in Alzheimer's Disease""}]",539
794,Brain metabolic function,"[{'article': 'PMC4981900.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to RF treatment in AD mice'}]",539
795,Brain structure (grey matter density and amygdala volume),"[{'article': 'PMC4526336.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Social network size and communication ability'}]",634
796,Brain volume,"[{'article': 'PMC4283145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC6218435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Primary progressive aphasia'}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Atabecestat treatment'}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Attenuated brain volume decline in Alzheimer's Disease""}]",160
797,Brain volume (MRI),"[{'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",549
798,Brain volume loss,"[{'article': 'PMC5372150.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",430
799,Brain water content,"[{'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain Edema'}]",82
800,Brain-age gap,"[{'article': 'PMC10310693.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's disease and other neurodegenerative disorders""}]",82
801,Brain-derived neurotrophic factor,"[{'article': 'PMC4707222.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",234
802,Brain-derived neurotrophic factor (BDNF),"[{'article': 'PMC4908397.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Trophic factors in hBM-MSCs dynamic conditioned media'}, {'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved neurogenesis and neuronal survival'}, {'article': 'PMC5105117.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",234
803,BrainAGE,"[{'article': 'PMC3695013.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': ""Conversion to Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'PREDICTS_CONVERSION_TO_AD', 'object': 'Within a time span of 36 months'}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Worse cognitive outcomes and disease severity'}, {'article': 'PMC3695013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Conversion to Alzheimer's Disease in mild cognitive impairment subjects""}, {'article': 'PMC3695013.txt', 'relationship': 'PREDICTS', 'object': ""Conversion to Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Higher risk of developing Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Increased risk of Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Survival: Higher BrainAGE scores predict increased risk of AD conversion'}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Higher scores indicate increased risk of developing Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""BrainAGE reflects cognitive decline and disease progression in Alzheimer's Disease.""}]",82
804,BrainAGE score,"[{'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prediction of conversion to Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better prediction of Alzheimer's Disease compared to cognitive scores and other biomarkers""}]",82
805,BrdU,"[{'article': 'PMC4159858.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Enhanced neurogenesis in AD-like mice'}, {'article': 'PMC4159858.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cell proliferation in Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Impaired brain cell genesis'}, {'article': 'PMC8873004.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Neurogenesis in Alzheimer's Disease""}]",338
806,BrdU-positive cells,"[{'article': 'PMC4159858.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Increased proliferation in AD-like mice'}, {'article': 'PMC4159858.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Sulforaphane treatment'}]",72
807,Breathing patterns,"[{'article': 'PMC9412195.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Physical activity and exercise intensity in Alzheimer's Disease patients""}]",69
808,Bridging integrator 1 (BIN1),"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Proinflammatory activation and neurodegeneration in Alzheimer's Disease""}]",555
809,Bristol ADL,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",121
810,Bristol scores ADL,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",121
811,Burst firing patterns,"[{'article': 'PMC6130053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Critical component of NBM function and effective stimulation'}]",128
812,Butyrate,"[{'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaque deposition in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased amyloid plaque load in Alzheimer's Disease""}, {'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",110
813,Butyric acid,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anti-inflammatory response in Alzheimer's Disease""}]",34
814,C reactive protein,"[{'article': 'PMC2871786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}]",38
815,C-DF,"[{'article': 'PMC4854436.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4854436.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",345
816,C-TMT-A,"[{'article': 'PMC4465490.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Malingering in head injury evaluations'}, {'article': 'PMC4465490.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Functional outcome in TBI patients'}]",84
817,C-TMT-B,"[{'article': 'PMC4465490.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Malingering in head injury evaluations'}, {'article': 'PMC4465490.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in TBI patients'}]",84
818,C-peptide (ICP),"[{'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Correction of brain functions in DM and MS'}]",308
819,C-reactive protein (CRP),"[{'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced inflammation'}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",38
820,C-reactive protein (CRP) levels,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",38
821,C-reactive protein [CRP],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",38
822,C1q,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ phagocytosis and inflammation'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Aβ clearance'}]",111
823,C1qb,"[{'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",111
824,C3,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Aβ clearance'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Reduction in hippocampal levels associated with exercise-induced protection against immune and neuroinflammatory responses after surgery'}, {'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Postoperative Cognitive Dysfunction'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}]",359
825,C3 signaling,"[{'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive impairment'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Learning and memory dysfunction after surgery'}]",359
826,C3ar,"[{'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Reduction in hippocampal levels associated with exercise-induced protection against immune and neuroinflammatory responses after surgery'}]",359
827,C3ar1,"[{'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",359
828,C3b,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ deposition and inflammation'}]",359
829,C4d,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ deposition and inflammation'}]",269
830,C5,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ aggregates and neurotoxic effects'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",233
831,"C99, C89, and C83","[{'article': 'PMC2880593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",148
832,C9ORF72,"[{'article': 'PMC6110931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Linked to primary progressive aphasia (PPA) variants'}]",148
833,C9orf72,"[{'article': 'PMC6158742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",148
834,CA1 volume,"[{'article': 'PMC10075195.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Memory impairment in Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'MEDIATES', 'object': 'The relationship between FBP SUVR and retroactive interference (RI)'}, {'article': 'PMC10075195.txt', 'relationship': 'MEDIATES', 'object': 'The relationship between p-tau and retroactive interference (RI)'}, {'article': 'PMC10075195.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Memory impairment in preclinical Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",604
835,CA2+3 Volume,"[{'article': 'PMC6167961.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease outcome""}]",604
836,CA3 volume,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'RI (hippocampal-dependent memory process)'}]",604
837,CA4 volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",604
838,CAA,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",193
839,CAB101,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",144
840,CAB102,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",144
841,CAD106,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Phase II/III clinical trials in cognitively unimpaired individuals with 2 apoe4 genes'}, {'article': 'PMC6916654.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Active immunotherapy targeting Aβ'}]",144
842,CAM,"[{'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease or related dementia""}]",127
843,CAMCOG,"[{'article': 'PMC3859216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",127
844,CANTAB-RVP,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in attention in participants with mild to moderate Alzheimer's disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",110
845,CASI,"[{'article': 'PMC8305709.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9361147.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]",86
846,CASP4,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",86
847,CASS4,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Associated with decreased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with AD pathogenesis and pathological features'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",219
848,CAVIRE,"[{'article': 'PMC8650134.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC8650134.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early cognitive impairment in Alzheimer's Disease""}]",193
849,CAW,"[{'article': 'PMC8797052.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC8797052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive improvements in Alzheimer's Disease""}]",193
850,CB2R,"[{'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",338
851,CBF,"[{'article': 'PMC3467226.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3467226.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4351428.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to cognitive training in Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",338
852,CBF (Cerebral Blood Flow),"[{'article': 'PMC8690894.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",511
853,CCA-IMT,"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor prognosis in Alzheimer's Disease""}]",465
854,CCA-IMT progression,"[{'article': 'PMC6074058.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive function improvement'}]",465
855,CCH,"[{'article': 'PMC7477392.txt', 'relationship': 'ACCELERATES', 'object': 'Cerebral Aβ deposition'}, {'article': 'PMC7477392.txt', 'relationship': 'PROMOTES', 'object': 'Cognitive impairment in combination with APP gene mutations'}, {'article': 'PMC7477392.txt', 'relationship': 'UPREGULATES', 'object': 'APP processing and β-secretase expression'}]",687
856,CCI,"[{'article': 'PMC8127192.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]",465
857,CCL11,"[{'article': 'PMC4617238.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""10-year delay in the age at onset of Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive function and neurogenesis in Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Elevated levels leading to microglial activation and Aβ clearance'}]",465
858,CCO (Cytochrome C Oxidase),"[{'article': 'PMC9527145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",341
859,CCT,"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Behavioral and Psychological Symptoms of Dementia (BPSD)'}]",83
860,CD-11b,"[{'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",194
861,CD11b,"[{'article': 'PMC4227681.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Microglia activation in Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",194
862,CD11c,"[{'article': 'PMC7389451.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Microglial activation and treatment response in Alzheimer's Disease""}]",194
863,CD127low-neg Tregs,"[{'article': 'PMC6584558.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",156
864,CD163,"[{'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease, particularly in frontal and occipital cortex regions""}, {'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ plaques'}, {'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Increased levels linked to worse prognosis in Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Linked to immune response and microglial activation in Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",194
865,CD25high Tregs,"[{'article': 'PMC6584558.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",156
866,CD2AP,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",39
867,CD2AP SNP rs9349407,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased neuritic plaque pathology'}]",39
868,CD31,"[{'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",194
869,CD33,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction of amyloid plaques and improvement of cognitive function in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Clinical trials for AD treatment (AL003)'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Blocked CD33 expression promoted Aβ phagocytosis and clearance; decreased neuroinflammatory.'}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8066440.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6158742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Advanced Cognitive Decline and Alzheimer's Disease""}]",194
870,CD39,"[{'article': 'PMC6584558.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",194
871,CD39 surface expression,"[{'article': 'PMC6584558.txt', 'relationship': 'NOT_IMPAIRED_IN', 'object': ""Alzheimer's Disease patients""}]",704
872,CD39+ Tregs,"[{'article': 'PMC6584558.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",156
873,CD4,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Severe dementia in Alzheimer's Disease""}]",194
874,CD4+ T cells,"[{'article': 'PMC5342482.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",379
875,CD4+/CD8+ ratio,"[{'article': 'PMC9290489.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Improved immune recovery through MBSR/MBCT/MBCR'}]",379
876,CD4+CD25+Foxp3+ regulatory T cells (Tregs),"[{'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-beta (Aβ) deposition'}, {'article': 'PMC5342482.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapeutic approach for Alzheimer's Disease""}]",313
877,CD4+CD25− T cells (Teffs),"[{'article': 'PMC5342482.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive deficits in Alzheimer's Disease""}]",379
878,CD45high cells,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",379
879,CD47,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",194
880,CD59,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",194
881,CD63,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",194
882,CD68,"[{'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Phagocytic properties of CD163 immunoreactive microglia'}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Phagocytic phenotype in microglia in Alzheimer's Disease""}]",194
883,CD8,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Severe dementia in Alzheimer's Disease""}]",194
884,CD8 cells,"[{'article': 'PMC8258160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",379
885,CD8+ T cells,"[{'article': 'PMC5342482.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",379
886,CD8+ TEMRA,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Worse cognitive function in AD'}]",379
887,CDK5,"[{'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7805132.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment mechanism""}]",233
888,CDK5 kinase,"[{'article': 'PMC7805132.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",399
889,CDR,"[{'article': 'PMC3226277.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3748825.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Staging of Alzheimer's Disease""}, {'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease at mild dementia stage or prodromal AD""}, {'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Clinical Dementia Rating scale score for defining mild-to-moderate AD'}, {'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4611852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8028783.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8305709.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'DIAGNOSITC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4484882.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Dementia Severity Assessment'}, {'article': 'PMC5619332.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Dementia progression in Alzheimer's Disease""}, {'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease or related dementia""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Severity of dementia in Alzheimer's Disease""}, {'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease severity""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-care in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess acquiring new skills in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess driving difficulties in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess motivation in Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Dementia severity in Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease dementia severity""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Disease severity in Alzheimer's Disease""}]",137
890,CDR (global),"[{'article': 'PMC8028783.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of dementia severity in Alzheimer's Disease""}]",137
891,CDR Sum of Boxes,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment severity in Alzheimer's Disease""}]",137
892,CDR score,"[{'article': 'PMC7822717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9395831.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Severity of Alzheimer's Disease""}]",137
893,CDR total score,"[{'article': 'PMC5026133.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",137
894,CDR-SB,"[{'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease clinical decline""}, {'article': 'PMC4484882.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dementia severity in Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia Severity'}]",137
895,CDR-SB score,"[{'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to crenezumab treatment'}]",137
896,CDR-SB scores,"[{'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Change in disease severity over 12 months'}]",137
897,CDR-SOB,"[{'article': 'PMC4396171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4798753.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher CDR-SOB scores in participants with dementia'}, {'article': 'PMC8028783.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dementia severity in Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Disease severity in Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Improvement in clinical dementia rating in patients with Alzheimer's Disease""}]",137
898,CDR-Sb,"[{'article': 'PMC7106668.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Slow gait speed in Alzheimer's Disease patients""}]",137
899,CDR-sb,"[{'article': 'PMC7067750.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",137
900,CDRS,"[{'article': 'PMC9871821.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}]",137
901,CDT,"[{'article': 'PMC3481364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Visuo-spatial disturbances in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Assessment of cognitive decline in AD'}, {'article': 'PMC5326769.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive dysfunction in Alzheimer's Disease""}]",83
902,CE,"[{'article': 'PMC8581408.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-β associated with Alzheimer's Disease""}]",18
903,CELF1,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",349
904,CERAD,"[{'article': 'PMC7001626.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",18
905,CERAD Word List,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection of amnestic mild cognitive impairment'}]",18
906,CERAD battery of mental status tests,"[{'article': 'PMC4983010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",102
907,CERAD neuritic plaque score,"[{'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",18
908,CERAD score,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",18
909,CES-D,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",18
910,CES-D scale,"[{'article': 'PMC3978714.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Depression in Alzheimer's Disease""}]",18
911,CFC,"[{'article': 'PMC4611062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",386
912,CFT,"[{'article': 'PMC9871821.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Biomarker Dynamics: Improved executive function after tPBM treatment'}]",386
913,CFr,"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes in Alzheimer's Disease prevention""}, {'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""poorer cognitive performance in Alzheimer's Disease""}, {'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Alzheimer’s Disease'}]",386
914,CFr (carbohydrate/fat ratio),"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better global cognition in older adults at risk for dementia'}, {'article': 'PMC10236460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Cognitive health in older adults at risk for dementia'}]",54
915,CGA-NPI,"[{'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC5546604.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}]",352
916,CGDS-SF,"[{'article': 'PMC9871821.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Reduced depressive symptoms after tPBM treatment'}]",187
917,CGI-I,"[{'article': 'PMC7930223.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Clinical improvement in Alzheimer's Disease""}]",187
918,CGIC,"[{'article': 'PMC2731764.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor: Clinical Global Impression of Change'}, {'article': 'PMC4712287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Clinical improvement in Alzheimer's Disease""}]",187
919,CHL1,"[{'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",269
920,CIBIC,"[{'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",422
921,CIBIC-Plus,"[{'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",422
922,CIBIC-plus,"[{'article': 'PMC9972756.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Clinical improvement in Alzheimer's Disease""}]",422
923,CIBIS-plus,"[{'article': 'PMC3226311.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Global function in Alzheimer's Disease patients""}]",422
924,CLEC7A,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Rescue of microglia activation and attenuation of Aβ burden in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Microglia activation in AD'}]",302
925,CLOX1,"[{'article': 'PMC3088375.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Executive function deficits in older adults'}]",302
926,CLOX1 clock-drawing task,"[{'article': 'PMC3088375.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment related to Alzheimer's Disease""}]",302
927,CLQT Composite Severity,"[{'article': 'PMC4283612.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Higher scores are associated with more improvement in therapy tasks.'}, {'article': 'PMC4283612.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}]",107
928,CLU,"[{'article': 'PMC4003513.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ levels in Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease inflammation""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Brain atrophy and disease severity in Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",302
929,CMAI,"[{'article': 'PMC9116897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Agitation'}]",212
930,CMAI score,"[{'article': 'PMC8496617.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8496617.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",212
931,CMB,"[{'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",212
932,CMBs,"[{'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral small vessel disease in Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'All-cause dementia risk'}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology'}]",212
933,CMMSE,"[{'article': 'PMC4380493.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4380493.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive function in Alzheimer's Disease""}]",212
934,CMRO2,"[{'article': 'PMC3467226.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",39
935,CMRgl,"[{'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6646979.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Effect of AZD0530 treatment on 52-week reductions in relative CMRgl'}, {'article': 'PMC6646979.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC7489025.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cerebral metabolic rate for glucose in brain regions affected by AD'}]",212
936,CMRglc,"[{'article': 'PMC4877513.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease progression""}]",212
937,CMV pp65 response,"[{'article': 'PMC4013077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",212
938,CNB-001,"[{'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Better prognosis in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of: Alzheimer's Disease""}]",545
939,CNP520,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Phase II/III clinical trials for Alzheimer's Disease""}]",545
940,CNV,"[{'article': 'PMC4195286.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",545
941,CNV amplitude,"[{'article': 'PMC4195286.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Attentional network differences in Alzheimer's Disease""}]",545
942,COI scores,"[{'article': 'PMC5226952.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher semantic organization and improved performance in Experiment 2'}]",1
943,COMT,"[{'article': 'PMC7648990.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",83
944,CONSCIENTIOUSNESS,"[{'article': 'PMC4200223.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower levels linked to increased Behavioral and Psychological Symptoms of Dementia (BPSD)'}]",174
945,COR,"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS', 'object': ""Change in body mass (∆BM) in women and men with Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Involuntary weight loss in AD patients'}]",364
946,COX,"[{'article': 'PMC3978916.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Mitochondrial dysfunction in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Mitochondrial dysfunction in Alzheimer's Disease""}]",615
947,COX-1,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflammation in microglia surrounding amyloid plaques'}, {'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neuroinflammation in Alzheimer's Disease""}]",615
948,COX-2,"[{'article': 'PMC3116821.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegeneration and inflammation'}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaque formation and cognitive impairment'}, {'article': 'PMC3741576.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Therapy for Alzheimer's Disease""}]",615
949,COX2,"[{'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased inflammation in Alzheimer's Disease""}]",615
950,CPNE4,"[{'article': 'PMC6154782.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",269
951,CPT,"[{'article': 'PMC4407573.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",83
952,CQAs,"[{'article': 'PMC8797052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive improvements in Alzheimer's Disease""}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Protection against Aβ-induced cytotoxicity'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased Nrf2 gene expression'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased mitochondrial respiration in neuroblastoma cells'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improved cognition in the 5xFAD mouse model of AD'}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Metabolites in plasma'}]",195
953,CR1,"[{'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD risk'}, {'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment and amyloid plaque formation'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease age at onset""}, {'article': 'PMC4888851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",112
954,CR3,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",112
955,CREB,"[{'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""J147 treatment in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'RESPONDED_TO', 'object': ""J147 Treatment in Alzheimer's Disease""}]",48
956,CRP,"[{'article': 'PMC4013077.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}, {'article': 'PMC6945614.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher CRP levels in the n-IF group were associated with poorer outcomes and increased inflammation.'}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function improvement in older adults with mild cognitive impairment'}, {'article': 'PMC7690082.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",112
957,CRP levels,"[{'article': 'PMC4013077.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Lower levels in ApoE ε4 allele carriers'}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced systemic inflammation'}]",112
958,CRT,"[{'article': 'PMC4407573.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4656817.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4656817.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Alzheimer's Disease progression""}]",112
959,CRT latencies,"[{'article': 'PMC4656817.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Malingering in neuropsychological testing'}]",112
960,CRY1,"[{'article': 'PMC8470960.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Circadian rhythm in Alzheimer's Disease""}]",680
961,CRY2,"[{'article': 'PMC8470960.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Circadian rhythm in Alzheimer's Disease""}]",680
962,CS Del,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Impairment in Alzheimer's Disease""}]",557
963,CS Imm,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Impairment in Alzheimer's Disease""}]",557
964,CS metric,"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Behavioral and Psychological Symptoms of Dementia (BPSD)'}]",315
965,CSDD,"[{'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease or related dementia""}, {'article': 'PMC7749592.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of depressive symptoms in Alzheimer's Disease""}, {'article': 'PMC7749592.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduction in depressive symptoms in Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Comorbid depression in Alzheimer's Disease""}, {'article': 'PMC9116897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Depressive symptoms'}]",315
966,CSDD Behavioral disturbance,"[{'article': 'PMC8317398.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Behavioral disturbances in dementia'}]",315
967,CSDD Mood-related signs,"[{'article': 'PMC8317398.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Mood-related depression in dementia'}]",315
968,CSDD total,"[{'article': 'PMC8317398.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Depression in dementia patients'}]",315
969,CSE,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Homocysteine metabolism issues'}]",83
970,CSF Aβ,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",532
971,CSF Aβ(1–42),"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",532
972,CSF Aβ42,"[{'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",532
973,CSF P-Tau,"[{'article': 'PMC3733998.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
974,CSF amyloid and tau biomarkers,"[{'article': 'PMC6236893.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Distinguish AD from VaD with 80% specificity'}]",8
975,CSF cytokine levels,"[{'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",666
976,CSF p-tau,"[{'article': 'PMC4461930.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Changes in phosphorylated tau (p-tau) levels in cerebral spinal fluid'}]",40
977,"CSF p-tau (T181, T217, T231)","[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]",40
978,CSF p-tau(181),"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
979,CSF t-tau,"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
980,CSF tau,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",669
981,CSF1R,"[{'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related neuropathology""}]",349
982,CSS,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral small vessel disease in Alzheimer's Disease""}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",557
983,CST7,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",83
984,CT,"[{'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",434
985,CT scan,"[{'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",434
986,CTF-α,"[{'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",420
987,CTF-β,"[{'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",420
988,CTNNB1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",219
989,CVFT,"[{'article': 'PMC4380493.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC4380493.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive function in Alzheimer's Disease""}]",49
990,CVLT-II,"[{'article': 'PMC4804486.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4804486.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",49
991,CX3CR1,"[{'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",187
992,CXCL10,"[{'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",187
993,CYP2D6,"[{'article': 'PMC3764973.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC3764973.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for donepezil and galantamine metabolism in Alzheimer's Disease treatment""}]",265
994,"CYP2D6, CYP3A4, CYP3A5","[{'article': 'PMC3764973.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Guiding selection of acetylcholinesterase inhibitors based on genetic alleles'}]",265
995,CYP3A4,"[{'article': 'PMC3764973.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for donepezil and galantamine metabolism in Alzheimer's Disease treatment""}]",265
996,CYP3A5,"[{'article': 'PMC3764973.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for donepezil and galantamine metabolism in Alzheimer's Disease treatment""}]",265
997,CYP450,"[{'article': 'PMC3764973.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Drug metabolism in Alzheimer's Disease treatment""}]",265
998,CYP46A1,"[{'article': 'PMC3712995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved spatial memory retention in aged mice with Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Brain cholesterol metabolism in Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Activation by low-dose EFV'}, {'article': 'PMC9797897.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection: Low-dose EFV for Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target of Efavirenz treatment for Alzheimer's Disease""}]",265
999,CYP46A1 rs754203,"[{'article': 'PMC9797897.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",265
1000,Ca2+,"[{'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Intracellular Ca2+ changes in postsynaptic neuron during tDCS'}]",193
1001,CaV1.2,"[{'article': 'PMC3362564.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""L-VSCC activity in Alzheimer's Disease""}]",193
1002,CaV1.3,"[{'article': 'PMC3362564.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""L-VSCC activity in Alzheimer's Disease""}]",193
1003,Caffeic acid,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Bioavailability in brain'}]",458
1004,Caffeic acid (CA),"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring of Centella asiatica water extract treatment in cognitively impaired older adults'}]",458
1005,Caffeoylquinic acids (CQA),"[{'article': 'PMC8797052.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}]",458
1006,Caffeoylquinic acids (CQAs),"[{'article': 'PMC8868383.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Improved cognitive function in Alzheimer's Disease""}]",458
1007,"California Verbal Learning Test-Second Edition, Adult Version (CVLT-II)","[{'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Verbal Learning and Memory Impairment in Alzheimer's Disease""}]",133
1008,Calretinin,"[{'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",64
1009,Cannabinoid-2 receptor,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]",316
1010,Carbohydrate intake,"[{'article': 'PMC8502814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid accumulation in the posterior cingulate gyrus in preclinical Alzheimer's Disease""}]",54
1011,Cardiorespiratory fitness,"[{'article': 'PMC4497726.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive benefits in older adults'}]",69
1012,Carotid Intima-Media Thickness (CCA-IMT),"[{'article': 'PMC6074058.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Progression of non-dementia vascular cognitive impairment'}]",405
1013,Caspase 3,"[{'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neuronal death'}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Apoptosis'}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",86
1014,Catalase,"[{'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Upregulation of catalase during osteogenesis in human MSCs'}]",14
1015,Category Fluency,"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",394
1016,Category fluency,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",394
1017,Category fluency test,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",394
1018,Category fluency test scores,"[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease diagnosis""}]",394
1019,Cathepsin B,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Amyloid plaques and Aβ levels in Alzheimer's Disease""}]",14
1020,Cathepsin L,"[{'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alpha-secretase activity and Aβ suppression in Alzheimer's Disease""}]",14
1021,Caudate,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",237
1022,Caudate Volume,"[{'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",237
1023,Caudate and putamen volume,"[{'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",237
1024,Caudate volume loss,"[{'article': 'PMC9606044.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}]",237
1025,Cav1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Transcellular transport across the BBB'}]",193
1026,Ccl12,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",465
1027,Cd14,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",194
1028,Cd44,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",194
1029,Cd9,"[{'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'AD-associated microglial activation'}]",194
1030,Cdh5,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Tight junctions'}]",233
1031,Ceftriaxone,"[{'article': 'PMC4857621.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}]",18
1032,CentPT latencies,"[{'article': 'PMC4656817.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cognitive processing time in participants'}]",80
1033,Centiloid (CL),"[{'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid burden in Alzheimer's Disease""}]",342
1034,Centiloid method,"[{'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",342
1035,Centiloid scale assessments,"[{'article': 'PMC9768996.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Slowing of clinical decline in Alzheimer's Disease""}]",342
1036,Centiloid threshold values,"[{'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early amyloid accumulation in Alzheimer's Disease""}]",342
1037,Centiloid value,"[{'article': 'PMC6909550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-beta plaques'}]",342
1038,Centiloids,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",342
1039,Central Executive Network (CEN),"[{'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better cognitive performance in older adults'}]",437
1040,Central memory helper T lymphocytes (CD45RA−CCR7+),"[{'article': 'PMC2871786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}]",139
1041,Cereb,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",18
1042,Cerebellar hemispheric mass,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",93
1043,Cerebellum and brain stem volume loss,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",430
1044,Cerebelum_8_L (aal),"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",588
1045,Cerebelum_8_R,"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",588
1046,Cerebelum_8_R (aal),"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",588
1047,Cerebral Atrophy,"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",184
1048,Cerebral Blood Flow,"[{'article': 'PMC6538045.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring during cognitive training in Alzheimer’s Disease'}]",511
1049,Cerebral Blood Flow (CBF),"[{'article': 'PMC8211849.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4351428.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive Gains in Healthy Seniors'}, {'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved Cognitive Function in Aging Population'}, {'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher cognitive performance'}, {'article': 'PMC9269742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Cerebrovascular change'}, {'article': 'PMC9269742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",511
1050,Cerebral Blood Flow (CBF) in Central Executive Network (CEN),"[{'article': 'PMC4351428.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",511
1051,Cerebral Blood Flow (CBF) in Default Mode Network (DMN),"[{'article': 'PMC4351428.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",511
1052,Cerebral Blood Flow Velocity (CBFv),"[{'article': 'PMC6538045.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Assess neurovascular response to cognitive training'}]",511
1053,Cerebral Metabolic Rate of Glucose (CMRglc),"[{'article': 'PMC4153084.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC4153084.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring of treatment response in Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to MSDC-0160 treatment'}]",539
1054,Cerebral SVD,"[{'article': 'PMC7477392.txt', 'relationship': 'MAY_BE_A_CAUSE_OF', 'object': 'Cognitive impairment in AD'}, {'article': 'PMC7477392.txt', 'relationship': 'PROMOTES', 'object': 'Aβ accumulation and neuronal damage'}]",298
1055,Cerebral Spinal Fluid (CSF) Influx,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",155
1056,Cerebral amyloid angiopathy (CAA),"[{'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]",8
1057,Cerebral atrophy,"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive aging'}]",184
1058,Cerebral atrophy on MRI,"[{'article': 'PMC7477392.txt', 'relationship': 'REFLECTS', 'object': 'Cumulative loss and shrinkage of neuropil'}]",651
1059,Cerebral blood flow,"[{'article': 'PMC4153084.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",511
1060,Cerebral blood flow (CBF),"[{'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Improved cerebral blood flow during physical exercise in Alzheimer's Disease""}]",511
1061,Cerebral blood flow (CBF) in left middle temporal gyrus (MTG),"[{'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive improvements in Strategic Reasoning and Executive Function'}]",52
1062,Cerebral glucose metabolic rate,"[{'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",539
1063,Cerebral glucose metabolism,"[{'article': 'PMC5026133.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Treatment response to DBS in Alzheimer's Disease""}, {'article': 'PMC7489025.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC7489025.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment with GV-971""}]",539
1064,Cerebral glucose uptake,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduced gait speed and reduced cadence'}]",586
1065,Cerebral hypometabolism on FDG PET,"[{'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",664
1066,Cerebral infarcts,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",404
1067,Cerebral metabolic rate for glucose (CMRgl),"[{'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",539
1068,Cerebral metabolic rate of glucose (CMRgl),"[{'article': 'PMC1373642.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Reduced CMRgl in MTL and cortical regions of AD patients and ε4 carriers'}]",539
1069,Cerebral microbleeds,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",311
1070,Cerebral microbleeds (CMBs),"[{'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",311
1071,Cerebral spinal fluid,"[{'article': 'PMC7171193.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",155
1072,Cerebral spinal fluid (CSF),"[{'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",155
1073,Cerebral spinal fluid (CSF) biomarkers,"[{'article': 'PMC7364345.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",155
1074,Cerebral spinal fluid (CSF) tests,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",155
1075,Cerebral spinal fluid Aβ levels,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",140
1076,Cerebral spinal fluid Aβ(1–42) levels,"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s disease'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Alzheimer’s disease'}, {'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Crenezumab treatment'}]",140
1077,Cerebral spinal fluid Aβ40,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",140
1078,Cerebral spinal fluid Aβ42,"[{'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Parenchymal Aβ42'}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}]",140
1079,Cerebral spinal fluid Aβ42 measurement,"[{'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4304279.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Target engagement and amyloid accumulation'}]",140
1080,Cerebral spinal fluid Aβ42/40 ratio,"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",140
1081,Cerebral spinal fluid Aβ42/Aβ40,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Volumes of CA1, subiculum, and transentorhinal cortex/BA35'}]",140
1082,Cerebral spinal fluid F2-IsoPs,"[{'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",155
1083,Cerebral spinal fluid Mid-p-tau231,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",98
1084,Cerebral spinal fluid N-p-tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",98
1085,Cerebral spinal fluid N-p-tau217,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",98
1086,Cerebral spinal fluid Phospho-tau,"[{'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",98
1087,Cerebral spinal fluid Total tau,"[{'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",98
1088,Cerebral spinal fluid amyloid-β 42 peptide (Aβ42),"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",140
1089,Cerebral spinal fluid biomarkers,"[{'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides treatment selection: Alzheimer's Disease""}]",155
1090,Cerebral spinal fluid markers,"[{'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional disability progression in Alzheimer's Disease""}]",155
1091,Cerebral spinal fluid p-tau,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Volumes of CA1, subiculum, and transentorhinal cortex/BA35'}, {'article': 'PMC4970664.txt', 'relationship': 'DIAGNOSITIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]",98
1092,Cerebral spinal fluid t-tau,"[{'article': 'PMC4970664.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",98
1093,Cerebro-cerebral spinal fluid examination,"[{'article': 'PMC6110931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",155
1094,Cerebrospinal fluid Aβ42/40,"[{'article': 'PMC8808989.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",351
1095,Cerebrospinal fluid Aβ42/40 ratio,"[{'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",351
1096,Cerebrospinal fluid P-tau/Aβ42,"[{'article': 'PMC8808989.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",351
1097,Cerebrospinal fluid T-tau/Aβ42,"[{'article': 'PMC8808989.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",351
1098,Cerebrospinal fluid p-Tau,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau pathology'}]",351
1099,Cerebrospinal fluid t-tau,"[{'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau pathology'}]",351
1100,Cerebrovascular disease,"[{'article': 'PMC5389824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",107
1101,Ch1/2 subfield volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",700
1102,Ch3 subfield volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",700
1103,Ch4 subfield atrophy,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive and spatial navigation deficits in Alzheimer's Disease""}]",286
1104,Ch4a-i,"[{'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better executive function'}]",269
1105,Ch4a-i subfield volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",700
1106,Ch4p,"[{'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better language function'}, {'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better navigation function'}]",269
1107,Ch4p subfield volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",700
1108,ChAT,"[{'article': 'PMC2765081.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Memory improvement'}, {'article': 'PMC4159858.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cholinergic neuron loss in AD-like mice'}, {'article': 'PMC4159858.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cholinergic neuron loss in Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cholinergic activity in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Improved cognitive function and memory performance in AD rat model'}]",684
1109,ChAT activity,"[{'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Correlated with cognitive changes in Alzheimer's Disease""}]",684
1110,ChAT immuno-positive neurons,"[{'article': 'PMC4159858.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cholinergic neuron loss in AD-like mice'}, {'article': 'PMC4159858.txt', 'relationship': 'RESPONDED_TO', 'object': 'Sulforaphane treatment'}]",72
1111,Chemokines,"[{'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",64
1112,Chitinase-3-like protein 1 (CHI3L1 or YKL-40),"[{'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",147
1113,Cho/Cr,"[{'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild Cognitive Impairment related to Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",112
1114,Cholesterol,"[{'article': 'PMC3397527.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Increased risk of Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced parietal cortical amyloid burden in apoe4 noncarriers'}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",413
1115,Cholesterol levels,"[{'article': 'PMC8351379.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'White matter integrity preservation'}, {'article': 'PMC6208946.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",413
1116,Choline,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",529
1117,Choline (Cho),"[{'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",529
1118,Choline acetyltransferase (ChAT),"[{'article': 'PMC4159858.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",191
1119,Cholinergic activity,"[{'article': 'PMC6565843.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",191
1120,Cholinergic neurons,"[{'article': 'PMC4159858.txt', 'relationship': 'RESPONDED_TO', 'object': 'Sulforaphane treatment'}, {'article': 'PMC4159858.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",191
1121,Cholinergic system,"[{'article': 'PMC5326769.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Vascular Cognitive Impairment'}]",191
1122,Cholinesterase activity,"[{'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",191
1123,Cingulum bundle,"[{'article': 'PMC6306691.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Hippocampal formation disruption in Alzheimer's Disease""}]",196
1124,Cingulum bundle disruption,"[{'article': 'PMC7477392.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Memory decline in Alzheimer's Disease""}]",196
1125,Cingulum_Mid_R,"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",196
1126,Cingulum_Mid_R (aal),"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",196
1127,Circadian Clocks Desynchronization,"[{'article': 'PMC6520689.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",164
1128,Cirrhosis,"[{'article': 'PMC5389824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",126
1129,Cldn5,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Tight junctions'}]",302
1130,Cleaved caspase 3,"[{'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",86
1131,Cleaved caspase-3,"[{'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",86
1132,Clec7a,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Microglial Neurodegenerative Phenotype (MGnD) in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'AD-associated microglial activation'}, {'article': 'PMC7389451.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Enhanced Aβ clearance in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",302
1133,Clic5a,"[{'article': 'PMC10917684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Upregulated in 40Hz stimulation'}]",302
1134,Clinical Dementia Rating (CDR),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4497726.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia'}, {'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Severity of dementia'}]",686
1135,Clinical Dementia Rating (CDR) scores,"[{'article': 'PMC5648830.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]",686
1136,Clinical Dementia Rating Scale (CDR),"[{'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dementia severity in Alzheimer's Disease""}]",686
1137,Clinical Dementia Rating Sum of Boxes (CDR-SB),"[{'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Alzheimer's Disease""}]",686
1138,Clinical Dementia Rating scale,"[{'article': 'PMC6343283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Dementia severity in Alzheimer's Disease""}]",21
1139,Clinical Dementia Rating scale-Sum of Boxes (CDR-SB),"[{'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",686
1140,Clinical dementia Rating (CDR),"[{'article': 'PMC8336239.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}]",686
1141,Clinical dementia Rating–sum of boxes (CDR-SB),"[{'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}]",686
1142,Clock C,"[{'article': 'PMC7354597.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression in hypertensive patients""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher proportion of progression to AD in hypertensive group'}]",122
1143,Clock Drawing Test,"[{'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC5619332.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",68
1144,Clock Drawing test,"[{'article': 'PMC7662628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive impairment and dementia conversion'}]",68
1145,Clock T3111C,"[{'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Higher risk of conversion to Alzheimer's Disease in carriers with hypertension""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Conversion to Alzheimer's Disease in hypertensive patients""}]",122
1146,Clock Test,"[{'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",68
1147,Clock drawing,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",68
1148,Clock-Drawing Test,"[{'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Cognitive impairment in Alzheimer's Disease""}]",68
1149,Clock-drawing test,"[{'article': 'PMC4804486.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",68
1150,Clusterin,"[{'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Late-onset Alzheimer's Disease""}]",114
1151,Clusterin genotype,"[{'article': 'PMC4846650.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Pre-AD'}]",114
1152,CoQ10,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",111
1153,CoV of stride time,"[{'article': 'PMC3898226.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Memantine treatment'}]",646
1154,Coefficient of Variation (CoV) of stride time,"[{'article': 'PMC3156726.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3898226.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to memantine treatment in Alzheimer's Disease patients""}, {'article': 'PMC3898226.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Gait safety improvement in Alzheimer's Disease patients treated with memantine""}, {'article': 'PMC3898226.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to anti-dementia treatment'}]",646
1155,Cognition,"[{'article': 'PMC3581819.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Better cognitive function in Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]",104
1156,Cognitive Level (MMSE),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",41
1157,Cognitive Reserve (CR),"[{'article': 'PMC6937673.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Medication Therapy Management (MTM) interventions'}]",580
1158,Cognitive behavioral deficits,"[{'article': 'PMC4707222.txt', 'relationship': 'RESPONDED_TO', 'object': ""Response: Improvement in cognitive behavioral deficits in Alzheimer's Disease""}]",516
1159,Cognitive composite score,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]",41
1160,Cognitive deficits,"[{'article': 'PMC6530014.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Improvement in cognitive deficits in AD patients'}]",516
1161,Cognitive disorders examination test,"[{'article': 'PMC3681660.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Guide subjects with memory impairment to full memory consultations at hospitals'}]",41
1162,Cognitive disorders examination test (CODEX),"[{'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",41
1163,Cognitive function,"[{'article': 'PMC4981900.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis in AD mice'}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Improvement in Alzheimer's Disease""}]",104
1164,Cognitive function (ADAS-cog),"[{'article': 'PMC4324943.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive function in individuals with mild to moderate dementia'}]",41
1165,Cognitive impairment,"[{'article': 'PMC1914346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Nursing home admission'}, {'article': 'PMC4923754.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional impairment in Alzheimer's Disease""}, {'article': 'PMC4923754.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Disease-modifying treatments for Alzheimer's Disease""}]",516
1166,Cognitive intra-individual variability (IIV),"[{'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Functional decline and incident dementia'}]",55
1167,Cognitive performance,"[{'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}]",41
1168,Cognitive reserve (CR),"[{'article': 'PMC4846650.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Pre-AD'}]",580
1169,Cognitive reserve change score (CRCS),"[{'article': 'PMC6937673.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Cognitive reserve'}]",580
1170,Cognitive score,"[{'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",41
1171,Cognitive scores (ADAS-Cog11),"[{'article': 'PMC6685277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}]",41
1172,Cognitive scores (MMSE),"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",41
1173,"Cognitive tasks (visual oddball, flanker, n-back, delayed match-to-sample)","[{'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Track cognitive ageing and progression of Alzheimer's Disease""}]",332
1174,Cognitive test scores,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease based on cognitive decline""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",41
1175,Cognitive tests,"[{'article': 'PMC4497726.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Cognitive impairment'}]",41
1176,Cohen-Mansfield Agitation Inventory,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Agitation and aggressiveness in Alzheimer's Disease""}]",282
1177,Collaborative network spontaneous activity,"[{'article': 'PMC10439779.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Verbal memory improvement (AVLT-S changes)'}, {'article': 'PMC10439779.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'General cognitive improvement (MoCA score changes)'}, {'article': 'PMC10439779.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Episodic memory improvement (AVLT-L changes)'}, {'article': 'PMC10439779.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Sleep quality improvement (PSQI changes)'}]",437
1178,Colony-stimulating factor 1 receptor,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]",316
1179,Communication Problems Scale,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Semantic and pragmatic communication issues in Alzheimer's Disease""}]",128
1180,Community consistency in SMC,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased community consistency in the sensorimotor community'}]",437
1181,Complement C3,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Ameliorated C3b/CR3 complement activation, decreased inflammatory cytokines, promoted Aβ phagocytosis, and inhibited synapse loss.'}]",392
1182,Complement proteins,"[{'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Complement-mediated synapse loss in Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Synaptic pruning'}]",392
1183,Complement system components,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuroprotective response in Alzheimer's Disease""}]",392
1184,Complete Blood Count (CBC),"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",623
1185,Complex attention,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]",407
1186,Compliance,"[{'article': 'PMC3212921.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Memantine treatment adherence'}]",627
1187,Complutense Verbal Learning Test (TAVEC),"[{'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Memory and learning processes in Alzheimer's Disease""}]",133
1188,Composite PET SUVR,"[{'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",375
1189,Composite SUVR,"[{'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",375
1190,Composite z-scores for cognitive function,"[{'article': 'PMC4153084.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive response to treatment in Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",41
1191,Comprehensive Trail Making Test (TMT),"[{'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Executive Function Impairment in Alzheimer's Disease""}]",662
1192,Computer-based touchscreen cognitive task,"[{'article': 'PMC8325256.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement due to Levetiracetam treatment'}]",346
1193,Conformationally changed Tau (MC1),"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",40
1194,Congo red,"[{'article': 'PMC3978916.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Mature amyloid plaques'}]",57
1195,Connected speech,"[{'article': 'PMC3859216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s disease'}]",74
1196,Constant Therapy performance,"[{'article': 'PMC9513684.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to cognitive training'}, {'article': 'PMC9513684.txt', 'relationship': 'RESPONDED_TO', 'object': 'Cognitive training intervention'}]",310
1197,Contactin,"[{'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",452
1198,Contactin 2,"[{'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",452
1199,Contactin-2,"[{'article': 'PMC6182869.txt', 'relationship': 'NOT_USED_TO_DIAGNOSE', 'object': 'No significant changes in levels'}]",452
1200,Controlled Oral Word Association Test (COWAT),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",101
1201,Cookie Theft descriptions,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",77
1202,Copper,"[{'article': 'PMC9755275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",244
1203,Cornell Scale for Depression in dementia,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Depression in Alzheimer's Disease""}, {'article': 'PMC4431827.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depression in Alzheimer's Disease patients""}]",21
1204,Correct-word scores,"[{'article': 'PMC5147824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}]",17
1205,Cortical AD signature,"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': ""Alzheimer's Disease development""}]",44
1206,Cortical Aβ,"[{'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
1207,Cortical Plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",44
1208,Cortical Surface Area,"[{'article': 'PMC10310693.txt', 'relationship': 'PREDICTS_NEURODEGENERATIVE_DISORDERS', 'object': ""Alzheimer's Disease""}]",566
1209,Cortical Thickness,"[{'article': 'PMC10310693.txt', 'relationship': 'PREDICTS_NEURODEGENERATIVE_DISORDERS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",197
1210,Cortical Thickness (CT),"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amild cognitive impairment'}, {'article': 'PMC4870937.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Neuropsychological scores (MMSE and MoCA)'}]",197
1211,Cortical amyloid β (Aβ) deposition,"[{'article': 'PMC6615169.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
1212,Cortical atrophy,"[{'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Poor clinical response in Alzheimer's Disease""}]",184
1213,Cortical plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'PREDICTS_THERAPEUTIC_OUTCOME', 'object': ""Cognitive improvement in Alzheimer's Disease patients""}]",44
1214,Cortical surface area,"[{'article': 'PMC6547570.txt', 'relationship': 'USED_TO_DETECT', 'object': 'Brain structural alterations in individuals with Subjective Cognitive Decline (SCD)'}]",566
1215,Cortical tau load,"[{'article': 'PMC7477392.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'WMH burden'}]",40
1216,Cortical thickness,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Predict disease progression in AD'}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",197
1217,Cortical thickness in early regions,"[{'article': 'PMC6167961.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",197
1218,Cortical thickness in entorhinal cortex,"[{'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",36
1219,Cortical thickness in inferior temporal gyri,"[{'article': 'PMC2764863.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]",90
1220,Cortical thickness in temporal gyri,"[{'article': 'PMC2764863.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",90
1221,Cortical volume,"[{'article': 'PMC8638526.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6910674.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease progression""}]",160
1222,Cortico-motor plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function changes in Alzheimer's Disease""}]",44
1223,Cortico-motor reactivity,"[{'article': 'PMC7360860.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Cognitive improvement in Alzheimer's Disease""}]",44
1224,Corticosteroid Circadian Rhythm,"[{'article': 'PMC6520689.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",164
1225,Cortisol,"[{'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress linked to Alzheimer's Disease""}, {'article': 'PMC3652205.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to yoga and compassion meditation program intervention'}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Exacerbation of behavioral disorders in Alzheimer's Disease""}, {'article': 'PMC8336239.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Sleep-wake disorders in persons with Alzheimer's Disease""}, {'article': 'PMC8336239.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Changes in sleep-wake disturbances (SWDs)'}, {'article': 'PMC5301048.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Accelerated disease progression in Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved executive function (Stroop performance)'}, {'article': 'PMC6162846.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Executive function improvement in mild cognitive impairment'}]",132
1226,Cortisol (COR),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",132
1227,Cortisol levels,"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Weight loss in patients with Alzheimer's Disease""}]",132
1228,Cortisolism,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Weight loss in Alzheimer's Disease patients""}]",132
1229,Creatine kinase,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced levels in AD brains'}]",633
1230,Creatine+Phosphocreatine,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",633
1231,Creatinine,"[{'article': 'PMC2194921.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Kidney function during indomethacin treatment'}, {'article': 'PMC2194921.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Return to previous levels after treatment discontinuation'}, {'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Renal function in Alzheimer's Disease patients""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",633
1232,Crenezumab,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Phase III study in prodromal-to-mild AD'}]",48
1233,Crohn’s Disease,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",416
1234,Cst7,"[{'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'AD-associated microglial activation'}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",83
1235,Ctrough (Plasma drug concentration),"[{'article': 'PMC8157623.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to neflamapimod treatment'}]",27
1236,Cu/Zn-superoxide dismutase (SOD),"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",515
1237,Curcumin,"[{'article': 'PMC3237323.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of: Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3397527.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaques in Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",344
1238,Cx43,"[{'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",187
1239,CyPA,"[{'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease vs. Subcortical Ischemic Vascular Dementia""}, {'article': 'PMC9393528.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease severity in Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Differential diagnosis between Alzheimer's Disease (AD) and Subcortical Ischemic Vascular Dementia (SIVD)""}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Distinguish between AD and SIVD diagnosis'}]",400
1240,Cyanocobalamin,"[{'article': 'PMC3849204.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",400
1241,Cyclooxygenase,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]",341
1242,Cys C,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotection and neurite outgrowth'}]",400
1243,Cystatin C,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroregulatory molecules in dynamic hBM-MSCs secretome'}]",400
1244,Cytochrome c,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",341
1245,Cytochrome c oxidase (COX),"[{'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease treatment response""}]",341
1246,Cytokine and chemokine signatures,"[{'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuro-inflammation'}]",666
1247,Cytokines,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RESPONDED_TO', 'object': 'Transcranial Electromagnetic Treatment (TEMT)'}, {'article': 'PMC9108275.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reversal of Cognitive Impairment'}, {'article': 'PMC9108275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Progression""}, {'article': 'PMC9108275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to TEMT treatment in Alzheimer's Disease patients""}]",666
1248,D-KEFS,"[{'article': 'PMC4854436.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",345
1249,D-serine,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Cognitive performance in Alzheimer's Disease""}]",345
1250,D1 receptor,"[{'article': 'PMC8048550.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC8048550.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor outcome in Alzheimer's Disease""}]",316
1251,D1-like receptors,"[{'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",316
1252,D2-like receptors,"[{'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",316
1253,D54D2,"[{'article': 'PMC10917684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid presence in Alzheimer's Disease""}]",143
1254,DA,"[{'article': 'PMC4174765.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline and apathy in Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increase in DA levels'}]",578
1255,DA metabolite HVA,"[{'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}]",0
1256,DA9,"[{'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",561
1257,DA9-positive Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
1258,DAD,"[{'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Disability Assessment in Dementia due to Alzheimer's Disease""}, {'article': 'PMC5111338.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess: Functional impairment in Alzheimer's Disease""}, {'article': 'PMC5111338.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Functional response to galantamine treatment in memantine nonusers'}, {'article': 'PMC5111338.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Functional outcome monitoring during treatment'}, {'article': 'PMC5403784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",113
1259,DAD scores,"[{'article': 'PMC5111338.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Functional decline: Slower progression in galantamine-treated patients'}, {'article': 'PMC5111338.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mortality: Lower rates in galantamine-treated patients'}]",21
1260,DAM,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",578
1261,DAMPs,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",337
1262,DAN alterations,"[{'article': 'PMC5399035.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",345
1263,DAS,"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",113
1264,DC11,"[{'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",574
1265,DC25,"[{'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",574
1266,DC8E8,"[{'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'DIAGNOSITC_OF', 'object': ""Diagnose: Early stages of Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Inhibits pathological tau–tau interactions'}, {'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Mis-disordered tau protein in Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",63
1267,DC8E8 antibody,"[{'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treat: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treat: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for: Alzheimer's Disease treatment""}]",25
1268,DCS,"[{'article': 'PMC9354045.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia and Mild Cognitive Impairment'}, {'article': 'PMC9354045.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Cognitive outcomes in older adults'}]",574
1269,DCX,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuronal differentiation and survival in Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Newborn neurons in the dentate gyrus (DG)'}]",574
1270,DDIT4,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",269
1271,DELAPAGTGVSREAVSG,"[{'article': 'PMC4780148.txt', 'relationship': 'RESPONDED_TO', 'object': ""Biomarker for Alzheimer's Disease""}, {'article': 'PMC4780148.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'APLP1 cleavage'}]",193
1272,DEMQOL,"[{'article': 'PMC5067903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",674
1273,DEMQoL scale,"[{'article': 'PMC7413274.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Health-related Quality of Life (QoL) in Persons with Dementia (PwD)'}]",674
1274,DG volume,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'RI (hippocampal-dependent memory process)'}]",6
1275,DHA,"[{'article': 'PMC3335851.txt', 'relationship': 'RESPONDED_TO', 'object': 'Treatment with n-3 FAs'}, {'article': 'PMC3335851.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to n-3 FA treatment'}, {'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline and Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Slowing disease progression in Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Dietary supplementation in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive performance in Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced transport to cerebral spinal fluid in APOE ε4 carriers'}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Lower levels in cerebral spinal fluid of participants with low Aβ42'}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased cerebrospinal fluid DHA levels after supplementation'}, {'article': 'PMC4928349.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Lower levels in participants with lower Aβ42 tertiles'}, {'article': 'PMC4928349.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Alzheimer's Disease treatment""}, {'article': 'PMC4928349.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'RESPONDED_TO', 'object': ""Response to Treatment in Alzheimer's Disease""}, {'article': 'PMC5223628.txt', 'relationship': 'PREDICTS_BETTER_OUTCOME', 'object': 'Predicts improved or stabilised ADAS-Cog at 12 months'}, {'article': 'PMC6521224.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment compliance and biological activity'}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility for study participation based on plasma levels'}, {'article': 'PMC7223540.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC9644639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive outcomes in Alzheimer's Disease""}]",438
1276,DHA (22:6n-3),"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline in the elderly'}, {'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}]",438
1277,DHEA-S,"[{'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",438
1278,DHEA-s,"[{'article': 'PMC5301048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': '11β-HSD1 inhibition'}]",438
1279,DJ-1,"[{'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Treatment response in Alzheimer's Disease""}]",620
1280,DLPFC,"[{'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7735856.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Improved item memory performance in elderly populations'}]",489
1281,DLPFC activity,"[{'article': 'PMC7364345.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Cognitive functions in Alzheimer's Disease""}]",489
1282,DMN,"[{'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",143
1283,DMN connectivity changes,"[{'article': 'PMC4503593.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4503593.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]",543
1284,DMN disruptions,"[{'article': 'PMC5399035.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",543
1285,DMS48,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Visual recognition memory deficits in Alzheimer's Disease""}]",143
1286,DNA damage,"[{'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced DNA damage'}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced DNA damage events and improved cognitive function'}]",472
1287,DNA methylation,"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Biological age and lifespan'}]",472
1288,DNAm age-acceleration,"[{'article': 'PMC5508035.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5508035.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease severity and progression'}]",472
1289,DO 80,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",63
1290,DPs,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",143
1291,DR,"[{'article': 'PMC3675142.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Demyelination and axonal degeneration associated with Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Early Alzheimer's Disease""}]",383
1292,DRG1,"[{'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",628
1293,DRS,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",383
1294,DRS-2,"[{'article': 'PMC6130053.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Disease severity in patients with Alzheimer's Disease.""}]",383
1295,DSB,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",570
1296,DSF,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",570
1297,DSG2,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",570
1298,DSM criteria,"[{'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",570
1299,DTI,"[{'article': 'PMC8760674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'White matter structural integrity'}, {'article': 'PMC5200876.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcomes for individuals with Alzheimer's Disease through pre-symptomatic detection""}, {'article': 'PMC6130053.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Structural and functional features of frontostriatal and hippocampus-PCC neural circuits'}, {'article': 'PMC9246122.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'White matter structural integrity changes in mild cognitive impairment and AD'}]",228
1300,DTI and GM volume measures,"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment with improved accuracy'}]",228
1301,DTI measures,"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}]",228
1302,DWMH,"[{'article': 'PMC5546604.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease based on white matter hyperintensity severity""}]",30
1303,DYRK1A,"[{'article': 'PMC4675859.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostic model""}, {'article': 'PMC4675859.txt', 'relationship': 'MODULATES', 'object': ""Alzheimer's Disease""}]",143
1304,DYRK1A kinase activity,"[{'article': 'PMC4675859.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Neurocognitive symptoms and neurodegenerative phenotypes in Down syndrome'}]",143
1305,Da,"[{'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""White matter integrity in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",578
1306,DaTscan®,"[{'article': 'PMC6236893.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",294
1307,Decline of executive functions,"[{'article': 'PMC4174765.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",460
1308,Decreased alpha-band power,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",42
1309,Decreased beta-band power,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",42
1310,Default Mode Network (DMN),"[{'article': 'PMC8287201.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive brain health'}]",543
1311,Default network dysregulation,"[{'article': 'PMC4150993.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poorer memory performance in Alzheimer's Disease""}]",543
1312,Default-mode network (DMN),"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Acupuncture treatment response in Alzheimer's Disease""}]",543
1313,Default-mode network (DMN) disruption,"[{'article': 'PMC9309357.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]",543
1314,Delayed Memory Recall (MDR),"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",221
1315,Delayed Recall,"[{'article': 'PMC4380493.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC4380493.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}]",221
1316,Delayed Recall (DR),"[{'article': 'PMC5226952.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",221
1317,Delayed Verbal and Visual Recall,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]",221
1318,Delayed memory,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease""}]",221
1319,Delayed memory domain score,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Significant improvement in delayed memory functions in suspected mild cognitive impairment'}]",157
1320,Delayed recall,"[{'article': 'PMC4181752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in INPH patients'}]",221
1321,Delta Power,"[{'article': 'PMC10758173.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in memory performance'}]",58
1322,Delta band,"[{'article': 'PMC3914466.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",58
1323,Delta band activity,"[{'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",58
1324,Delta frequency band,"[{'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",58
1325,Delta power,"[{'article': 'PMC10758173.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Relative memory increase at post-intervention and follow-up'}, {'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'NREM sleep classification'}]",58
1326,Deltaproteobacteria,"[{'article': 'PMC8843023.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Contribution to AD pathology'}]",643
1327,Delusions,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",174
1328,Dementia Mood Assessment Scale,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Depression severity in Alzheimer's Disease""}]",21
1329,Dementia Quality of Life Instrument (DQoL),"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Quality of life in mild to moderate dementia'}]",480
1330,Dentate gyrus (DG) volume,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Retroactive interference (RI)'}]",90
1331,Dentate gyrus volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",90
1332,Depressive symptoms,"[{'article': 'PMC9246122.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",270
1333,Design Fluency,"[{'article': 'PMC4854436.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Decline in Alzheimer's Disease""}]",104
1334,Desulfovibrionaceae,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology in transgenic mice'}]",503
1335,Di-CQAs,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Protection against cell death, excitotoxic and hypoxic damage in rat cortical neurons'}]",195
1336,Diabetes,"[{'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia incidence'}]",390
1337,Diabetes Management,"[{'article': 'PMC10542675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved diabetes management reduces Alzheimer's Disease risk""}]",390
1338,Diabetes Mellitus,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC5389824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",390
1339,Diabetes mellitus,"[{'article': 'PMC5389824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}, {'article': 'PMC5389824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive deterioration'}]",390
1340,Dialister,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid Aβ42/Aβ40 ratio (lower levels reflect greater amyloid burden)'}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Less AD pathology'}]",141
1341,Diastolic BP,"[{'article': 'PMC8000213.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to MBSR intervention'}]",297
1342,Dicaffeoylquinic acids,"[{'article': 'PMC8868383.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Centella asiatica treatment in cognitively impaired older adults'}]",458
1343,Diet (MIND diet),"[{'article': 'PMC8857690.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced risk of Alzheimer's Disease""}]",145
1344,Diffuse loss of brain volume,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",430
1345,Diffuse plaques (DPs),"[{'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]",548
1346,Diffusion tensor imaging (DTI),"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression in Familial Alzheimer’s disease'}]",228
1347,Diffusion tensor imaging measures of white matter integrity,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor gait performance'}]",23
1348,Digit Span,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection of amnestic mild cognitive impairment'}, {'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}]",654
1349,Digit Symbol,"[{'article': 'PMC4876902.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Disease Progression in Alzheimer's Disease""}]",424
1350,Digit span forward,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",654
1351,Digit span forward test,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Short-term memory in Alzheimer's Disease""}]",654
1352,Digit span test,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",654
1353,Digit-span,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",654
1354,Digit-symbol substitution,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in attention in participants with mild to moderate Alzheimer's disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",424
1355,Digital Neuro Signature (DNS),"[{'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease and mild cognitive impairment""}, {'article': 'PMC8225898.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Predicting conversion from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: Disease progression and treatment response in Alzheimer's Disease""}]",408
1356,Digital biomarkers,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]",257
1357,"Digital biomarkers (e.g., Neuro-Motor Index (NMI))","[{'article': 'PMC9203627.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}, {'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}]",218
1358,Digital biomarkers (micro hand gestures from accelerometer data),"[{'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9203627.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",218
1359,Dihydrocaffeic acid (DHCA),"[{'article': 'PMC8868383.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Pharmacokinetic dynamics of Centella asiatica water extract in cognitively impaired older adults'}]",518
1360,Dihydroferulic acid (DHFA),"[{'article': 'PMC8868383.txt', 'relationship': 'RESPONDED_TO', 'object': 'Response to Centella asiatica water extract treatment in cognitively impaired older adults'}]",518
1361,Dimensional Apathy Scale (DAS),"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}]",663
1362,Diminished Cerebral Glucose Metabolism (DCGM),"[{'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}]",539
1363,Disability Assessment dementia (DAD),"[{'article': 'PMC7413274.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Functional status in dementia'}]",21
1364,Disability Assessment dementia (DAD) scale,"[{'article': 'PMC7413274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dependency levels in Persons with Dementia (PwD)'}]",21
1365,Discomfort Scale - dementia of Alzheimer Type,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Discomfort in Alzheimer's Disease patients""}]",21
1366,Discourse difficulties,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",174
1367,Discrimination learning,"[{'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",149
1368,Disinhibition,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",174
1369,Dispersion,"[{'article': 'PMC8225898.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'PREDICTS_CONVERSION_EVENT', 'object': ""From mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'USED_TO_MONITOR', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",625
1370,Dispersion-based methodology,"[{'article': 'PMC8225898.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'AD phenotypic variation and cognitive health changes'}]",625
1371,Disruption of limbic white matter pathways,"[{'article': 'PMC7477392.txt', 'relationship': 'CAUSES', 'object': 'Decreased glucose metabolism in parietal and temporal cortices'}]",23
1372,Dkk1,"[{'article': 'PMC6145937.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ synaptotoxicity'}, {'article': 'PMC6145937.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased Aβ production and synapse loss'}, {'article': 'PMC6145937.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",143
1373,Dll4,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'VEGF signaling'}]",269
1374,Donepezil,"[{'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC3706879.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Reversal of scopolamine-induced cognitive impairment'}, {'article': 'PMC4743597.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Alzheimer’s disease'}, {'article': 'PMC4922661.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'USED_TO_TREAT', 'object': 'Neurodegeneration with diabetes-related cognitive dysfunction'}, {'article': 'PMC9340683.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]",272
1375,Dopamine,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Impaired neuronal circuits in Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'RESPONDED_TO', 'object': ""rTMS treatment in Alzheimer's Disease""}, {'article': 'PMC8048550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased release of dopamine leading to cardiovascular effects'}, {'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-cognitive effects in Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Pro-cognitive effects in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]",491
1376,Dopamine (DA),"[{'article': 'PMC4174765.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",491
1377,Dopamine Transporter,"[{'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",491
1378,Dopamine depletion,"[{'article': 'PMC4150993.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]",491
1379,Dopamine transporter (DAT),"[{'article': 'PMC6236893.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Lewy Body Dementia (LBD) vs. AD'}]",491
1380,Dr,"[{'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""White matter integrity in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",383
1381,Drebrin,"[{'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prevention of synaptic spine loss in AD mice'}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",79
1382,Drp1,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Excessive mitochondrial fragmentation in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Down-regulation of Drp1 expression improves mitochondrial function in Alzheimer's Disease""}]",628
1383,Dual-task cost,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",446
1384,Dual-task gait,"[{'article': 'PMC4197903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amnestic mild cognitive impairment (a-MCI)'}]",446
1385,Dual-task gait velocity,"[{'article': 'PMC4197903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild Cognitive Impairment (MCI) associated with Alzheimer's Disease""}]",446
1386,Dual-tasking impairment,"[{'article': 'PMC5434395.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",446
1387,Dubois’ five-word test,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",17
1388,Dynamic cross-frequency coupling (CFC) patterns,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Early detection of Alzheimer's Disease progression""}, {'article': 'PMC4611062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: High classification accuracy (95%) for early diagnosis'}]",276
1389,Dyslipidemia,"[{'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Progression to Alzheimer's Disease in ApoE ε4 carriers""}]",630
1390,Dysphoria,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",57
1391,E-Selectin,"[{'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",163
1392,E2609,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Phase III clinical trials for Alzheimer's Disease""}]",144
1393,E280A Presenilin-1 mutation,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",487
1394,EAAT1,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",163
1395,EAAT2,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",163
1396,EB,"[{'article': 'PMC4397698.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Blood-Brain Barrier Integrity'}]",290
1397,EB extravasation,"[{'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Blood-Brain Barrier Disruption (BBBD)'}]",311
1398,ECG,"[{'article': 'PMC7729136.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cardiovascular health in Alzheimer's Disease""}]",118
1399,ECG/HRV,"[{'article': 'PMC8154928.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}]",118
1400,ECbche,"[{'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",48
1401,ECog,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess managing finances in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess use of technology/devices in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess gait in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess driving difficulties in Alzheimer's Disease""}]",37
1402,EDN1,"[{'article': 'PMC4835514.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Therapy for Alzheimer's Disease""}]",293
1403,EDNRA,"[{'article': 'PMC4835514.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Therapy for Alzheimer's Disease""}]",293
1404,EDVGSNK,"[{'article': 'PMC4780148.txt', 'relationship': 'RESPONDED_TO', 'object': ""Biomarker for Alzheimer's Disease""}, {'article': 'PMC4780148.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Amyloid-beta production'}]",293
1405,EEG,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3914466.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Disease progression'}, {'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}, {'article': 'PMC8281974.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to treatment in Alzheimer's Disease""}, {'article': 'PMC8281974.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8325256.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}, {'article': 'PMC8325256.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Predicting response to levetiracetam in Alzheimer's Disease patients""}, {'article': 'PMC8325256.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': ""Levetiracetam treatment response in Alzheimer's Disease""}, {'article': 'PMC8325256.txt', 'relationship': 'PREDICTS_RESPONSE_TO_TREATMENT', 'object': ""Predicts response to levetiracetam treatment in Alzheimer's Disease patients.""}, {'article': 'PMC8325256.txt', 'relationship': 'PREDICTS_OUTCOME', 'object': ""Correlated with outcomes for each participant at the study end in Alzheimer's Disease.""}, {'article': 'PMC8325256.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8325256.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment response prediction""}, {'article': 'PMC8760674.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Alterations in SEP components specific to somatosensory processing'}, {'article': 'PMC6130053.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC7288029.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in cognitive function'}, {'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of mild cognitive impairment, which is associated with Alzheimer's Disease""}]",567
1406,EEG abnormalities,"[{'article': 'PMC3914466.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",567
1407,EEG alpha power,"[{'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",42
1408,EEG markers,"[{'article': 'PMC8381483.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Varoglutamstat'}]",567
1409,EEG microstates,"[{'article': 'PMC10363100.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease severity""}]",567
1410,EEG oscillatory activity,"[{'article': 'PMC7364345.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Rotigotine treatment in Alzheimer's Disease""}]",567
1411,EEG phase,"[{'article': 'PMC9053232.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Auditory stimulation timing'}]",567
1412,EEG spectral parameters (fast frequency bands),"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",567
1413,"EEG-based measures (ERPs, spectral band-power)","[{'article': 'PMC8281974.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",567
1414,EEG/ERP tasks,"[{'article': 'PMC8281974.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}]",567
1415,EEG/MEG,"[{'article': 'PMC6370863.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring network dysfunction in Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapeutic approaches for Alzheimer's Disease""}]",483
1416,EF,"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",349
1417,EF and L (Executive Function and Learning),"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",460
1418,EFE,"[{'article': 'PMC10092214.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Reduced positive emotional response to music with disease progression in Alzheimer's Disease""}]",37
1419,EFE+,"[{'article': 'PMC10092214.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC10092214.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression in neurodegenerative disorders'}]",37
1420,EFEs (Emotional Facial Expressions),"[{'article': 'PMC8316394.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Emotional and social engagement in patients with dementia'}]",328
1421,EFEs+,"[{'article': 'PMC8316394.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive Impairment in Alzheimer's Disease""}]",37
1422,EGCG,"[{'article': 'PMC4675859.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Combined with EE for spatial learning and memory deficits in Ts65Dn mice'}, {'article': 'PMC4675859.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment selection for improving hippocampal-dependent spatial learning'}, {'article': 'PMC4675859.txt', 'relationship': 'RESPONDED_TO', 'object': 'Improved learning performance in Ts65Dn mice'}, {'article': 'PMC4857621.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4857621.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",37
1423,EGlob,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Improvements in EGlob values reflect better brain network global efficiency in Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",37
1424,ELISA Anti-HIV Test,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",25
1425,ELoc,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Changes in ELoc values are associated with brain network efficiency in Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",12
1426,EPA,"[{'article': 'PMC3335851.txt', 'relationship': 'RESPONDED_TO', 'object': 'Treatment with n-3 FAs'}, {'article': 'PMC3335851.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to n-3 FA treatment'}, {'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Dietary supplementation in Alzheimer's Disease""}, {'article': 'PMC5223628.txt', 'relationship': 'PREDICTS_BETTER_OUTCOME', 'object': 'Predicts improved or stabilised ADAS-Cog at 12 months'}, {'article': 'PMC6521224.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment compliance and biological activity'}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility for study participation based on plasma levels'}]",263
1427,EPHA1,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Associated with decreased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",163
1428,EPS8,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",63
1429,EQ VAS,"[{'article': 'PMC7749592.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improvement in self-rated health in Alzheimer's Disease""}]",49
1430,EQ-5D-3L,"[{'article': 'PMC5067903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",238
1431,EQ-5D-3L proxy,"[{'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",238
1432,EQ-5D-5L,"[{'article': 'PMC5067903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",238
1433,ERC thickness,"[{'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': 'Mild cognitive impairment'}]",405
1434,ERC volume,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}]",6
1435,ERC volume loss,"[{'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': 'Mild cognitive impairment'}]",6
1436,ERN,"[{'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8281974.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}]",597
1437,ERN (Error-related negativity) amplitude,"[{'article': 'PMC8281974.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",109
1438,ERP,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive deficits associated with Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease progression in Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment with cholinesterase inhibitors'}]",597
1439,ERP measures,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive deficits associated with Alzheimer's Disease""}]",597
1440,ESS,"[{'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Excessive Daytime Sleepiness in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",22
1441,EVP-0962,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Discontinued in Phase II clinical trials'}]",144
1442,EWS,"[{'article': 'PMC5100351.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",37
1443,Early AD markers,"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Clinical disease onset'}, {'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of conversion to mild cognitive impairment or dementia'}]",181
1444,Education,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Object and action naming performance in PPA'}]",113
1445,Effector helper and cytotoxic T lymphocytes (CD28−),"[{'article': 'PMC2871786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}]",139
1446,Eglob,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Eglob values reflect global efficiency in brain networks of Alzheimer's Disease patients""}]",37
1447,Egr-3,"[{'article': 'PMC3706879.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""BDNF Signaling in Alzheimer's Disease""}]",37
1448,Egr3,"[{'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""J147 treatment in Alzheimer's Disease mice""}]",37
1449,Eicosanoid metabolites,"[{'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""J147 treatment in Alzheimer's Disease""}]",317
1450,"Eicosanoid metabolites (e.g., DHA, 9-HETE, 8-iso-15-keto PGF2β, 11- and 13-HDoHEs, 9- and 13-HODEs)","[{'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]",317
1451,Eicosanoids,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Vascular dynamics in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",317
1452,Elecsys Aβ1–42,"[{'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}]",166
1453,Elecsys® immunoassay,"[{'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",25
1454,Electroencephalography (EEG),"[{'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild Cognitive Impairment (MCI), a prodromal stage of Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'NBM DBS treatment response'}, {'article': 'PMC6130053.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'NBM DBS treatment response'}]",567
1455,Electrophysiological response,"[{'article': 'PMC11493878.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Memory performance in Alzheimer's Disease""}, {'article': 'PMC11493878.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Response to PLAS intervention in Alzheimer's Disease""}]",162
1456,Eloc,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Eloc values are associated with local efficiency in brain networks of Alzheimer's Disease patients""}]",12
1457,Emp1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'BBB assembly'}]",163
1458,"Encoding, Storage and Recuperation (ESR) word list","[{'article': 'PMC6615169.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Memory assessment in Alzheimer's Disease""}]",167
1459,Endosomal volume,"[{'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",427
1460,Endostatin,"[{'article': 'PMC8645072.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Contribution to AD pathology'}]",242
1461,Endothelial function,"[{'article': 'PMC7934383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Exercise intervention in Alzheimer's Disease""}]",248
1462,Endothelin-1 (EDN1),"[{'article': 'PMC4835514.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cerebral hypoperfusion in Alzheimer's Disease""}]",88
1463,Enterotype I,"[{'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'higher prevalence of cerebral small vessel disease (SVD) components, such as white matter hypersensitivity (WMH)'}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'lower global cognitive function'}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'higher voxel-based specific regional analysis system for Alzheimer’s Disease (VSRAD) scores'}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]",418
1464,Enterotype III,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Higher risk of Alzheimer's Disease""}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'lower prevalence of cerebral SVD components, such as white matter hypersensitivity (WMH)'}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'lower voxel-based specific regional analysis system for Alzheimer’s Disease (VSRAD) scores'}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'increased global cognitive function'}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]",418
1465,Entorhinal (% TIV),"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",36
1466,Entorhinal Cortical Thickness,"[{'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",36
1467,Entorhinal cortex thickness,"[{'article': 'PMC2764863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': ""Mortality: Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",36
1468,Entorhinal cortex volume,"[{'article': 'PMC4811920.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",36
1469,Entorhinal cortical thickness,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}]",36
1470,Entorhinal thickness,"[{'article': 'PMC6646979.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",36
1471,Entorrhinal cortex volume,"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': 'Cognitive decline'}]",36
1472,Eotaxin,"[{'article': 'PMC8789895.txt', 'relationship': 'RESPONDED_TO', 'object': 'Intranasal insulin treatment'}]",48
1473,Eotaxin [CCL11],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",48
1474,Eotaxin-3 [CCL26],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",48
1475,Epichaperomes,"[{'article': 'PMC8333062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease-related processes and biological functions""}]",665
1476,Epilepsy,"[{'article': 'PMC6004911.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': ""Reduced survival in Alzheimer's Disease""}]",70
1477,Episodic memory,"[{'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",463
1478,Episodic memory deficits,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",463
1479,Episodic memory performance,"[{'article': 'PMC4750048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive Decline'}]",463
1480,Epworth Sleepiness scale,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess sleep quality in Alzheimer's Disease""}]",479
1481,Escherichia/Shigella,"[{'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Amyloid deposition on PET imaging'}]",331
1482,Estradiol,"[{'article': 'PMC8060832.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes in women with Alzheimer's Disease""}]",299
1483,Estradiol levels,"[{'article': 'PMC8060832.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No significant change with benzoate treatment'}]",299
1484,Estradiol to FSH ratio,"[{'article': 'PMC8060832.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement in women with later-phase dementia'}, {'article': 'PMC8060832.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive function in women with later-phase dementia'}]",299
1485,Estrogen levels,"[{'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'GABAergic interneurons in the hippocampus'}]",299
1486,Etanercept,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Lower risk of Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced risk for Alzheimer's Disease""}]",110
1487,Eubacterium rectale,"[{'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Less amyloid deposition'}]",331
1488,Euphoria,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",57
1489,Evans Blue (EB),"[{'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Blood-Brain Barrier Disruption'}]",426
1490,Executive Functioning (EF),"[{'article': 'PMC5359367.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early stages of Alzheimer's Disease""}]",460
1491,Executive dysfunction,"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease in people with Down Syndrome""}]",460
1492,Executive function,"[{'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4712287.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to rTMS-COG treatment'}, {'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improvement in cognition in mild cognitive impairment patients'}, {'article': 'PMC7674649.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Predicts functional decline in Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease cognitive decline""}]",460
1493,Executive function deficits,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",460
1494,Executive functioning,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]",460
1495,Exercise,"[{'article': 'PMC8873004.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Low Intensity Exercise to Reduce Postoperative Cognitive Dysfunction'}]",260
1496,Eye Movement,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease and Mild Cognitive Impairment""}]",208
1497,Eye gaze detection test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Eye gaze detection deficits in Alzheimer's Disease""}]",208
1498,F/B ratio,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC6920432.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",179
1499,F2-IsoPs,"[{'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",431
1500,F2-isoprostanes,"[{'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]",431
1501,FA,"[{'article': 'PMC3675142.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""White matter alterations in mild cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Early Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts: Cognitive Deficits in Alzheimer's Disease""}, {'article': 'PMC8351379.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: White matter microstructure changes in Alzheimer's Disease""}, {'article': 'PMC8351379.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""White matter integrity in Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Reduction in step length over time'}]",95
1502,FA of left hippocampus-PCC tract,"[{'article': 'PMC9972804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease in APOEε4 group""}]",457
1503,FA-rate,"[{'article': 'PMC4374455.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",95
1504,FAB,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function deficits in Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': ""Predicts fall risk reduction in older adults with Alzheimer's Disease""}, {'article': 'PMC5546604.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive function improvement in Alzheimer's Disease""}, {'article': 'PMC7364345.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment with rotigotine in Alzheimer's Disease""}]",325
1505,FACIAL EMOTION RECOGNITION,"[{'article': 'PMC4200223.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Linked to Behavioral and Psychological Symptoms of Dementia (BPSD)'}]",328
1506,FAK,"[{'article': 'PMC3226277.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",325
1507,FAQ,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Diagnose: Impaired function consistent with dementia'}, {'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease or related dementia""}, {'article': 'PMC9871821.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",95
1508,FAQ scores,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",95
1509,FAST,"[{'article': 'PMC8127192.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Disease progression in Alzheimer's Disease""}]",330
1510,FBB,"[{'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",290
1511,FBB PET,"[{'article': 'PMC8570037.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ deposition in Alzheimer's Disease""}]",290
1512,FBB SUVR,"[{'article': 'PMC8570037.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-beta deposition in Alzheimer's Disease""}]",375
1513,FBP SUVR,"[{'article': 'PMC10075195.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'MEDIATES', 'object': 'The relationship between CA1 volume and retroactive interference (RI)'}]",375
1514,FC of left caudate-rMFG tract,"[{'article': 'PMC9972804.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in APOEε4 group'}]",498
1515,FCRT,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Verbal episodic memory deficits in Alzheimer's Disease""}]",11
1516,FCSRT,"[{'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Decline in FCSRT scores indicates presence of Alzheimer's Disease.""}]",11
1517,FDG,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild cognitive impairment subtypes'}, {'article': 'PMC8905724.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Decreased FDG uptake indicating poorer prognosis in Alzheimer's Disease.""}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assessment of metabolic activity in Alzheimer's Disease.""}]",59
1518,FDG PET,"[{'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Detect and characterize antecedent changes in AD'}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Hypometabolism correlating with onset of dementia'}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Preclinical treatment of AD in adults with DS'}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment'}, {'article': 'PMC8905724.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced glucose metabolism in Alzheimer's Disease""}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",59
1519,FDG PET SUVR,"[{'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Glucose metabolism changes in Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to crenezumab treatment'}]",59
1520,FDG PET scan,"[{'article': 'PMC7171193.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",296
1521,FDG SUVR,"[{'article': 'PMC4461930.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}]",59
1522,FDG uptake,"[{'article': 'PMC8905724.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Decreased glucose metabolism in the left cortex and temporoparietal regions'}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Hypometabolism in Alzheimer's Disease""}]",593
1523,FDG-PET,"[{'article': 'PMC2500042.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of hypometabolism in the left parietal and left temporal regions'}, {'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Abnormalities in brain glucose metabolism'}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline'}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Hypometabolism associated with Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease pathology in CBS patients""}, {'article': 'PMC4346122.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Diagnostically useful in uncertain cases'}, {'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease characteristics in clinically normal subjects""}, {'article': 'PMC4153084.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain glucose metabolism in Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': ""Conversion to Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Conversion into dementia in mild cognitive impairment subjects'}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease progression""}, {'article': 'PMC4506984.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor: Hypometabolism in medial temporal lobes'}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Hypometabolism'}, {'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': ""Predicts conversion from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4826954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Typical AD (amnestic multidomain dementia)'}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Worse cognitive symptoms'}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5026133.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to liraglutide treatment'}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Brain glucose metabolism during treatment'}, {'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7489025.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral glucose metabolism changes in Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",59
1524,FDG-PET Hypometabolism,"[{'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",664
1525,FDG-PET SUVR,"[{'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Alzheimer’s disease'}, {'article': 'PMC7814451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Hypometabolism in Alzheimer's Disease""}]",59
1526,FDG-PET SUVRs,"[{'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",59
1527,FDG-PET cerebral metabolic rate of glucose,"[{'article': 'PMC4153084.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease progression""}]",357
1528,FDG-PET glucose metabolism measures,"[{'article': 'PMC3767625.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis of mild cognitive impairment'}]",357
1529,FDG-PET hypometabolism,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",664
1530,FDG-PET imaging,"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",296
1531,FDG-PET markers,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",59
1532,FDG-PET measures,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",59
1533,FDG-PET uptake,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",59
1534,FDG-PET-derived metabolic measures,"[{'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': 'Mild cognitive impairment'}]",357
1535,FDG-ROI,"[{'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cerebral glucose metabolic rate changes in Alzheimer's Disease""}]",59
1536,FDG-SUVR,"[{'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities (WMH) in multiple brain regions'}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Temporo-parietal hypometabolism'}]",59
1537,FERMT2,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",366
1538,FES,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""FES scores are related to balance confidence in Alzheimer's Disease patients""}]",366
1539,FETZ-test,"[{'article': 'PMC4401690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reaction time, hand-eye quickness, and attention in Alzheimer's Disease patients""}]",366
1540,FFA,"[{'article': 'PMC4153084.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Metabolic changes in Alzheimer's Disease patients""}]",11
1541,FFG,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",11
1542,FGF-2,"[{'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in cerebral spinal fluid levels reflects response to resveratrol treatment in Alzheimer's Disease patients.""}]",192
1543,FGF9,"[{'article': 'PMC5445077.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better cognitive performance in AD mice'}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Reduction in Alzheimer's Disease""}]",192
1544,FGP,"[{'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Glucose metabolism in Alzheimer's Disease patients""}]",522
1545,FJB,"[{'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal degeneration'}]",290
1546,FJB-positive cells,"[{'article': 'PMC4747225.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuronal Death in Alzheimer's Disease""}, {'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Degenerating neurons'}]",72
1547,FLT1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",577
1548,FMQ,"[{'article': 'PMC9513684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",111
1549,FNDC5,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",233
1550,FOXF2,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",610
1551,FPG,"[{'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Glucose metabolism in Alzheimer's Disease patients""}]",11
1552,FPN,"[{'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",11
1553,FR,"[{'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Proactive balance and physical frailty'}]",113
1554,FRAP assay,"[{'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Decreased levels in mild cognitive impairment and Alzheimer's Disease""}]",334
1555,FSH,"[{'article': 'PMC8060832.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8060832.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Eligibility for benzoate treatment in women with Alzheimer's Disease""}]",343
1556,FSH levels,"[{'article': 'PMC8060832.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No significant change with benzoate treatment'}]",343
1557,FTD-4R tau,"[{'article': 'PMC6110931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Mixed pathology in Alzheimer's Disease""}]",40
1558,FTM-PET visual read,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",296
1559,FTO,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",343
1560,FUS,"[{'article': 'PMC5100351.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5100351.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neurodegenerative diseases'}]",22
1561,FYN,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neuronal Sensitivity to Excitotoxicity'}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Therapeutic target for Alzheimer's Disease""}]",11
1562,FYN palmitoylation,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",273
1563,Fabp5,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",233
1564,Facial emotion recognition test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Facial emotion recognition deficits in Alzheimer's Disease""}]",328
1565,Facial gender recognition test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Gender recognition deficits in Alzheimer's Disease""}]",328
1566,Faecalibacterium,"[{'article': 'PMC8843023.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",331
1567,Family history of dementia,"[{'article': 'PMC4987494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk of Alzheimer's Disease""}]",18
1568,Fasting Glucose,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",200
1569,Fasting Insulin Levels,"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function improvement in patients with non-dementia vascular cognitive impairment'}]",200
1570,Fasting blood glucose,"[{'article': 'PMC8857690.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Glucose metabolism in Alzheimer's Disease patients""}]",200
1571,Fasting glucose,"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",200
1572,Fasting insulin,"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",200
1573,Fasting insulin levels,"[{'article': 'PMC6074058.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]",200
1574,Fasting plasma glucose,"[{'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk for Alzheimer's Disease""}, {'article': 'PMC6208946.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",200
1575,Fasting plasma glucose (FPG),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Metabolic changes in Alzheimer's Disease""}]",200
1576,Fasudil,"[{'article': 'PMC6145937.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Reduction of Aβ burden and protection against synapse loss'}]",95
1577,Fatty Acids,"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function in elderly subjects'}]",259
1578,Ferritin,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognostic biomarker for Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Screening of preclinical Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Screening of preclinical Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}]",366
1579,Ferulic acid,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Bioavailability in brain'}]",34
1580,Fibrin,"[{'article': 'PMC4939696.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4939696.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",2
1581,Fibrinogen,"[{'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Blood-brain barrier damage in Alzheimer's Disease""}]",2
1582,Field excitatory postsynaptic potentials (EPSPs),"[{'article': 'PMC3362564.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'XPro1595 therapy'}]",162
1583,Finger-Tapping Test,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Motor dysfunction in Alzheimer's Disease""}]",76
1584,Firmicutes,"[{'article': 'PMC8843023.txt', 'relationship': 'ASSOCIATED_WITH_ABSENCE_OF', 'object': 'Amyloid-β-positive status in cognitively normal participants'}, {'article': 'PMC8843023.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease pathology""}]",56
1585,Firmicutes/Bacteroidetes (F/B) ratio,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}]",179
1586,Fis1,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Down-regulation of Fis1 expression improves mitochondrial function in Alzheimer's Disease""}]",135
1587,Five Time Sit-to-Stand test (FTSS) score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Postural and physical impairments'}]",1
1588,Five-word test,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment and Alzheimer's Disease""}]",17
1589,Flanker test,"[{'article': 'PMC10475546.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improvements in inhibitory control of attention'}]",291
1590,Florbenazine,"[{'article': 'PMC4027995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]",4
1591,Florbetapir,"[{'article': 'PMC4027995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4027995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of amyloid-beta (Aβ)'}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaques'}, {'article': 'PMC6236893.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",362
1592,Florbetapir (AV-45),"[{'article': 'PMC3978219.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",301
1593,Florbetapir (AV45),"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",301
1594,Florbetapir F 18 PET,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",362
1595,Florbetapir F-18 PET,"[{'article': 'PMC8502814.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Amyloid accumulation'}]",362
1596,Florbetapir PET,"[{'article': 'PMC4731943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid burden in Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amyloid pathology in Alzheimer’s disease'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid plaques'}]",362
1597,Florbetapir PET SUVR,"[{'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Amyloid burden in Alzheimer's Disease""}]",362
1598,Florbetapir-PET,"[{'article': 'PMC6615169.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid deposition in Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",362
1599,Flortaucipir,"[{'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau tangles'}]",4
1600,Flortaucipir SUVr,"[{'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",4
1601,Flt-1,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",577
1602,Flt1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'VEGF signaling'}]",577
1603,Fluent but Empty Speech,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",568
1604,FluoSphere beads,"[{'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Lymphatic clearance in Alzheimer's Disease""}]",337
1605,Fluorescein-conjugated dextran,"[{'article': 'PMC10917684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",247
1606,Fluorodeoxyglucose (FDG),"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",43
1607,Flutemetamol,"[{'article': 'PMC4526582.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",393
1608,Flutemetamol F 18,"[{'article': 'PMC5352784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",393
1609,Flutemetamol F 18 Injection,"[{'article': 'PMC5352784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",393
1610,Fms-like tyrosine kinase 1 [FLT-1],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",399
1611,Folate,"[{'article': 'PMC3849204.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",46
1612,Folic Acid,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",46
1613,Fornix,"[{'article': 'PMC6126036.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Targeting TMS treatment based on functional connectivity with the fornix for cognitive dysfunction in Alzheimer's Disease""}]",187
1614,Fos,"[{'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",343
1615,Foveal Avascular Zones (FAZ),"[{'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Preclinical Alzheimer's Disease""}]",280
1616,FoxO,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",610
1617,Foxp3,"[{'article': 'PMC2765081.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",610
1618,Fractalkine receptor,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]",316
1619,Fractional Anisotropy,"[{'article': 'PMC4351428.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White Matter Integrity Changes with Cognitive Training'}]",368
1620,Fractional Anisotropy (FA),"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Mild Cognitive Impairment and Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcomes for individuals with Alzheimer's Disease through pre-symptomatic detection""}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",368
1621,Fractional anisotropy,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Cerebral spinal fluid p-tau'}]",368
1622,Fractional anisotropy (FA),"[{'article': 'PMC8760674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6110931.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'White matter damage in nfvPPA'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Slower gait velocity and shorter step length in Alzheimer's Disease""}]",368
1623,Fractional anisotropy (FA) in cholinergic pathways,"[{'article': 'PMC5326769.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in VCI'}]",191
1624,Fractional anisotropy (FA) of left uncinate fasciculus (UF),"[{'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'White matter integrity'}]",368
1625,Free Recall (FR) scores,"[{'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}]",157
1626,Free and Cued Selective Reminding Test (FCSRT),"[{'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Memory impairments in Alzheimer's Disease""}]",77
1627,Free-fatty acids (FFA),"[{'article': 'PMC4153084.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment monitoring""}]",259
1628,Frequency magnitudes,"[{'article': 'PMC9203627.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}]",276
1629,Frontal Assessment Battery,"[{'article': 'PMC5619332.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive function impairment in Alzheimer's Disease""}]",102
1630,Frontal Assessment Battery (FAB),"[{'article': 'PMC5546604.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Improvement in frontal function in Alzheimer's Disease patients with minimal WMHs""}, {'article': 'PMC7364345.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Frontal cognitive improvement'}]",102
1631,Frontal Assessment Battery (FAB) score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Executive function abnormalities'}]",102
1632,Frontal Cortex Atrophy,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for cognitive decline or dementia'}]",184
1633,Frontal Cortical Thickness,"[{'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive changes in Alzheimer's Disease""}]",197
1634,Frontal brain volume loss,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",430
1635,Frontal lobe function (FAB score),"[{'article': 'PMC5546604.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improved frontal lobe function in patients with AD with minimal WMHs'}]",102
1636,Fronto-Parietal Network (FPN),"[{'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",11
1637,Frontostriatal and hippocampus-PCC circuits,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'General cognitive function and disease severity in FAD'}]",457
1638,Frontostriatal circuit functional connectivity,"[{'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early detection of Alzheimer's disease""}]",172
1639,Frontostriatal circuit structural integrity,"[{'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early detection of Alzheimer's disease""}]",172
1640,Frontotemporal behaviour scale,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dysexecutive behavioural syndrome in Alzheimer's Disease""}]",16
1641,Functional Assessment Staging Scale (FAST),"[{'article': 'PMC7313126.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",117
1642,Functional Connectivity,"[{'article': 'PMC4351428.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain Plasticity and Cognitive Training Response'}, {'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher cognitive performance'}, {'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower cognitive function'}, {'article': 'PMC4351428.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to cognitive training in Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",175
1643,Functional Connectivity (FC),"[{'article': 'PMC9309357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",175
1644,Functional Independence Measure,"[{'article': 'PMC4722852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",681
1645,Functional MRI (fMRI),"[{'article': 'PMC9373273.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",329
1646,Functional connectivity,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4545875.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]",175
1647,Functional connectivity (FC),"[{'article': 'PMC5399035.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5399035.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Subjective Cognitive Decline and mild cognitive impairment related to Alzheimer's Disease""}]",175
1648,Functional connectivity (FC) in the left precuneus,"[{'article': 'PMC9309357.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive function improvement in Alzheimer's Disease""}]",175
1649,Functional connectivity (FC) in the precuneus and temporal gyrus,"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Acupuncture combined with Donepezil intervention'}]",175
1650,Functional connectivity (FC) in the temporal gyrus,"[{'article': 'PMC9309357.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive function improvement in Alzheimer's Disease""}]",175
1651,Functional connectivity (FC-values),"[{'article': 'PMC5399035.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5399035.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",175
1652,Functional connectivity (PLV),"[{'article': 'PMC9011335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",175
1653,Functional connectivity (left DLPFC to right IPL),"[{'article': 'PMC6961663.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved accuracy on 2-Back task'}]",489
1654,Functional connectivity of hippocampus,"[{'article': 'PMC4846650.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Pre-AD'}]",229
1655,Functional near-infrared spectroscopy (fNIRS),"[{'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild Cognitive Impairment (MCI), a prodromal stage of Alzheimer's Disease""}]",243
1656,Fusiform (% TIV),"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",236
1657,Fusiform gyrus thickness,"[{'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",90
1658,Fyn,"[{'article': 'PMC3226277.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Saracatinib (AZD0530)'}]",11
1659,Fyn kinase,"[{'article': 'PMC4396171.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment approach using AZD0530'}]",399
1660,G Allele,"[{'article': 'PMC8074126.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",188
1661,GABA,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Synaptic alteration in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]",15
1662,GABAergic interneuron numbers,"[{'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",673
1663,GABAergic interneurons,"[{'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",673
1664,GABAergic modulation,"[{'article': 'PMC4267230.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",530
1665,GABAergic synaptic strength,"[{'article': 'PMC7822717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer Disease'}, {'article': 'PMC7822717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Modulation of inhibitory/excitatory balance in Alzheimer Disease'}]",530
1666,GABAergic transmission,"[{'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",530
1667,GAD,"[{'article': 'PMC3534053.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Estrogen levels in ovariectomized rats'}]",32
1668,GAD67,"[{'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",32
1669,GAD67-positive interneurons,"[{'article': 'PMC3534053.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Spatial learning deficits in female apoe4-KI mice'}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related spatial learning deficits""}]",673
1670,GAITRite®,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Gait parameters in Alzheimer's Disease""}]",159
1671,GAS-10,"[{'article': 'PMC9871821.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Reduced anxiety symptoms after tPBM treatment'}]",620
1672,GBA,"[{'article': 'PMC5496518.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",642
1673,GBS,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia severity'}]",642
1674,GCLC,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Target engagement of NRF2 pathway'}]",32
1675,GDF-15,"[{'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Enhanced endogenous adult neurogenesis and synaptic activity'}, {'article': 'PMC8439008.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'hUCB-MSC treatment'}]",572
1676,GDN,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotection and neurite outgrowth'}]",32
1677,GDNF,"[{'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Neuroprotection'}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Exercise blocks the surgery-induced decrease in GDNF levels in the hippocampus, suggesting its role in regulating immune and inflammatory responses after surgery'}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: GDNF attenuates surgery-induced immune and inflammatory responses, which are important for POCD development'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Surgery-induced cognitive impairment in mice'}, {'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Neuroinflammation and reduction in brain cell genesis'}, {'article': 'PMC8873004.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Neuroprotection and Reduced Cognitive Dysfunction'}, {'article': 'PMC8873004.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Brain response to surgery and treatment'}, {'article': 'PMC8873004.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7001626.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}]",32
1678,GDS,"[{'article': 'PMC4200223.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease patients""}, {'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved GDS scores correlate with better quality of life in Alzheimer's Disease patients""}, {'article': 'PMC4484882.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4712287.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Depression in Alzheimer's Disease patients""}, {'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Geriatric Depression in Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7928298.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Geriatric Depression in Alzheimer's Disease""}]",32
1679,GFAP,"[{'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced astrocyte activation in Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Astrocyte activation in Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Astrocyte activation in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Astrocytosis in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Astrocytic reactivity in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""J147 treatment in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Astrocyte activation in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'RESPONDED_TO', 'object': 'Fingolimod treatment'}, {'article': 'PMC4847010.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression'}, {'article': 'PMC4899632.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Astrocyte activation in Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Astrocytic cells in the dentate gyrus (DG)'}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Astrocyte reactivity surrounding Aβ deposits'}, {'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of astrocyte activation in Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Diagnosis""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ pathology in preclinical AD'}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor outcome in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Aβ pathology in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Aβ deposition as quantified by Aβ PET'}, {'article': 'PMC8524356.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment Selection: Distinguishing Aβ status with high AUC'}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ pathology in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Advanced clinical diagnosis of Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Aβ+ from Aβ– individuals with high accuracy'}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Early reactive astrocytes in preclinical Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Astrocyte reduction'}, {'article': 'PMC8966264.txt', 'relationship': 'PREDICTS_PROGRESSION_TO', 'object': ""Alzheimer's Disease dementia""}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_AD_PROGRESSION', 'object': 'Progression to AD dementia (minimal contribution)'}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': 'Presence of: Neuroinflammation and Aβ pathology'}, {'article': 'PMC4939696.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5520675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'No astrocyte activation after TI stimulation'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Astrogliosis in Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",32
1680,GIP,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'EXERTS_NEUROPROTECTIVE_EFFECT', 'object': 'In AD mice'}]",61
1681,GIP analogs,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]",61
1682,GLP-1,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive functioning in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'REDUCES_Aβ_LOAD_IN', 'object': ' Vivo and in cultured neuronal cells'}, {'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and treatment of Alzheimer's Disease""}]",429
1683,GLP-1 Analog,"[{'article': 'PMC4877513.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for treating Alzheimer's Disease""}]",429
1684,GLUT1,"[{'article': 'PMC6211704.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Microvascular pathology in Alzheimer's Disease""}]",68
1685,GLUT4,"[{'article': 'PMC6211704.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to anti-diabetic medications in Alzheimer's Disease""}]",68
1686,GM volume,"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Early Alzheimer's Disease""}]",6
1687,GM-CSF,"[{'article': 'PMC9108275.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improved MMSE scores in AD patients following treatment'}]",108
1688,GMV,"[{'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities (WMH) in all regions of interest'}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Medial-temporal atrophy'}]",108
1689,GMcerebral spinal fluid,"[{'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Levels reflect response to Transcranial Electromagnetic Treatment (TEMT)'}]",541
1690,GP-Cog,"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",364
1691,GPX,"[{'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Upregulation of GPX during adipogenesis in human MSCs'}]",432
1692,GPx,"[{'article': 'PMC4890804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Oxidative stress response in mTBI'}, {'article': 'PMC4890804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Phenserine treatment in Alzheimer's Disease""}]",432
1693,GPx1,"[{'article': 'PMC4890804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Phenserine treatment response in mTBI'}]",432
1694,GR/GPx ratio,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's Disease""}]",16
1695,GRN,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction of amyloid plaque pathology and preservation of hippocampal neurons in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Onset of late-stage AD'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Lowered plaque load and prevented spatial memory deficits.'}]",32
1696,GRP78,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",32
1697,GSH,"[{'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Oxidative stress management in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Antioxidant response in Alzheimer's Disease""}]",226
1698,GSH-PX,"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Oxidative stress reduction in Alzheimer's Disease""}]",226
1699,GSH-Px,"[{'article': 'PMC4659639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher GSH-Px levels in intervention groups'}]",226
1700,GSH-peroxidase,"[{'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}]",205
1701,GSH/GSSH,"[{'article': 'PMC4981900.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Assess: Safety and efficacy of EMF treatment in Alzheimer's Disease""}]",226
1702,GSK-3B,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",333
1703,GSK-3β,"[{'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease through tau phosphorylation""}]",333
1704,GSK2647544,"[{'article': 'PMC5209404.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Brain exposure and penetration'}]",602
1705,GSK3,"[{'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",333
1706,GSK3B,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",333
1707,GSK3β,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Tau hyperphosphorylation in Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease neuropathology""}, {'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",333
1708,GSK933776,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Failed to show clinical benefit'}]",602
1709,GSSH,"[{'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}]",226
1710,GV1001,"[{'article': 'PMC7995588.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",108
1711,Gad67,"[{'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Loss of hippocampal GABAergic interneurons in Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with Kgp inhibitor COR271'}, {'article': 'PMC6357742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Hippocampal interneuron health in Alzheimer's Disease""}]",32
1712,Gait,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease and Mild Cognitive Impairment""}, {'article': 'PMC4197903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",159
1713,Gait Speed,"[{'article': 'PMC8564955.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predictive of decline in activities of daily living (ADL) and instrumental ADL'}, {'article': 'PMC8564955.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement with exercise reflects response to treatment'}]",703
1714,Gait Velocity,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",703
1715,Gait characteristics,"[{'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",159
1716,Gait speed,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher global white matter hyperintensity volume'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced total grey matter volume'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced metabolic rates of glucose uptake in the prefrontal, posterior cingulate, and parietal cortices'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Higher burden of white matter hyperintensities'}, {'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline in older adults'}]",703
1717,"Gait variables (velocity, variability, frequency)","[{'article': 'PMC4406069.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Dementia due to Alzheimer's Disease""}]",159
1718,Gait velocity,"[{'article': 'PMC4197903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'More severe global age-related white matter changes'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased mean diffusivity in brainstem, projection, association, limbic and callosal tracts'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",703
1719,Gait-speed,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Gait abnormalities in Alzheimer's Disease""}]",703
1720,Gal-1,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurogenesis and neural stem cell self-renewal'}]",620
1721,Galactin-3,"[{'article': 'PMC8439008.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'hUCB-MSC treatment'}]",632
1722,Galantamine,"[{'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease treatment""}]",632
1723,Galectin-1 (Gal-1),"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroregulatory molecules in dynamic hBM-MSCs secretome'}]",632
1724,Galectin-3,"[{'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Protection against Aβ neurotoxicity'}]",632
1725,Gallagher index,"[{'article': 'PMC4675859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Learning and memory deficits in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor reference memory in Ts65Dn mice'}, {'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive flexibility impairments in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",131
1726,Gallic Acid,"[{'article': 'PMC4857621.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}]",34
1727,Gallic acid,"[{'article': 'PMC4857621.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",34
1728,Gamified cognitive tasks,"[{'article': 'PMC8281974.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}]",104
1729,Gamma oscillations,"[{'article': 'PMC3682121.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved tactile sensations'}, {'article': 'PMC6130053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Local network activity and learning and memory processes'}, {'article': 'PMC9539040.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Improvement in cognitive function in Alzheimer's Disease patients""}]",9
1730,Gamma sensory stimulation therapy effect on sleep,"[{'article': 'PMC8500065.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Therapeutic response in mild to moderate Alzheimer's Disease""}]",310
1731,Gamma spectral power,"[{'article': 'PMC8690894.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",9
1732,Gamma-Glutamyl Transferase (GGT),"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",321
1733,Gantenerumab,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Phase III clinical trials in mild AD'}]",33
1734,Gap duration,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",168
1735,Gaze direction,"[{'article': 'PMC8316394.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Social engagement in patients with dementia'}]",208
1736,Gbp2,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",642
1737,Gbp6,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",642
1738,Gcerebral,"[{'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",541
1739,Gcerebral spinal fluid,"[{'article': 'PMC9108275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor cognitive performance in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RESPONDED_TO', 'object': 'Transcranial Electromagnetic Treatment (TEMT)'}]",541
1740,Gd-DOTA concentration,"[{'article': 'PMC8905724.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Blood-brain barrier disruption efficacy'}]",3
1741,Gene expression profiles,"[{'article': 'PMC7884393.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC7884393.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Intermediate-stage Alzheimer's Disease""}, {'article': 'PMC7884393.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Late-stage Alzheimer's Disease""}]",638
1742,Generalized Anxiety Disorder (GAD-7),"[{'article': 'PMC4066282.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Prognosis""}]",270
1743,Generalized low uptake on SPECT/PET perfusion/metabolism scan,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]",27
1744,"Genes (complement receptor 1, CD33, TREM2)","[{'article': 'PMC6530014.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",392
1745,Genetic Data,"[{'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates Presence: Increased Risk of Alzheimer's Disease""}]",453
1746,Genetic data,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",453
1747,Genetic factors,"[{'article': 'PMC4150993.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",453
1748,Genetic status,"[{'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4511231.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility for clinical trials'}]",453
1749,Geriatric Depression Scale,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Depression in Alzheimer's Disease""}, {'article': 'PMC8518196.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Assess health outcomes in Alzheimer's Disease""}, {'article': 'PMC5619332.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease patients""}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Depression in Alzheimer's patients""}]",611
1750,Geriatric Depression Scale (GDS),"[{'article': 'PMC7001626.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Depressive symptoms in Alzheimer's Disease patients""}, {'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Depressive symptoms in Alzheimer's Disease""}]",611
1751,Ghrelin,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroprotection in Alzheimer's Disease""}]",68
1752,Giant Component Size,"[{'article': 'PMC8795741.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}]",456
1753,Giant component size,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased size of the giant component in brain networks'}]",456
1754,Gingipains,"[{'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Tau and ubiquitin pathology in Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Neurotoxic effects on tau'}, {'article': 'PMC6357742.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Small-molecule inhibitors reduce bacterial load and Aβ1–42 production'}]",587
1755,Gingko biloba,"[{'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",587
1756,Ginsenoside Rb1,"[{'article': 'PMC4857621.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",587
1757,Ginsenosides,"[{'article': 'PMC4857621.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}]",587
1758,Glia-derived nexin (GDN),"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroregulatory molecules in dynamic hBM-MSCs secretome'}]",13
1759,Glial activation biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",13
1760,Glial fibrillary acidic protein (GFAP),"[{'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",13
1761,Global Deterioration Scale (GDS) score,"[{'article': 'PMC6794759.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Severity of dementia in Alzheimer's Disease""}]",3
1762,Global Efficiency (GE),"[{'article': 'PMC8760674.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased GE in sensorimotor network after TPS stimulation'}]",565
1763,Global Microbleed and Infarct Presence,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",404
1764,Global cognition,"[{'article': 'PMC5016950.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",104
1765,Global cognitive score,"[{'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Conversion to AD dementia'}]",41
1766,Global efficiency,"[{'article': 'PMC8760674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved brain network efficiency'}]",565
1767,GluR1,"[{'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Increased membrane levels in XPro1595-treated rats'}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved synaptic function in Alzheimer's Disease""}]",68
1768,Glucocorticoid Production,"[{'article': 'PMC6520689.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",606
1769,Glucose,"[{'article': 'PMC4615808.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Metabolic changes in Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Lower levels of glucose during fasting lead to autophagy in Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",586
1770,Glucose metabolism,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8905724.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC5026133.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor: Deep brain stimulation (DBS) effects on brain regions affected by AD'}, {'article': 'PMC5026133.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Patients ≥65 years showed increased metabolism with DBS'}, {'article': 'PMC5026133.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Younger patients (<65 years) showed decreased metabolism and greater cognitive decline'}, {'article': 'PMC5026133.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased glucose metabolism at 6 months in temporal and parietal regions'}, {'article': 'PMC5026133.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to DBS-f treatment'}, {'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Subjective Cognitive Decline (SCD) related to Alzheimer's Disease""}, {'article': 'PMC9011335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Fornix stimulation'}]",586
1771,Glucose metabolism (FDG-PET),"[{'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}]",357
1772,Glucose metabolism levels,"[{'article': 'PMC9011335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Deep Brain Stimulation treatment'}]",586
1773,Glucose metabolism rates,"[{'article': 'PMC8470960.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",586
1774,Glucose uptake,"[{'article': 'PMC3467226.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",586
1775,Glutamate,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Neuronal death and AD pathogenesis'}, {'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Decreased brain glutamate levels in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6015016.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease through excitotoxicity and neuronal damage""}]",321
1776,Glutamine,"[{'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",321
1777,Glutamine synthetase,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced levels in AD brains'}]",321
1778,Glutamine synthetase (GS),"[{'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",321
1779,Glutathione,"[{'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Recovered basal content in the presence of oleanolic acid and combined biomolecules'}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}]",205
1780,Glutathione (GSH),"[{'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}]",205
1781,Glutathione peroxidase (GSH-Px),"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]",205
1782,Glutathione peroxidase activity,"[{'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}]",205
1783,Glx,"[{'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",432
1784,GlyRS functioning,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anxiety in Alzheimer's Disease""}]",165
1785,Glycemic control,"[{'article': 'PMC6208946.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",145
1786,Glymphatic Exchange,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",165
1787,Gpb3,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",432
1788,Gpnmb,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",432
1789,Granule cell layer cellularity,"[{'article': 'PMC4979550.txt', 'relationship': 'RESPONDED_TO', 'object': 'Restored by T3D-959 treatment'}]",125
1790,Granule cell layer thickness,"[{'article': 'PMC4979550.txt', 'relationship': 'RESPONDED_TO', 'object': 'Partially restored by T3D-959 treatment'}]",125
1791,Granulocytes,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for developing all-cause dementia'}]",125
1792,Granulocytes-to-lymphocytes ratio,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for developing all-cause dementia'}]",125
1793,Granulovacuolar degeneration,"[{'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]",125
1794,Graph theory-based brain network changes,"[{'article': 'PMC4846650.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Pre-AD'}]",82
1795,Gray Matter (GM) volume,"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}]",350
1796,Gray Matter Volume,"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Mild Cognitive Impairment and Alzheimer's Disease""}]",350
1797,Gray Matter Volume (GMV),"[{'article': 'PMC7814451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",350
1798,Gray matter volume,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5348543.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Brain health in dancers'}]",350
1799,Grey Matter Density,"[{'article': 'PMC2764863.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",350
1800,Grey Matter Density in Hippocampus,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",634
1801,Grey Matter Density in Temporal Lobe,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",634
1802,Grey Matter Volume,"[{'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",350
1803,Grey matter atrophy,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor gait performance'}]",23
1804,Grey matter density in medial temporal lobe,"[{'article': 'PMC2764863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",634
1805,Grey matter volume,"[{'article': 'PMC8760674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Lower grey matter volume in SCD-community'}, {'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Subjective Cognitive Decline (SCD) related to Alzheimer's Disease""}]",350
1806,Grey matter volumes,"[{'article': 'PMC4506984.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predicting conversion to dementia in mild cognitive impairment subjects'}]",350
1807,Grip Strength,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",435
1808,Grober–Buschke scale,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Episodic memory in Alzheimer's Disease""}]",16
1809,Growth associated protein 43,"[{'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",199
1810,Guanfacine,"[{'article': 'PMC9340683.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}]",15
1811,Gut Microbiota,"[{'article': 'PMC6520689.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",353
1812,Gut hormones,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Influence on Alzheimer's Disease processes""}]",126
1813,Gut microbiome,"[{'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease modulation""}]",353
1814,Gut microbiome diversity,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",353
1815,Gut microbiota,"[{'article': 'PMC4956742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Therapeutic strategy for Alzheimer's Disease""}]",353
1816,Gut microbiota composition,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",353
1817,HATA volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",6
1818,HDAC,"[{'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",451
1819,HDL,"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher HDL levels were associated with better outcomes in the r-IF group.'}]",451
1820,HDL cholesterol,"[{'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk for Alzheimer's Disease""}, {'article': 'PMC4987494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Behavior change and improved clinical outcomes in Alzheimer's Disease risk reduction""}, {'article': 'PMC4987494.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improvement in HDL cholesterol levels'}, {'article': 'PMC4987494.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvements in HDL cholesterol levels'}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Metabolic changes in Alzheimer's Disease""}]",622
1821,HDL levels,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6208946.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",451
1822,HDL-C,"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function in elderly subjects'}, {'article': 'PMC8351379.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",451
1823,HDL/LDL,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",542
1824,HDoHes,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""DHA oxidation in Alzheimer's Disease""}]",451
1825,HF,"[{'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]",0
1826,HIF-1α,"[{'article': 'PMC9962062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cell adaptation to hypoxia in ischemia'}]",88
1827,HKLLT,"[{'article': 'PMC9871821.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improved verbal memory after tPBM treatment'}]",138
1828,HLA,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",554
1829,HLA-DR,"[{'article': 'PMC6584558.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",554
1830,HLA-DR expression,"[{'article': 'PMC6584558.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",554
1831,HLA-DR surface expression,"[{'article': 'PMC6584558.txt', 'relationship': 'NOT_IMPAIRED_IN', 'object': ""Alzheimer's Disease patients""}]",704
1832,HLA-DRB1,"[{'article': 'PMC6158742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",628
1833,HLA-DRB5/HLA-DRB1,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with increased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",628
1834,HMOX,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Target engagement of NRF2 pathway'}]",314
1835,HMW adiponectin,"[{'article': 'PMC4153084.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved insulin sensitivity in Alzheimer's Disease patients""}]",528
1836,HOMA-B,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Beta-cell dysfunction in Alzheimer's Disease""}]",15
1837,HOMA-IR,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Insulin resistance in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Insulin resistance in Alzheimer's Disease patients""}, {'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",15
1838,HOP,"[{'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Heat shock protein response: Decreased to control levels by J147'}, {'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",620
1839,HOP-1,"[{'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of heat shock protein in AD mice'}]",620
1840,HP 129Xe,"[{'article': 'PMC7554935.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Alzheimer’s Disease'}, {'article': 'PMC7554935.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cerebral perfusion and blood–brain barrier permeability in Alzheimer's Disease""}, {'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Brain oxygenation mapping in Alzheimer's Disease""}, {'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Brain disease detection'}, {'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9314594.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9314594.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",614
1841,HR,"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",0
1842,HRV,"[{'article': 'PMC8154928.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Pathological states'}, {'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Autonomic dysfunction in dementia'}, {'article': 'PMC8154928.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Better cognitive performance and executive functions'}, {'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",0
1843,HS score,"[{'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]",1
1844,HS scores,"[{'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease presence via Aβ PET status correlation""}]",1
1845,HSD17B11,"[{'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",602
1846,HSP40,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Stress in Alzheimer's Disease""}]",495
1847,HSP60,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Stress in Alzheimer's Disease""}]",495
1848,HSP70,"[{'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Heat shock protein response: Decreased to control levels by J147'}, {'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of heat shock protein in AD mice'}]",495
1849,HSP90,"[{'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Heat shock protein response: Decreased to control levels by J147'}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of heat shock protein in AD mice'}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Stress in Alzheimer's Disease""}, {'article': 'PMC8333062.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC8333062.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",495
1850,HSP90α,"[{'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",495
1851,HSP90β,"[{'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",495
1852,HT7,"[{'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",0
1853,HVA,"[{'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome: Increased dopamine levels in Alzheimer's Disease""}]",0
1854,Hachinski Ischemic Score (HIS),"[{'article': 'PMC5546604.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Vascular risk factors in Alzheimer's Disease""}]",509
1855,Hallucinations,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",174
1856,Hand Grip Strength,"[{'article': 'PMC7084863.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",435
1857,Hand Movement,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease and Mild Cognitive Impairment""}]",435
1858,Hand-Motor Performance,"[{'article': 'PMC3581819.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better motor function in Alzheimer's Disease""}]",526
1859,Handwriting,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",119
1860,Hb,"[{'article': 'PMC7023686.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Hospitalization'}, {'article': 'PMC7023686.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Decreased hospitalization rates and improved nutritional status in older patients'}]",0
1861,HbA1c,"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Thinner cortical thickness in the lateral orbitofrontal cortex, frontal gyrus, motor region, lateral temporal lobe, and superior and inferior parietal cortex.'}, {'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6208946.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6208946.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",124
1862,HbA1c levels,"[{'article': 'PMC6074058.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]",124
1863,Hcy,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline and Alzheimer's Disease""}, {'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Vascular inflammation and oxidative stress'}]",309
1864,Hcy (Homocysteine),"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment and cardiovascular risk'}]",46
1865,Health Utility Index (HUI),"[{'article': 'PMC4066282.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Prognosis""}]",263
1866,Heart Rate Variability (HRV),"[{'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild Cognitive Impairment (MCI), a prodromal stage of Alzheimer's Disease""}]",118
1867,Heart disease,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid deposition associated with Alzheimer's Disease""}, {'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia incidence'}]",126
1868,Heart rate,"[{'article': 'PMC5123349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Monitoring health in Alzheimer's Disease patients""}, {'article': 'PMC9412195.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Exercise intensity and physical activity in Alzheimer's Disease patients""}, {'article': 'PMC9412195.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Physical activity and treatment response in Alzheimer's Disease""}]",118
1869,Helicobacter,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology in transgenic mice'}]",33
1870,Helicobacteraceae,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology in transgenic mice'}]",33
1871,Heme oxygenase 1 (HO-1),"[{'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Oxidative stress response: Decreased to control levels by J147'}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of oxidative stress in AD mice'}]",124
1872,Hemoglobin,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Anemia in Alzheimer's Disease patients""}, {'article': 'PMC4153084.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Hemodilution in Alzheimer's Disease patients""}]",124
1873,Hemoglobin A1c (HbA1c),"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",124
1874,Hesitation Ratio,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",179
1875,Hey1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'VEGF signaling'}]",135
1876,High CS levels,"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Reduction in agitation in Alzheimer's Disease patients""}]",557
1877,High Cholesterol,"[{'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",413
1878,High glycemic diet,"[{'article': 'PMC8502814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid accumulation in the precuneus, lateral temporal lobe, and posterior cingulate gyrus in preclinical Alzheimer's Disease""}]",145
1879,High illuminance (350–750 lux),"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Reduction in agitation in Alzheimer's Disease patients""}]",440
1880,High molecular weight adiponectin,"[{'article': 'PMC4153084.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment monitoring""}, {'article': 'PMC4153084.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improvement in insulin sensitivity in Alzheimer's Disease patients""}]",528
1881,High-density lipoprotein (HDL),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cholesterol levels in Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",622
1882,High-sensitivity C-Reactive Protein (hsCRP),"[{'article': 'PMC4153084.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment monitoring""}]",38
1883,High-sensitivity C-reactive protein (hs-CRP),"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",38
1884,Hippocampal Atrophy,"[{'article': 'PMC6201586.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Brain volume changes in AD patients'}, {'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of cognitive decline and dementia'}, {'article': 'PMC6910674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease Progression""}]",391
1885,Hippocampal Atrophy Rate,"[{'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Progression""}]",391
1886,Hippocampal GM density,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and progression of Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",229
1887,Hippocampal Occupancy (HOC),"[{'article': 'PMC4568340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",229
1888,Hippocampal Synaptic Immunoreactivity,"[{'article': 'PMC4351428.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects response to cognitive training in Alzheimer's Disease""}]",229
1889,Hippocampal Volume,"[{'article': 'PMC2764863.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Progression of Alzheimer's Disease neuropathology""}, {'article': 'PMC4563885.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4563885.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5302785.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5399035.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': ""Exercise intervention in Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}]",648
1890,Hippocampal Volume (HV),"[{'article': 'PMC8570373.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive Impairment'}, {'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment in stroke patients'}]",648
1891,Hippocampal activation,"[{'article': 'PMC1373642.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Reduced activation during episodic encoding in ε3/4 heterozygotes'}]",229
1892,Hippocampal activity,"[{'article': 'PMC4150993.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early memory decline in Alzheimer's Disease""}]",229
1893,Hippocampal and amygdalar volume,"[{'article': 'PMC2764863.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]",182
1894,Hippocampal atrophy,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6910674.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7424995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",391
1895,Hippocampal atrophy in CA1 subfield region,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage dementia due to Alzheimer's Disease""}]",391
1896,Hippocampal atrophy on MRI,"[{'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Clinically probable Alzheimer's Disease""}]",651
1897,Hippocampal atrophy rates,"[{'article': 'PMC8570373.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment response in clinical trials'}]",391
1898,Hippocampal formation atrophy,"[{'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",391
1899,Hippocampal perfusion,"[{'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Loss of spatial memory in older individuals'}]",311
1900,Hippocampal size,"[{'article': 'PMC9011335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Fornix stimulation'}]",229
1901,Hippocampal subfield atrophy,"[{'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Verbal memory impairment'}]",391
1902,Hippocampal subfield volume,"[{'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",648
1903,Hippocampal volume,"[{'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild cognitive impairment conversion to Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}, {'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}, {'article': 'PMC3767625.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis of mild cognitive impairment'}, {'article': 'PMC4283145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic exercise intervention'}, {'article': 'PMC4283145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4461930.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment efficacy in Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Conversion to AD dementia'}, {'article': 'PMC5399035.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5399035.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline and smaller hippocampal volumes'}, {'article': 'PMC5399035.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Hippocampal volume increase in Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease neurodegeneration""}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7995588.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",648
1904,Hippocampal volume (HV),"[{'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8570373.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",648
1905,Hippocampal volume loss,"[{'article': 'PMC3675142.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Memory deficits in Mild Cognitive Impairment'}]",648
1906,Hippocampal volume rate of change,"[{'article': 'PMC4283145.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",648
1907,Hippocampal volume reduction,"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",648
1908,Hippocampal volumetry,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",648
1909,Hippocampal/parahippocampal atrophy,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",391
1910,Hippocampus,"[{'article': 'PMC10439779.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Memory consolidation circuits in sleep and cognitive improvement'}, {'article': 'PMC6126036.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Targeting TMS treatment based on functional connectivity with the hippocampus for cognitive dysfunction in Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7203806.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease subtypes""}, {'article': 'PMC7203806.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: NGF treatment response in Alzheimer's Disease""}, {'article': 'PMC7203806.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Longitudinal atrophy rates in Alzheimer's Disease subtypes""}, {'article': 'PMC7489025.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Brain region affected by Alzheimer's Disease""}, {'article': 'PMC7662091.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7735856.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Episodic memory performance'}]",229
1911,Hippocampus (% TIV),"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",236
1912,Hippocampus and precuneus atrophy,"[{'article': 'PMC7203806.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nerve growth factor (NGF) treatment response'}]",391
1913,Hippocampus atrophy rate,"[{'article': 'PMC7203806.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease subtypes""}]",391
1914,Hippocampus glucose metabolism,"[{'article': 'PMC5026133.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",539
1915,Hippocampus volume,"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': 'Mild cognitive impairment'}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with: Independent risk factor for AD and conversion to AD in mild cognitive impairment subjects'}, {'article': 'PMC4811920.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in APOEε4 group'}]",648
1916,Hippocampus volume loss,"[{'article': 'PMC9606044.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}]",648
1917,Hippocampus volumes,"[{'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",648
1918,Hippocampus-PCC circuit,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression in Familial Alzheimer’s disease'}]",457
1919,Hippocampus-PCC circuit structural connectivity,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's disease""}]",457
1920,Hippocampus_L,"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",229
1921,Hippocampus_L (aal),"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",229
1922,Hirano bodies,"[{'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuronal loss and cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",92
1923,Histamine,"[{'article': 'PMC8048550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cortical activation and maintenance of wakefulness'}]",309
1924,Hit rate,"[{'article': 'PMC4656817.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Malingering in neuropsychological testing'}]",7
1925,Hit-rate,"[{'article': 'PMC4374455.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",7
1926,Homeostasis model of assessment-estimated insulin resistance (HOMA-IR),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Insulin resistance in Alzheimer's Disease""}]",73
1927,Homeostatic model assessment for B-cell function (HOMA-B),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Insulin resistance in Alzheimer's Disease""}]",139
1928,Homeostatic model of assessment for insulin resistance (HOMA-IR),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Insulin resistance in Alzheimer's Disease""}]",73
1929,Homer 1,"[{'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}]",240
1930,Homer-1,"[{'article': 'PMC3706879.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor outcome in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""J147 treatment in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""BDNF Signaling in Alzheimer's Disease""}]",240
1931,Homocysteine,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Increased risk of Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",46
1932,Homocysteine (Hcy),"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment in elderly subjects'}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]",46
1933,Homovanillic Acid,"[{'article': 'PMC5008228.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Nilotinib treatment'}]",34
1934,Hub location,"[{'article': 'PMC4545875.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Shift from posterior to anterior regions'}]",579
1935,Hub strength,"[{'article': 'PMC4545875.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Decrease in posterior regions'}]",579
1936,Huntingtin,"[{'article': 'PMC4899632.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Huntington's Disease model in Alzheimer's research""}]",114
1937,Huperzine A,"[{'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4202787.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}]",31
1938,Hypercortisolism,"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Weight loss in men with Alzheimer's Disease""}]",606
1939,Hyperlipidemia,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",630
1940,Hyperphosphated tau protein,"[{'article': 'PMC9389745.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
1941,Hyperphosphorylated Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",40
1942,Hyperphosphorylated tau,"[{'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurovascular dysfunction and reduced energy supply'}, {'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to Near-infrared light treatment in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's disease-type dementia in Down syndrome individuals""}, {'article': 'PMC4707222.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Decreased hyperphosphorylated tau in Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
1943,Hyperphosphorylated tau (PHF1),"[{'article': 'PMC9527145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",40
1944,Hyperphosphorylated tau (p-tau),"[{'article': 'PMC5596480.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
1945,Hyperphosphorylated tau (phospho-tau),"[{'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",40
1946,Hyperphosphorylated tau protein,"[{'article': 'PMC3097009.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4826954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
1947,Hyperpolarized 129Xe MRI,"[{'article': 'PMC7554935.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cerebral perfusion changes associated with Alzheimer’s disease'}]",158
1948,Hyperspectral (HS) imaging,"[{'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",698
1949,Hyperspectral (HS) score,"[{'article': 'PMC6748929.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6748929.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",698
1950,Hypertension,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5389824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}, {'article': 'PMC5389824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive deterioration'}]",297
1951,Hypoalbuminemia,"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Weight loss in women with Alzheimer's Disease""}]",319
1952,Hypocretin-1,"[{'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",241
1953,I-ADL,"[{'article': 'PMC7749592.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional decline in Alzheimer's Disease""}]",540
1954,I2BS,"[{'article': 'PMC8481830.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Astrocytosis in Alzheimer's Disease""}]",39
1955,I2PP2A,"[{'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease through inhibition of PP2A activity""}]",39
1956,IA-Elc Aβ42/40,"[{'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",166
1957,IADL,"[{'article': 'PMC4468784.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor functional abilities in Alzheimer's Disease""}, {'article': 'PMC8436545.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Instrumental functional impairment in Alzheimer’s Disease'}, {'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Instrumental Activities of Daily Living assessment in Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Activities of daily living in Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Instrumental Activities of Daily Living in Alzheimer's Disease""}, {'article': 'PMC7745768.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Functional independence in Alzheimer's Disease""}, {'article': 'PMC9501541.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Impairment in Alzheimer's Disease""}]",505
1958,IADL (instrumental activities of daily living),"[{'article': 'PMC3382377.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Functional status in Alzheimer's Disease""}]",419
1959,IAF peak,"[{'article': 'PMC3914466.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early stages of Alzheimer's Disease""}]",505
1960,IATI index,"[{'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",505
1961,IBA-1,"[{'article': 'PMC4956742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of microglial activation in Alzheimer's Disease""}, {'article': 'PMC4956742.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuroinflammation in Alzheimer's Disease""}]",75
1962,ICAM-1,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",547
1963,ICAM1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",547
1964,ICVF,"[{'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""White matter integrity in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",349
1965,IDE,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Aβ protein accumulation in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive response to ketosis in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Influence insulin levels affecting ketogenesis in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ Degradation'}]",67
1966,IDE rs2251101,"[{'article': 'PMC3213220.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection for Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive improvement in Alzheimer's Disease""}]",144
1967,IFB-2,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",388
1968,IFG,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",388
1969,IFN-γ,"[{'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Immune response in Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction in pro-inflammatory cytokine levels'}, {'article': 'PMC6916654.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduced IFN-γ levels in peripheral plasma and improved cognition defects'}]",26
1970,IFN-γ secretion,"[{'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",26
1971,IFNɣ,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]",388
1972,IFNγ,"[{'article': 'PMC6837488.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduction in Alzheimer's Disease risk through anti-inflammatory effects in the brain""}]",26
1973,IGF-1,"[{'article': 'PMC10001958.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Protection of neurons from Aβ oligomers'}, {'article': 'PMC3110111.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease: Brain function improvement through exercise""}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4333880.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4333880.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal differentiation and hippocampal neurogenesis'}, {'article': 'PMC4908397.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8201462.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Neuroprotection and cognitive enhancement in Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognition'}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved executive function (Stroop performance)'}, {'article': 'PMC6162846.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Executive function improvement in mild cognitive impairment'}, {'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Exercise-induced response'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurotrophic Factor Levels'}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Reduced Aβ toxicity and enhanced Aβ phagocytosis'}, {'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for therapeutic intervention in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Neuroprotective effects in traumatic brain injury'}, {'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Protective effect on astrocytes and prevention of glutamate excitotoxicity in Alzheimer's Disease""}]",227
1974,IGF-1 receptor,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved health and increased lifespan'}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",227
1975,IGF-I,"[{'article': 'PMC1325254.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Protection against neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",227
1976,IGF1,"[{'article': 'PMC8211849.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Changes in brain health and cognition related to Alzheimer's Disease""}, {'article': 'PMC8211849.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",227
1977,IGF1R,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",227
1978,IIV,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Frontal gray and white matter integrity changes on MRI scans'}, {'article': 'PMC4406069.txt', 'relationship': 'PREDICTS', 'object': 'Greater cognitive decline'}, {'article': 'PMC8225898.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Predict impending cognitive decline and increased mortality risk'}, {'article': 'PMC8225898.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",108
1979,IL-1,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ formation and neuronal degeneration'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased neuroinflammation and cognitive impairment'}]",81
1980,IL-10,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Cognitive deficits'}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Augmentation in Treg transferred 3xTg-AD mice'}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotective effects in AD models'}, {'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Inflammatory status in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Physical function decline in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}, {'article': 'PMC6916654.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7690082.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster disease progression in AD patients with low plasma cytokine levels'}, {'article': 'PMC9108275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Regulated by TEMT treatment in AD patients'}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Poor cognitive performance in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved cognitive function and reduced Aβ toxicity'}]",81
1981,IL-12,"[{'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}]",81
1982,IL-12:IL-23p40,"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",81
1983,IL-12P40,"[{'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in plasma levels reflects response to placebo treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-inflammatory response in Alzheimer's Disease""}]",506
1984,IL-12P70,"[{'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduction in plasma levels reflects response to resveratrol treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-inflammatory response in Alzheimer's Disease""}]",506
1985,IL-12p70,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",506
1986,IL-13,"[{'article': 'PMC3940003.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",81
1987,IL-15,"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Inflammatory status in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster disease progression in AD patients with low plasma cytokine levels'}, {'article': 'PMC9108275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Regulated by TEMT treatment in AD patients'}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]",81
1988,IL-16,"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",81
1989,IL-17,"[{'article': 'PMC2765081.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}]",81
1990,IL-17A,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction in pro-inflammatory cytokine levels'}]",81
1991,IL-17F,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",81
1992,IL-17α,"[{'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RESPONDED_TO', 'object': 'Transcranial Electromagnetic Treatment (TEMT)'}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",81
1993,IL-18,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]",81
1994,IL-1R4,"[{'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in plasma levels reflects response to placebo treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-inflammatory response in Alzheimer's Disease""}]",81
1995,IL-1RA,"[{'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Resveratrol treatment in Alzheimer's Disease""}]",81
1996,IL-1b,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",81
1997,IL-1α,"[{'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",177
1998,IL-1β,"[{'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Canakinumab'}, {'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3116821.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in rats and mice exposed to isoflurane'}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in rodents after isoflurane exposure'}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment'}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment'}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory responses in Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegeneration and inflammation'}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4991069.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4991069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation and stress, which are associated with Alzheimer's Disease""}, {'article': 'PMC4991069.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Clinical treatments for inflammation and related diseases'}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Reduction in hippocampal levels associated with exercise-induced protection against immune and neuroinflammatory responses after surgery'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced inflammation in AD models'}, {'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neurotoxic effects'}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased inflammation in Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduced release in the presence of oleanolic acid, β-sitosterol, and α-tocopherol'}, {'article': 'PMC9321013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroinflammation in AD'}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased astrocyte activation and Aβ accumulation'}]",115
1999,IL-2,"[{'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'slower cognitive decline in patients with mild cognitive impairment'}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6837488.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduction in Alzheimer's Disease risk through expansion of neuroprotective Treg cells""}, {'article': 'PMC7690082.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",81
2000,IL-22,"[{'article': 'PMC2765081.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}]",81
2001,IL-3,"[{'article': 'PMC9527145.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",81
2002,IL-4,"[{'article': 'PMC11274940.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility: AAV-mediated overexpression'}, {'article': 'PMC3940003.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in cerebral spinal fluid levels reflects response to resveratrol treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Adaptive immune response in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved cognitive function and reduced Aβ toxicity'}]",81
2003,IL-5,"[{'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroinflammation in AD'}]",81
2004,IL-6,"[{'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Microglial phagocytic capacity'}, {'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2765081.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduction of inflammation in Alzheimer's Disease""}, {'article': 'PMC2871786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3116821.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory responses in Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegeneration and inflammation'}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Aβ elimination'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Reduction in hippocampal levels associated with exercise-induced protection against immune and neuroinflammatory responses after surgery'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory processes in Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction in pro-inflammatory cytokine levels'}, {'article': 'PMC5381339.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}, {'article': 'PMC5381339.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5381339.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC5381339.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with cognitive decline in Alzheimer's Disease""}, {'article': 'PMC5381339.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC5381339.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflammation and cognitive decline'}, {'article': 'PMC5381339.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Dietary patterns and accelerated cognitive decline'}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Inflammatory status in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neurotoxic effects'}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased inflammation in Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC7690082.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Faster disease progression in AD patients with low plasma cytokine levels'}, {'article': 'PMC9108275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Regulated by TEMT treatment in AD patients'}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduced release in the presence of α-tocopherol'}, {'article': 'PMC9321013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",81
2005,IL-7,"[{'article': 'PMC8258160.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Immune system replenishment in Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",81
2006,IL-8,"[{'article': 'PMC2871786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}, {'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4991069.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4991069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'reduced Aβ42, Aβ40, and P-tau levels'}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]",81
2007,IL-8/CXCL8,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ aggregation and BDNF formation'}]",63
2008,IL12,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]",81
2009,IL12P70,"[{'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",506
2010,IL17,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]",81
2011,IL1B,"[{'article': 'PMC3213220.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive response to ketosis in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Inflammatory response inhibiting ketosis in Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",177
2012,IL1B rs1143627,"[{'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC3213220.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive improvement in Alzheimer's Disease""}]",177
2013,IL1B rs16944,"[{'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]",177
2014,IL1α,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]",177
2015,IL1β,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]",115
2016,IL2,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]",81
2017,IL6,"[{'article': 'PMC2765081.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Diagnosis""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5381339.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]",81
2018,INF-γ,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",26
2019,INFγ,"[{'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]",26
2020,INI,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Restoration of white matter function impaired during cerebral ischemia in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Postoperative Delirium (POD)'}]",67
2021,INPP5D,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with increased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",233
2022,INSR,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",67
2023,IP-10,"[{'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",657
2024,IP-MS-WashU Aβ42/40,"[{'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",166
2025,IPL,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8287201.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",657
2026,IQ-CODE,"[{'article': 'PMC3481364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}]",428
2027,IR,"[{'article': 'PMC10001958.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognition and mood regulation in Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",243
2028,IR index,"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with Metformin'}]",243
2029,IRS,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease neuropathology""}, {'article': 'PMC6211704.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapy for Alzheimer's Disease""}]",599
2030,IRS-1,"[{'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",599
2031,IRS-1/2,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Reduced Aβ deposition and behavioural deficits'}]",599
2032,IRS1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Anti-diabetic treatment in Alzheimer's Disease""}]",599
2033,IRS2,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",599
2034,IRSP,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]",599
2035,ISI,"[{'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Insomnia Disorder in Alzheimer's Disease""}]",67
2036,ITG,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",469
2037,IVIG,"[{'article': 'PMC9606044.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",67
2038,IWIs,"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement over test sessions'}]",67
2039,Iba-1,"[{'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Inflammatory response: Reduced levels in J147-treated mice'}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of microglial activation in AD mice'}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced microglial activation in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Microgliosis in Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Reduction in hippocampal levels associated with exercise-induced protection against immune and neuroinflammatory responses after surgery'}, {'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Microglial reaction in Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC5297247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",75
2040,Iba1,"[{'article': 'PMC3520904.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'CD163 immunoreactive microglia'}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'RESPONDED_TO', 'object': 'Fingolimod treatment'}, {'article': 'PMC5520675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'No reactive microglia after TI stimulation'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Loss of motility in microglia in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Increased Aβ phagocytosis in GF 5xFAD mice'}]",75
2041,Icam1,"[{'article': 'PMC8581408.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflamed BBB endothelium'}]",547
2042,Idalopirdine,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",126
2043,IgG,"[{'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Blood-brain barrier disruption in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Blood-brain barrier disruption in Alzheimer's Disease""}]",569
2044,IgG Antibodies,"[{'article': 'PMC6201586.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",25
2045,IgG against Axon Peptide 108,"[{'article': 'PMC6201586.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]",308
2046,IgG antibodies,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pathological tau protein in Alzheimer's Disease""}]",25
2047,IgG antibody levels,"[{'article': 'PMC6201586.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment response to AADvac1'}]",25
2048,IgG response,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",569
2049,IgG titres,"[{'article': 'PMC6201586.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive decline and hippocampal atrophy in AD patients'}, {'article': 'PMC6201586.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive benefit and disease severity in AD patients'}, {'article': 'PMC6201586.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease patients""}, {'article': 'PMC6201586.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Immune response to AADvac1 treatment'}, {'article': 'PMC6201586.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to AADvac1 and need for re-vaccination'}]",569
2050,IgG1,"[{'article': 'PMC6201586.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",569
2051,IgG1 and IgG3 antibodies,"[{'article': 'PMC6201586.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment Monitoring: Alzheimer's Disease""}]",25
2052,IgG2,"[{'article': 'PMC6201586.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",569
2053,IgG3,"[{'article': 'PMC6201586.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",569
2054,IgG4,"[{'article': 'PMC6201586.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",569
2055,IgM,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",67
2056,Il1a,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",177
2057,Il1b,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",177
2058,Il6,"[{'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",81
2059,Imagined Timed 'Up & Go' (iTUG) score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Motor imagery deficits'}]",1
2060,Imidazoline-2 binding sites,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]",88
2061,Immediate Memory Recall (MIR),"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",221
2062,Immediate Recall,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]",221
2063,Immediate Recall (IR),"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive Decline in Alzheimer's Disease""}]",221
2064,Immediate memory,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease""}]",221
2065,Immediate memory domain score,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Significant improvement in memory functions in suspected mild cognitive impairment'}]",157
2066,Impaired Auditory and Written Comprehension,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",220
2067,Impaired sound perception and recognition,"[{'article': 'PMC6950055.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",220
2068,"In-home activity data (computer use, walking speed, time out of house)","[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early changes in Mild Cognitive Impairment'}]",323
2069,Increased delta-band power,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",58
2070,Increased silent pauses,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",621
2071,Increased theta-band power,"[{'article': 'PMC3914466.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",210
2072,Infarct presence,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",404
2073,Inferior Parietal Lobule (IPL),"[{'article': 'PMC7735856.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",657
2074,Inferior frontal lobe grey matter volume,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease""}]",634
2075,Inferior parietal gyrus cortical thickness,"[{'article': 'PMC2764863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",90
2076,Inflammation,"[{'article': 'PMC4707222.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Decreased inflammation in Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",289
2077,Inflammation biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",289
2078,Inflammatory Bowel Disease,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",416
2079,Inflammatory cytokines,"[{'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",666
2080,Inflammatory factors,"[{'article': 'PMC7934383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Exercise intervention response in Alzheimer's Disease""}]",289
2081,Inflammatory markers,"[{'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""J147 treatment in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}]",289
2082,"Inflammatory markers (e.g., Map3k7, Map2k4, C1qa, C1qb, C3, C4a, Flt1)","[{'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]",289
2083,Infliximab,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Lower risk of Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced risk for Alzheimer's Disease""}]",33
2084,Inhibition cost,"[{'article': 'PMC8281974.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}]",152
2085,Inhibitory/Excitatory Intracortical Circuits,"[{'article': 'PMC7360860.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': ""rTMS treatment in Alzheimer's Disease""}]",152
2086,Innate immunity signaling,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",72
2087,Instrumental ADL performance,"[{'article': 'PMC4666316.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",540
2088,Instrumental Activities of Daily Living (IADLs),"[{'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Functional decline in Alzheimer's Disease""}]",419
2089,Insula,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease""}]",67
2090,Insular cortical thickness,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}]",197
2091,Insular lobe,"[{'article': 'PMC10439779.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",409
2092,Insulin,"[{'article': 'PMC10001958.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Protection of neurons from Aβ oligomers'}, {'article': 'PMC10233712.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Amyloid-beta (Aβ) and pathological tau'}, {'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3761088.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides treatment selection for Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with Metformin'}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease neuropathology and cognitive decline""}, {'article': 'PMC6211704.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapy for Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive performance in Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reduced risk of major adverse metabolic events affecting cognitive functions'}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guiding treatment selection in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for therapeutic intervention in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RESPONDED_TO', 'object': ""Responds to treatment by improving cognitive functions and reducing brain damage in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neuroprotective effects in cerebral ischemia'}]",73
2093,Insulin (INI),"[{'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment of cognitive and metabolic disorders in T2DM'}]",653
2094,Insulin Resistance,"[{'article': 'PMC10306194.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",73
2095,Insulin Resistance (IR),"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function improvement in patients with non-dementia vascular cognitive impairment'}]",73
2096,Insulin degrading enzyme,"[{'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Monomeric Aβ'}]",85
2097,Insulin growth factor 1 (IGF-1),"[{'article': 'PMC4908397.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Trophic factors in hBM-MSCs dynamic conditioned media'}]",227
2098,Insulin levels,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved insulin sensitivity and reduced cognitive impairment'}]",73
2099,Insulin metabolism markers,"[{'article': 'PMC5105117.txt', 'relationship': 'RESPONDED_TO', 'object': 'Probiotic supplementation'}]",73
2100,Insulin receptor signaling pathway (IRSP) genes,"[{'article': 'PMC6211704.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Normalization of compromised IRSP functions in AD with anti-diabetic treatments'}]",202
2101,Insulin sensitivity,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",73
2102,Insulin signaling,"[{'article': 'PMC10001958.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced premature mortality associated with Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",202
2103,Insulin-like Growth Factor 1 (IGF1),"[{'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotective and therapeutic effects of exercise on the brain'}]",227
2104,Intepirdine,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",309
2105,Intercellular adhesion molecule-1 [ICAM-1],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",447
2106,"Interferon gamma induced protein 10 [IP-10, CXCL10]","[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",26
2107,Interferon-gamma [IFN-γ],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",26
2108,Interferon-γ,"[{'article': 'PMC8789895.txt', 'relationship': 'RESPONDED_TO', 'object': 'Intranasal insulin treatment'}]",26
2109,Interleukin-1 (IL-1),"[{'article': 'PMC2194921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]",115
2110,Interleukin-2,"[{'article': 'PMC8789895.txt', 'relationship': 'RESPONDED_TO', 'object': 'Intranasal insulin treatment'}]",115
2111,Interleukin-6,"[{'article': 'PMC8789895.txt', 'relationship': 'RESPONDED_TO', 'object': 'Intranasal insulin treatment'}]",115
2112,Interleukin-6 (IL-6),"[{'article': 'PMC2194921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Alzheimer’s Disease'}, {'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",115
2113,Interpausal unit duration,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",168
2114,Intraindividual Variability (IIV),"[{'article': 'PMC8225898.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8225898.txt', 'relationship': 'PREDICTS_CONVERSION_EVENT', 'object': ""From mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'USED_TO_MONITOR', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8225898.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",55
2115,Intranasal Insulin (INI),"[{'article': 'PMC10306194.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved global cognition in Alzheimer's Disease patients""}]",653
2116,Intranasal insulin (INI),"[{'article': 'PMC10306194.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC10306194.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognition in Alzheimer's Disease""}, {'article': 'PMC6483338.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': 'Improvement in verbal fluency, motor performance, and functional health'}]",653
2117,Ioflupane (123I),"[{'article': 'PMC4091455.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis of striatal dopaminergic deficit disorders (SDDDs)'}, {'article': 'PMC4091455.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis of diseases with striatal dopaminergic deficit'}, {'article': 'PMC4091455.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4091455.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Striatal dopaminergic deficit'}, {'article': 'PMC4091455.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of a striatal dopaminergic deficit'}, {'article': 'PMC4091455.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment selection for differentiating PD from ET, and DLB from AD'}, {'article': 'PMC4091455.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Correction to treatment following imaging results'}]",640
2118,Irisin,"[{'article': 'PMC7274941.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",79
2119,Iron,"[{'article': 'PMC9755275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",366
2120,Iron metabolism biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",257
2121,Irritability,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",624
2122,Isaac’s set test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Verbal fluency deficits in Alzheimer's Disease""}]",291
2123,Isoleucine,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiation between mild cognitive impairment due to AD and healthy controls'}, {'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to GV-971 treatment'}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}]",309
2124,Isoprostanes (F2-IsoPs),"[{'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",431
2125,Itga5,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Basement membrane interaction'}]",469
2126,Itgax,"[{'article': 'PMC7389451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'AD-associated microglial activation'}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",469
2127,Itgax (CD11c),"[{'article': 'PMC7389451.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Microglial phagocytosis during treatment of Alzheimer's Disease""}]",194
2128,J147,"[{'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Better prognosis in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Amyloid toxicity in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Memory improvements in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Learning and memory enhancements in Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Spatial learning and memory in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement in AD mice'}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Improvement in spatial navigational memory'}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction in disinhibition phenotype'}, {'article': 'PMC3706879.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in short-term working memory and spatial memory in scopolamine-induced memory impairment model'}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Reversal of memory deficits in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved spatial memory and hippocampal-dependent associative learning'}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction of soluble Aβ levels'}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",272
2129,J147 + Donepezil,"[{'article': 'PMC3706879.txt', 'relationship': 'SYNERGISTIC_EFFECT', 'object': 'Improved hippocampal-dependent associative memory'}]",272
2130,JAK inhibitors,"[{'article': 'PMC7884393.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",399
2131,JAK kinases,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]",399
2132,JAK1,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]",589
2133,JAK2,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]",589
2134,JAK3,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]",589
2135,JAM-1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Tight junctions'}]",620
2136,JNJ-54861911,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Phase II/III clinical trials for Alzheimer's Disease""}]",602
2137,JNK1,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",589
2138,Jag1,"[{'article': 'PMC4304279.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Alzheimer's Disease""}]",589
2139,Jmild cognitive impairment S score,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease""}]",41
2140,K-BNT,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Language Function Impairment in Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",138
2141,K-MMSE,"[{'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",347
2142,KBIT-2 nonverbal raw score,"[{'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Prodromal dementia'}]",1
2143,KBIT-2 verbal raw score,"[{'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Preclinical dementia'}]",1
2144,KU complex (Ku70 and Ku80),"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aging-associated autoimmunity'}]",223
2145,Kcnk1,"[{'article': 'PMC10917684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Astrocytic response to 40Hz stimulation in Alzheimer's Disease""}]",589
2146,Ketogenic diet,"[{'article': 'PMC9644639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Improved cognition in Alzheimer's Disease""}]",373
2147,Ketones,"[{'article': 'PMC8470960.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Improved cognitive functioning in patients with Alzheimer's Disease or mild cognitive impairment""}]",373
2148,Ketones (BHB),"[{'article': 'PMC8470960.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Improved cognitive functioning in Alzheimer's Disease patients""}]",373
2149,Kgp,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC6357742.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",61
2150,Ki-67,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Proliferating cells in the dentate gyrus (DG)'}]",223
2151,Kir6.2,"[{'article': 'PMC6679855.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Development of Alzheimer's Disease""}]",223
2152,Kp,"[{'article': 'PMC5209404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Blood-to-brain penetration'}]",61
2153,L IFG orbitalis,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",388
2154,L ITG,"[{'article': 'PMC6218435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",469
2155,L MTG,"[{'article': 'PMC6218435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",169
2156,L-VSCC,"[{'article': 'PMC3362564.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}]",198
2157,L-VSCC activity,"[{'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced activity in XPro1595-treated rats'}]",198
2158,L-VSCCs,"[{'article': 'PMC3362564.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Synaptic plasticity and cognitive function in Alzheimer's Disease""}]",198
2159,L-carnitine (CAR),"[{'article': 'PMC7831739.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",484
2160,L-type voltage sensitive Ca2+ channels (L-VSCCs),"[{'article': 'PMC3362564.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased activity in hippocampal CA1 neurons'}]",198
2161,LAL,"[{'article': 'PMC4489713.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Autophagy-lysosomal cascade functionality'}]",20
2162,LAMP1,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",29
2163,LAMP2,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",29
2164,LBP,"[{'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]",61
2165,LC-MS-Arc Aβ42/40,"[{'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",166
2166,LC3,"[{'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4489713.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Muscle pathology and autophagy dysfunction'}, {'article': 'PMC5456028.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'VCP disease pathology in patient myoblasts'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Rapamycin treatment in VCP disease'}]",443
2167,LC3 (Atg8),"[{'article': 'PMC4485995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Autophagosome formation in Alzheimer's Disease""}]",443
2168,LC3-I,"[{'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Autophagic dysfunction in VCPR155H/+ mice'}]",443
2169,LC3-I/II,"[{'article': 'PMC4489713.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Autophagy dysfunction in VCP disease'}, {'article': 'PMC5456028.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'VCP disease pathology'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}]",443
2170,LC3-II,"[{'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Autophagic dysfunction in VCPR155H/+ mice'}, {'article': 'PMC5076443.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5076443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Autophagy levels in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5445077.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Autophagy activation in Alzheimer's Disease""}]",443
2171,LC3A,"[{'article': 'PMC8470960.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Autophagy in Alzheimer's Disease""}]",443
2172,LC3B,"[{'article': 'PMC5076443.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5076443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Autophagy'}]",443
2173,LDAM,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",542
2174,LDL cholesterol,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC4987494.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvements in low-density lipoprotein cholesterol levels'}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Metabolic changes in Alzheimer's Disease""}]",622
2175,LDL levels,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",542
2176,LDL-C,"[{'article': 'PMC8351379.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",542
2177,LDL-cholesterol,"[{'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",622
2178,LDR,"[{'article': 'PMC9321013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Enhanced amyloid deposition and reduced cognitive function in Alzheimer's Disease""}]",542
2179,LICI,"[{'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced long-interval intracortical inhibition in Alzheimer's Disease""}]",151
2180,LOC101929163,"[{'article': 'PMC6158742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",602
2181,LOC399491,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",602
2182,LRP-1,"[{'article': 'PMC9321013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Suppression of microglial activation and Alzheimer's Disease progression""}]",258
2183,LRP1,"[{'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ efflux and degradation in Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",258
2184,LTP,"[{'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Memory enhancement in Alzheimer's Disease""}]",61
2185,Lachnospiraceae,"[{'article': 'PMC8266337.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Good cognition behaviors and production of beneficial metabolites'}]",503
2186,Lacunar Infarcts,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Linked to cognitive decline and increased risk of dementia'}]",608
2187,Lacunar infarct,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",608
2188,Lacunar infarcts,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",608
2189,Lacunes,"[{'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower general cognitive ability in older age'}, {'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",605
2190,Language,"[{'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4712287.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to rTMS-COG treatment'}]",568
2191,Language severity,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Object and action naming impairments in PPA'}]",568
2192,Latency to reach new platform,"[{'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Learning impairments in Alzheimer's Disease""}]",80
2193,Latency to reach the platform,"[{'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",80
2194,Latency to target,"[{'article': 'PMC4675859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Learning and memory deficits in Alzheimer's Disease""}]",80
2195,Left Cerebellum,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Shorter interpausal units in Alzheimer's Disease""}]",93
2196,Left Fusiform Gyrus (L FFG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Shorter interpausal units in Alzheimer's Disease""}]",52
2197,Left IFG orbitalis,"[{'article': 'PMC6218435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predicts naming performance in PPA'}, {'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",388
2198,Left ITG,"[{'article': 'PMC6218435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predicts naming performance in PPA'}, {'article': 'PMC6218435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Language severity in PPA'}, {'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",469
2199,Left Inferior Frontal Gyrus (L IFG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Shorter interpausal units in Alzheimer's Disease""}]",284
2200,Left Inferior Temporal Gyrus (L ITG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Shorter interpausal units in Alzheimer's Disease""}]",284
2201,Left MTG,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor performance in naming verbs'}, {'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",169
2202,Left Middle Temporal Gyrus (L MTG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Slower speech rate and shorter turns in Alzheimer's Disease""}]",52
2203,Left angular gyrus,"[{'article': 'PMC10439779.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""rTMS treatment for cognitive improvement in Alzheimer's Disease""}]",52
2204,Left angular gyrus (AG) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (lvPPA variant)""}]",52
2205,Left caudate-rMFG tract FC,"[{'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",498
2206,Left frontal parietal network,"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Acupuncture treatment response in Alzheimer's Disease""}]",172
2207,Left hippocampal volume,"[{'article': 'PMC4563885.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor diet quality (high Western dietary factor scores, low prudent dietary factor scores)'}, {'article': 'PMC4563885.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Good diet quality (high prudent dietary factor scores, low Western dietary factor scores)'}, {'article': 'PMC4563885.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Smaller left hippocampal volume associated with poorer diet quality and Alzheimer's Disease""}]",648
2208,Left inferior frontal gyrus (IFG) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (nfvPPA variant)""}]",284
2209,Left posterior temporal gyrus atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (lvPPA variant)""}]",284
2210,Left putamen-rMFG tract fiber number,"[{'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in APP group""}]",498
2211,Left supramarginal gyrus (SMG) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (lvPPA variant)""}]",284
2212,Leptin,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ' Restoration of leptin levels in diabetic rats'}]",134
2213,Lesions Load,"[{'article': 'PMC4939696.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",23
2214,Letter (FAS) and Category Verbal Fluency,"[{'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Verbal Fluency Impairment in Alzheimer's Disease""}]",101
2215,Letter fluency,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",101
2216,Levetiracetam,"[{'article': 'PMC8325256.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",309
2217,Lexical and semantic retrieval deficits,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",656
2218,Lexical components,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",217
2219,Lexical features,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Probable Alzheimer's Disease""}]",217
2220,Lgals3,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Basement membrane interaction'}]",29
2221,Life Experience Questionnaire (LEQ),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",117
2222,Life-space characteristics,"[{'article': 'PMC9501541.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Impairment in Alzheimer's Disease""}]",337
2223,Lifestyle activities,"[{'article': 'PMC5016950.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive outcomes in Alzheimer's Disease""}]",260
2224,Linguistic density,"[{'article': 'PMC4526336.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Lower risk of Alzheimer's Disease""}]",568
2225,Linguistic features,"[{'article': 'PMC5237556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Probable Alzheimer's Disease""}, {'article': 'PMC9171270.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",217
2226,Lipid peroxidation,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",384
2227,Lipid peroxides,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]",384
2228,Lipid profiles,"[{'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Lipid metabolism in Alzheimer's Disease patients""}]",384
2229,Lipopolysaccharides (LPS),"[{'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Brain amyloid deposition in Alzheimer's Disease""}]",384
2230,Liver enzyme elevations,"[{'article': 'PMC6685277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Liver toxicity'}]",85
2231,Local Gyrification Index (LGI),"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amild cognitive impairment'}, {'article': 'PMC4870937.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Neuropsychological scores (MMSE and MoCA)'}]",52
2232,Local efficiency in SMC and DMN,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased local efficiency in brain network architecture'}]",437
2233,Logical Memory,"[{'article': 'PMC4876902.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Mild Cognitive Impairment to AD Conversion'}]",546
2234,Logical Memory (WMS-III),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",546
2235,Logical Memory I (LMI) and II (LMII) from the Wechsler Memory Scale-Abbreviated (WMS-a),"[{'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Memory Impairment in Alzheimer's Disease""}]",546
2236,Longer pause duration,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",693
2237,Low memory scores,"[{'article': 'PMC6945608.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}]",157
2238,Low-density lipoprotein (LDL),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cholesterol levels in Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",622
2239,Lower BBS scores,"[{'article': 'PMC4431827.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Predicted improvement in 30-second chair stand test after intervention'}]",322
2240,Lp-PLA2,"[{'article': 'PMC5209404.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC5209404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5209404.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to GSK2647544 treatment'}, {'article': 'PMC5209404.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Brain Lp-PLA2 inhibition'}, {'article': 'PMC5209404.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",173
2241,Lumosity game scores,"[{'article': 'PMC7729136.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive changes due to MPH treatment in Alzheimer's Disease""}]",1
2242,LxR,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",486
2243,Lycium barbarum extract,"[{'article': 'PMC3097009.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3097009.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",33
2244,M1 microglia,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Late-stage Alzheimer's Disease""}]",423
2245,M1-type microglia,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",423
2246,M2 microglia,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-stage Alzheimer's Disease""}]",423
2247,MADRS,"[{'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Depressive symptoms in Alzheimer's Disease patients""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",22
2248,MAG:PLP1,"[{'article': 'PMC4835514.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",173
2249,MAG:PLP1 ratio,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral hypoperfusion in Alzheimer's Disease""}]",173
2250,MAN2A1,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",99
2251,MAO-B,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Astrocytosis in Alzheimer's Disease""}, {'article': 'PMC5478550.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease: Neuroinflammatory processes in glial cells""}, {'article': 'PMC5478550.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease: Reduction of neurodegenerative processes""}, {'article': 'PMC5478550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5478550.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",120
2252,MAP-2,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Mature neuronal differentiation in Alzheimer's Disease""}]",414
2253,MAPT,"[{'article': 'PMC5100351.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neurodegenerative diseases'}, {'article': 'PMC5450399.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Inherited frontotemporal dementia and parkinsonism with Tau inclusions'}]",414
2254,MAPT mutations,"[{'article': 'PMC5450399.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",414
2255,MB,"[{'article': 'PMC3467226.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",348
2256,MBA,"[{'article': 'PMC8581408.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-β associated with Alzheimer's Disease""}]",113
2257,MC max. plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",123
2258,MC mean plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",123
2259,MC1 (conformationally changed Tau),"[{'article': 'PMC4294473.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",40
2260,MCP-1,"[{'article': 'PMC3116821.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4991069.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4991069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation, which is linked to Alzheimer's Disease""}, {'article': 'PMC4991069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",150
2261,MCP-1/CCL2,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",150
2262,MCS-B,"[{'article': 'PMC5619332.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia severity as assessed by Pfeffer-FAQ and CDR'}]",150
2263,MD,"[{'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""White matter integrity in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Increased step time variability (pace) and increased double support time (rhythm)'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Short stance time (rhythm)'}]",434
2264,MDA,"[{'article': 'PMC4659639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower MDA levels indicating reduced oxidative stress'}, {'article': 'PMC4659639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Oxidative stress reduction in Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Oxidative stress in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'RESPONDED_TO', 'object': 'Probiotic supplementation'}, {'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiating AD-MCA; biomarkers of AD progression'}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased MDA levels in the n-IF group indicate oxidative stress, which is associated with Alzheimer's Disease presence.""}]",694
2265,MDA levels,"[{'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced oxidative stress and lipid peroxidation'}]",694
2266,MDA lipid peroxidation marker,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",384
2267,MDC,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in cerebral spinal fluid levels reflects response to resveratrol treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuro-inflammation in Alzheimer's Disease""}]",694
2268,MDC (CCL22),"[{'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""increased risk of Alzheimer's Disease""}]",465
2269,MEF2C,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with increased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",326
2270,MEG,"[{'article': 'PMC6370863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC9011335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Theta band hypoconnectivity associated with early cognitive improvements in Alzheimer's Disease""}]",483
2271,MEP amplitude,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease patients""}, {'article': 'PMC7360860.txt', 'relationship': 'PREDICTS', 'object': ""Clinical response in Alzheimer's Disease patients""}]",109
2272,MEP amplitudes,"[{'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",109
2273,METs,"[{'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Aerobic fitness in Alzheimer's Disease""}]",240
2274,MEV,"[{'article': 'PMC5068716.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflects Alzheimer's Disease progression""}]",108
2275,MFG,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",326
2276,MFG1,"[{'article': 'PMC7735856.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Item memory gains'}]",326
2277,MFIp75NTR,"[{'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",660
2278,MFN1,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved expression of MFN1 enhances mitochondrial fusion in Alzheimer's Disease""}]",326
2279,MFN2,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved expression of MFN2 enhances mitochondrial fusion in Alzheimer's Disease""}]",326
2280,MGnD,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",138
2281,MHIS,"[{'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",314
2282,MIP-1α,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Immune cell migration and inflammation'}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",150
2283,MIP-1β [CCL4],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",150
2284,MIS score,"[{'article': 'PMC3543284.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3543284.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Better cognitive function in Alzheimer's Disease""}, {'article': 'PMC3543284.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC3543284.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poorer cognitive outcomes in older participants with Alzheimer's Disease""}]",468
2285,MIS-T,"[{'article': 'PMC7031904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease and Related Dementias""}]",468
2286,MIS-T screening instrument,"[{'article': 'PMC4066282.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia screening'}]",468
2287,MLU (Mean Length of Utterance),"[{'article': 'PMC5237556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Probable Alzheimer's Disease""}]",167
2288,MME,"[{'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",347
2289,MMN,"[{'article': 'PMC6370863.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",347
2290,MMP-9,"[{'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Resveratrol treatment in Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",561
2291,MMP10,"[{'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in plasma levels reflects response to resveratrol treatment in Alzheimer's Disease patients.""}]",561
2292,MMP9,"[{'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduction in cerebral spinal fluid levels reflects response to treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Resveratrol treatment response in Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in cerebral spinal fluid MMP9 levels after resveratrol treatment'}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""T cell migration and neuro-inflammation in Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline in Subcortical Ischemic Vascular Dementia'}, {'article': 'PMC9393528.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Blood-brain barrier (BBB) integrity in Alzheimer's Disease (AD)""}, {'article': 'PMC9393528.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline in AD'}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD'}]",561
2293,MMQ,"[{'article': 'PMC9513684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",347
2294,MMSE,"[{'article': 'PMC10092214.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neurocognitive impairment in Alzheimer's Disease""}, {'article': 'PMC10092214.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease severity""}, {'article': 'PMC10092214.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10092214.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive Impairment in Neurocognitive Disorders'}, {'article': 'PMC10092214.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Severity of Neurocognitive Disorders'}, {'article': 'PMC10127414.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC2194921.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive changes in Alzheimer's Disease""}, {'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive state in Alzheimer's Disease""}, {'article': 'PMC2949590.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3226277.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3226311.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3382377.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Wii-Fit intervention'}, {'article': 'PMC3481364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive function in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower MMSE score associated with increased risk of AD'}, {'article': 'PMC3493328.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3580400.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3748825.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease patients""}, {'article': 'PMC3898226.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease severity""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4153626.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment'}, {'article': 'PMC4153626.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Chronic recurring falls leading to injurious outcomes'}, {'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Global cognitive function in Alzheimer's Disease""}, {'article': 'PMC4283145.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Mini-Mental State Examination score criteria for study inclusion'}, {'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4353453.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4401690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Global cognitive function in Alzheimer's Disease patients""}, {'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4468784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild cognitive impairment'}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment and Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: AD dementia'}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: AD dementia'}, {'article': 'PMC4562190.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Diagnosis of: AD dementia'}, {'article': 'PMC4562190.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Helps in prognosis of AD dementia'}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive Impairment in Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4611852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4798753.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower MMSE scores in participants with dementia'}, {'article': 'PMC4804486.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4822297.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease severity""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'PREDICTS', 'object': ""Change in body mass (∆BM) in men with Alzheimer's Disease""}, {'article': 'PMC8028783.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8028783.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Patient awareness of dementia'}, {'article': 'PMC8127192.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8305709.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8316394.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive Impairment'}, {'article': 'PMC8316394.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC8317398.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease based on cognitive impairment severity""}, {'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8436545.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in Alzheimer’s Disease'}, {'article': 'PMC8439008.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function assessment in Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8918152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC8957010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease progression""}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC4197903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC4484882.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4712287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease severity and progression""}, {'article': 'PMC4712287.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function in Alzheimer's Disease patients""}, {'article': 'PMC4764002.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5016950.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5016950.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive function in Alzheimer's Disease patients""}, {'article': 'PMC5111338.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Severity of Alzheimer's Disease""}, {'article': 'PMC5111338.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive response to galantamine treatment in memantine nonusers'}, {'article': 'PMC5111338.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cognitive decline monitoring during treatment'}, {'article': 'PMC5122007.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5122007.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive function in Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive Impairment Assessment'}, {'article': 'PMC5381339.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC5403784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5434395.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease severity in Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement in AD patients after rTMS treatment'}, {'article': 'PMC5464918.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5496421.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive impairment severity'}, {'article': 'PMC5546604.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5619332.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better outcomes on the MMSE were associated with more ventral/caudal locations.'}, {'article': 'PMC6182869.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6260857.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC6366025.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Global cognitive function in mild cognitive impairment and AD'}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive Impairment in Alzheimer's Disease""}, {'article': 'PMC6685277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk of fall/injury in all groups including placebo'}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive impairment'}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945614.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7171193.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Change in cognitive function related to Alzheimer's Disease""}, {'article': 'PMC7288029.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7364345.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}, {'article': 'PMC7592675.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment related to Alzheimer's Disease""}, {'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Mild Cognitive Impairment related to Alzheimer's Disease""}, {'article': 'PMC7662628.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive impairment and dementia conversion'}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess use of technology/devices in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess dysnomia in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess motivation in Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Total ADL and IADL in Alzheimer's Disease patients""}, {'article': 'PMC7749592.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7749592.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7798342.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease patients""}, {'article': 'PMC7798342.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7928298.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7928298.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7930223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive deficits in Alzheimer's Disease""}, {'article': 'PMC9092839.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9092839.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9204250.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Lower MMSE scores are associated with more severe Alzheimer's Disease stages.""}, {'article': 'PMC9361147.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC9389745.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9395831.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC9539040.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Used to diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive loss in prodromal Alzheimer's Disease""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease cognitive impairment""}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}]",347
2295,MMSE (Mini Mental State Examination),"[{'article': 'PMC3382377.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive status in Alzheimer's Disease""}, {'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",467
2296,MMSE (Mini-Mental State Examination),"[{'article': 'PMC8564955.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline predicts functional decline'}]",467
2297,MMSE score,"[{'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC2880123.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC2880123.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment'}, {'article': 'PMC3748825.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3898226.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Decrease in CoV of stride time'}, {'article': 'PMC4335024.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4335024.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC4335024.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Disease progression in Alzheimer's Disease""}, {'article': 'PMC5123349.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment severity in Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6685277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease severity""}]",347
2298,MMSE score < 17,"[{'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Moderate or severe Alzheimer’s Disease'}]",347
2299,MMSE scores,"[{'article': 'PMC4396171.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive response to treatment in Alzheimer's Disease""}, {'article': 'PMC5111338.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline: Slower progression in galantamine-treated patients'}, {'article': 'PMC5111338.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mortality: Lower rates in galantamine-treated patients'}, {'article': 'PMC9309357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease severity""}]",347
2300,MMSE-2,"[{'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",347
2301,MMSE-2:BV,"[{'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Alzheimer's Disease""}]",347
2302,MMSE-2:EV,"[{'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",347
2303,MMSE-2:SV,"[{'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Moderate Alzheimer's Disease""}]",347
2304,MNA,"[{'article': 'PMC7505369.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive stage and bone health status'}]",314
2305,MOCA,"[{'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive impairment'}]",476
2306,MRC1,"[{'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'CD163 immunoreactive perivascular macrophages'}]",219
2307,MRI,"[{'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Predicts: Future cognitive decline and conversion to AD'}, {'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and progression of Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Supports diagnostic assessment of CBS and other heterogeneous disorders'}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Hippocampal atrophy in Down Syndrome'}, {'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early diagnosis of pathological cognitive decline'}, {'article': 'PMC4822297.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Amyloid-related imaging abnormalities (ARIA)'}, {'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease characteristics in clinically normal subjects""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment'}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Regional atrophy and disease progression'}, {'article': 'PMC4970664.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Typical AD (amnestic multidomain dementia)'}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Worse cognitive symptoms'}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5399035.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5642413.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional disability progression in Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Atrophy progression in Alzheimer's Disease""}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early functional changes in striatum and hippocampus'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Structural imaging and quantitative analysis of atrophy in mild cognitive impairment and Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Brain plasticity and structure in Alzheimer's Disease""}, {'article': 'PMC9246122.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Episodic memory impairment in mild cognitive impairment and AD'}, {'article': 'PMC9606044.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring structural changes in the brain during PE treatment'}, {'article': 'PMC9606044.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Volume loss in subcortical structures'}, {'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Structural changes in Alzheimer's Disease such as cerebral atrophy and ventricular enlargement""}, {'article': 'PMC9606044.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Hippocampus volume stabilization in Alzheimer's Disease patients""}, {'article': 'PMC9606044.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'response to PE treatment in AD patients'}]",10
2308,MRI (Hippocampi and ventricles volumes),"[{'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Structural atrophy in Alzheimer's Disease""}]",549
2309,MRI (Whole-brain volume percentage change),"[{'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Structural atrophy in Alzheimer's Disease""}]",549
2310,MRI Biomarkers,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Alzheimer’s Disease'}]",10
2311,MRI Temporal Atrophy,"[{'article': 'PMC3733998.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Progression""}]",651
2312,MRI and FDG-PET measures,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment within 48 months'}]",296
2313,MRI and PET scans,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]",296
2314,MRI atrophy rates,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}]",651
2315,MRI biomarkers,"[{'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",10
2316,MRI findings,"[{'article': 'PMC9295361.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced insular cortical thinning and more preserved hippocampi compared to prodromal Alzheimer's disease patients""}]",10
2317,MRI hippocampal volume,"[{'article': 'PMC6685277.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",549
2318,MRI markers (regional cerebral atrophy),"[{'article': 'PMC4200223.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Presence of delusions, apathy, depression, agitation, anxiety, and irritability in BPSD'}]",651
2319,MRI measurements,"[{'article': 'PMC7001626.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: Alzheimer's Disease progression and treatment response""}, {'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}]",10
2320,MRI measures,"[{'article': 'PMC3767625.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis of mild cognitive impairment'}, {'article': 'PMC9295361.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",10
2321,"MRI measures (hippocampus and ERC volumes, temporal lobe cerebral glucose metabolism)","[{'article': 'PMC3767625.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Future conversion to mild cognitive impairment'}]",549
2322,MRI measures of cerebral atrophy,"[{'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline'}]",651
2323,MRI or 18F-FDG PET,"[{'article': 'PMC7477392.txt', 'relationship': 'PREDICTS', 'object': 'Future cognitive decline'}]",296
2324,MRI scans,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and staging of Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': ""PREDICTS_CONVERSION_TO_ALZHEIMER'S_DISEASE"", 'object': ""Conversion from mild cognitive impairment to Alzheimer's Disease""}]",10
2325,MRI volumetric,"[{'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': ""Conversion to Alzheimer's Disease""}]",549
2326,MRI-based atrophy measurements,"[{'article': 'PMC6218435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",651
2327,MRI-based biomarkers,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]",10
2328,MRI-derived WMH,"[{'article': 'PMC6521224.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease risk in older adults'}]",158
2329,MRI-derived measures,"[{'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No detectable structural brain changes'}]",10
2330,MRI-derived structural measures,"[{'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': 'Mild cognitive impairment'}]",10
2331,MRI-derived total WMH,"[{'article': 'PMC6521224.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'n-3 PUFA supplementation effects'}]",158
2332,MRglc in posterior cingulate region,"[{'article': 'PMC3767625.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': 'Mild cognitive impairment'}]",280
2333,MS4A,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",575
2334,MS4A4A,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Detrimental effect on LOAD pathogenesis'}]",575
2335,MS4A6A,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased Braak tangle and plaque in AD patients'}]",575
2336,MTA-scale,"[{'article': 'PMC9309357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",16
2337,MTG,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",169
2338,MTHFR,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Elevated homocysteine levels'}]",169
2339,MTL density and volume,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Predict conversion from mild cognitive impairment to AD'}]",169
2340,MTL network flexibility,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",169
2341,MTL subregions (DG/CA1),"[{'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease pathology""}]",169
2342,MTOR,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",652
2343,MTP,"[{'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Aerobic fitness in Alzheimer's Disease""}]",169
2344,MVGT,"[{'article': 'PMC5016950.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",138
2345,"Macrophage inflammatory protein-1α [MIP-1α, CCL3]","[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",150
2346,Macrophage-derived chemokine,"[{'article': 'PMC8789895.txt', 'relationship': 'RESPONDED_TO', 'object': 'Placebo group'}]",278
2347,"Macrophage-derived chemokine [MDC, CCL22]","[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",278
2348,Madecassic acid,"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Centella asiatica product (CAP) administration'}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuroprotective effects in Alzheimer's Disease""}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Bioavailability in brain'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Centella asiatica treatment in cognitively impaired older adults'}]",696
2349,Madecassoside,"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Centella asiatica product (CAP) administration'}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuroprotective effects in Alzheimer's Disease""}]",696
2350,Maff,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Neurogenesis'}]",314
2351,Magnetic Resonance Imaging (MRI),"[{'article': 'PMC8733254.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring Alzheimer's Disease progression""}, {'article': 'PMC9011335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral atrophy in Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",10
2352,Magnetoencephalography (MEG),"[{'article': 'PMC9011335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",483
2353,Major depression,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid burden associated with Alzheimer's Disease""}]",270
2354,Malformation of venous development,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",324
2355,Malondialdehyde (MDA),"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress levels in Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to probiotic treatment'}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced oxidative stress'}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]",668
2356,Markers of insulin metabolism,"[{'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Insulin metabolism in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}]",73
2357,Mast cells,"[{'article': 'PMC3226277.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",72
2358,Matrices (WAIS-III),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",428
2359,Matrix metalloproteinases,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]",601
2360,Mattis dementia Rating Scale (DRS),"[{'article': 'PMC6615169.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Global cognition in Alzheimer's Disease""}]",21
2361,Maximum plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease patients""}]",123
2362,Maximum plasticity (T5–30),"[{'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function changes in Alzheimer's Disease""}]",123
2363,Mean Diffusivity (MD),"[{'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5200876.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcomes for individuals with Alzheimer's Disease through pre-symptomatic detection""}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",474
2364,Mean Endosome Volume (MEV),"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",427
2365,Mean atrophy,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease patients""}]",286
2366,Mean diffusivity,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",474
2367,Mean diffusivity (MD),"[{'article': 'PMC8760674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6110931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter damage in nfvPPA'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Poor white matter integrity and slower gait velocity in Alzheimer's Disease""}]",474
2368,Mean plasticity (T5–30),"[{'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function changes in Alzheimer's Disease""}]",123
2369,Mean plasticity T5-T30,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease patients""}]",123
2370,Mean stride time,"[{'article': 'PMC3156726.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",246
2371,Medial Temporal Lobe Atrophy (MTA),"[{'article': 'PMC5496421.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",444
2372,Medial temporal atrophy,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",444
2373,Medial temporal lobe atrophy,"[{'article': 'PMC4750048.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INTERACTS_WITH', 'object': 'WMHs in AD'}]",444
2374,Medial temporal lobe volume,"[{'article': 'PMC4750048.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Smaller medial temporal lobe volumes'}]",409
2375,Medial temporal lobe volumes,"[{'article': 'PMC4750048.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",409
2376,Medication Compliance,"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",627
2377,Mediterranean Diet Adherence,"[{'article': 'PMC10542675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Adherence to Mediterranean diet lowers Alzheimer's Disease risk""}]",145
2378,Mediterranean diet,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",145
2379,Medium Chain Triglycerides (MCTs),"[{'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",264
2380,Melatonin,"[{'article': 'PMC4485995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease by blocking tau hyperphosphorylation""}, {'article': 'PMC8317398.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of symptom improvement in Alzheimer's Disease patients undergoing BLT""}, {'article': 'PMC8336239.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Sleep-wake disorders in persons with Alzheimer's Disease""}, {'article': 'PMC8336239.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Changes in sleep-wake disturbances (SWDs)'}, {'article': 'PMC4069047.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive functioning and sleep maintenance in Alzheimer's Disease patients""}, {'article': 'PMC4069047.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive performance and sleep efficiency in Alzheimer's Disease patients""}, {'article': 'PMC4069047.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved sleep quality in AD patients'}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Sleep maintenance improvements in AD patients'}, {'article': 'PMC9644639.txt', 'relationship': 'RESPONDED_TO', 'object': ""Alzheimer's Disease-related sleep disturbances""}, {'article': 'PMC9644639.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Alzheimer's Disease treatment efficacy""}, {'article': 'PMC9666898.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Cognitive improvement in Alzheimer’s disease'}]",536
2381,Memantine,"[{'article': 'PMC3212921.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3212921.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Glutamatergic Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC3212921.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease and Related Dementia (ADRD)""}, {'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4743597.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Alzheimer’s disease'}, {'article': 'PMC4922661.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",96
2382,Memory,"[{'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Shorter interpausal units and slower speech rate'}, {'article': 'PMC4712287.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to rTMS-COG treatment'}, {'article': 'PMC5016950.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Predicts functional decline in Alzheimer's Disease""}]",546
2383,Memory Alteration Test (M@T),"[{'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]",77
2384,Memory Awareness Rating Scale-Memory Functioning (MARS-MF),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",636
2385,Memory Complaints Scale (MCS),"[{'article': 'PMC5619332.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early detection of Alzheimer's Disease""}, {'article': 'PMC5619332.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5619332.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Early screening and preventive or therapeutic interventions for Alzheimer's Disease""}]",636
2386,Memory Impairment Screen (MIS),"[{'article': 'PMC4983010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",702
2387,Memory Impairment Screen (MIS-T),"[{'article': 'PMC4066282.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis of Dementia'}]",702
2388,Memory T cells,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",631
2389,Memory/visuospatial predominant pattern,"[{'article': 'PMC4346122.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'PIB+ status'}]",463
2390,Memory—Delayed Recall,"[{'article': 'PMC6052695.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",221
2391,Memory—Delayed Recognition,"[{'article': 'PMC6052695.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease Progression""}]",221
2392,Memory—Immediate Recall,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",221
2393,Meningeal Lymphatic Vessels,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",154
2394,Meningioma,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",319
2395,Mer,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Microglia recognition and phagocytosis of amyloid plaques in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Pathogenesis of AD'}]",0
2396,"MetS components (waist circumference, triglyceride, HDL, hypertension, fasting glucose)","[{'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Brain aging and neurodegenerative disorders, including Alzheimer's disease""}]",27
2397,Metabolic Syndrome (MetS),"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",27
2398,Metalloproteinases,"[{'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",601
2399,Metformin,"[{'article': 'PMC6074058.txt', 'relationship': 'USED_TO_TREAT', 'object': 'Neurodegeneration with diabetes-related cognitive dysfunction'}, {'article': 'PMC9755275.txt', 'relationship': 'RESPONDED_TO', 'object': 'cognition'}]",96
2400,Methionine,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Longevity and Alzheimer's Disease""}]",96
2401,Methoxy-X-O4,"[{'article': 'PMC7389451.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Microglial Aβ phagocytosis'}]",591
2402,Methylene Blue,"[{'article': 'PMC3836814.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",426
2403,Methylene Blue (MB),"[{'article': 'PMC3467226.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3467226.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Hypometabolism in the posterior cingulate/retrosplenial cortex'}, {'article': 'PMC3467226.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Slowed progression of AD pathology and cognitive function decline'}, {'article': 'PMC3467226.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Neuroprotective strategies for Alzheimer's Disease""}]",426
2404,Mfn1,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}]",326
2405,Mfn2,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}]",326
2406,MicroRNA-155 (miR155) and IFN-γ,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Restricted neurodegenerative pathology and preserved cognitive function.'}]",161
2407,Microbleed presence,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",600
2408,Microbleeds,"[{'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower general cognitive ability in older age'}, {'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cognitive decline in older adults'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced gait velocity in Alzheimer's Disease""}]",600
2409,Microcapillary VD,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",65
2410,Microglia,"[{'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",423
2411,Microglia activation,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",423
2412,Microglial activation,"[{'article': 'PMC3362564.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'XPro1595 treatment'}, {'article': 'PMC8043748.txt', 'relationship': 'PREDICTS_AD_PROGRESSION', 'object': 'Microglial activation predicts AD progression via Aβ plaque load'}, {'article': 'PMC6448216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease progression""}]",423
2413,Microhaemorrhage,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",525
2414,Microhaemorrhages,"[{'article': 'PMC5372150.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",525
2415,Microhemorrhages,"[{'article': 'PMC4772335.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Adverse outcome in Alzheimer's Disease treatment""}]",525
2416,Microinfarcts,"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive aging'}]",404
2417,Microvasculature genes,"[{'article': 'PMC6211704.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Normalization of compromised microvascular functions in AD with anti-diabetic treatments'}]",311
2418,Mid temporal (% TIV),"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",28
2419,Mid-p-tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease (standard assay)""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
2420,Mid-p-tau231,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Higher accuracy in discriminating Aβ-positive from Aβ-negative individuals'}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
2421,Middle Frontal Gyrus (MFG),"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",284
2422,Mid‐p‐tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
2423,Mid‐p‐tau231,"[{'article': 'PMC7721364.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Early changes in preclinical Alzheimer's Disease""}]",40
2424,Mild cognitive impairment (MCI),"[{'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Prodromal stage of Alzheimer's Disease""}]",516
2425,Mini Geriatric Depression Scale,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",611
2426,Mini Mental State Examination (MMSE),"[{'article': 'PMC4431827.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}, {'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}]",467
2427,Mini Mental State Examination (MMSE) score,"[{'article': 'PMC4820235.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]",467
2428,Mini Mental Status Examination (MMSE),"[{'article': 'PMC7313126.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Activities of Daily Living (ADL) in Alzheimer's Disease""}]",467
2429,Mini-Cog,"[{'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC7031904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease and Related Dementias""}]",364
2430,Mini-Mental State Exam (MMSE),"[{'article': 'PMC8615710.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive impairment in neurodegenerative disorders'}, {'article': 'PMC9011335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive changes over time in Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Cognitive function in Alzheimer's Disease""}]",467
2431,Mini-Mental State Examination,"[{'article': 'PMC3804449.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3804449.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3859216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}]",467
2432,Mini-Mental State Examination (MMS),"[{'article': 'PMC8436545.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Intervention effectiveness in Alzheimer's Disease patients""}]",467
2433,Mini-Mental State Examination (MMSE),"[{'article': 'PMC2500042.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Diagnosis of moderate stage Alzheimer's Disease""}, {'article': 'PMC4153626.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}, {'article': 'PMC4922661.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Severity of dementia'}, {'article': 'PMC8436545.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of mild to moderately severe Alzheimer's Disease (MMSE score 11–26)""}, {'article': 'PMC4722852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876902.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognition in Alzheimer's Disease patients""}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6615169.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Global cognition in Alzheimer's Disease""}, {'article': 'PMC7413274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive impairment in Persons with Dementia (PwD)'}, {'article': 'PMC7413274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia severity'}, {'article': 'PMC9412195.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Assessing stabilization of global cognition in mild Alzheimer's disease""}]",467
2434,Mini-Mental State Examination (MMSE) score,"[{'article': 'PMC3212921.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia'}, {'article': 'PMC4722852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",467
2435,Mini-Mental Status Examination score,"[{'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease patients""}]",467
2436,Mini-mental State Examination (MMSE),"[{'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",467
2437,Mini-mental state examination (MMSE) score,"[{'article': 'PMC5105117.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive function improvement in Alzheimer's Disease patients""}]",467
2438,Mini–Mental State Examination (MMSE),"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Global cognitive functioning in Alzheimer's Disease""}]",467
2439,Mir107,"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Amild cognitive impairment (aMCI) associated with Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early biomarker for Alzheimer's Disease""}]",24
2440,Mitochondrial Function,"[{'article': 'PMC9527145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",295
2441,Mitochondrial biogenesis-related protein,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Mitochondrial deficits and Alzheimer's Disease progression""}]",295
2442,Mitochondrial dysfunction,"[{'article': 'PMC4707222.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",295
2443,Mitochondrial enzymes,"[{'article': 'PMC8868383.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",295
2444,Mitochondrial function,"[{'article': 'PMC4707222.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Improved mitochondrial function in Alzheimer's Disease""}]",295
2445,Mitochondrial quality control markers,"[{'article': 'PMC9755275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Prognosis: Alzheimer's Disease""}]",295
2446,MoCA,"[{'article': 'PMC10439779.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10475546.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive functioning and memory performance in Alzheimer's Disease""}, {'article': 'PMC10475546.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cognitive function in older adults with mild-to-moderate cognitive decline'}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild cognitive impairment'}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment and Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Mild cognitive impairment and Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Monitoring cognitive function over time in Mild cognitive impairment and Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild cognitive impairment and AD dementia'}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Mild cognitive impairment and AD dementia'}, {'article': 'PMC4562190.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Diagnosis of: Early detection and diagnosis of AD'}, {'article': 'PMC4562190.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Helps differentiate between MCI and AD'}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Early Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Early Symptoms of Alzheimer's Disease""}, {'article': 'PMC8110716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8650134.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}, {'article': 'PMC8650134.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC4197903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive function in Alzheimer's Disease""}, {'article': 'PMC5326769.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Global cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement in AD patients after rTMS treatment'}, {'article': 'PMC5464918.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease""}, {'article': 'PMC6538045.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild to moderate Alzheimer's Disease""}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC7171193.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}, {'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7822717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC9354045.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild cognitive impairment'}, {'article': 'PMC9354045.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia'}, {'article': 'PMC9354045.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cognitive Impairment'}, {'article': 'PMC9513684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9539040.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Cognitive impairment in Alzheimer's Disease""}]",476
2447,MoCA score,"[{'article': 'PMC7822717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",476
2448,MoCA scores,"[{'article': 'PMC8690894.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'treatment effects'}, {'article': 'PMC9797897.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive changes in Alzheimer's Disease""}]",476
2449,Modified Hachinski Ischemia Ratings,"[{'article': 'PMC5026133.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease vs. vascular dementia""}]",509
2450,Modified Hachinski Ischemia Scale,"[{'article': 'PMC6646979.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Vascular Dementia vs. Alzheimer's Disease""}]",509
2451,Modified Hachinski score,"[{'article': 'PMC6201586.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",509
2452,Modular organization of the brain,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased modular organization in response to dance intervention'}]",82
2453,Molecular layer thickness,"[{'article': 'PMC4979550.txt', 'relationship': 'RESPONDED_TO', 'object': 'Increased by T3D-959 treatment'}]",405
2454,Mono- and di-CQAs,"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Centella asiatica product (CAP) administration'}]",195
2455,Mono-CQAs,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Protection against glutamate excitotoxicity in mice'}]",195
2456,Monoamine oxidase B,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]",120
2457,Monocaffeoylquinic acids,"[{'article': 'PMC8868383.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Centella asiatica treatment in cognitively impaired older adults'}]",458
2458,"Monocyte chemoattractant protein-1 [MCP-1, CCL2]","[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",278
2459,"Monocyte chemoattractant protein-4 [MCP-4, CCL13]","[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",278
2460,Monocytes,"[{'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease Prognosis""}]",385
2461,Montreal Cognitive Assessment,"[{'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}]",41
2462,Montreal Cognitive Assessment (MoCA),"[{'article': 'PMC10475546.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC4562190.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}, {'article': 'PMC8518196.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6142366.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}]",41
2463,Mood,"[{'article': 'PMC8795741.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved mood and quality of life'}, {'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",624
2464,Morris Water Maze Performance,"[{'article': 'PMC4397698.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Deficits in Alzheimer's Disease""}]",412
2465,Morris water maze,"[{'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",412
2466,Motor Threshold (MT),"[{'article': 'PMC10439779.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""rTMS treatment intensity in Alzheimer's Disease""}]",16
2467,Motor performance profiles,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",526
2468,Motor test drawing features,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",526
2469,Motor test duration,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",526
2470,Motor-evoked potentials (MEPs),"[{'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cortico-motor reactivity and cortical plasticity in Alzheimer's Disease""}]",162
2471,Mtss1L,"[{'article': 'PMC6609409.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6609409.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6609409.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",219
2472,Munc18c,"[{'article': 'PMC10001958.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Dopamine release and cognitive function in AD'}]",122
2473,Music therapy (MT),"[{'article': 'PMC9246122.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Improved cognitive function in AD patients'}, {'article': 'PMC9246122.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive function in AD patients'}]",310
2474,Myelin proteins,"[{'article': 'PMC4835514.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",88
2475,Myo-inositol,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6015016.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",382
2476,Myristic acid,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",34
2477,N,"[{'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",578
2478,N-acetylaspartate (NAA),"[{'article': 'PMC4862247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",186
2479,N-gram features,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Probable Alzheimer's Disease""}]",167
2480,N-methyl-D-aspartate (NMDA) receptor,"[{'article': 'PMC3097009.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",449
2481,N-p-tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early amyloid-β pathology in cognitively unimpaired individuals'}, {'article': 'PMC7721364.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Levels reflect the presence of amyloid-β pathology'}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC7721364.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
2482,N-p-tau217,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early amyloid-β pathology in cognitively unimpaired individuals'}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC7721364.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
2483,N1,"[{'article': 'PMC4195286.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",135
2484,N1 amplitude,"[{'article': 'PMC4195286.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",109
2485,N1 component,"[{'article': 'PMC4195286.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Attentional deficits in Alzheimer's Disease""}]",466
2486,N100,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}, {'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",507
2487,N100 amplitude,"[{'article': 'PMC4879492.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Attention and memory deficits in Alzheimer's Disease""}]",109
2488,N200,"[{'article': 'PMC4611062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment (MCI)'}, {'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}, {'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",507
2489,N200 amplitude,"[{'article': 'PMC4879492.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",109
2490,N200 latency,"[{'article': 'PMC4879492.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",80
2491,NAA,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC9212787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",512
2492,NAA/Cr,"[{'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neuronal injury in Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuronal damage in Alzheimer's Disease""}]",512
2493,NAC,"[{'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Inhibition of adipogenesis in mouse MSC cell line 10T1/2'}]",512
2494,NAD+ levels,"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neurodegenerative disorders'}]",85
2495,NAIP,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",512
2496,NAP226-90,"[{'article': 'PMC5075013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Steady-state plasma concentrations in patients with Alzheimer’s disease'}, {'article': 'PMC5075013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Rivastigmine metabolism'}, {'article': 'PMC5075013.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Dosing in patients with renal impairment'}, {'article': 'PMC5075013.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'No dose adjustment required in patients with renal impairment'}]",144
2497,NBM,"[{'article': 'PMC6130053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'NBM stimulation may serve to facilitate communication across intact networks and revitalize networks that have fallen out of phase.'}, {'article': 'PMC6130053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment of dementia'}]",401
2498,NCAM2,"[{'article': 'PMC4674770.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased proteolysis in AD hippocampus'}, {'article': 'PMC4674770.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Synaptic accumulation and proteolysis in Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4674770.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased cleavage of NCAM2 in AD brains, particularly in synaptosomes'}, {'article': 'PMC4674770.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4674770.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Neuronal response to Aβ1-42 treatment'}, {'article': 'PMC4674770.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",39
2499,NEFA,"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Vascular dysfunction in Alzheimer's Disease""}]",250
2500,NEK6,"[{'article': 'PMC7884393.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",250
2501,NEUROTICISM,"[{'article': 'PMC4200223.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with increased Behavioral and Psychological Symptoms of Dementia (BPSD)'}]",70
2502,NF-L,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive impairment and survival time in Alzheimer's Disease patients""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection and prognosis in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}]",277
2503,NF-κB,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Inflammation in Alzheimer's Disease patients""}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",288
2504,NFKBIA,"[{'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",649
2505,NFKBIZ,"[{'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",649
2506,NFL,"[{'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4936020.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Acute tissue damage in Alzheimer's Disease patients""}, {'article': 'PMC5067556.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's disease-related neuropathological features""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",58
2507,NFQ,"[{'article': 'PMC8530186.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",111
2508,NFκB,"[{'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",288
2509,NGF,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Weight loss and back pain in Alzheimer's Disease patients""}, {'article': 'PMC3543237.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guiding treatment selection for Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection for Alzheimer's Disease""}, {'article': 'PMC3543237.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""J147 treatment in Alzheimer's Disease mice""}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cholinergic neuronal morphology and memory improvement'}, {'article': 'PMC3706879.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive Performance in Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'INCREASES', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurogenesis and neuronal/glial maturation'}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease therapy""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Nerve growth factor (NGF) release for Alzheimer's Disease therapy""}, {'article': 'PMC5427593.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognitive function in AD models'}, {'article': 'PMC6130053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""NGF release is induced by NBM activity, which may be associated with improved prognosis in Alzheimer's Disease.""}, {'article': 'PMC6130053.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Neuronal survival'}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6893800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Elevated neurotrophin levels indicating improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC6893800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognitive function and performance'}, {'article': 'PMC6893800.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuronal plasticity and cognitive enhancement in Alzheimer's Disease""}, {'article': 'PMC6893800.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive performance in Alzheimer's Disease""}, {'article': 'PMC6893800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RESPONDED_TO', 'object': 'Transcranial Electromagnetic Treatment (TEMT)'}, {'article': 'PMC9108275.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment Response in Alzheimer's Disease""}]",116
2510,NIC5-15,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Phase II clinical trials for Alzheimer's Disease""}]",233
2511,NINCDS/ADRDA criteria,"[{'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",3
2512,NLRP3,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Ameliorated Aβ pathology and improved cognitive deficits.'}, {'article': 'PMC11274940.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: JC124'}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Reduced inflammation and enhanced motor function recovery in Alzheimer's Disease""}]",258
2513,NLRP3 inflammasome,"[{'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: IL-1β maturation and release'}]",258
2514,NMDA receptor,"[{'article': 'PMC5372260.txt', 'relationship': 'INHIBITS', 'object': 'NMDA receptor'}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD-like cognitive decline'}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': 'NMDA receptor-associated neuroplastic changes underlying tDCS effects'}]",449
2515,NMDA receptor NR2A density,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anxiety in Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""chronic anxiety in Alzheimer's Disease""}]",449
2516,NMDA receptors,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",449
2517,NMDAR,"[{'article': 'PMC8060832.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7930223.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Enhanced synaptic plasticity in Alzheimer's Disease""}]",492
2518,NMDAR1,"[{'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Increased levels linked to improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Spatial memory deficits in Alzheimer's Disease""}]",492
2519,NMDAR2B,"[{'article': 'PMC10294511.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Synaptic dysfunction in Alzheimer's Disease""}]",492
2520,NMDS criteria,"[{'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",3
2521,NME8,"[{'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease immune response""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Associated with decreased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with cognitive decline and elevated tau levels'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",701
2522,NMED,"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS', 'object': ""Change in body mass (∆BM) in women with Alzheimer's Disease""}]",701
2523,NNI-362,"[{'article': 'PMC7805132.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7805132.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurogenesis and improved memory function in aging mice'}]",144
2524,NO,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Aβ formation and neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduced generation in the presence of β-sitosterol and oleanolic acid'}]",578
2525,NOS,"[{'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",15
2526,NOSGER,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia screening'}]",15
2527,NPE,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ Degradation'}]",519
2528,NPI,"[{'article': 'PMC2194921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric Symptoms in Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC3481364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3748825.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC4324943.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dementia-related behaviors in Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4481070.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neuropsychiatric Symptoms in Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'PREDICTS', 'object': ""Change in body mass (∆BM) in women with Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6260857.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Behavioral disturbance in Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric Symptoms in Alzheimer's Disease""}, {'article': 'PMC7364345.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment with rotigotine in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess sleep quality in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess motivation in Alzheimer's Disease""}, {'article': 'PMC7745768.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC7749592.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC7798342.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC7889418.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""BPSD in Alzheimer's Disease patients""}, {'article': 'PMC7995588.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in Neuropsychiatric Inventory scores at week 12'}, {'article': 'PMC7995588.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: Neuropsychiatric symptoms in patients with Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",352
2529,NPI scores,"[{'article': 'PMC7364345.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Behavioral symptoms in Alzheimer's Disease""}]",352
2530,NPI total score,"[{'article': 'PMC4401690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptom profiles in Alzheimer's Disease patients""}, {'article': 'PMC8436545.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Behavioural and psychological symptoms in Alzheimer’s Disease'}]",352
2531,NPI-NH,"[{'article': 'PMC8127192.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}]",352
2532,NPI-NH Affective symptoms,"[{'article': 'PMC8317398.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Affective symptoms in dementia'}]",672
2533,NPI-NH Agitation,"[{'article': 'PMC8317398.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Agitation in dementia patients'}]",672
2534,NPI-NH Psychosis,"[{'article': 'PMC8317398.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Psychosis in dementia patients'}]",672
2535,NPI-NH total,"[{'article': 'PMC8317398.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuropsychiatric symptoms in dementia'}]",352
2536,NPI-Q,"[{'article': 'PMC8386362.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment efficacy in Alzheimer's Disease""}]",352
2537,NPI-Q Apathy,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",663
2538,NPI-Q Depression,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",672
2539,NPID+A,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Changes in NPID+A scores reflect prognosis of mood and cognitive impairment in Alzheimer's Disease""}]",352
2540,NPY,"[{'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'GABAergic interneurons in the hilus'}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Metabolic and cardiovascular diseases'}]",519
2541,NPs,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",519
2542,NQ01,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Target engagement of NRF2 pathway'}]",111
2543,NRF2,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Antioxidant response in Alzheimer's Disease""}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Activation of antioxidant response element (ARE) genes'}]",116
2544,NRG1,"[{'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",135
2545,NRGN,"[{'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decrease in NRGN levels in cerebral spinal fluid'}, {'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Neurodegeneration'}, {'article': 'PMC10287562.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]",138
2546,NSE,"[{'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Neuronal and glial death in Alzheimer's Disease""}]",67
2547,NSP subfield volume,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",700
2548,NTB,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Memory and executive function in mild to moderate AD'}, {'article': 'PMC6371616.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",138
2549,Naming Disorders,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",185
2550,Natural killer cells,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC9290489.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Enhanced activity under MBSR/MBCT/MBCR intervention'}]",72
2551,Navβ2,"[{'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",39
2552,Naïve T cells,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",631
2553,NbM measurement,"[{'article': 'PMC5326769.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostic evaluation""}]",401
2554,NbM volume,"[{'article': 'PMC5326769.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive impairment in subcortical VCIND'}]",401
2555,Neopterin,"[{'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}]",64
2556,Neprilysin,"[{'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ load'}]",250
2557,Neprilysin (NPE),"[{'article': 'PMC5297247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",250
2558,Nerve Growth Factor (NGF),"[{'article': 'PMC3543237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",203
2559,Nerve growth factor (NGF),"[{'article': 'PMC4908397.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Trophic factors in hBM-MSCs dynamic conditioned media'}]",203
2560,Nervonic acid,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive performance (attention and language domains) in Alzheimer's Disease""}]",34
2561,Nestin,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",114
2562,NeuN,"[{'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4227681.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuronal loss in Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mature neuronal cells in Alzheimer's Disease""}, {'article': 'PMC5520675.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neuronal density in stimulated brain regions'}]",250
2563,Neural Flexibility Quotient (NFQ),"[{'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",288
2564,Neuritic plaques,"[{'article': 'PMC5144753.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline'}]",548
2565,Neuritic plaques (NPs),"[{'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]",548
2566,Neuro-Psychiatric Inventory (NPI),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Behavioral disorders in Alzheimer's Disease""}]",645
2567,Neurofibrillary Tangles (NTFs),"[{'article': 'PMC5516350.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Targeting tau aggregation (TRx0237)'}]",475
2568,Neurofibrillary tangles,"[{'article': 'PMC3226277.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8061233.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8570037.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6236893.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuronal loss and cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",475
2569,Neurofibrillary tangles (NFTs),"[{'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC6679484.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""NFTs are associated with neuronal loss, disease severity, and clinical course in Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of NFTs indicates Alzheimer's Disease progression and cognitive decline""}]",475
2570,Neurofibrillary tangles (tau protein),"[{'article': 'PMC6530014.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",40
2571,Neurofilament light,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment effect in Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",415
2572,Neurofilament light (NfL),"[{'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",415
2573,Neurofilament light chain,"[{'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'NOT_USED_TO_DIAGNOSE', 'object': 'No significant changes in levels'}, {'article': 'PMC6966425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",415
2574,Neurofilament light chain (NFL),"[{'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",415
2575,Neurofilament light chain (NfL),"[{'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8287201.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",415
2576,Neurofilament light chain (NfL) in CSF,"[{'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",415
2577,Neurofilament proteins,"[{'article': 'PMC6679484.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",281
2578,Neurogranin,"[{'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Synaptic Degeneration'}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Cognitive decline'}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to lecanemab treatment'}, {'article': 'PMC8053280.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Changes in neurogranin levels during treatment'}, {'article': 'PMC8157623.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to neflamapimod treatment'}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Diagnosis""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment with Varoglutamstat'}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dystrophic synapses in Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: AD progression and cognitive decline'}, {'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6182869.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher neurogranin levels in ApoE4 carriers'}, {'article': 'PMC6182869.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to PQ912 treatment'}, {'article': 'PMC6966425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Disease progression in AD'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Disease progression and patient selection in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to BAN2401 treatment in Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC7890889.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",685
2579,Neurogranin (in CSF),"[{'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",685
2580,Neuron Specific Enolase (NSE),"[{'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}]",281
2581,Neuropeptide Y (NPY),"[{'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Total-Tau (T-Tau) and Phosphorylated-Tau (P-Tau)'}]",281
2582,Neurophysiological measures,"[{'article': 'PMC7360860.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Interventions in Alzheimer's Disease""}]",162
2583,Neuroplasticity,"[{'article': 'PMC4804486.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",70
2584,Neuroprotective biomarkers,"[{'article': 'PMC4095696.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]",464
2585,Neuropsychiatric Inventory,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in neuropsychiatric symptoms in participants with mild to moderate Alzheimer's disease""}]",645
2586,Neuropsychiatric Inventory (NPI),"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Behavioral abnormalities in Alzheimer's Disease""}, {'article': 'PMC4431827.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric symptoms in Alzheimer's Disease""}, {'article': 'PMC8336239.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuropsychiatric behaviors in Alzheimer's Disease""}, {'article': 'PMC5026133.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Clinically significant neuropsychiatric symptoms'}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",645
2587,"Neuropsychiatric Inventory, 10-item total score","[{'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduction in neuropsychiatric symptoms of Alzheimer's Disease""}]",645
2588,Neuropsychological Test Battery (NTB),"[{'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",102
2589,Neurotrophic Factors,"[{'article': 'PMC8211849.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",234
2590,Neurotrophin concentration,"[{'article': 'PMC6893800.txt', 'relationship': 'RESPONDED_TO', 'object': 'Dark chocolate intake'}]",281
2591,Neurotropic factors,"[{'article': 'PMC7934383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Exercise intervention response in Alzheimer's Disease""}]",234
2592,Neutrophil,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",598
2593,Neutrophils,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Chronic inflammation in Alzheimer's Disease""}]",598
2594,NfH,"[{'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Increase in NfH levels in cerebral spinal fluid'}, {'article': 'PMC10287562.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]",277
2595,NfL,"[{'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decrease in NfL levels in cerebral spinal fluid'}, {'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Axonal Injury'}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Alzheimer's Disease treatment""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to lecanemab treatment'}, {'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Higher levels associated with worse cognitive outcomes in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reflects: Disease progression and prognosis'}, {'article': 'PMC8280160.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Disease progression and neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease in individuals with Down syndrome""}, {'article': 'PMC8280160.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor drug effects on Alzheimer's Disease pathology in clinical trials""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ pathology in cognitively unimpaired individuals'}, {'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Diagnosis""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in early Alzheimer's Disease continuum""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neuronal death and axonal loss in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Progression from mild cognitive impairment to Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Therapy response in Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Pathology-confirmed AD from healthy controls'}, {'article': 'PMC8480485.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Pathology-confirmed Alzheimer's Disease dementia from Aβ-PET–negative healthy controls""}, {'article': 'PMC8480485.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neural injury'}, {'article': 'PMC8524356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Worse prognosis in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Aβ status in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'PREDICTS_PROGRESSION_TO', 'object': ""Alzheimer's Disease dementia""}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_AD_PROGRESSION', 'object': 'Progression to AD dementia (minimal contribution)'}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Neurodegeneration'}, {'article': 'PMC5333515.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5333515.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment monitoring: Axonal degeneration in neurodegenerative disorders'}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurodegeneration'}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6110931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to BAN2401 treatment in Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuronal injury in Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring of: Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection for: Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Central nervous system damage'}, {'article': 'PMC9297091.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor: Treatment response and disease progression'}, {'article': 'PMC9297091.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Neurological disease progression'}, {'article': 'PMC9297091.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",58
2596,NfL (Neurofilament light chain),"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",415
2597,NfL (Neurofilament light),"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Neurodegeneration in Alzheimer's Disease""}]",415
2598,NfL (Neurofilament-light chain),"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",415
2599,NfL levels,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",58
2600,Nfh,"[{'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Neurodegeneration'}]",277
2601,Nfkb2,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",649
2602,Nicastrin,"[{'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",79
2603,Nicotinic binding,"[{'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Correlated with cognitive changes in Alzheimer's Disease""}]",355
2604,Nicotinic α7 receptors,"[{'article': 'PMC4890804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",355
2605,Night behavioral disturbances,"[{'article': 'PMC7789403.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",283
2606,Nilotinib,"[{'article': 'PMC4247762.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4247762.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4247762.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'p-Tau and Aβ1-42 reduction'}]",79
2607,Nitric oxide (NO),"[{'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}]",573
2608,Nitric oxide synthase,"[{'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]",573
2609,Nitrite,"[{'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}]",79
2610,Nongenetic biomarkers,"[{'article': 'PMC5103503.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pathological processes leading to Alzheimer's Disease""}]",257
2611,Noradrenergic modulation,"[{'article': 'PMC4267230.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",162
2612,Norepinephrine,"[{'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'RESPONDED_TO', 'object': ""rTMS treatment in Alzheimer's Disease""}]",520
2613,Norepinephrine (NE),"[{'article': 'PMC9340683.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",520
2614,Normalized Brain Volume (NBV),"[{'article': 'PMC1325254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC1325254.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",160
2615,Norton scale,"[{'article': 'PMC7023686.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mortality'}]",16
2616,Notch,"[{'article': 'PMC4461930.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Inhibition of Notch cleavage linked to gastrointestinal symptoms'}]",314
2617,Nrf2,"[{'article': 'PMC4159858.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment mechanism""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",116
2618,Nucleic acid oxidative modifications,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]",472
2619,Number of animals named during TUGdt,"[{'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates: Cognitive impairment in Alzheimer's Disease""}]",454
2620,Number of animals named during TUGdt test,"[{'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",454
2621,Number of medications,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Weight loss in female Alzheimer's Disease patients""}]",690
2622,Number of medications (NMED),"[{'article': 'PMC4922661.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Weight loss in women with Alzheimer's Disease""}]",690
2623,Number of revolutions,"[{'article': 'PMC9203627.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Personalized treatment for Alzheimer's Disease""}]",141
2624,Nutrition,"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",145
2625,Nuts,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",314
2626,N‐p‐tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",40
2627,N‐p‐tau217,"[{'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",40
2628,O3PUFA,"[{'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Less executive decline and fewer white matter hyperintensities (WMH)'}, {'article': 'PMC3863786.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Better executive function and reduced white matter hyperintensity volume'}, {'article': 'PMC3863786.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cognitive function as measured by Trail Making Test Part B, WMS-R Logical Memory Story delayed, and MMSE'}, {'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Less executive decline (Trails B)'}, {'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Better executive function (Trail Making Test Part B)'}, {'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Less white matter hyperintensity (WMH) burden'}, {'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Deceleration in executive decline trajectory'}, {'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Better executive function'}, {'article': 'PMC3863786.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Executive function decline'}, {'article': 'PMC3863786.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Executive dysfunction'}, {'article': 'PMC3863786.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Cognitive decline'}]",31
2629,OA,"[{'article': 'PMC6921051.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",31
2630,ODI,"[{'article': 'PMC8336239.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Sleep-disordered breathing in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""White matter integrity in Alzheimer's Disease""}]",240
2631,OEF,"[{'article': 'PMC3467226.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",31
2632,OGG1,"[{'article': 'PMC4981900.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Assess: Safety and efficacy of EMF treatment in Alzheimer's Disease""}]",135
2633,OLB,"[{'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Advanced dementia and cognitive decline in AD'}]",290
2634,OPA1,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved expression of OPA1 enhances mitochondrial fusion in Alzheimer's Disease""}]",63
2635,OXPHOS complex levels,"[{'article': 'PMC9755275.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",585
2636,Obesity,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC10310693.txt', 'relationship': 'PREDICTS_NEURODEGENERATIVE_DISORDERS', 'object': ""Alzheimer's Disease""}]",19
2637,Object naming test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Language deficits in Alzheimer's Disease""}]",185
2638,Odoribacter,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology in transgenic mice'}]",331
2639,Oleanolic Acid (OA),"[{'article': 'PMC6921051.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC9321013.txt', 'relationship': 'RESPONDED_TO', 'object': 'Reduction of IL-1β, IL-6, and TNF-α release in BV-2 cells'}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction of inflammatory cytokines in BV-2 cells'}, {'article': 'PMC9321013.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC9321013.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduction of oxidative stress and inflammation in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",317
2640,Olig2,"[{'article': 'PMC4899632.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oligodendrocyte progenitor cells in Alzheimer's Disease""}]",39
2641,Olive oil,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",249
2642,Omega-3 PUFAs,"[{'article': 'PMC7698404.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved glymphatic function and reduced amyloid-beta aggregation'}]",559
2643,Omni-z,"[{'article': 'PMC4407573.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",576
2644,Omnibus Scores (Omn),"[{'article': 'PMC5226952.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease Progression""}]",1
2645,Optineurin,"[{'article': 'PMC4489713.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",79
2646,Orexin,"[{'article': 'PMC3761088.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides treatment selection for Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Amyloid-β (Aβ) pathology in Alzheimer’s disease'}, {'article': 'PMC4267230.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Aβ deposition in the brain'}, {'article': 'PMC4267230.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ deposition'}, {'article': 'PMC4267230.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4267230.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",314
2647,Orientation,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Shorter interpausal units and longer pauses'}, {'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Preclinical dementia'}]",91
2648,Ornithine transcarbamylase (OTC),"[{'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",267
2649,Other bacteria (enterotype III),"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}, {'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}]",418
2650,Overall Pathology,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",626
2651,Overall pathology,"[{'article': 'PMC4003513.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",626
2652,Oxidative markers,"[{'article': 'PMC4981900.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",517
2653,Oxidative phosphorylation,"[{'article': 'PMC2432467.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Energy metabolism and cellular stress'}]",209
2654,Oxidative stress,"[{'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau hyperphosphorylation in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'REDUCES', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Decreased oxidative stress in Alzheimer's Disease""}]",517
2655,Oxidative stress biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",517
2656,Oxidative stress markers (4-hydroxynonenal and 8-hydroxy-2′-deoxyguanosine),"[{'article': 'PMC3978916.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease treatment response""}]",517
2657,Oxygen blood level,"[{'article': 'PMC5123349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Monitoring health in Alzheimer's Disease patients""}]",232
2658,Oxygenated hemoglobin (Oxy-Hb),"[{'article': 'PMC6893800.txt', 'relationship': 'RESPONDED_TO', 'object': 'Dark chocolate intake'}]",124
2659,Oxytocin,"[{'article': 'PMC3761088.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides treatment selection for Alzheimer's Disease""}]",585
2660,P-Tau,"[{'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Higher levels associated with higher risk of Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'DIAGNOSITC_OF', 'object': 'Diagnose: Differential diagnosis between AD and DLB'}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Normal levels in prodromal DLB patients, distinguishing from prodromal Alzheimer's disease""}, {'article': 'PMC9295361.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
2661,P-tau,"[{'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4746584.txt', 'relationship': 'MEASURED USING', 'object': 'INNOTEST ELISAs'}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8901176.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Aβ38'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Significant association with MMSE score change'}, {'article': 'PMC8901176.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Adjustment in models for prognosis'}, {'article': 'PMC5067556.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5067556.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive and motor progression in Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6182869.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'NOT_USED_TO_DIAGNOSE', 'object': 'No significant changes in levels'}, {'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",287
2662,P-tau181,"[{'article': 'PMC8733254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid P-tau181 and tau PET imaging parameters'}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnostic of: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differential dementia diagnosis'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differential diagnosis between AD and non-AD dementia'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Prodromal AD in case of mild cognitive impairment'}, {'article': 'PMC5565643.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Select subjects for clinical trials with potentially disease-modifying drugs against AD'}, {'article': 'PMC5565643.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Identify asymptomatic subjects at risk to develop symptoms of AD'}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7648990.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",40
2663,P-tau181P,"[{'article': 'PMC4875639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
2664,P-tau217,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early AD brain pathology'}, {'article': 'PMC7653537.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early preclinical stages of Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Early stages of AD when insoluble tau aggregates are not yet detectable by tau-PET'}, {'article': 'PMC7653537.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Monitoring of treatment response in AD'}, {'article': 'PMC7653537.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Tau pathology in the brain'}]",40
2665,P-tau217 levels,"[{'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Higher levels associated with worse prognosis in Alzheimer's Disease""}]",287
2666,P-tau231,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
2667,P. gingivalis,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain DNA'}]",587
2668,P. gingivalis DNA,"[{'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",587
2669,P1,"[{'article': 'PMC4195286.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early detection of Alzheimer's Disease""}]",135
2670,P1 amplitude,"[{'article': 'PMC4195286.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive processing in Alzheimer's Disease""}]",109
2671,P1 component,"[{'article': 'PMC4195286.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Attentional deficits in Alzheimer's Disease""}]",466
2672,P181 tau,"[{'article': 'PMC7067750.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
2673,P181 tau (ptau),"[{'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",40
2674,P200,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Alzheimer's Disease""}]",507
2675,P231-Tau,"[{'article': 'PMC4396171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
2676,P2RY12,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",550
2677,P2X4,"[{'article': 'PMC3835777.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",256
2678,P2X7,"[{'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""M1 microglial phenotype in Alzheimer's Disease""}]",256
2679,P2X7 receptor,"[{'article': 'PMC11274940.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': 'Therapy: Inflammation reduction'}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",256
2680,P2X7R,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Ameliorated amyloid pathology and promoted behavioral alterations.'}]",256
2681,P2Y12,"[{'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""M2 microglial phenotype in Alzheimer's Disease""}]",550
2682,P2Y12 receptor,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]",550
2683,P2ry12,"[{'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Microglial activation in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",550
2684,P3,"[{'article': 'PMC4195286.txt', 'relationship': 'ASSOCIATED_WITH_COGNITIVE_DECLINE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",466
2685,P3 amplitude,"[{'article': 'PMC4195286.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease-related cognitive decline""}]",109
2686,P3 component,"[{'article': 'PMC4195286.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Attentional network differences in Alzheimer's Disease""}]",466
2687,P300,"[{'article': 'PMC3923761.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Superior information processing'}, {'article': 'PMC3923761.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aging-related cognitive decline'}, {'article': 'PMC4611062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment (MCI)'}, {'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}, {'article': 'PMC8281974.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8281974.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}]",507
2688,P300 amplitude,"[{'article': 'PMC3923761.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",109
2689,P300 amplitude and latency,"[{'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",80
2690,P300 latency,"[{'article': 'PMC3923761.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",80
2691,P301S Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
2692,P3a,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",466
2693,P3a amplitude,"[{'article': 'PMC4879492.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Attention and executive function deficits in Alzheimer's Disease""}]",109
2694,P3b,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",466
2695,P3b amplitude,"[{'article': 'PMC4879492.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",109
2696,P3b latency,"[{'article': 'PMC4879492.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",80
2697,P50,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",507
2698,PAC,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI), a precursor to Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",537
2699,PAC001381_s,"[{'article': 'PMC8266337.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive health and beneficial metabolite production'}]",602
2700,PACC score,"[{'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Predict future decline in AD'}]",537
2701,PACC-like composite,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",537
2702,PAL first trial memory score,"[{'article': 'PMC6374283.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Clinical dementia'}]",157
2703,PAL scores,"[{'article': 'PMC10916999.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment and Alzheimer's Disease""}, {'article': 'PMC10916999.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Longitudinal decline predicts progression from mild cognitive impairment to Alzheimer's Disease""}]",1
2704,PALT,"[{'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",83
2705,PARP,"[{'article': 'PMC4981900.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Assess: Safety and efficacy of EMF treatment in Alzheimer's Disease""}]",53
2706,PARP1,"[{'article': 'PMC3335851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",53
2707,PC1,"[{'article': 'PMC4675859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Learning performance and cognitive flexibility in Ts65Dn mice'}, {'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Learning and cognitive flexibility improvements'}, {'article': 'PMC4675859.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Spatial learning and memory deficits in Ts65Dn mice'}]",206
2708,PCC metabolism,"[{'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",27
2709,PCC/PCu ALFF,"[{'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",533
2710,PCC/PCu rCBF,"[{'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",533
2711,PCC/PCu rCBF and ALFF combination,"[{'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",533
2712,PCUN metabolism,"[{'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",27
2713,PD-1,"[{'article': 'PMC8258160.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment approaches""}]",370
2714,PDE4B,"[{'article': 'PMC7089534.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]",370
2715,PDE9,"[{'article': 'PMC6371616.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Alzheimer’s Disease'}]",370
2716,PDGF,"[{'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}]",691
2717,PDGFR,"[{'article': 'PMC3226277.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",691
2718,PDGFRB,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",691
2719,PDGFRα,"[{'article': 'PMC4899632.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",691
2720,PDM,"[{'article': 'PMC9552361.txt', 'relationship': 'PREDICTS', 'object': ""Alzheimer's Disease and Related Dementias (ADRD)""}]",370
2721,PE,"[{'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9212787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",263
2722,PECAM1,"[{'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",127
2723,PEDF,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotection and functional recovery after CNS disorders'}]",572
2724,PEN2,"[{'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",39
2725,PER1,"[{'article': 'PMC8470960.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Circadian rhythm in Alzheimer's Disease""}]",188
2726,PER2,"[{'article': 'PMC5076443.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Autophagy regulation in Alzheimer's Disease""}]",188
2727,PER2 C111G,"[{'article': 'PMC8074126.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC8074126.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in executive function, language, and visual–spatial ability in patients progressing to mild cognitive impairment'}, {'article': 'PMC8074126.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Progression to mild cognitive impairment (MCI)'}, {'article': 'PMC8074126.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Worsening of cognitive functions in SCD patients'}, {'article': 'PMC8074126.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Association with cognitive reserve mechanisms'}]",188
2728,PER2 C111G polymorphism,"[{'article': 'PMC8074126.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better language performance in SCD patients'}, {'article': 'PMC8074126.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Greater worsening of executive function, visual-spatial ability, and language composite scores in MCI patients'}]",188
2729,PER2 G allele,"[{'article': 'PMC8074126.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in language, executive function, and visual–spatial ability in patients with cognitive impairment'}]",188
2730,PER2 genotype,"[{'article': 'PMC8074126.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",188
2731,PET,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional disability progression in Alzheimer's Disease""}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",5
2732,PET imaging,"[{'article': 'PMC8690894.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",296
2733,PET with Pittsburgh Compound B (PIB),"[{'article': 'PMC6110931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",683
2734,PET-PiB,"[{'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differential diagnosis of dementia'}]",5
2735,PET-quantified Aβ,"[{'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
2736,PET-quantified tau,"[{'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",213
2737,PG5 (Ser(P)409)-positive Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",40
2738,PGC-1α,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Improved mitochondrial biogenesis and function through PGC-1α in Alzheimer's Disease""}]",562
2739,PGE2,"[{'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",562
2740,PGRN mutation carriers,"[{'article': 'PMC6110931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Presenting with mixed PPA profiles (lvPPA and nfvPPA)'}]",100
2741,PHF,"[{'article': 'PMC4774258.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4774258.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",277
2742,PHLPP-1,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",429
2743,PHLPP-2,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",429
2744,PI3K,"[{'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",29
2745,PIB,"[{'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease-related cognitive impairment""}, {'article': 'PMC4346122.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease presence of amyloid plaques""}]",5
2746,PIB imaging,"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",5
2747,PIB-PET,"[{'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Amyloid plaques associated with Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Predict Pittsburgh compound B positivity'}]",5
2748,PICALM,"[{'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ levels in Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease age at onset""}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Aβ transport across the blood–brain barrier'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5068716.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",56
2749,PICALM SNP rs3851179,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Thickening of entorhinal cortex and hippocampal degeneration'}]",609
2750,PICALM SNP rs541458,"[{'article': 'PMC4876682.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Decreased levels of cerebral spinal fluid Aβ42'}]",609
2751,PIGF,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",277
2752,PILRB,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",5
2753,PKB,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",183
2754,PLAS,"[{'article': 'PMC10758173.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]",173
2755,PLD3,"[{'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ levels in Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease susceptibility""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease risk""}]",173
2756,PLI (Phase Lag Index),"[{'article': 'PMC4545875.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Decreasing functional connectivity with increasing disease severity in the lower alpha band in the posterior region'}]",439
2757,PLVβ2 → γ,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]",285
2758,PLVθ → β1,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]",285
2759,PP2A,"[{'article': 'PMC4485995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Tau hyperphosphorylation and Alzheimer's Disease progression""}, {'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",262
2760,PPAR,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",262
2761,PPAR delta,"[{'article': 'PMC4979550.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""T3D-959 treatment for Alzheimer's Disease""}]",262
2762,PPAR gamma,"[{'article': 'PMC4979550.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""T3D-959 treatment for Alzheimer's Disease""}]",262
2763,PPAR-β/δ,"[{'article': 'PMC4979550.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""T3D-959 treatment for Alzheimer's Disease""}]",285
2764,PPAR-γ,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Reduced amyloid pathology and decreased gliosis activation.'}, {'article': 'PMC4979550.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""T3D-959 treatment for Alzheimer's Disease""}]",262
2765,PPAR-δ agonist,"[{'article': 'PMC4979550.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",285
2766,PPARGC1A,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",262
2767,PPARγ,"[{'article': 'PMC6074058.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Metformin'}]",262
2768,PPQSA,"[{'article': 'PMC5067903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",262
2769,PQ912,"[{'article': 'PMC6182869.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Inhibition of QC activity to reduce pGlu-Aβ production'}, {'article': 'PMC6182869.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Reduction of cognitive decline in Alzheimer's Disease""}]",111
2770,PRP,"[{'article': 'PMC4227681.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuroprotection against Aβ42-induced toxicity in Alzheimer's Disease""}]",61
2771,PS,"[{'article': 'PMC4659639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Dietary supplementation in Alzheimer's Disease""}]",578
2772,PS1,"[{'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Familial Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early identification of Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in preclinical Familial Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",206
2773,PS1 gene mutation,"[{'article': 'PMC6961388.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Familial Alzheimer’s disease'}]",378
2774,PS1 mutation,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Compensatory effect on frontostriatal circuits'}]",378
2775,PS2,"[{'article': 'PMC7389451.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",206
2776,PSD95,"[{'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Increased levels linked to improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Increased expression in the hippocampus associated with exercise-induced protection against reduction of synaptic proteins after surgery'}, {'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Synaptic loss in Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Cognitive Improvement'}]",206
2777,PSEN,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid production in Alzheimer's Disease""}]",206
2778,PSEN1,"[{'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal Dominant Alzheimer's Disease""}, {'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal Dominant Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Increased Aβ42 levels and Aβ plaques'}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased Aβ42/Aβ40 ratio and amyloidogenic plaques'}, {'article': 'PMC4876682.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5100351.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal dominant Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Familial Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Familial Alzheimer's Disease""}]",206
2779,PSEN1 mRNA,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",378
2780,PSEN1 mutations,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Earlier onset of dementia in Alzheimer's Disease""}]",378
2781,PSEN2,"[{'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal Dominant Alzheimer's Disease""}, {'article': 'PMC4511231.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal Dominant Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5100351.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Autosomal dominant Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Familial Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Familial Alzheimer's Disease""}]",206
2782,PSEN2 mutations,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Older age of onset in Alzheimer's Disease""}]",378
2783,PSG confirmation of REM sleep without atonia,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]",283
2784,PSQI,"[{'article': 'PMC10439779.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Poor Sleep Quality in Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Presence: Sleep disturbances in Alzheimer's Disease""}]",206
2785,PTEN,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",490
2786,PTK2B,"[{'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease immune response""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with increased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",502
2787,PTP1B,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: INI and ICP combination'}]",502
2788,PU-HZ151,"[{'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Brain permeability and proteome dysfunction in Alzheimer's Disease""}, {'article': 'PMC8333062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Proteome dysfunction in Alzheimer's Disease""}, {'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8333062.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]",635
2789,PUFAs,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4694064.txt', 'relationship': 'RESPONDED_TO', 'object': 'J147 treatment'}]",559
2790,PWF,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive Function Impairment in Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",277
2791,PWMH,"[{'article': 'PMC5546604.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease based on white matter hyperintensity severity""}]",30
2792,Palmitic acid,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Production of Aβ peptides and amyloid plaques in Alzheimer's Disease""}]",273
2793,Palmitoleic acid,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",273
2794,Para-hippocampal volume,"[{'article': 'PMC6167961.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",648
2795,Parafoveal SCP AFI,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Early Alzheimer's Disease""}]",603
2796,Parafoveal SCP VD,"[{'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}]",603
2797,Parathyroid hormone (PTH),"[{'article': 'PMC3212921.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Assess cognitive benefits and treatment response in Alzheimer's Disease""}]",318
2798,Parietal Activation,"[{'article': 'PMC6538045.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better response to cognitive training'}]",53
2799,Parietal CMBs,"[{'article': 'PMC7477392.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cerebral Aβ burden'}]",212
2800,Parietal activity,"[{'article': 'PMC4150993.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection: Compensatory mechanisms in Alzheimer's Disease""}]",130
2801,Parietal brain volume loss,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",430
2802,Parietal cortex glucose metabolism,"[{'article': 'PMC5026133.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",539
2803,Parietal lobe,"[{'article': 'PMC7662091.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",409
2804,Part-Of-Speech cross-entropy,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",167
2805,Parvalbumin,"[{'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",53
2806,Parvalbumin (PV),"[{'article': 'PMC3534053.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",53
2807,Passive Digital Marker (PDM),"[{'article': 'PMC9552361.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease and Related Dementia (ADRD)""}]",181
2808,Patient Health Questionnaire (PHQ-9),"[{'article': 'PMC4066282.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease Prognosis""}]",117
2809,Pause Length,"[{'article': 'PMC4611852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",693
2810,Pe (Error Positivity),"[{'article': 'PMC8281974.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",263
2811,Peak VO2,"[{'article': 'PMC5302785.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",521
2812,Per1,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Memory-related signaling'}]",188
2813,Per2 G,"[{'article': 'PMC7354597.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7354597.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression in mild cognitive impairment patients""}, {'article': 'PMC7354597.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher conversion rate to AD'}]",188
2814,Perceived stress levels,"[{'article': 'PMC4987494.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvements in perceived stress levels'}]",624
2815,Performance-Oriented Assessment of Mobility (POMA),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Mobility performance in Alzheimer's Disease""}]",323
2816,Performed Timed 'Up & Go' (TUG) score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Gait and postural performance issues'}]",60
2817,Pericalcarine cortical thickness,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}]",197
2818,Peripapillary RPC VD,"[{'article': 'PMC6445433.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive impairment in Alzheimer's Disease""}]",65
2819,Peripheral adiposity,"[{'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",19
2820,Perivascular Spaces,"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",583
2821,Perivascular spaces,"[{'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower general cognitive ability in older age'}, {'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cognitive decline in older adults'}]",583
2822,Perspective-taking tests,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Perspective-taking deficits in Alzheimer's Disease""}]",332
2823,Phase Locking Value (PLV),"[{'article': 'PMC5399035.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates Presence: Alzheimer's Disease""}]",439
2824,Phase locking of oscillations,"[{'article': 'PMC6130053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Information transfer and learning'}]",439
2825,Phenserine,"[{'article': 'PMC4890804.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",105
2826,Phenylalanine,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiation between mild cognitive impairment due to AD and healthy controls'}, {'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to GV-971 treatment'}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease through neurotoxicity and cognitive disruption""}]",105
2827,Phonation Rate,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",377
2828,Phonemic paraphasia,"[{'article': 'PMC4611852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",92
2829,Phospho-Abl (pan-tyrosine),"[{'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}]",267
2830,Phospho-Tau,"[{'article': 'PMC6174237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",40
2831,Phospho-Tau (181P),"[{'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
2832,Phospho-Tau181,"[{'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
2833,Phospho-tau (tau-p181),"[{'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
2834,Phospho-tau181,"[{'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
2835,Phospholipase A2 (PLA2) activity,"[{'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",209
2836,Phosphor-tau181,"[{'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
2837,Phosphorylated Tau,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC4366075.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9539040.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment: Significant decrease following tACS'}]",40
2838,Phosphorylated Tau (p-tau181),"[{'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
2839,Phosphorylated tau,"[{'article': 'PMC10787596.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC4055052.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Associated with poor outcome: Rapid cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'RELATED_TO', 'object': 'Rapid progression toward AD'}]",40
2840,Phosphorylated tau (P-tau),"[{'article': 'PMC4606063.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Brain tangle pathology in Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",40
2841,Phosphorylated tau (P-tau181),"[{'article': 'PMC5565643.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}]",40
2842,Phosphorylated tau (p-tau(181)),"[{'article': 'PMC8866346.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Nonpathological (A−/T−/N−) cerebral spinal fluid profile'}]",40
2843,Phosphorylated tau (p-tau),"[{'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
2844,Phosphorylated tau (p-tau181),"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
2845,Phosphorylated tau (p-tau181p),"[{'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
2846,Phosphorylated-Tau (P-Tau),"[{'article': 'PMC6174237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
2847,Phosphorylated-Tau (p-Tau) in blood,"[{'article': 'PMC8733254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of tau burden in the brain and CSF'}]",40
2848,Phosphorylated-tau,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
2849,Photopic illuminance,"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Behavioral and Psychological Symptoms of Dementia (BPSD)'}]",440
2850,Physical Activity Scale for the Elderly (PASE),"[{'article': 'PMC4153626.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Physical activity levels'}]",260
2851,Physical Performance Test (PPT),"[{'article': 'PMC4497726.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Functional health'}]",291
2852,Physical activity,"[{'article': 'PMC8857690.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved cognitive performance'}, {'article': 'PMC5123349.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment Monitoring: Tracking adherence in Alzheimer's Disease""}, {'article': 'PMC9501541.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Decline in Alzheimer's Disease""}]",260
2853,Physical activity (PA),"[{'article': 'PMC5504954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Reduced risk of developing dementia'}]",260
2854,Physical activity levels,"[{'article': 'PMC4849800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of mild Alzheimer's dementia associated with apathy and more daytime napping""}]",260
2855,Physical function,"[{'article': 'PMC4283145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",50
2856,Physical performance (SPPB),"[{'article': 'PMC4324943.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Improved physical performance in individuals with mild to moderate dementia'}]",470
2857,PiB,"[{'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Amyloid-beta (Aβ) burden'}, {'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuritic Plaques (NPs)'}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Diffuse Plaques (DPs)'}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral Amyloid Angiopathy (CAA)'}]",5
2858,PiB SUVR,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",375
2859,PiB load,"[{'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early AD marker'}]",5
2860,PiB-PET,"[{'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain amyloid load in preclinical Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Amyloid Positivity in Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid Accumulation in Alzheimer's Disease""}, {'article': 'PMC5144753.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-beta pathology'}, {'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early detection of amyloid-beta burden'}, {'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline associated with neuritic plaques'}]",5
2861,PiB-positive individuals,"[{'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Risk for AD-type dementia'}]",5
2862,Piezo1,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction of brain Aβ load and improvement of cognitive dysfunction in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Mechanical sensor for detecting Aβ fibers in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Ameliorated brain Aβ burden and cognitive impairment.'}]",56
2863,Pigment epithelium-derived factor (PEDF),"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroregulatory molecules in dynamic hBM-MSCs secretome'}]",572
2864,Pioglitazone,"[{'article': 'PMC4615808.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",56
2865,Pittsburgh Compound-B (PiB) SUVR,"[{'article': 'PMC5144753.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of amyloid presence in Alzheimer's Disease""}]",683
2866,Pittsburgh compound B (PIB),"[{'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Amyloid deposition associated with Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Amyloid deposition levels in corticobasal syndrome patients'}]",683
2867,Pittsburgh compound B (PiB),"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'AD-type dementia in healthy older individuals'}]",683
2868,Pittsburgh compound B (PiB) amyloid imaging,"[{'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",8
2869,Pituitary mass,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",93
2870,PlGF,"[{'article': 'PMC8789895.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Aβ42/T-tau ratio'}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",173
2871,PlGF and Tie-2,"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Intranasal insulin treatment'}]",173
2872,Placental growth factor,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",203
2873,Placental growth factor [PIGF],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",203
2874,Plasma 24HC,"[{'article': 'PMC9797897.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Treatment Eligibility: CYP46A1 activation in Alzheimer's Disease""}]",230
2875,Plasma AD biomarkers,"[{'article': 'PMC10127414.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",257
2876,Plasma Amyloid-β (Aβ),"[{'article': 'PMC8733254.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Aβ burden in the brain'}]",8
2877,Plasma Aβ,"[{'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in plasma Aβ peptides with semagacestat treatment'}, {'article': 'PMC4568340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",551
2878,Plasma Aβ markers,"[{'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain amyloidosis in Alzheimer's Disease""}]",551
2879,Plasma Aβ seeding activity,"[{'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",8
2880,Plasma Aβ(1-40),"[{'article': 'PMC4822297.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",551
2881,Plasma Aβ(1–40),"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",551
2882,Plasma Aβ(1–42),"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",551
2883,Plasma Aβ40,"[{'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",551
2884,Plasma Aβ42,"[{'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",551
2885,Plasma Aβ42/40,"[{'article': 'PMC9768996.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",551
2886,Plasma Aβx–40 levels,"[{'article': 'PMC4866415.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment'}]",551
2887,Plasma BACbche gene mRNA expression,"[{'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amild cognitive impairment'}]",481
2888,Plasma BACbche gene mRNA levels,"[{'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",481
2889,Plasma EPA and DHA levels,"[{'article': 'PMC6521224.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]",518
2890,Plasma GFAP,"[{'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-β (Aβ) pathology'}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",13
2891,Plasma Mir107 expression,"[{'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amild cognitive impairment'}, {'article': 'PMC4870937.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Cortical Thickness (CT)'}, {'article': 'PMC4870937.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Surface Area (SA)'}, {'article': 'PMC4870937.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Local Gyrification Index (LGI)'}]",161
2892,Plasma Mir107 levels,"[{'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Pathogenesis of Alzheimer's Disease""}]",161
2893,Plasma N-p-tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",239
2894,Plasma N-terminal p-tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early detection of Alzheimer's Disease""}]",239
2895,Plasma NfL,"[{'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",58
2896,Plasma P-tau217,"[{'article': 'PMC7653537.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Progression of Alzheimer's Disease""}]",239
2897,Plasma PUFA index,"[{'article': 'PMC6521224.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]",559
2898,Plasma amyloid β,"[{'article': 'PMC4772335.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
2899,Plasma biomarkers,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Preclinical treatment of AD in adults with DS'}, {'article': 'PMC6966425.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides treatment selection: Alzheimer's Disease""}]",257
2900,Plasma cholesterol,"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",413
2901,Plasma docosahexaenoic acid (DHA),"[{'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",518
2902,Plasma eicosapentaenoic acid (EPA),"[{'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",317
2903,Plasma fatty acids,"[{'article': 'PMC5223628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",259
2904,Plasma genistein,"[{'article': 'PMC9635167.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to genistein treatment'}]",64
2905,Plasma kallikrein,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",105
2906,Plasma malondialdehyde (MDA),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]",668
2907,Plasma nitric oxide (NO),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress levels in Alzheimer's Disease""}]",573
2908,Plasma p-tau181,"[{'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'PREDICTS_DISEASE_PROGRESSION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Pathology-confirmed AD from non-AD dementia'}, {'article': 'PMC9768996.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",239
2909,Plasma p-tau217,"[{'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'PREDICTS_DISEASE_PROGRESSION', 'object': ""Alzheimer's Disease""}]",239
2910,Plasma p-tau231,"[{'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Alzheimer's Disease""}]",239
2911,Plasma phosphorylated tau (p-tau),"[{'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia'}]",40
2912,Plasma superoxide dismutase (SOD) activity,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Mild cognitive impairment and Alzheimer's Disease progression""}]",515
2913,Plasma tau,"[{'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Alzheimer's Disease""}]",239
2914,Plasma total antioxidant capacity (TAC),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress levels in Alzheimer's Disease""}]",374
2915,Plasma vitamin B12,"[{'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",231
2916,Plasticity T10,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease patients""}]",123
2917,Plasticity T5,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease patients""}]",123
2918,Plasticity measures,"[{'article': 'PMC7360860.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Cognitive function in Alzheimer's Disease""}]",123
2919,Platelets-to-lymphocytes ratio,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for developing all-cause dementia'}]",139
2920,Polygonum multiflorum Thunb.,"[{'article': 'PMC4471648.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",33
2921,Porphyromonas gingivalis infection,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ1–42 production'}]",587
2922,Posterior cingulate FDG-PET,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Conversion to mild cognitive impairment'}]",296
2923,Posterior cingulate glucose metabolism,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Future cognitive decline'}]",539
2924,Posterior cingulate island sign on FDG-PET imaging,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]",296
2925,Posture and Balance,"[{'article': 'PMC3581819.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced fall risk in Alzheimer's Disease patients""}]",91
2926,Potassium,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",223
2927,Pragmatic Language Function,"[{'article': 'PMC5359367.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Assessment of dementia status (DMR Cognitive Scale)'}]",568
2928,Praxis test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Praxis deficits in Alzheimer's Disease""}]",291
2929,Precuneus,"[{'article': 'PMC10439779.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Reduced activity in early phases of Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7203806.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease subtypes""}]",677
2930,Precuneus atrophy rate,"[{'article': 'PMC7203806.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease subtypes""}]",286
2931,Precuneus cortex thickness,"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",197
2932,Precuneus cortical thickness,"[{'article': 'PMC2764863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",197
2933,Precuneus thickness,"[{'article': 'PMC4811920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",197
2934,Precuneus_R,"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",677
2935,Prefrontal Activation,"[{'article': 'PMC6538045.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Better training benefits in working memory'}]",497
2936,Prefrontal activity,"[{'article': 'PMC4150993.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection: Compensatory mechanisms in Alzheimer's Disease""}]",497
2937,Prefrontal cortex,"[{'article': 'PMC7662091.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",497
2938,Prefrontal cortex activity,"[{'article': 'PMC7364345.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Increased prefrontal cortical activity'}, {'article': 'PMC7364345.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Dopaminergic interventions for Alzheimer's Disease""}]",497
2939,Prefrontal cortex atrophy,"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_CONVERSION', 'object': 'Dementia onset'}]",184
2940,Presenilin genes,"[{'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Familial Alzheimer's Disease""}]",487
2941,Presenilin-1 mutation,"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in carriers with mild cognitive impairment""}]",487
2942,Prevotella,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD pathology in transgenic mice'}]",503
2943,Prevotellaceae,"[{'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",503
2944,Pro-inflammatory cytokines,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Inflammation and disease progression in Alzheimer's Disease""}]",666
2945,"Pro-inflammatory cytokines (e.g., TNF-α)","[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]",666
2946,Probiotics,"[{'article': 'PMC6530014.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reversal of ampicillin-induced cognitive and behavioral abnormalities'}]",211
2947,Processing speed,"[{'article': 'PMC4283145.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}, {'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",330
2948,Prognostic biomarkers,"[{'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection of AD pathology'}]",257
2949,Progranulin,"[{'article': 'PMC3389343.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'hUCB-MSC treatment'}]",56
2950,Proinflammatory cytokines,"[{'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease severity""}]",666
2951,"Proinflammatory cytokines (IL-1, IL-6, TNF-alpha, TGF-beta)","[{'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",666
2952,Propionate,"[{'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid plaque deposition in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased amyloid plaque load in Alzheimer's Disease""}, {'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",500
2953,Propionibacterium acnes (P. acnes),"[{'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",186
2954,Propionic acid,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anti-inflammatory response in Alzheimer's Disease""}, {'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",34
2955,Propionyl-CoA carboxylase,"[{'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",186
2956,Proportion of spoken words during free conversation,"[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early signs of Alzheimer's Disease""}]",417
2957,Proportion of spoken words in conversation,"[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment (MCI)'}]",417
2958,Proportion of words spoken by participants,"[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild cognitive impairment (MCI) related to Alzheimer's Disease""}]",417
2959,Prostaglandin E2 (PGE2),"[{'article': 'PMC2194921.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Indomethacin treatment response in Alzheimer's Disease""}]",562
2960,Protein carbonyl,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",147
2961,Protein carbonyl content,"[{'article': 'PMC4981900.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Assess: Safety and efficacy of EMF treatment in Alzheimer's Disease""}]",147
2962,Protein carbonyls,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]",147
2963,Proteobacteria,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",643
2964,Protofibrils,"[{'article': 'PMC4054967.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Neurotoxicity and cognitive deficits in Alzheimer's Disease""}]",56
2965,Pseudoflavonifractor,"[{'article': 'PMC8266337.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive dysfunction and memory impairment'}]",105
2966,Psoriasis,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",606
2967,Psychoaffective Factors,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Linked to early cognitive deficits and subsequent dementia'}]",174
2968,Ptau,"[{'article': 'PMC7295920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease neuropathological changes""}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",490
2969,Pupil dilation,"[{'article': 'PMC6943370.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6943370.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Alzheimer's Disease progression""}]",208
2970,Purinergic P2X7 receptor,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]",256
2971,Purkinje cell layer cellularity,"[{'article': 'PMC4979550.txt', 'relationship': 'RESPONDED_TO', 'object': 'Improved by T3D-959 treatment'}]",280
2972,P‐tau,"[{'article': 'PMC5067556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Worsening of motor symptoms as measured by UPDRS III'}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Worsening of cognitive executive function as measured by letter fluency'}]",40
2973,Q,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Q values are associated with community structure in brain networks of Alzheimer's Disease patients""}]",325
2974,Q values,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased Q values after dance intervention'}]",524
2975,QC activity,"[{'article': 'PMC8381483.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Varoglutamstat'}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",152
2976,QC inhibition,"[{'article': 'PMC8381483.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Biological effect on QC inhibition'}]",152
2977,QDRS,"[{'article': 'PMC9552361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease and Related Dementias (ADRD)""}]",542
2978,QEEG,"[{'article': 'PMC6130053.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",325
2979,QOL-AD,"[{'article': 'PMC3382377.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Wii-Fit intervention'}, {'article': 'PMC4324943.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Quality of life in Alzheimer's Disease""}, {'article': 'PMC5496421.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Quality of life in Alzheimer's Disease""}, {'article': 'PMC7168967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Quality of life in Alzheimer's Disease patients""}, {'article': 'PMC9389745.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC9513684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",170
2980,QOL-AD (quality of life-Alzheimer's disease),"[{'article': 'PMC3382377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Quality of life improvements in Alzheimer's Disease""}]",480
2981,QTc,"[{'article': 'PMC4051660.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Diagnosis: Arrhythmia'}, {'article': 'PMC4051660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Arrhythmia'}, {'article': 'PMC4051660.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Increased risk of arrhythmia'}, {'article': 'PMC4051660.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased risk of arrhythmia and related complications'}]",524
2982,QTc interval,"[{'article': 'PMC4051660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'QT prolongation and risk of Torsade de pointes (TdP)'}, {'article': 'PMC4051660.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Citalopram treatment in Alzheimer's disease patients""}, {'article': 'PMC4051660.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to citalopram treatment in Alzheimer's Disease patients""}, {'article': 'PMC4051660.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment with citalopram'}]",524
2983,QUICKI,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Insulin sensitivity in Alzheimer's Disease""}]",67
2984,QoL-AD,"[{'article': 'PMC8795741.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Increased QoL-AD scores are associated with improved quality of life in Alzheimer's Disease patients""}, {'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Quality of life in Alzheimer's Disease""}]",170
2985,Quality of Life - Alzheimer's Disease (QoL-AD),"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Quality of life in Alzheimer's Disease""}]",480
2986,Quality of Life in Late-Stage dementia Scale (QUALID),"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Quality of life in late-stage dementia'}]",480
2987,Quality of life (QOL-AD),"[{'article': 'PMC4324943.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Enhanced quality of life in individuals with mild to moderate dementia'}]",480
2988,Quantitative EEG analysis,"[{'article': 'PMC3914466.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",567
2989,Quantitative Electroencephalography (QEEG),"[{'article': 'PMC6130053.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'NBM DBS treatment response'}, {'article': 'PMC6130053.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'NBM DBS treatment response'}]",567
2990,Quantitative insulin sensitivity check index (QUICKI),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved insulin sensitivity in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Insulin sensitivity in Alzheimer's Disease""}]",73
2991,Quick dementia Rating Scale (QDRS),"[{'article': 'PMC9552361.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection and staging of Alzheimer’s disease and related disorders (ADRD)'}]",21
2992,Qβ-induced T-cell responses,"[{'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Immune response to amyloid-beta in Alzheimer's Disease""}]",139
2993,R-WAB AQ,"[{'article': 'PMC4283612.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Higher scores are associated with more improvement in therapy tasks.'}, {'article': 'PMC4283612.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Language impairment in Alzheimer's Disease""}]",290
2994,RAB27A,"[{'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",28
2995,RAGE,"[{'article': 'PMC4679337.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",624
2996,RAK1,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",28
2997,RANTES,"[{'article': 'PMC5234138.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-inflammatory response in Alzheimer's Disease""}]",699
2998,RANTES/CCL5,"[{'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduction in plasma levels reflects response to resveratrol treatment in Alzheimer's Disease patients.""}]",699
2999,RAP1B,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",219
3000,RAVL,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",28
3001,RAVLT,"[{'article': 'PMC1373642.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive function related to Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4811920.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Disease progression in amild cognitive impairment group'}, {'article': 'PMC6945614.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive performance in Alzheimer's Disease""}, {'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}]",28
3002,RAVLT Del,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive Impairment in Alzheimer's Disease""}]",28
3003,RAVLT delayed recall,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",221
3004,RBANS,"[{'article': 'PMC3832588.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3832588.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Cognitive decline in Alzheimer's Disease during BCI intervention""}, {'article': 'PMC3832588.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8110716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8564643.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in social engagement and performance of ADLs'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Change in cognitive function related to Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7592675.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment and early signs of Alzheimer's Disease""}, {'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Cognitive improvement in memory functions'}, {'article': 'PMC7729136.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC9513684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",411
3005,RBANS Total Score,"[{'article': 'PMC7729136.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive changes due to MPH treatment in Alzheimer's Disease""}]",411
3006,RBANS scores,"[{'article': 'PMC9513684.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Constant Therapy intervention'}, {'article': 'PMC9513684.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cognitive function in Alzheimer's Disease patients""}]",411
3007,RBANS subtest scores,"[{'article': 'PMC9513684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",411
3008,RBANS total scale index scores,"[{'article': 'PMC3832588.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to BCI-based intervention in elderly participants'}]",411
3009,RBANS total score,"[{'article': 'PMC7592675.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Improvement in cognitive functions in suspected mild cognitive impairment'}, {'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease""}]",411
3010,RBMT,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease-related cognitive impairment""}]",84
3011,RCFT,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Visuospatial Function Impairment in Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",303
3012,RD,"[{'article': 'PMC8351379.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: White matter microstructure changes in Alzheimer's Disease""}, {'article': 'PMC8351379.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Gait characteristics in the same way as MD'}]",138
3013,REGIONAL CEREBRAL VOLUME,"[{'article': 'PMC4200223.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of Behavioral and Psychological Symptoms of Dementia (BPSD)'}]",160
3014,REM sleep behavior disorder,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dementia with Lewy Bodies (DLB), which is often misdiagnosed as Alzheimer's Disease""}]",283
3015,REM sleep changes,"[{'article': 'PMC9053232.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mood changes'}]",283
3016,RFFT,"[{'article': 'PMC4854436.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",303
3017,RHOB,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",290
3018,RICTOR,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",151
3019,RIPK1,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Reduction of Aβ accumulation and improvement of behavioral deficits in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Inhibition of microglial phagocytic activity in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Reduced amyloid burden, levels of inflammatory cytokines, and memory deficits.'}]",135
3020,RMBPC,"[{'article': 'PMC4468784.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Behavioral symptoms of Alzheimer's Disease""}]",462
3021,RMR (Resting Metabolic Rate),"[{'article': 'PMC4922661.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Energy expenditure in Alzheimer's Disease patients""}]",27
3022,RMSSD,"[{'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]",204
3023,RMT,"[{'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",462
3024,RMTG,"[{'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Subjective Cognitive Decline (SCD) related to Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with serious cognitive complaints, depression, and poor delayed recall performance'}, {'article': 'PMC8028241.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Indicates early marker for progression towards Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Subjective Cognitive Decline (SCD)'}, {'article': 'PMC8028241.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Future cognitive deterioration in Alzheimer's Disease""}]",462
3025,RMTG hypometabolism,"[{'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Subjective Cognitive Decline (SCD)'}, {'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",319
3026,RNFL,"[{'article': 'PMC4529274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Correlated with MMSE scores in AD patients'}, {'article': 'PMC4529274.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Retinal nerve fiber layer thickness is a useful tool for AD diagnosis'}, {'article': 'PMC4529274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",116
3027,RNFL thickness,"[{'article': 'PMC4529274.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4529274.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""treatment selection in Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Disease progression in Alzheimer's Disease""}]",116
3028,ROS,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory responses and oxidative stress in Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: High ROS levels inhibit MSC self-renewal, differentiation, and proliferation'}, {'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",22
3029,ROSA,"[{'article': 'PMC3218804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC3218804.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment effects""}, {'article': 'PMC3218804.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Assessing change due to treatment in Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reflecting response to treatment in Alzheimer's Disease""}]",57
3030,RPS6KA1,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",136
3031,RPS6KA2,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",136
3032,RPS6KB1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",136
3033,RPTOR,"[{'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",110
3034,RT,"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",138
3035,RUD-Lite,"[{'article': 'PMC5067903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",151
3036,RXR,"[{'article': 'PMC4731943.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",486
3037,Rab3,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",28
3038,Rab7,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",28
3039,Rac1,"[{'article': 'PMC3226277.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",28
3040,Radial Diffusivity (DR),"[{'article': 'PMC3675142.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Mild Cognitive Impairment and Alzheimer's Disease""}]",224
3041,Radial Diffusivity (RD),"[{'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",224
3042,Reaction Times,"[{'article': 'PMC3581819.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced risk of falls in Alzheimer's Disease patients""}]",168
3043,Reaction time (RT),"[{'article': 'PMC8281974.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}]",168
3044,Reactive Oxygen Species,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",232
3045,Receptor for advanced glycation end products,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]",165
3046,Recognition Accuracy (Recog),"[{'article': 'PMC5226952.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",167
3047,Reduced DAT uptake in basal ganglia,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]",558
3048,Reduced Sentences,"[{'article': 'PMC5237556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Probable Alzheimer's Disease""}]",568
3049,Reduced blood flow in posterior cingulate gyrus/precuneus,"[{'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",679
3050,Reduced occipital activity on FDG-PET imaging,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]",296
3051,Reduced primacy effects,"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5226952.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': ""Alzheimer's Disease""}]",149
3052,Reduced syntactic complexity,"[{'article': 'PMC4611852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",217
3053,Reduced uptake on metaiodobenzylguanidine myocardial scintigraphy,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]",564
3054,Reduction in blood flow in the posterior cingulate gyrus and/or precuneus,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",679
3055,Regional Cerebral Blood Flow (CBF),"[{'article': 'PMC4351428.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Enhanced brain function and structure'}]",511
3056,Regional Cerebral Blood Flow (rCBF),"[{'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Cognitive Decline in Alzheimer's Disease""}]",511
3057,Regional brain atrophy rates,"[{'article': 'PMC8570373.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Interventions to reduce post-stroke secondary degeneration'}]",184
3058,Regional glucose metabolism,"[{'article': 'PMC3767625.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",586
3059,Regulatory T cells (Tregs),"[{'article': 'PMC6584558.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Impaired systemic immunosuppression in Alzheimer's Disease""}]",313
3060,Relative preservation of medial temporal lobe structures on CT/MRI,"[{'article': 'PMC5496518.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia with Lewy bodies (DLB)'}]",409
3061,Relative volume of left hippocampus,"[{'article': 'PMC9972804.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in PS1 group'}]",648
3062,Renin-angiotensin system,"[{'article': 'PMC4835514.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapy for Alzheimer's Disease""}]",584
3063,Repeatable Battery for the Assessment of Neuropsychological Status (RBANS),"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive dysfunction associated with Alzheimer's Disease""}]",102
3064,Repeated Words,"[{'article': 'PMC5147824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",17
3065,Rest durations,"[{'article': 'PMC8500065.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC8500065.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]",168
3066,Resting CBF,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]",338
3067,Resting State Functional MRI (rsfMRI),"[{'article': 'PMC9373273.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",329
3068,Resting Treg Compartment,"[{'article': 'PMC6584558.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",514
3069,Resting Treg subset,"[{'article': 'PMC6584558.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Decrease in resting Treg frequencies in Alzheimer's Disease""}]",514
3070,Resting Tregs,"[{'article': 'PMC6584558.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",514
3071,Resting heart rate,"[{'article': 'PMC4987494.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Lowering of resting heart rate'}]",118
3072,Resveratrol,"[{'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC4857621.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}]",249
3073,Retinal Aβ,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Preclinical treatment of AD in adults with DS'}]",8
3074,Retinal Nerve Fiber Layer (RNFL) Thinning,"[{'article': 'PMC6445433.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Pathology: Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",266
3075,Retinal Nerve Fiber Layer (RNFL) thickness,"[{'article': 'PMC4529274.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",266
3076,Retinal Vessel Density,"[{'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",266
3077,Retinal amyloid index,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
3078,Retinal nerve fiber layer thickness,"[{'article': 'PMC10787596.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early diagnosis of dementia'}]",266
3079,Retinal thickness,"[{'article': 'PMC4529274.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4529274.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]",266
3080,Retinoic Acid (RA),"[{'article': 'PMC2765081.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Maintenance of olfactory function, potentially preventive for Alzheimer's Disease""}, {'article': 'PMC2765081.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapeutic potential for neurodegenerative disorders, including Alzheimer's Disease""}]",225
3081,Retinoic acid receptors (RARs),"[{'article': 'PMC2765081.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]",225
3082,Retinoids,"[{'article': 'PMC2765081.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}, {'article': 'PMC2765081.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Memory deficits'}]",225
3083,Retinol,"[{'article': 'PMC4922661.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Adequacy of energy intake in Alzheimer's Disease patients""}]",225
3084,Retroactive interference (RI) performance,"[{'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease pathology""}]",128
3085,Rey Auditory Verbal Learning Test,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",133
3086,Rey Auditory Verbal Learning Test (RAVLT),"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Long-term memory in Alzheimer's Disease""}]",133
3087,Rey Auditory Verbal Learning Test (RAVLT) delayed recall score,"[{'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amnestic mild cognitive impairment (amild cognitive impairment)'}]",133
3088,Rey Auditory Verbal Learning Test (RAVLT) total score,"[{'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amnestic mild cognitive impairment (amild cognitive impairment)'}]",133
3089,Rey Complex Figure Test,"[{'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Cognitive processes in Alzheimer's Disease""}]",523
3090,Rey Figure reproduction,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Visual construction deficits in Alzheimer's Disease""}]",523
3091,Rey-O,"[{'article': 'PMC9871821.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improved visual memory after tPBM treatment'}]",523
3092,RgpB,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",522
3093,Rheumatoid Arthritis,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",606
3094,Ribosomal proteins,"[{'article': 'PMC2432467.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cellular stress response'}]",147
3095,Right Inferior Temporal Gyrus (R ITG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Longer gap durations in Alzheimer's Disease""}]",284
3096,Right Middle Temporal Gyrus (R MTG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Slower speech rate and shorter turns in Alzheimer's Disease""}]",52
3097,Right Superior Temporal Gyrus (R STG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Slower speech rate and shorter turns in Alzheimer's Disease""}]",284
3098,Right caudate-rMFG tract AxD,"[{'article': 'PMC6961388.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",498
3099,Right frontal parietal network,"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Acupuncture treatment response in Alzheimer's Disease""}]",172
3100,Right hippocampus volume,"[{'article': 'PMC10127414.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Progression to mild cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",648
3101,Right middle temporal gyrus (RMTG) hypometabolism,"[{'article': 'PMC8028241.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Subjective cognitive decline (SCD) and early stages of Alzheimer's Disease""}]",52
3102,Right middle temporal gyrus (RMTG) metabolism,"[{'article': 'PMC8028241.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease and differentiation from other cognitive impairments""}]",52
3103,Rikenellaceae,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",503
3104,Rivastigmine,"[{'article': 'PMC3407718.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC5075013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5075013.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Dosing in patients with renal impairment'}, {'article': 'PMC5075013.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'No dose adjustment required in patients with renal impairment'}]",595
3105,Rivermead Behavioural Memory Test (RBMT),"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Mild Cognitive Impairment (MCI) associated with progression to Alzheimer's Disease""}]",77
3106,Ruminococcaceae,"[{'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",503
3107,RxR,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",486
3108,S-IADL,"[{'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",505
3109,S100A12,"[{'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}]",320
3110,S100B,"[{'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Diagnosis""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Neuronal and glial death in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",320
3111,S100b,"[{'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Reactive astrocytes in Alzheimer's Disease""}]",320
3112,S100β,"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebrovascular inflammation in Alzheimer's Disease""}, {'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain-to-blood leakage'}, {'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Blood-Brain Barrier (BBB) leakage in Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegeneration and dystrophic neurites'}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ formation and neuronal damage'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",320
3113,S24-7,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",320
3114,SAA,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",38
3115,SAFr,"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes in Alzheimer's Disease prevention""}, {'article': 'PMC10236460.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""lower cognitive performance in Alzheimer's Disease""}]",38
3116,SAP,"[{'article': 'PMC7274941.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7690082.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",214
3117,SAP102,"[{'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]",214
3118,SAPK/JNK,"[{'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Abnormal tau phosphorylation in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RESPONDED_TO', 'object': ""J147 treatment in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory response in Alzheimer's Disease""}]",183
3119,SASP factors,"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease progression""}]",99
3120,SBD,"[{'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",20
3121,SBP,"[{'article': 'PMC4987494.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvements in systolic blood pressure'}]",20
3122,SCAG,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Senile dementia'}]",66
3123,SCD,"[{'article': 'PMC4750048.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]",66
3124,SCD (Subjective Cognitive Decline),"[{'article': 'PMC6945608.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease (did not predict in this sample)""}]",215
3125,SCD-Q,"[{'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",66
3126,SCFA,"[{'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ levels'}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Microglial activation and Aβ plaque load'}, {'article': 'PMC8043748.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased Aβ plaque load and microglial recruitment'}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased Aβ plaque burden in Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'PREDICTS_AD_PROGRESSION', 'object': 'SCFA promotes AD progression via microglial activation and ApoE upregulation'}]",66
3127,SCFA (Short Chain Fatty Acids),"[{'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased Aβ plaque deposition in Alzheimer's Disease""}]",186
3128,SCFAs,"[{'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ plaque deposition'}, {'article': 'PMC8043748.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Spatial memory deficits in Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'EXERT_NEUROMODULATOR_EFFECTS_AND_ACT_ON_GASTROINTESTINAL_CELLS_STIMULATING_SYNTHESIS_OF', 'object': 'Leptin and GLP-1'}, {'article': 'PMC5445077.txt', 'relationship': 'HAVE_THERAPEUTIC_POTENTIAL_IN', 'object': 'Neurodegenerations'}, {'article': 'PMC6530014.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",66
3129,"SCFAs (butyrate, acetate, propionate)","[{'article': 'PMC6593891.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",186
3130,SCOT,"[{'article': 'PMC3213220.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",66
3131,SCP VD (parafoveal),"[{'article': 'PMC6445433.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive performance in Alzheimer's Disease""}]",603
3132,SDI,"[{'article': 'PMC8127192.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7083107.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Sleep disturbances in institutionalized dementia patients'}, {'article': 'PMC7083107.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment selection: Identifying patients for sleep interventions and mapping underlying causes of sleep problems'}]",204
3133,SDMT,"[{'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Total ADL and IADL in Alzheimer's Disease patients""}]",84
3134,SDST,"[{'article': 'PMC7288029.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Information processing speed deficits in Alzheimer's Disease""}]",204
3135,SDT,"[{'article': 'PMC4637414.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",204
3136,SE,"[{'article': 'PMC8127192.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",261
3137,SEMA4D,"[{'article': 'PMC4966508.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'VX15/2503 treatment'}]",261
3138,SENSORIMOTOR SYNCHRONIZATION (SMS),"[{'article': 'PMC10092214.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression in neurodegenerative disorders'}]",70
3139,SFA,"[{'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",582
3140,SFN,"[{'article': 'PMC4159858.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Neuroprotection in Alzheimer's Disease""}, {'article': 'PMC4159858.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment Selection: Alzheimer's Disease therapy""}, {'article': 'PMC4159858.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]",582
3141,SFS,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess managing finances in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-care in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess use of technology/devices in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess motivation in Alzheimer's Disease""}]",582
3142,SG performance data,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: Delay cognitive and motor decline in the elderly'}]",330
3143,SHIP2,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",39
3144,SI,"[{'article': 'PMC8795741.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""SI scores are correlated with somatomotor network changes in Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",367
3145,SIB,"[{'article': 'PMC2949590.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Preserved abilities in severe AD'}, {'article': 'PMC3218804.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3218804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Severe impairment in Alzheimer's Disease""}, {'article': 'PMC3226311.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive improvement in Alzheimer's Disease patients treated with donepezil 23 mg/day""}, {'article': 'PMC7995588.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Change from baseline to week 24 in Severe Impairment Battery scores'}, {'article': 'PMC7995588.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Improvement in cognitive function in patients with Alzheimer's Disease""}]",367
3146,SIB-L,"[{'article': 'PMC3226311.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Language function improvement in Alzheimer's Disease patients treated with donepezil 23 mg/day""}, {'article': 'PMC3226311.txt', 'relationship': 'RESPONDED_TO', 'object': 'Donepezil 23 mg/day treatment'}]",367
3147,SIB[lang],"[{'article': 'PMC3226311.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in language abilities'}]",367
3148,SICI,"[{'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease cognitive decline""}, {'article': 'PMC7360860.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced short-interval intracortical inhibition in Alzheimer's Disease""}]",75
3149,SIK1,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",135
3150,SIRT1,"[{'article': 'PMC8470960.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Insulin sensitivity in Alzheimer's Disease""}, {'article': 'PMC6074058.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Metformin'}, {'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive behavior and mitochondrial function in Alzheimer's Disease""}]",641
3151,SLAB51 probiotic formulation,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment of Alzheimer's Disease""}]",211
3152,SLC24A4,"[{'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",544
3153,SLC24A4/RIN3,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",544
3154,SLC2A1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",544
3155,SLC2A4,"[{'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to anti-diabetic medications in Alzheimer's Disease""}]",544
3156,SLI,"[{'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",38
3157,SLIs,"[{'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral small vessel disease in Alzheimer's Disease""}]",38
3158,SLUMS,"[{'article': 'PMC7745768.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Dementia range in Alzheimer's Disease""}]",38
3159,SMB53,"[{'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebral spinal fluid Aβ42/Aβ40 ratio (lower levels reflect greater amyloid burden)'}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased cerebral spinal fluid YKL-40 levels (marker of astroglial and/or microglial activation)'}, {'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Less AD pathology'}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Glial activation in AD'}]",245
3160,SMS,"[{'article': 'PMC10092214.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Sensorimotor Synchronization in Neurocognitive Disorders'}, {'article': 'PMC10092214.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Motor and Socioemotional Responses to Music Rhythm'}]",119
3161,SMS consistency,"[{'article': 'PMC10092214.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Motor and cognitive dysfunction in Alzheimer's Disease""}]",119
3162,SNAP-25,"[{'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dystrophic synapses in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Patient selection'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection in Alzheimer's Disease""}]",620
3163,SNCA,"[{'article': 'PMC5496518.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",434
3164,SNX17,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",320
3165,SO power,"[{'article': 'PMC10758173.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Relative memory increase at post-intervention and follow-up'}]",42
3166,SO/spindle coupling strength,"[{'article': 'PMC10758173.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Relative memory increase at post-intervention and follow-up'}]",354
3167,SOD,"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Higher SOD levels in intervention groups'}, {'article': 'PMC4659639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Oxidative stress reduction in Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Oxidative stress response in mTBI'}, {'article': 'PMC4981900.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Assess: Safety and efficacy of EMF treatment in Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiating mild cognitive impairment from healthy controls'}]",35
3168,SOD activity,"[{'article': 'PMC7551340.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased antioxidant defense mechanisms'}]",35
3169,SOD1,"[{'article': 'PMC4890804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Phenserine treatment response in mTBI'}, {'article': 'PMC4890804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Phenserine treatment in Alzheimer's Disease""}]",35
3170,SOD2,"[{'article': 'PMC4890804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Phenserine treatment response in mTBI'}, {'article': 'PMC4890804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Phenserine treatment in Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Upregulation of SOD2 during osteogenesis in human MSCs'}]",35
3171,SOD3,"[{'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in SOD3 levels during chondrogenesis'}]",35
3172,SOM,"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Higher levels of Aβ1–42 in Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': 'All-cause and cardiovascular mortality'}, {'article': 'PMC6174237.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}]",35
3173,SORCS1,"[{'article': 'PMC3523068.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Late-onset Alzheimer's Disease""}]",35
3174,SORL1,"[{'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3335851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC5068716.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",35
3175,SPECT,"[{'article': 'PMC4826954.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5642413.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",294
3176,SPECT imaging,"[{'article': 'PMC8690894.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",294
3177,SPECT scan,"[{'article': 'PMC7171193.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",294
3178,SPECT-DaTscan®,"[{'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Functional disability progression in Alzheimer's Disease""}]",294
3179,SPMSQ >= 4 errors,"[{'article': 'PMC1914346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Nursing home admission'}]",254
3180,SPPB,"[{'article': 'PMC8564955.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Disability and all-cause mortality'}, {'article': 'PMC8564955.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction of risk in functional capacity'}]",470
3181,SPPB (Short Physical Performance Battery),"[{'article': 'PMC8564955.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Low scores predictive of ADL decline'}]",470
3182,SRSS,"[{'article': 'PMC10439779.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10439779.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Sleep Disturbances in Alzheimer's Disease""}]",190
3183,SRT,"[{'article': 'PMC4637414.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",190
3184,SRT latencies,"[{'article': 'PMC4656817.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Malingering in neuropsychological testing'}]",190
3185,SRT latency,"[{'article': 'PMC4374455.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",190
3186,SRT variance,"[{'article': 'PMC4374455.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",55
3187,SUVR,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Amyloid burden'}, {'article': 'PMC4519341.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Higher amyloid burden'}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Aβ pathology'}, {'article': 'PMC8005243.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Disease progression'}, {'article': 'PMC8005243.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8005243.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early Aβ accumulation'}, {'article': 'PMC8570037.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-beta presence in Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Probable Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Amyloid Burden'}, {'article': 'PMC5352784.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to crenezumab treatment'}, {'article': 'PMC6937673.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guide treatment selection based on amyloid burden in Alzheimer's Disease""}]",375
3188,SUVR 18F-FBP,"[{'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease via higher SUVR values""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Higher SUVR values associated with worse outcomes in Alzheimer's Disease""}]",375
3189,SUVR 18F-FDG,"[{'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease via lower SUVR values""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Lower SUVR values associated with more severe Alzheimer's Disease""}]",552
3190,SUVR in caudate,"[{'article': 'PMC6204612.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}]",340
3191,SUVR in globus pallidus,"[{'article': 'PMC6204612.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}]",340
3192,SUVR in putamen,"[{'article': 'PMC6204612.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}]",340
3193,SUVR in thalamus,"[{'article': 'PMC6204612.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}]",340
3194,SUVRMNI-CB,"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid accumulation in Alzheimer's Disease""}]",151
3195,SUVRMNI-WM,"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid accumulation in Alzheimer's Disease""}]",151
3196,SUVr (Standardized Uptake Value Ratio),"[{'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid deposition in Alzheimer's Disease""}]",16
3197,SV2A,"[{'article': 'PMC8325256.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Amyloid precursor protein (APP)'}]",298
3198,SVD features,"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment and dementia'}, {'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive dysfunction'}]",298
3199,SVD score,"[{'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cognitive decline in older adults'}]",298
3200,SVD-associated features,"[{'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive aging'}]",298
3201,SVLT,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Verbal Memory Impairment in Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",298
3202,SWA,"[{'article': 'PMC9053232.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Auditory stimulation effects on Alzheimer's Disease""}]",38
3203,SWF,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive Function Impairment in Alzheimer's Disease""}, {'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",38
3204,SWM performance,"[{'article': 'PMC10916999.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Worse performance in Alzheimer's Disease compared to healthy controls""}]",330
3205,SYK,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Modulation of Aβ phagocytosis and cognitive deficits in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Development of DAM and Aβ deposition in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Rescued microglia activation.'}]",183
3206,Saccular function,"[{'article': 'PMC9344717.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",50
3207,Salivary cortisol,"[{'article': 'PMC3652205.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in salivary cortisol levels after yoga and compassion meditation program'}, {'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4922661.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8336239.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",132
3208,Salivary melatonin,"[{'article': 'PMC8336239.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",536
3209,Sarkosyl-insoluble Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Tau aggregation and conversion from soluble Tau'}, {'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",619
3210,Sarkosyl-insoluble tau,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",619
3211,Sarkosyl-soluble Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Tau aggregation and conversion to insoluble Tau'}]",619
3212,Saturated fatty acids (14:0 and 16:0),"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive impairment in Alzheimer's Disease""}]",259
3213,"Saturated fatty acids (14:0, 16:0)","[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment related to Alzheimer's Disease""}]",259
3214,Schedule for the Evaluation of Individual Quality of Life - Direct Weighing (SEIQoL-DW),"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Individual quality of life domains in Alzheimer's Disease""}]",117
3215,Sedentary lifestyle,"[{'article': 'PMC9501541.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease Progression""}]",260
3216,Sele,"[{'article': 'PMC8581408.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflamed BBB endothelium'}]",261
3217,Selective serotonin reuptake inhibitors (SSRIs),"[{'article': 'PMC5648830.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",688
3218,Semagacestat,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Failed Phase III clinical trials due to worsening symptoms'}]",261
3219,Semantic Deficits,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",656
3220,Semantic Fluency,"[{'article': 'PMC4876902.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Disease-Related Declines in Cognitive Abilities'}]",656
3221,Semantic Paraphasia,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",92
3222,Semantic memory,"[{'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9373273.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",546
3223,Semantic word fluency,"[{'article': 'PMC4401690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive function and language ability in Alzheimer's Disease patients""}]",656
3224,Semicircular canal function,"[{'article': 'PMC9344717.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",50
3225,Senile plaques,"[{'article': 'PMC8061233.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",548
3226,Sensorimotor network,"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Acupuncture treatment response in Alzheimer's Disease""}]",70
3227,Sensory impairment,"[{'article': 'PMC6004911.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Delayed diagnosis of Alzheimer's Disease""}]",220
3228,Serotonin (5-HT),"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]",688
3229,Serum albumin,"[{'article': 'PMC7023686.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower levels in the NGF group compared to the AHF group (3.7 ± 0.6 vs. 4.0 ± 0.6, p = 0.045)'}, {'article': 'PMC7023686.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Pneumonia risk'}]",363
3230,Serum amyloid A (SAA),"[{'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'greater preservation of function'}]",8
3231,Serum amyloid A [SAA],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",8
3232,Serum calcium,"[{'article': 'PMC3212921.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",51
3233,Serum calcium concentration,"[{'article': 'PMC3212921.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor occurrence of hypercalcemia and treatment response'}]",51
3234,Serum high sensitivity C-reactive protein (hs-CRP),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation levels in Alzheimer's Disease""}]",38
3235,Serum high-sensitivity C-reactive protein (hs-CRP),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}]",38
3236,Serum insulin,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Insulin resistance in Alzheimer's Disease""}]",73
3237,Serum total cholesterol,"[{'article': 'PMC8351379.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}]",413
3238,Serum triglyceride (TG),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Metabolic changes in Alzheimer's Disease""}]",264
3239,Serum triglycerides,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Lower triglyceride levels in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}]",264
3240,Serum β-hydroxybutyrate (BHB),"[{'article': 'PMC2731764.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive improvement in Alzheimer's Disease""}, {'article': 'PMC2731764.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease cognitive outcomes""}, {'article': 'PMC2731764.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'AC-1202 treatment response'}]",361
3241,Severe Impairment Battery (SIB),"[{'article': 'PMC3126705.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive benefit in response to Donepezil 23 mg/d treatment'}]",102
3242,Silent lacunar infarcts (SLIs),"[{'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}]",608
3243,Similarities (WAIS-III),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",428
3244,Simple Attention,"[{'article': 'PMC4497726.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive performance'}]",407
3245,Single cavernous malformation,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",324
3246,Single-key tapping test,"[{'article': 'PMC10916999.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]",76
3247,Sirt1,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",641
3248,Six-Item Screen (SIS),"[{'article': 'PMC3088375.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Cognitive impairment in older adults'}, {'article': 'PMC3088375.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive impairment related to Alzheimer's Disease""}]",346
3249,Skin color,"[{'article': 'PMC9412195.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Physical activity and exercise intensity in Alzheimer's Disease patients""}]",57
3250,Sleep Disorder Inventory (SDI),"[{'article': 'PMC7083107.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Sleep disturbances in Alzheimer's Disease""}]",283
3251,Sleep Efficiency,"[{'article': 'PMC4069047.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive performance in AD patients'}, {'article': 'PMC4069047.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",479
3252,Sleep Patterns,"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",283
3253,Sleep Quality Index,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess sleep quality in Alzheimer's Disease""}]",479
3254,Sleep Quality Scores,"[{'article': 'PMC10439779.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improved Sleep Quality Post-Treatment'}]",479
3255,Sleep activity,"[{'article': 'PMC5123349.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment Monitoring: Tracking adherence in Alzheimer's Disease""}]",283
3256,Sleep quality,"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}, {'article': 'PMC5504954.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Efficient and successful aging and maintenance of high cognitive function'}]",479
3257,Slow Oscillations (SO),"[{'article': 'PMC10758173.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in memory performance'}]",421
3258,Slow Wave (SW) activity,"[{'article': 'PMC11493878.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease progression""}]",421
3259,Slow gait speed,"[{'article': 'PMC7106668.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of falls in Alzheimer's Disease patients""}]",703
3260,Slow oscillatory brain activity,"[{'article': 'PMC3682121.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Memory consolidation during non-REM sleep'}]",567
3261,Slow wave,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",421
3262,Slow wave latency,"[{'article': 'PMC4879492.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",421
3263,Slow-wave sleep (SWS),"[{'article': 'PMC9053232.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Deep NREM sleep'}]",421
3264,Slower speech rate,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",74
3265,Small intraventricular mass,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",93
3266,Smart-vest steps,"[{'article': 'PMC9395831.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease progression""}]",305
3267,Smoking,"[{'article': 'PMC10542675.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Smoking associated with higher risk of Alzheimer's Disease""}]",69
3268,"Social cognition tests (e.g., facial recognition, perspective taking)","[{'article': 'PMC4200223.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Risk of developing BPSD'}]",332
3269,Sodium,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",105
3270,Solanezumab,"[{'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Failed to meet primary endpoint in Phase III trial'}]",268
3271,Soluble Aβ,"[{'article': 'PMC4054967.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Cognitive deficits in Alzheimer's Disease""}]",8
3272,Soluble Aβ protofibrils,"[{'article': 'PMC4054967.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Early-onset Alzheimer's Disease""}]",8
3273,Soluble Aβ40,"[{'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
3274,Soluble Aβ42,"[{'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
3275,Soluble Intercellular Adhesion Molecule-1 (sICAM-1),"[{'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflammation'}]",447
3276,Somatostatin,"[{'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",242
3277,Somatostatin (SOM),"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ1–42'}]",242
3278,Somatostatin-positive interneurons,"[{'article': 'PMC3534053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related spatial learning deficits""}]",673
3279,Sorcs1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]",35
3280,Souvenaid,"[{'article': 'PMC4202787.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]",35
3281,Spatial abilities,"[{'article': 'PMC9373273.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",104
3282,Spatial navigation,"[{'article': 'PMC10127414.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Progression to mild cognitive impairment'}]",323
3283,Spatio-temporal analysis of walking (GAITRite),"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Gait impairments'}]",159
3284,Spectral power distribution,"[{'article': 'PMC9116897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Behavioral and Psychological Symptoms of Dementia (BPSD)'}]",9
3285,Speech,"[{'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",74
3286,Speech Tempo,"[{'article': 'PMC4611852.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",74
3287,"Speech characteristics (sentence complexity, verbal fluency)","[{'article': 'PMC4526336.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Cognitive impairment'}]",568
3288,Speech rate,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",74
3289,Speech rate and pause characteristics,"[{'article': 'PMC8110716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",693
3290,Speech timing,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}]",74
3291,Spinal fluid measures,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring disease progression in Alzheimer's Disease""}]",155
3292,Spindle Power,"[{'article': 'PMC10758173.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in memory performance'}]",354
3293,Spindle power,"[{'article': 'PMC10758173.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Relative memory increase at post-intervention and follow-up'}]",354
3294,Src,"[{'article': 'PMC3226277.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",190
3295,Stages of Objective Memory Impairment (SOMI),"[{'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}]",636
3296,Standard Pause Rate,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",693
3297,Standardized Uptake Value (SUV),"[{'article': 'PMC5026133.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",16
3298,Statins,"[{'article': 'PMC4615808.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Reduction of Aβ levels in Alzheimer's Disease""}, {'article': 'PMC6208946.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}]",134
3299,Stem cells,"[{'article': 'PMC3761088.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides treatment selection for Alzheimer's Disease""}]",72
3300,Step Length,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",305
3301,Step Length (SL),"[{'article': 'PMC7084863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",305
3302,Step Width,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",305
3303,Step frequency,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction in metabolic rates of glucose uptake in the prefrontal, posterior cingulate, and parietal cortices'}]",305
3304,Step length (SL) before turning,"[{'article': 'PMC7084863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",305
3305,Step length variability,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased mean diffusivity within the hippocampus and anterior cingulate cortex'}]",305
3306,Step width,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced fractional anisotropy in the left corticospinal tract'}]",305
3307,Streptococcus,"[{'article': 'PMC8266337.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment and memory dysfunction'}]",331
3308,Stress,"[{'article': 'PMC8857690.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive dysfunction and increased risk of Alzheimer's Disease""}]",624
3309,Stress and cortisol,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Hippocampal shrinkage associated with Alzheimer's Disease""}]",132
3310,Stride Length,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",246
3311,Stride Time Variability (STV),"[{'article': 'PMC3156726.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",646
3312,Stride length,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased mean diffusivity in brainstem, projection, association, limbic and callosal tracts'}]",246
3313,Stride time,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",246
3314,Stride time variability,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4197903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Mild Cognitive Impairment (MCI) associated with Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Larger temporal horns and middle portions of ventricular bodies'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced grey matter volume in the right parietal lobe'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Larger hippocampal volume'}]",246
3315,Stride time variability (CVst),"[{'article': 'PMC4197903.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",646
3316,Stride time variability (CoV),"[{'article': 'PMC3156726.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}]",646
3317,Stride variability,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",246
3318,Stride width variability,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'No significant associations with hippocampal or somatosensory cortex volumes'}]",246
3319,Stroke,"[{'article': 'PMC7414752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia incidence'}]",107
3320,Stroke lesion volume,"[{'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",107
3321,Stroop Color-Word Interference Test,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",251
3322,Stroop Color-Word Test,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive Function Impairment in Alzheimer's Disease""}]",251
3323,Stroop Color-Word test,"[{'article': 'PMC5036810.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",251
3324,Stroop incongruent words test,"[{'article': 'PMC4181752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in INPH patients'}]",251
3325,Stroop test,"[{'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function deficits in Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function in Alzheimer's Disease""}]",251
3326,Stroop test performance,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anxiety and Depression in Alzheimer's Disease""}]",251
3327,Stroop trial 3,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",251
3328,Structural MRI,"[{'article': 'PMC4506984.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Conversion into dementia in mild cognitive impairment subjects'}, {'article': 'PMC4506984.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease progression""}]",10
3329,Subclinical Depression,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk of developing Alzheimer's clinical syndrome""}]",270
3330,Subcortical Volumes,"[{'article': 'PMC10310693.txt', 'relationship': 'PREDICTS_NEURODEGENERATIVE_DISORDERS', 'object': ""Alzheimer's Disease""}]",160
3331,Subcortical atrophy,"[{'article': 'PMC10127414.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive decline in Alzheimer's Disease""}]",184
3332,Subcortical white-matter hyperintensities,"[{'article': 'PMC7674649.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Associated with functional impairments in Alzheimer's Disease""}]",23
3333,Subiculum volume,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",160
3334,Subjective Cognitive Decline (SCD),"[{'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""First symptomatic manifestation of Alzheimer's Disease""}]",215
3335,Subjective Memory Complaint (SMC),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",636
3336,Subjective Memory Complaints (SMC),"[{'article': 'PMC5619332.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5619332.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",636
3337,Subjective Memory Complaints (SMCs),"[{'article': 'PMC5619332.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor quality of life and impaired activities of daily living (ADL)'}]",636
3338,Substantia innominata (SI) thickness,"[{'article': 'PMC5326769.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Nucleus basalis of Meynert (NbM) atrophy'}]",405
3339,Sugar intake,"[{'article': 'PMC8502814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid accumulation in the posterior cingulate gyrus in preclinical Alzheimer's Disease""}]",586
3340,Sum Index,"[{'article': 'PMC6052695.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive Decline in Alzheimer's Disease""}]",131
3341,Superior temporal gyrus,"[{'article': 'PMC6040685.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",284
3342,Superior temporal gyrus (STG) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (svPPA variant)""}]",284
3343,Superoxide Dismutase,"[{'article': 'PMC7551340.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",515
3344,Superoxide dismutase (SOD),"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}]",515
3345,Superoxide dismutase (SOD) activity,"[{'article': 'PMC7551340.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced oxidative stress'}]",515
3346,Surface Area (SA),"[{'article': 'PMC4870937.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4870937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amild cognitive impairment'}, {'article': 'PMC4870937.txt', 'relationship': 'CORRELATED_WITH', 'object': 'Neuropsychological scores (MMSE and MoCA)'}]",566
3347,Sweating level,"[{'article': 'PMC9412195.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Physical activity and exercise intensity in Alzheimer's Disease patients""}]",232
3348,Swimming speed,"[{'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",97
3349,Symbol Digit Modalities Test (SDMT),"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7693499.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Activities of Daily Living (ADL) in Alzheimer's Disease""}]",424
3350,Synapsin 1,"[{'article': 'PMC8873004.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Synaptic loss in Alzheimer's Disease""}]",129
3351,Synapsin-1,"[{'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prevention of synaptic vessel release in AD mice'}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Increased levels linked to improved synaptic function in Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Increased expression in the hippocampus associated with exercise-induced protection against reduction of synaptic proteins after surgery'}]",129
3352,Synapthophysin,"[{'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Increased levels linked to improved synaptic function in Alzheimer's Disease""}]",129
3353,Synaptic dysfunction biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",616
3354,Synaptic proteins,"[{'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Synaptic loss and cognitive decline'}, {'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Improved cognitive function in Alzheimer's Disease""}]",616
3355,Synaptic strength and plasticity measures,"[{'article': 'PMC3362564.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Hippocampal function in response to XPro1595'}]",616
3356,Synaptophysin,"[{'article': 'PMC3237323.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'J147 treatment'}, {'article': 'PMC3237323.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Maintenance of synaptic density in AD mice'}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC5504954.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to: Environmental Enrichment'}, {'article': 'PMC6796854.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",129
3357,Synaptophysin expression,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",129
3358,Synaptosomal associated protein 25,"[{'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",616
3359,Synaptotagmin,"[{'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dystrophic synapses in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection in Alzheimer's Disease""}]",129
3360,Syntactic complexity,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",217
3361,Syntactic components,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",217
3362,Syntactic features,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Probable Alzheimer's Disease""}]",217
3363,Systemic immune-inflammation index,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for developing all-cause dementia'}]",289
3364,Systolic BP,"[{'article': 'PMC8000213.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to MBSR intervention'}]",297
3365,Systolic blood pressure,"[{'article': 'PMC4987494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Stress reduction efforts and category changes in Alzheimer's Disease risk reduction""}]",297
3366,T,"[{'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",538
3367,T cells,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'chronic neuroinflammation and dementia'}, {'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease pathology""}]",631
3368,T-Tau,"[{'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC3695013.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Higher levels associated with higher risk of Alzheimer's Disease""}, {'article': 'PMC3733998.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",213
3369,T-cells,"[{'article': 'PMC9290489.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improved immune response under MBSR/MBCT/MBCR intervention'}]",631
3370,T-tau,"[{'article': 'PMC10294511.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4875639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aβ pathology changes in Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8808989.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differential dementia diagnosis'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differential diagnosis between AD and non-AD dementia'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Prodromal AD in case of mild cognitive impairment'}, {'article': 'PMC5565643.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Select subjects for clinical trials with potentially disease-modifying drugs against AD'}, {'article': 'PMC5565643.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Identify asymptomatic subjects at risk to develop symptoms of AD'}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7648990.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",213
3371,T1 relaxation time,"[{'article': 'PMC6023430.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",168
3372,T10 plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function changes in Alzheimer's Disease""}]",123
3373,T3,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",201
3374,T3D-959,"[{'article': 'PMC4979550.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Therapeutic effects in experimental Alzheimer's Disease models""}, {'article': 'PMC4979550.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Efficacy in preserving spatial learning and memory in Alzheimer's Disease models""}]",144
3375,T4,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",201
3376,T5 plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function changes in Alzheimer's Disease""}]",123
3377,TAC,"[{'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",442
3378,TACE,"[{'article': 'PMC3206445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'CORRELATES_WITH', 'object': ""Disease severity in Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",442
3379,TACE activity,"[{'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",442
3380,TAF15,"[{'article': 'PMC5100351.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",442
3381,TAM receptor,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Developed fewer dense-core plaques.'}]",316
3382,TAS Test single-key tapping,"[{'article': 'PMC10916999.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]",76
3383,TAUdown,"[{'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",213
3384,TAUup,"[{'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",213
3385,TBARS,"[{'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Oxidative stress in mTBI'}]",22
3386,TBC1D4,"[{'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",219
3387,TBV,"[{'article': 'PMC8570373.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in stroke survivors'}]",22
3388,TC,"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Plasma lipid levels in Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",538
3389,TC-PTP,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",61
3390,TChE,"[{'article': 'PMC4659639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4659639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower TChE levels in intervention groups'}, {'article': 'PMC4659639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Cognitive function improvement in Alzheimer's Disease""}]",538
3391,TDP,"[{'article': 'PMC5147824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",61
3392,TDP-43,"[{'article': 'PMC4346122.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP)'}, {'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4489713.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Protein homeostasis and neurodegeneration'}, {'article': 'PMC5382945.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Autophagy dysfunction in VCP disease'}, {'article': 'PMC5456028.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'VCP disease pathology'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'VCP disease pathology in patient myoblasts'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with AT101, Chloroquine, Spautin-1, and MHY1485'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Rapamycin treatment in VCP disease'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Overexpression in patient cells treated with MHY1485'}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: AD and FTD/ALS'}, {'article': 'PMC6110931.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Hippocampal sclerosis and cerebral atrophy in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Patient selection and prognosis'}, {'article': 'PMC6966425.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Greater brain atrophy and cognitive impairment in Alzheimer's Disease""}]",199
3393,TDP-43 (Transactive response DNA-binding protein 43 kDa),"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",199
3394,TDP-43 pathology biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",199
3395,TDP-43-A,"[{'article': 'PMC6110931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Pathological features in nfvPPA'}]",199
3396,TEMPOL,"[{'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",56
3397,TEMPau,"[{'article': 'PMC7928298.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC7928298.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",490
3398,TEMRA T cells,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",631
3399,TG,"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Plasma lipid levels in Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",201
3400,TGF-α,"[{'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RESPONDED_TO', 'object': 'Transcranial Electromagnetic Treatment (TEMT)'}]",380
3401,TGF-β,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}, {'article': 'PMC6448216.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6916654.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved cognitive function and reduced Aβ toxicity'}]",380
3402,TGF-β1,"[{'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloidogenesis'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Anti-neuroinflammation activity in Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",380
3403,TGF-β2,"[{'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",380
3404,TGFα,"[{'article': 'PMC9108275.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment Response in Alzheimer's Disease""}]",380
3405,TGFβ,"[{'article': 'PMC3940003.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",380
3406,TH17 cells,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild cognitive impairment'}]",365
3407,THFs/THE ratio,"[{'article': 'PMC5301048.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Liver 11β-HSD1 inhibition'}]",179
3408,THK-5351 PET,"[{'article': 'PMC6910674.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cortical atrophy and tau aggregates in Alzheimer's Disease""}]",245
3409,THK-5351 uptake,"[{'article': 'PMC6910674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'CORRELATED_WITH', 'object': ""Cortical atrophy in Alzheimer's Disease""}]",245
3410,THK5351,"[{'article': 'PMC6910674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cortical atrophy in Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6910674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease severity in Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Cortical volume changes in Alzheimer's Disease""}]",245
3411,TIB,"[{'article': 'PMC8918152.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Later age at onset of Subjective Cognitive Decline'}]",290
3412,TLR2,"[{'article': 'PMC11274940.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment: TLR2 inhibition'}]",581
3413,TLR2/4,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",581
3414,TLR3,"[{'article': 'PMC9666898.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Activation of anti-inflammatory cytokines and neuroprotective response'}]",581
3415,TLR4,"[{'article': 'PMC4956742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Microglial detection of Aβ and neuro-inflammatory responses'}, {'article': 'PMC7089534.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",581
3416,TMAO,"[{'article': 'PMC6353871.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Alzheimer’s disease'}]",201
3417,TMEM119,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",201
3418,TMS-induced plasticity,"[{'article': 'PMC7360860.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Changes in cognition after rTMS and cognitive training'}]",123
3419,TMT,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4200223.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function deficits in Alzheimer's Disease""}, {'article': 'PMC4804486.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",84
3420,TMT A,"[{'article': 'PMC7288029.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function deficits in Alzheimer's Disease""}]",84
3421,TMT B,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function in Alzheimer's Disease""}, {'article': 'PMC7288029.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive flexibility deficits in Alzheimer's Disease""}]",84
3422,TMT-A,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",84
3423,TMT-A (s),"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive function in Alzheimer's Disease""}]",84
3424,TMT-B,"[{'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7735856.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",84
3425,TMTB,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",84
3426,TNF,"[{'article': 'PMC3362564.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Brain aging and synaptic alterations'}, {'article': 'PMC3362564.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'XPro1595 therapy'}, {'article': 'PMC3362564.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease synaptic strength and LTD induction""}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuroinflammation and synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive function and reduced neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neurotoxic effects'}, {'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease progression""}, {'article': 'PMC7089534.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Increased risk for Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",629
3427,TNF blockers,"[{'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Reduced risk for co-morbid Alzheimer's Disease in patients with rheumatoid arthritis""}]",629
3428,TNF blocking agents,"[{'article': 'PMC7089534.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'treatment of inflammatory diseases'}]",629
3429,TNF-a,"[{'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",629
3430,TNF-alfa,"[{'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",629
3431,TNF-alpha,"[{'article': 'PMC2241592.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Perispinal etanercept administration for Alzheimer's Disease""}, {'article': 'PMC2241592.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Cognitive improvement in Alzheimer's Disease patients""}, {'article': 'PMC2500042.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Perispinal etanercept for Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Outcome: Improved verbal fluency, memory, and cognitive function in Alzheimer's Disease patients""}, {'article': 'PMC2500042.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2500042.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Etanercept treatment'}, {'article': 'PMC5410904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",629
3432,TNF-proteins,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",629
3433,TNF-α,"[{'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Reduced neuroinflammation, decreased APP processing, Aβ plaque formation, and promoted cognitive function.'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: XENP345, Thalidomide'}, {'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegeneration and inflammation'}, {'article': 'PMC3741576.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Aβ deposits and cognitive impairment'}, {'article': 'PMC3741576.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ aggregates'}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4013077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5022094.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease Prognosis""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory processes in Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Increase in plasma levels reflects response to placebo treatment in Alzheimer's Disease patients.""}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pro-inflammatory response in Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced inflammation in AD models'}, {'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6104449.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Inflammatory status in Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Neuroinflammation during treatment'}, {'article': 'PMC6448216.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7274941.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased inflammation in Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Targeted by drugs in AD treatment'}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduced release in the presence of oleanolic acid'}, {'article': 'PMC9321013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroinflammation in AD'}, {'article': 'PMC9666898.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased neuroinflammation and cognitive impairment'}]",629
3434,"TNF-α, IL-1β and IL-6","[{'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Inflammation'}]",115
3435,TNF-β,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",629
3436,TNFR1,"[{'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Elevated protein levels in the hippocampus of aged rats'}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased TNFR1/TNFR2 ratio during aging in Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""XPro1595 treatment in Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Apoptosis and neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: XPro1595 for Alzheimer's Disease""}]",629
3437,TNFR1 signaling,"[{'article': 'PMC3362564.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Aged rats with improved Morris Water Maze performance'}]",629
3438,TNFR2,"[{'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Significant decrease in TNFR2 with age in Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}, {'article': 'PMC3362564.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Excitotoxic damage in Alzheimer's Disease""}]",629
3439,TNFSR1A,"[{'article': 'PMC7089534.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",629
3440,TNFα,"[{'article': 'PMC3116821.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammatory responses in Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to P. gingivalis brain infection treatment'}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Inflammation related to Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7690082.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",629
3441,TOMM40,"[{'article': 'PMC5596480.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Risk assessment for mild cognitive impairment due to AD'}]",56
3442,TR,"[{'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ plaque-associated microglia'}]",538
3443,TREM-2,"[{'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Microglial activation in Alzheimer's Disease""}]",156
3444,TREM1,"[{'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease immune response""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",156
3445,TREM2,"[{'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Ameliorated amyloid pathology in AD'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis of AD pathology'}, {'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for treatment: Ameliorated amyloid pathology and behavioral deficits.'}, {'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Microglial response around senile plaques in Alzheimer's Disease""}, {'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease immune response""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043748.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8066440.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Microglial Activation in Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease susceptibility""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC6158742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease risk""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflammatory response and microglial phagocytosis'}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Phagocytic response'}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease Progression""}, {'article': 'PMC6916654.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Patient selection'}, {'article': 'PMC6966425.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Increased levels in Alzheimer's Disease""}, {'article': 'PMC7089534.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",156
3446,TREM2 R47H,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased LOAD risk'}, {'article': 'PMC4876682.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Early-onset dementia'}]",156
3447,TREM2 mutation,"[{'article': 'PMC4876682.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'More extensive brain atrophy in AD patients'}]",313
3448,TRPA1,"[{'article': 'PMC10001958.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",45
3449,TRPML1,"[{'article': 'PMC4489713.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lipid accumulation and lysosomal trafficking correction'}]",45
3450,TRx0237,"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",45
3451,TSH,"[{'article': 'PMC3849204.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8333062.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Thyroid function during treatment with [124I]-PU-HZ151'}, {'article': 'PMC6884754.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Reversible causes of cognitive impairment'}]",538
3452,TSPO,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Microglial activation in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Microglial activation in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9349172.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9349172.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in women'}, {'article': 'PMC9349172.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Microglial activation in Alzheimer's Disease""}, {'article': 'PMC9349172.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Microglial activation in Alzheimer's Disease""}]",538
3453,TSPO (18 kDa translocator protein),"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Neuroinflammation in Alzheimer’s Disease'}]",318
3454,TSPO expression in hypothalamus,"[{'article': 'PMC9349172.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",318
3455,TSPO expression in thalamus,"[{'article': 'PMC9349172.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",318
3456,TST,"[{'article': 'PMC8127192.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7083107.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",538
3457,TT,"[{'article': 'PMC3382377.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Wii-Fit intervention'}, {'article': 'PMC3382377.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Improvement in gait under Wii-Fit treatment'}]",94
3458,TT (Tinetti Test),"[{'article': 'PMC3382377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Gait improvements in Alzheimer's Disease""}]",94
3459,TT aglycones,"[{'article': 'PMC8868383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Centella asiatica product (CAP) administration'}]",94
3460,TTR,"[{'article': 'PMC2765081.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",94
3461,TTs,"[{'article': 'PMC8797052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive improvements in Alzheimer's Disease""}, {'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Bioavailability in plasma'}]",94
3462,TUG,"[{'article': 'PMC10475546.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Balance in older adults with cognitive decline'}, {'article': 'PMC3382377.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Wii-Fit intervention'}, {'article': 'PMC3382377.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Improvement in physical performance under Wii-Fit treatment'}, {'article': 'PMC8564955.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': 'Higher risk of institutionalization or long-term care admission'}, {'article': 'PMC8564955.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in functional mobility'}, {'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early cognitive impairment'}, {'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment'}, {'article': 'PMC7084863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Future cognitive decline'}, {'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mobility problems and high risk of falls'}]",60
3463,TUG (Timed Up and Go test),"[{'article': 'PMC8564955.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Low scores associated with worsening ADL'}]",60
3464,TUG (Timed Up and Go),"[{'article': 'PMC3382377.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Mobility in Alzheimer's Disease""}]",60
3465,TUG (Timed Up-and-Go) Test,"[{'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",60
3466,TUG dual-task test (TUGdt),"[{'article': 'PMC7662628.txt', 'relationship': 'PREDICTS', 'object': 'Dementia incidence among patients with SCI or mild cognitive impairment'}]",60
3467,TUG single-task,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7662628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive impairment and dementia conversion'}]",60
3468,TUG time,"[{'article': 'PMC7084863.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",60
3469,TUGdt,"[{'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}, {'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia'}, {'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive Decline'}, {'article': 'PMC7084863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Progression from Mild Cognitive Impairment to Dementia'}, {'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early dementia'}, {'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Dementia'}]",493
3470,"TUGdt ""animals/10 s""","[{'article': 'PMC7662628.txt', 'relationship': 'PREDICTS', 'object': 'Predicts: Dementia incidence'}]",454
3471,"TUGdt ""animals/10 s"" test","[{'article': 'PMC7662628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Dementia (related to Alzheimer's Disease)""}]",454
3472,TUGdt (Dual-task Test),"[{'article': 'PMC7084863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",60
3473,TUGdt MB,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia disorder, mild cognitive impairment, SCI, and no cognitive impairment'}]",493
3474,TUGdt MB months/10 s,"[{'article': 'PMC7662628.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Dementia incidence'}]",103
3475,TUGdt MB number of months,"[{'article': 'PMC7662628.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Dementia incidence'}]",103
3476,TUGdt MB time score,"[{'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",493
3477,"TUGdt MB, months/10 s","[{'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",103
3478,"TUGdt MB, number of months","[{'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",103
3479,TUGdt NA,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia disorder, mild cognitive impairment, SCI, and no cognitive impairment'}]",493
3480,TUGdt NA animals/10 s,"[{'article': 'PMC7662628.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Dementia incidence'}]",454
3481,TUGdt NA number of animals,"[{'article': 'PMC7662628.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Dementia incidence'}]",454
3482,TUGdt NA time score,"[{'article': 'PMC7662628.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Dementia incidence'}, {'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",493
3483,"TUGdt NA, animals/10 s","[{'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",454
3484,"TUGdt NA, number of animals","[{'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",454
3485,TUGdt naming animals (TUGdt NA),"[{'article': 'PMC7662628.txt', 'relationship': 'USED_TO', 'object': 'Predict dementia incidence among patients with SCI or mild cognitive impairment'}]",454
3486,TUGdt test outcomes,"[{'article': 'PMC7662628.txt', 'relationship': 'USED_TO', 'object': 'Improve predictive capacity compared to demographic characteristics and standard cognitive test results alone'}, {'article': 'PMC7662628.txt', 'relationship': 'PREDICTS', 'object': 'Dementia incidence among patients with SCI or mild cognitive impairment'}]",60
3487,TUGdt time,"[{'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates: Presence of Alzheimer's Disease""}]",493
3488,TUGst time score,"[{'article': 'PMC7662628.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",493
3489,TUNEL,"[{'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Apoptosis'}]",56
3490,TUNEL-positive cells,"[{'article': 'PMC4747225.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Apoptosis in Alzheimer's Disease""}, {'article': 'PMC4747225.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Apoptotic cell death'}]",72
3491,TVPAC,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI), a precursor to Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amild cognitive impairment detection'}]",113
3492,TXB2,"[{'article': 'PMC4694064.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Vascular dynamics and inflammation in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""J147 treatment in Alzheimer's Disease""}]",39
3493,TYK2,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease severity""}]",135
3494,TYROBP,"[{'article': 'PMC4617238.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease immune module""}, {'article': 'PMC6879435.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",20
3495,Tactile Domain,"[{'article': 'PMC3581819.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved sensory function in Alzheimer's Disease""}]",70
3496,Talk testing (TT),"[{'article': 'PMC9412195.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Exercise intensity and breathing difficulty in Alzheimer's Disease patients""}]",94
3497,Tapping speed,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",76
3498,Task Activation Responses,"[{'article': 'PMC6538045.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Monitor changes in brain blood flow during treatment'}]",332
3499,Tau,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Neuroinflammation and AD progression'}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10127414.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10787596.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease (AD)""}, {'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau-related pathology progression in Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cortical amyloid load and cerebral hypometabolism'}, {'article': 'PMC3534053.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'ApoE4-related GABAergic interneuron impairment'}, {'article': 'PMC3534053.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease pathogenesis""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3940003.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Neural loss in Alzheimer's Disease""}, {'article': 'PMC4054967.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to GSK933776 treatment in mild AD and mild cognitive impairment'}, {'article': 'PMC4055052.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Slight increase in cerebrospinal fluid levels during the study'}, {'article': 'PMC4095696.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Disease-modifying therapies in Alzheimer's Disease""}, {'article': 'PMC4095696.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Impaired intracellular Aβ1-42 clearance and increased plaque deposition'}, {'article': 'PMC4247762.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Aβ1-42 clearance'}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC4247762.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Aβ1-42 clearance and extracellular plaque deposition'}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4294473.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4396171.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cerebral spinal fluid biomarker levels'}, {'article': 'PMC4615808.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4888851.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Faster progression of Alzheimer's Disease""}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ pathology'}, {'article': 'PMC8005243.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease progression in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC8470960.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline and AD pathogenesis in mice'}, {'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC8500065.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8500065.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: 40 Hz gamma oscillation therapy'}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Advanced clinical diagnosis of Alzheimer's Disease""}, {'article': 'PMC8866346.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8866346.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Non-pathological cerebral spinal fluid profiles'}, {'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurodegenerative cerebral spinal fluid profiles'}, {'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related neurodegeneration""}, {'article': 'PMC4267230.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4506984.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Predicts AD dementia'}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increases in P‐tau, YKL‐40, and NFL levels over 2 years'}, {'article': 'PMC5234138.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5234138.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5315443.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Nerve cell dysfunction in Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5450399.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}, {'article': 'PMC5450399.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5496518.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5596480.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'NOT_USED_TO_DIAGNOSE', 'object': 'No significant changes in levels'}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'P. gingivalis infection'}, {'article': 'PMC6357742.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'P. gingivalis infection'}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Correlation with synaptic loss and cognitive decline'}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6916654.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Targeted in combination therapies for Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts presence of: Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of treatment: LMTM'}, {'article': 'PMC7223540.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target for anti-tau therapies in Alzheimer's Disease trials""}, {'article': 'PMC7223540.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Biological outcome in Phase 2 studies for Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Associated with prognosis in Alzheimer's Disease and tauopathies""}, {'article': 'PMC7223540.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides selection of participants in basket trials for Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7995588.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of TEMT treatment to disaggregate toxic oligomers'}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Normal levels in prodromal DLB patients, distinguishing from prodromal Alzheimer's disease""}, {'article': 'PMC9295361.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Anti-tau therapies in Alzheimer's Disease""}, {'article': 'PMC9438329.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9438329.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild cognitive impairment to major neurocognitive disorder'}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Alleviates tau hyperphosphorylation'}, {'article': 'PMC9666898.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduced tau hyperphosphorylation levels and improved spatial learning and memory impairment'}, {'article': 'PMC9972756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",213
3500,Tau (MAPT),"[{'article': 'PMC3389343.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",213
3501,Tau (t-tau and p-tau181),"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
3502,Tau (total tau and phosphorylated tau),"[{'article': 'PMC10013957.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
3503,Tau Neurofibrillary tangles,"[{'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Synaptic loss and cognitive decline'}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",40
3504,Tau PET,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Preclinical treatment of AD in adults with DS'}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",213
3505,Tau PET pathology,"[{'article': 'PMC6374283.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",40
3506,Tau Protein,"[{'article': 'PMC5516350.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Vaccines or antibodies targeting tau protein'}, {'article': 'PMC6201586.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",40
3507,Tau accumulation,"[{'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",40
3508,Tau aggregates,"[{'article': 'PMC4294473.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neurodegenerative disorders'}]",40
3509,Tau deposition,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",40
3510,Tau filaments,"[{'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurofibrillary tangles'}]",40
3511,Tau formation,"[{'article': 'PMC6448216.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}]",40
3512,Tau fragments,"[{'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",40
3513,Tau hyperphosphorylation,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3226277.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
3514,Tau isoforms,"[{'article': 'PMC4294473.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Disease-specific inclusion composition'}, {'article': 'PMC5450399.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
3515,Tau pathology,"[{'article': 'PMC4995360.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",40
3516,Tau phosphorylated at Ser202/Thr205 (AT8),"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",40
3517,Tau phosphorylated at Ser235 (MC6),"[{'article': 'PMC4294473.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",40
3518,Tau phosphorylated at threonine 181,"[{'article': 'PMC10233712.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",40
3519,Tau phosphorylated at threonine 181 (p-tau181),"[{'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
3520,Tau phosphorylation,"[{'article': 'PMC6796854.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}]",40
3521,Tau protein,"[{'article': 'PMC10001958.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10363100.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC3741576.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4174765.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Associated with poor outcome: Rapid cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Neuronal injury in Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegenerative changes in Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'SUPPORTS_INTERVENTION', 'object': ""Intervention: Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurofibrillary tangles'}, {'article': 'PMC7089534.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC9539040.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Reduction of tau protein accumulation through 40-Hz auditory stimulation'}, {'article': 'PMC9539040.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved cognitive function in patients with AD'}, {'article': 'PMC9606044.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9606044.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
3522,Tau protein tangles,"[{'article': 'PMC8868383.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
3523,Tau proteins,"[{'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8287201.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",40
3524,Tau-P301L,"[{'article': 'PMC5516350.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}]",40
3525,Tau-PET,"[{'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of tau pathology in Alzheimer's Disease""}]",213
3526,Tau/Aβ42 ratio,"[{'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid positivity in Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",473
3527,Tau:Aβ42 ratio,"[{'article': 'PMC3523068.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Conversion from normal cognition to dementia in Alzheimer's Disease""}]",473
3528,Taurine,"[{'article': 'PMC4847010.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Inverse correlation with Aβ levels and GFAP in Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'RESPONDED_TO', 'object': 'Fingolimod treatment'}]",213
3529,Tcf-4,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",538
3530,Telomerase activity,"[{'article': 'PMC5022094.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease Prognosis""}]",513
3531,Telomere activity,"[{'article': 'PMC9290489.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Increased activity associated with MBSR/MBCT/MBCR'}]",513
3532,Temporal Decline Percentage (TDP),"[{'article': 'PMC5147824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]",3
3533,Temporal Lobe Atrophy,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk for cognitive decline'}]",444
3534,Temporal brain volume loss,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",430
3535,Temporal cortex glucose metabolism,"[{'article': 'PMC5026133.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",539
3536,Temporal meta-ROI cortical thickness,"[{'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Decline in cortical thickness associated with cognitive decline'}, {'article': 'PMC8530186.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",197
3537,Temporoparietal hypometabolism,"[{'article': 'PMC6615169.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",319
3538,Tenascin-R,"[{'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",344
3539,Tenericutes,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",344
3540,Test of Everyday Attention,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in attention in participants with mild to moderate Alzheimer's disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",407
3541,Test time score,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",1
3542,Tests of Attention: Trails A and B,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in attention in participants with mild to moderate Alzheimer's disease""}]",407
3543,Texas Red-Dextran-70kD,"[{'article': 'PMC10917684.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': ""Extravasation and clearance in Alzheimer's Disease""}]",247
3544,Texas Red–dextran,"[{'article': 'PMC10917684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",247
3545,Text,"[{'article': 'PMC10363100.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",119
3546,TgP301S Tau,"[{'article': 'PMC4294473.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",40
3547,Th1 cells,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Late-stage Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Decreased Th1 cells in Alzheimer's Disease mice treated with GV-971""}, {'article': 'PMC6796854.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroinflammation in Alzheimer's Disease""}]",365
3548,Th1/Th2 ratio,"[{'article': 'PMC9290489.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Improved immune recovery through MBSR/MBCT/MBCR'}]",179
3549,Th17,"[{'article': 'PMC2765081.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",365
3550,Th17 cells,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive dysfunction in Alzheimer's Disease""}]",365
3551,Th2 cells,"[{'article': 'PMC6796854.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-stage Alzheimer's Disease""}]",365
3552,Thal amyloid phase,"[{'article': 'PMC5144753.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",8
3553,Thalamic dysfunction,"[{'article': 'PMC8570373.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Clinical impairments post-stroke'}]",255
3554,Thalamus,"[{'article': 'PMC10439779.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",255
3555,Theta Power,"[{'article': 'PMC10758173.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Improvement in memory performance'}]",210
3556,Theta band oscillations,"[{'article': 'PMC6561937.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",210
3557,Theta band power,"[{'article': 'PMC3914466.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Probable Alzheimer's Disease""}]",210
3558,Theta frequency band,"[{'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6370863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",210
3559,Theta oscillations,"[{'article': 'PMC3682121.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Theta-tDCS'}]",210
3560,Theta power,"[{'article': 'PMC6370863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment risk'}, {'article': 'PMC7288029.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Cognitive function improvements in VR intervention group'}, {'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Significant decrease in the parietal and temporal areas'}]",210
3561,Theta/Beta ratio (TBR),"[{'article': 'PMC7288029.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mind wandering and reduced attention'}, {'article': 'PMC7288029.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Improvements in attention and cognitive function'}]",179
3562,Thigmotactic behavior,"[{'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",255
3563,Thigmotaxis,"[{'article': 'PMC4675859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Learning and memory deficits in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased thigmotactic behavior in untreated Ts65Dn mice'}, {'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Anxiety-related behavior in Alzheimer's models""}]",255
3564,Thioflavin S,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",2
3565,Thioflavin T,"[{'article': 'PMC5297247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Amyloid deposits in Alzheimer's Disease""}]",2
3566,"Thymus and activation-regulated chemokine [TARC, CCL17]","[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",278
3567,Thyroid-Stimulating Hormone (TSH),"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",318
3568,Tie-2,"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Aβ42/40 ratio'}, {'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",620
3569,Timed Gait Test,"[{'article': 'PMC6521224.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]",159
3570,Tlr2,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",581
3571,Tmem66,"[{'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",201
3572,Tnf,"[{'article': 'PMC8581408.txt', 'relationship': 'ASSOCIATED_WITH_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7674923.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",629
3573,TorCA Subscores,"[{'article': 'PMC6052695.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Mild Cognitive Impairment'}]",92
3574,TorCA Sum Index,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",131
3575,Total Antioxidant Capacity (TAC),"[{'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to probiotic treatment'}]",374
3576,Total Brain Volume (TBV),"[{'article': 'PMC8570373.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive Impairment'}, {'article': 'PMC8570373.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Post-Stroke Neurodegeneration'}, {'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment in stroke patients'}]",160
3577,Total Cholesterol,"[{'article': 'PMC4179179.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive impairment in elderly subjects'}, {'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",413
3578,Total GM volume,"[{'article': 'PMC8351379.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",6
3579,Total Glutathione (GSH),"[{'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to probiotic treatment'}]",205
3580,Total Gray Matter Volume,"[{'article': 'PMC5302785.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",350
3581,Total Phonation Time,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",377
3582,Total Recall (TR) scores,"[{'article': 'PMC9246122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}]",157
3583,Total Tau,"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC4294473.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9295361.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
3584,Total WM volume,"[{'article': 'PMC8351379.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Simvastatin treatment in Alzheimer's Disease""}]",6
3585,Total WMH volume,"[{'article': 'PMC6521224.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]",6
3586,Total antioxidant capacity (TAC),"[{'article': 'PMC6104449.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}]",374
3587,Total brain atrophy rates,"[{'article': 'PMC8570373.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment response in clinical trials'}]",184
3588,Total brain volume,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of Alzheimer's Disease""}]",160
3589,Total brain volume (TBV),"[{'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",160
3590,Total cholesterol,"[{'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Metabolic changes in Alzheimer's Disease""}]",413
3591,Total cholesterol (TC),"[{'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",413
3592,Total cholinesterase (TChE),"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",191
3593,Total fat mass,"[{'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",19
3594,Total glutathione (GSH),"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress levels in Alzheimer's Disease""}]",205
3595,Total protein,"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",147
3596,Total sAPP,"[{'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",214
3597,Total tau,"[{'article': 'PMC10233712.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4055052.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4366075.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8439008.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Therapeutic effects of hUCB-MSC injection'}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5008228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9797897.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
3598,Total tau (T-tau),"[{'article': 'PMC4606063.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuroaxonal degeneration in Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4606063.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Neuronal injury in Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuronal injury in Alzheimer's Disease""}]",40
3599,Total tau (t-Tau),"[{'article': 'PMC4487699.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",40
3600,Total tau (t-tau),"[{'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
3601,Total tau protein,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
3602,Total-Tau,"[{'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",40
3603,Total-Tau (T-Tau),"[{'article': 'PMC6174237.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
3604,Touch,"[{'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",346
3605,TrKA,"[{'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",45
3606,Trail Making A,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",477
3607,Trail Making A and B,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection of amnestic mild cognitive impairment'}]",477
3608,Trail Making B,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",477
3609,Trail Making B test,"[{'article': 'PMC4811920.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Frontal lobe involvement in mild cognitive impairment groups'}]",662
3610,Trail Making Test,"[{'article': 'PMC7729136.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Processing speed and mental flexibility in Alzheimer's Disease""}]",662
3611,Trail Making Test (TMT) A and B,"[{'article': 'PMC3110111.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",662
3612,Trail Making Test (TMT) parts A and B score,"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive decline'}]",662
3613,Trail Making Test (TMT) times,"[{'article': 'PMC6074058.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",662
3614,Trail Making Test A,"[{'article': 'PMC4181752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in INPH patients'}]",662
3615,Trail Making Test B,"[{'article': 'PMC4181752.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment in INPH patients'}]",662
3616,Trail Making Test Part B,"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Executive function deficits in Alzheimer's Disease""}]",662
3617,Trail Making Test part B,"[{'article': 'PMC4811920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}]",662
3618,Trail-Making Test-B,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",662
3619,Trailing Off,"[{'article': 'PMC5237556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Probable Alzheimer's Disease""}]",621
3620,Trails A,"[{'article': 'PMC4465490.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Malingering behavior'}]",477
3621,Trails A and B,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",477
3622,Trails B,"[{'article': 'PMC4465490.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Malingering behavior'}]",477
3623,Transformed Phonation Rate,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",377
3624,Traumatic Brain Injury (TBI),"[{'article': 'PMC4890804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",107
3625,Treg Frequencies,"[{'article': 'PMC6584558.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",276
3626,Treg cells,"[{'article': 'PMC2765081.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Immune system homeostasis in Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Reduction of disease progression in Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'AD progression'}]",313
3627,Tregs,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia status changes'}, {'article': 'PMC6584558.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6584558.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6837488.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",156
3628,Trehalose,"[{'article': 'PMC4857621.txt', 'relationship': 'USED_TO_TREAT', 'object': ""Alzheimer's Disease""}]",156
3629,Trem2,"[{'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Disease-Associated Microglia (DAM) phenotype in Alzheimer's Disease""}, {'article': 'PMC7389451.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Aβ detection and clearance'}, {'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",156
3630,Trial-to-trial CRT variance,"[{'article': 'PMC4656817.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Malingering in neuropsychological testing'}]",55
3631,Triggering receptor expressed on myeloid cells 2 (TREM2),"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Neuroinflammation in Alzheimer’s Disease'}]",313
3632,Triglyceride,"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'RESPONDED_TO', 'object': 'Probiotic supplementation'}]",264
3633,Triglycerides,"[{'article': 'PMC4179179.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive impairment in elderly subjects'}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Increased risk for Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4731943.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cardiovascular risk in bexarotene-treated patients'}, {'article': 'PMC4731943.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced cortical amyloid burden in apoe4 noncarriers'}, {'article': 'PMC8857690.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Dyslipidemia in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Lipid profiles in Alzheimer's Disease patients""}, {'article': 'PMC6208946.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6208946.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",264
3634,Triglycerides (TG),"[{'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",264
3635,Triglycerides levels,"[{'article': 'PMC8470960.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",264
3636,Triglycerides/HDL-cholesterol ratio,"[{'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",622
3637,Triterpenes (TT),"[{'article': 'PMC8797052.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment of Alzheimer's Disease""}]",667
3638,Triterpenoid saponins (TT),"[{'article': 'PMC8868383.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",667
3639,TrkA,"[{'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurotrophin receptor activity in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",45
3640,TrkA Mono,"[{'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",45
3641,TrkB,"[{'article': 'PMC2765081.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Synaptic plasticity'}]",183
3642,Trypan blue dye exclusion assay,"[{'article': 'PMC4981900.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""No oxidative stress in Alzheimer's Disease""}]",334
3643,Tumor Necrosis Factor (TNF),"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower risk for Alzheimer’s Disease'}]",406
3644,Tumor necrosis factor alpha (TNFα),"[{'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Alzheimer’s Disease'}]",406
3645,Tumor necrosis factor alpha [TNF-α],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",406
3646,Tumor necrosis factor beta [TNF-β],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",406
3647,Turicibacter,"[{'article': 'PMC5648830.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased cerebral spinal fluid YKL-40 levels (marker of astroglial and/or microglial activation)'}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Glial activation in AD'}]",331
3648,Turn duration,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",168
3649,Tyrobp,"[{'article': 'PMC7389451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",20
3650,Tyrosine Hydroxylase Enzyme,"[{'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",267
3651,Tyrosine kinase-2 [Tie-2],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",399
3652,UBE2V1,"[{'article': 'PMC3335851.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",293
3653,UBQLN1,"[{'article': 'PMC5100351.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegenerative diseases'}]",697
3654,UBQLN2,"[{'article': 'PMC5100351.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Neurodegenerative diseases'}]",697
3655,UE2343,"[{'article': 'PMC5301048.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain 11β-HSD1 inhibition and cognitive enhancement in Alzheimer's Disease""}]",144
3656,UFOV,"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",108
3657,UGT8,"[{'article': 'PMC7884393.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",293
3658,ULK1,"[{'article': 'PMC5076443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Autophagy levels in Alzheimer's Disease""}, {'article': 'PMC5076443.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Autophagy'}, {'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",135
3659,ULK2,"[{'article': 'PMC7884393.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",135
3660,UNC5C,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",233
3661,UPDRS III,"[{'article': 'PMC7364345.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Motor function in Alzheimer's Disease""}]",178
3662,UPDRS assessments,"[{'article': 'PMC7364345.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Parkinsonian symptoms in Alzheimer's Disease""}]",178
3663,UPSA,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess managing finances in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-care in Alzheimer's Disease""}, {'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess self-management in Alzheimer's Disease""}]",178
3664,Ubiquitin,"[{'article': 'PMC4489713.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Protein homeostasis and neurodegeneration'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Autophagy dysfunction in VCP disease'}, {'article': 'PMC5456028.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'VCP disease pathology'}]",650
3665,Ubiquitin-mediated proteolysis,"[{'article': 'PMC2432467.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Proteostasis and stress response'}]",650
3666,Ubiquitinated proteins,"[{'article': 'PMC5445077.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Neurodegeneration in Alzheimer's Disease""}]",650
3667,Ulcerative Colitis,"[{'article': 'PMC7089534.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",416
3668,Urea,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",34
3669,Uric acid,"[{'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to: Semagacestat treatment'}]",34
3670,Utricular function,"[{'article': 'PMC9344717.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",50
3671,VAT/SAT ratio,"[{'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",179
3672,VBM,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Assess atrophy and predict conversion from MCI to AD'}, {'article': 'PMC8760674.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cortical thickness changes'}, {'article': 'PMC9246122.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Brain regions associated with cognitive factors and brain atrophy'}]",401
3673,VCAM-1,"[{'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Vascular dysfunction in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Vascular pathology in Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",482
3674,VCAM1,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",482
3675,VCP,"[{'article': 'PMC3335851.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Late-onset Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: Autophagy modifiers for VCP disease myopathy'}, {'article': 'PMC9287862.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC9287862.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor overall survival in breast carcinoma'}]",482
3676,VDRL,"[{'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",336
3677,VEGF,"[{'article': 'PMC4835514.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Progenitor cell proliferation and neuronal differentiation'}, {'article': 'PMC4908397.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8211849.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of neurogenesis and brain blood flow changes related to Alzheimer's Disease""}, {'article': 'PMC8211849.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Vascular survival and memory restoration in Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Changes in MoCA scores over 2 weeks'}, {'article': 'PMC8789895.txt', 'relationship': 'PREDICTS_BETTER_OUTCOME', 'object': 'better performance on memory composite score'}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4397698.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5427593.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Associated with enhanced migratory activity of MSCs in Alzheimer's Disease treatment""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7001626.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment-induced changes in plasma levels'}, {'article': 'PMC9108275.txt', 'relationship': 'RESPONDED_TO', 'object': 'Transcranial Electromagnetic Treatment (TEMT)'}, {'article': 'PMC9108275.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9269742.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Exercise-induced response'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neurotrophic Factor Levels'}, {'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Upregulates VEGF levels to promote angiogenesis'}]",504
3678,VEGF-C,"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",504
3679,VEGF-D,"[{'article': 'PMC8789895.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",504
3680,VEGFA,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",504
3681,VEGFR1,"[{'article': 'PMC4304279.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",504
3682,VILIP-1,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Incipient cognitive decline, cognitive decline rates, and brain atrophy rates in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease diagnosis""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Alzheimer's Disease""}]",127
3683,VILIP1,"[{'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",127
3684,VIP,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Attenuation of Alzheimer’s disease pathology'}, {'article': 'PMC10917684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased VIP immunofluorescence in gamma-treated mice'}, {'article': 'PMC10917684.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to 40Hz stimulation in Alzheimer's Disease models""}]",49
3685,VIP interneurons,"[{'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Amyloid clearance in Alzheimer's Disease""}]",49
3686,VL,"[{'article': 'PMC2949590.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Quality of Life in severe dementia'}]",336
3687,VLD (pixel-wide vessel density),"[{'article': 'PMC6445433.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive performance in Alzheimer's Disease""}]",65
3688,VLDL,"[{'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Dyslipidemia in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'RESPONDED_TO', 'object': 'Probiotic supplementation'}]",336
3689,VO2 peak,"[{'article': 'PMC4497726.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Cardiorespiratory fitness'}, {'article': 'PMC4497726.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Improved cognitive outcomes in Alzheimer's Disease""}, {'article': 'PMC4497726.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved Visuospatial Processing'}, {'article': 'PMC4497726.txt', 'relationship': 'PREDICTS', 'object': 'Cognitive benefits'}, {'article': 'PMC7808620.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic exercise intervention'}]",521
3690,VO2max,"[{'article': 'PMC6406356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Global cognitive and physical function in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Preserved brain volume'}]",521
3691,VOR gain,"[{'article': 'PMC9344717.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",521
3692,VOSP,"[{'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3681660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",521
3693,VQIINK motif,"[{'article': 'PMC4294473.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Tau aggregation inhibition'}]",638
3694,VR-DOT,"[{'article': 'PMC4307822.txt', 'relationship': 'PREDICTS', 'object': ""Conversion to Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts: Conversion to Alzheimer's Disease""}, {'article': 'PMC4307822.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guides: Early identification and diagnosis of Alzheimer's Disease""}]",49
3695,VSRAD,"[{'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",336
3696,VWF,"[{'article': 'PMC6211704.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",336
3697,Valeric Acid,"[{'article': 'PMC8873004.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased Risk of Postoperative Cognitive Dysfunction'}]",563
3698,Valeric acid,"[{'article': 'PMC8873004.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive impairment'}]",563
3699,Valine,"[{'article': 'PMC7551340.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Mild Cognitive Impairment'}]",309
3700,Vascular Endothelial Growth Factor (VEGF),"[{'article': 'PMC9269742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuroprotective and therapeutic effects of exercise on the brain'}]",248
3701,Vascular abnormalities,"[{'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",324
3702,Vascular biomarkers,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]",257
3703,Vascular cell adhesion molecule-1 [VCAM-1],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",447
3704,Vascular endothelial growth factor (VEGF),"[{'article': 'PMC4908397.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Trophic factors in hBM-MSCs dynamic conditioned media'}]",248
3705,Vascular endothelial growth factor [VEGF],"[{'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",248
3706,"Vascular risk factors (e.g., smoking, obesity, diabetes)","[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",252
3707,Vcl,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Basement membrane interaction'}]",482
3708,Ventral and lateral anterior temporal pole (ATP) atrophy,"[{'article': 'PMC6218435.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease (svPPA variant)""}]",444
3709,Ventricles (% TIV),"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",410
3710,Ventricular volume,"[{'article': 'PMC4283145.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Greater ventricular expansion in high-dose treatment arm'}, {'article': 'PMC4461930.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4461930.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Related to prognosis of Alzheimer's Disease""}]",410
3711,Verbal Fluency,"[{'article': 'PMC5147824.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5147824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",101
3712,Verbal Fluency (VF) tests,"[{'article': 'PMC5147824.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",101
3713,Verbal Fluency (animal names),"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection of amnestic mild cognitive impairment'}]",101
3714,Verbal Fluency test,"[{'article': 'PMC7662628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive impairment and dementia conversion'}]",101
3715,Verbal Fluency—Animals,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",101
3716,Verbal Intrusions,"[{'article': 'PMC5359367.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",174
3717,Verbal Performance (number of animals recited),"[{'article': 'PMC7084863.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",101
3718,Verbal expression and learning scores,"[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]",133
3719,Verbal fluency,"[{'article': 'PMC4406069.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Executive function in Alzheimer's Disease""}]",101
3720,Verbal fluency difficulties,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",101
3721,Verbal fluency test,"[{'article': 'PMC3681660.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Guide subjects with memory impairment to full memory consultations at hospitals'}, {'article': 'PMC3681660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",101
3722,Verbal memory,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease and Related Dementia (ADRD)""}]",463
3723,Verbal memory function,"[{'article': 'PMC4804486.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",463
3724,Verrucomicrobia,"[{'article': 'PMC5297247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",126
3725,Verubecestat (MK-8931),"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Stopped in Phase III clinical trials due to lack of efficacy'}]",450
3726,Vessel Density (VD),"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",65
3727,Vessel Length Density (VLD),"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",65
3728,Vessel density (VD),"[{'article': 'PMC6445433.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early Alzheimer's Disease""}]",65
3729,Vestibular loss,"[{'article': 'PMC9344717.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",50
3730,Visual Analog Scale (VAS),"[{'article': 'PMC4175156.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Sustained emotional states in Alzheimer's Disease patients""}]",49
3731,Visual network,"[{'article': 'PMC9309357.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitor: Acupuncture treatment response in Alzheimer's Disease""}]",437
3732,Visuoconstructional/Executive function,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Slower speech rate and shorter turns'}]",274
3733,Visuospatial,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",274
3734,Visuospatial Function,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]",274
3735,Visuospatial Processing,"[{'article': 'PMC4497726.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC4497726.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive performance'}]",274
3736,Visuospatial/Constructional score,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease""}]",274
3737,Visuospatial/constructional domain score,"[{'article': 'PMC7592675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Significant improvement in visuospatial/constructional functions in suspected mild cognitive impairment'}]",274
3738,Vitamin B-12,"[{'article': 'PMC7831739.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",231
3739,Vitamin B12,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Increased risk of Alzheimer's Disease""}, {'article': 'PMC4487699.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",231
3740,Vitamin C,"[{'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",400
3741,Vitamin D,"[{'article': 'PMC3212921.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3212921.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC3212921.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease Treatment""}, {'article': 'PMC3212921.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease and Related Dementia (ADRD)""}]",553
3742,Vitamin D (25OHD),"[{'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Better cognitive performance in Alzheimer's Disease patients""}, {'article': 'PMC3212921.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved gait and functional abilities in Alzheimer's Disease patients""}]",553
3743,Vitamin E (α-tocopherol),"[{'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Slowed progression of AD at doses of 2000 IU per day'}, {'article': 'PMC4202787.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased all-cause mortality at doses higher than 400 IU per day'}]",249
3744,"Vitamin E, selenium","[{'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Decreased levels in mild cognitive impairment and Alzheimer's Disease""}]",249
3745,Voice,"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",74
3746,Volumetric MRI,"[{'article': 'PMC4568340.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4568340.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitoring: Preclinical treatment of AD in adults with DS'}]",549
3747,Voxel-based specific regional analysis system for Alzheimer's disease (VSRAD) scores,"[{'article': 'PMC6353871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Dementia'}]",549
3748,WAIS-IV Coding,"[{'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment in Alzheimer's Disease""}]",428
3749,WAM,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",30
3750,WASO,"[{'article': 'PMC8127192.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",12
3751,WBC,"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",658
3752,WBC count,"[{'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Inflammatory response'}]",658
3753,WHO-UCLA AVLT,"[{'article': 'PMC5464918.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5464918.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive improvement in AD patients after rTMS treatment'}, {'article': 'PMC5464918.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to rTMS treatment in mild AD patients'}, {'article': 'PMC5464918.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",499
3754,WHOdas 2.0,"[{'article': 'PMC7674649.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Assess motivation in Alzheimer's Disease""}]",99
3755,WHO–UCLA AVLT score,"[{'article': 'PMC6074058.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive function in Alzheimer's Disease""}]",499
3756,WHO–UCLA AVLT scores,"[{'article': 'PMC6074058.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",499
3757,WLA,"[{'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",554
3758,WM,"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",30
3759,WM alterations,"[{'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",30
3760,WM degeneration,"[{'article': 'PMC8364310.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",30
3761,WM diffusion metrics,"[{'article': 'PMC8364310.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Monitor or predict tau propagation in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}]",228
3762,WM volume,"[{'article': 'PMC8351379.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",6
3763,WMH,"[{'article': 'PMC3863786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive impairment and dementia risk'}, {'article': 'PMC3863786.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Executive dysfunction and cognitive flexibility impairment'}, {'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cognitive decline in older adults'}, {'article': 'PMC8351379.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebrovascular disease'}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive Decline'}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Greater cognitive deficits in African Americans'}, {'article': 'PMC6353871.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral small vessel disease in Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Vascular cognitive impairment'}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Poor cognitive outcomes'}, {'article': 'PMC6521224.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Poor cognitive function'}, {'article': 'PMC6920432.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Aβ burden and neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7814451.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'AD-typical neurodegeneration'}]",30
3764,WMH (Fazekas score),"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Processing speed'}, {'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive ability'}]",1
3765,WMH accumulation,"[{'article': 'PMC6521224.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",30
3766,WMH burden,"[{'article': 'PMC7477392.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Development of AD'}, {'article': 'PMC7477392.txt', 'relationship': 'NEGATIVELY_CORRELATED_WITH', 'object': 'Regional glucose metabolism in frontal, temporal, and parietal cortices'}]",30
3767,WMH presence,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Decline in gait velocity over time in Alzheimer's Disease""}]",30
3768,WMH progression,"[{'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",30
3769,WMH volume,"[{'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Slow gait speed, large total WMH volume, and WMH volume in the frontal lobe'}]",6
3770,WMHV,"[{'article': 'PMC10233712.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive outcomes in Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Amyloid-beta (Aβ) burden'}, {'article': 'PMC10233712.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cortical tau load in AD'}, {'article': 'PMC10233712.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Intranasal insulin treatment'}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Worsened cognitive scores (ADAS-Cog, ADCS-ADL, CDR-SOB)'}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Decreased cerebral spinal fluid Aβ42 levels and Aβ42/Aβ40 ratio'}, {'article': 'PMC10233712.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Insulin treatment'}]",30
3771,WMHs,"[{'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'PREDICTS_INCIDENCE_OF', 'object': ""Alzheimer's Disease risk""}, {'article': 'PMC7477392.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Cerebral Aβ burden'}, {'article': 'PMC7477392.txt', 'relationship': 'NOT_ASSOCIATED_WITH', 'object': 'Increased p-tau burden'}, {'article': 'PMC7477392.txt', 'relationship': 'CONTRIBUTES_TO', 'object': 'Brain atrophy patterns in AD'}, {'article': 'PMC7477392.txt', 'relationship': 'CAUSE', 'object': 'Disruption of functional connectivity and lower glucose metabolism'}]",30
3772,WML,"[{'article': 'PMC4746584.txt', 'relationship': 'MEASURED USING', 'object': 'Automated segmentation using the LST toolbox implemented in SPM8'}]",590
3773,WML (White Matter Lesions),"[{'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Lower cerebral spinal fluid Aβ38 and Aβ40 levels in Alzheimer's Disease""}]",23
3774,WML load,"[{'article': 'PMC5576287.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",590
3775,WMS-III,"[{'article': 'PMC5067903.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",30
3776,WMS-VR,"[{'article': 'PMC10439779.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",30
3777,WST,"[{'article': 'PMC5016950.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline related to Alzheimer's Disease""}]",30
3778,Waist Circumference,"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",510
3779,Walking speed,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Higher number of total, periventricular and deep white matter hyperintensities'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Smaller hippocampal volume and presence of microbleeds and lacunar infarcts'}]",97
3780,Wechsler Adult Intelligence Scale (WAIS),"[{'article': 'PMC3394709.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",428
3781,Weight,"[{'article': 'PMC7413274.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",19
3782,Weight loss,"[{'article': 'PMC9011335.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Deep brain stimulation (DBS)'}]",19
3783,Whishaw index,"[{'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Learning and memory deficits in Alzheimer's Disease""}, {'article': 'PMC4675859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Swimming efficiency in cognitive assessments'}]",131
3784,White Blood Cell (WBC),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",658
3785,White Blood Cells (WBC),"[{'article': 'PMC4922661.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Inflammation in Alzheimer's Disease""}]",658
3786,White Matter Hyperintensities (WMH),"[{'article': 'PMC4706154.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebrovascular Disease'}, {'article': 'PMC5372150.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with small vessel disease and subclinical pathology'}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive Decline'}, {'article': 'PMC6521224.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cerebral Small Vessel Disease'}, {'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",89
3787,White Matter Hyperintensities (WMHs),"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",89
3788,White Matter Hyperintensity Volume (WMH Volume),"[{'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",89
3789,White Matter Hyperintensity Volume (WMHV),"[{'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral spinal fluid Aβ42 levels in Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral spinal fluid Aβ42/Aβ40 ratio in Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral spinal fluid Aβ42/T-tau ratio in Alzheimer's Disease""}]",89
3790,White blood cell count,"[{'article': 'PMC2871786.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}]",623
3791,White matter atrophy,"[{'article': 'PMC8570373.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Executive function deficits'}]",23
3792,White matter hyperintensities,"[{'article': 'PMC5372150.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5372150.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",89
3793,White matter hyperintensities (WMH),"[{'article': 'PMC4706154.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower general cognitive ability in older age'}, {'article': 'PMC5372150.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5546604.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease treatment response""}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Subclinical cerebrovascular disease'}, {'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid beta (Aβ) deposition'}]",89
3794,"White matter hyperintensities (WMH) in the posterior corpus callosum, parietal, occipital, and frontal areas","[{'article': 'PMC7814451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Lower temporo-parietal glucose metabolism'}, {'article': 'PMC7814451.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Lower medial-temporal gray matter volume (GMV)'}]",23
3795,White matter hyperintensities (WMH) in the splenium of the corpus callosum,"[{'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Greater Aβ deposition'}]",23
3796,White matter hyperintensities (WMHs),"[{'article': 'PMC5546604.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Patients with AD with minimal WMHs had better responses to rivastigmine patch compared to those with moderate WMHs'}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",89
3797,White matter hyperintensity (WMH) volume,"[{'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Slower progression of white matter hyperintensity in response to aerobic exercise'}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Cerebrovascular disease'}]",89
3798,White matter hyperintensity lesions,"[{'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor gait performance'}]",23
3799,White matter hyperintensity volume (WMHV),"[{'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease progression""}]",89
3800,White matter hyperintensity volumetry,"[{'article': 'PMC5576287.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",89
3801,White matter imaging markers,"[{'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Gait velocity decline'}]",23
3802,White matter integrity,"[{'article': 'PMC3460756.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3460756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",23
3803,White matter lesion volume,"[{'article': 'PMC5576287.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",89
3804,"White matter microstructure metrics (FA, MD, Da, Dr, ICVF, OD)","[{'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",23
3805,White matter volume,"[{'article': 'PMC6565843.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Related to prognosis of Alzheimer's Disease""}]",89
3806,Whole brain (% TIV),"[{'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",236
3807,Whole brain volume,"[{'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",160
3808,Whole brain volume on volumetric MRI (vMRI),"[{'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",549
3809,Wisconsin Card Sorting Test,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",77
3810,Within-domain IIV,"[{'article': 'PMC4406069.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Early Alzheimer's Disease""}, {'article': 'PMC4406069.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of: Cognitive decline in Alzheimer's Disease""}]",445
3811,Wnt signaling,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Modulation in Alzheimer's Disease""}]",30
3812,Wnt3,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",30
3813,Word Frequency,"[{'article': 'PMC5147824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",417
3814,Word Typicality,"[{'article': 'PMC5147824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",17
3815,Word count in conversations,"[{'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]",417
3816,Word-finding difficulties,"[{'article': 'PMC4611852.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Mild Cognitive Impairment and Alzheimer's Disease""}]",17
3817,Words per clause,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",17
3818,Working Memory/Attention,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Shorter turns and shorter interpausal units'}]",659
3819,Working Memory/Attention/Executive Control,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}]",659
3820,Working Memory/Attention/Executive Control (ExecCon),"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",659
3821,Working memory,"[{'article': 'PMC9373273.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}]",659
3822,Working memory deficits,"[{'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",516
3823,Xenon washout parameter,"[{'article': 'PMC6023430.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",461
3824,Y maze,"[{'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",412
3825,YKL-40,"[{'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decrease in YKL-40 levels in cerebral spinal fluid'}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neuroinflammation'}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Varoglutamstat'}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Microglial activation in Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC5067556.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""inflammation in Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Neuroinflammation or astrogliosis in AD'}, {'article': 'PMC6966425.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Patient selection and prognosis'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's disease-related neuropathological features""}]",459
3826,YKL40,"[{'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Neurodegeneration'}, {'article': 'PMC10287562.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Preclinical Alzheimer's Disease""}]",459
3827,YKL‐40,"[{'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Worsening of cognitive function as measured by letter fluency'}]",459
3828,Yokukansan,"[{'article': 'PMC3097009.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3097009.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}]",15
3829,ZBI,"[{'article': 'PMC9513684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",576
3830,ZCWPW1,"[{'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Associated with LOAD'}, {'article': 'PMC4876682.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}]",576
3831,ZDHHC21,"[{'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Familial Alzheimer’s Disease'}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Cognitive Impairment and Synaptic Dysfunction'}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease Progression""}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Therapeutic target for Alzheimer's Disease""}]",230
3832,ZDHHC21 p.T209S mutation,"[{'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline and AD-related pathological changes'}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased Aβ levels'}]",230
3833,ZO-1,"[{'article': 'PMC8581408.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Tight junctions'}]",576
3834,Zarit Burden Interview,"[{'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Change in caregiver burden in participants with mild to moderate Alzheimer's disease""}, {'article': 'PMC9340683.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",141
3835,[11C]-Pittsburgh Compound B PET (PiB-PET),"[{'article': 'PMC4918115.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",683
3836,[11C]-l-deprenyl-D2,"[{'article': 'PMC5478550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5478550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",369
3837,[11C]Ascorbic,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",369
3838,[11C]PBR28,"[{'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Microglial activation and Aβ deposition in patients with AD'}, {'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Microglial activation and tau deposition in patients with AD'}]",369
3839,[11C]PIB,"[{'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose Alzheimer's Disease by measuring Aβ load""}, {'article': 'PMC4877513.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Aβ deposition in Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid load in Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Liraglutide treatment in Alzheimer's Disease patients""}, {'article': 'PMC4877513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-beta'}, {'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",5
3840,[11C]PK-11195,"[{'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ accumulation in patients with mild cognitive impairment and AD'}]",369
3841,[11C]PiB PET,"[{'article': 'PMC2764863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid deposition in AD'}]",5
3842,[11C]acetate,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",369
3843,[11C]dehydroascorbic acid,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",369
3844,[124I]-PU-HZ151,"[{'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",635
3845,[18F] florbetapir,"[{'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",689
3846,[18F]-FDG,"[{'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",180
3847,[18F]-fluoro-deoxyglucose PET (FDG-PET),"[{'article': 'PMC6130053.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6130053.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Disease progression in Alzheimer's Disease""}]",43
3848,[18F]-flutemetamol,"[{'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaques'}]",393
3849,[18F]2B-SRF101,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",180
3850,[18F]AZD4694,"[{'article': 'PMC8043944.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Amyloid-beta burden assessment'}]",180
3851,[18F]BR-351,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",180
3852,[18F]BR-420,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",180
3853,[18F]FBAT,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",180
3854,[18F]FDG,"[{'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Glucose metabolic rate in Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral glucose consumption in Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Liraglutide treatment in Alzheimer's Disease patients""}, {'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",180
3855,[18F]Flutemetamol,"[{'article': 'PMC5352784.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'β-amyloid neuritic plaques'}]",393
3856,[18F]GSK2647544,"[{'article': 'PMC5209404.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",180
3857,[18F]GTP1,"[{'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Identifying individuals at risk for rapid clinical progression in Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostication""}]",180
3858,[18F]GTP1 SUVR,"[{'article': 'PMC8638526.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8638526.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease severity""}, {'article': 'PMC8638526.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Clinical decline in cognitive assessments'}, {'article': 'PMC8638526.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8638526.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in prodromal, mild, or moderate AD'}]",180
3859,[18F]GTP1 tau PET,"[{'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]",180
3860,[18F]MK-6240,"[{'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in Alzheimer's Disease""}, {'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostication""}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Assessment of therapeutic interventions'}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease pathophysiology""}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring: Disease progression in Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring during Alzheimer's Disease treatment""}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC6069775.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",180
3861,[18F]RO948,"[{'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostication""}]",180
3862,[18F]ROStrace,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",180
3863,[18F]THK-5351,"[{'article': 'PMC6910674.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",180
3864,[18F]dihydromethidine,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",309
3865,[18F]florbetaben,"[{'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",689
3866,[18F]florbetapir,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",689
3867,[18F]florbetapir SUVR,"[{'article': 'PMC8638526.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",689
3868,[18F]flortaucipir,"[{'article': 'PMC8481830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Tau accumulation in patients with mild cognitive impairment and AD'}, {'article': 'PMC8638526.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostication""}]",689
3869,[18F]flutemetamol,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Fibrillar Aβ'}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Fibrillar Aβ burden in the brain'}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4526582.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4526582.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4526582.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of amyloid-beta plaques in Alzheimer's Disease""}, {'article': 'PMC4886210.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Amyloid deposition in Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",393
3870,[18F]flutemetamol PET,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",393
3871,[18F]ox-ROStrace,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",180
3872,[62Cu]ATSM,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",99
3873,[C11]PiB PET,"[{'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",5
3874,[¹⁸F]FEBU,"[{'article': 'PMC8481830.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",99
3875,aMT,"[{'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Severity of cognitive dysfunction in Alzheimer's Disease""}]",138
3876,abnormal protein deposition,"[{'article': 'PMC3389343.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",147
3877,acetylcholinesterase,"[{'article': 'PMC5372260.txt', 'relationship': 'INHIBITS', 'object': 'acetylcholinesterase'}]",253
3878,acquisition z-scores,"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",157
3879,activation of mitochondrial apoptosis,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Central Nervous System Dysfunction'}]",209
3880,active minutes,"[{'article': 'PMC4849800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",168
3881,activity count,"[{'article': 'PMC4849800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",130
3882,acyl carnitines,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4694064.txt', 'relationship': 'RESPONDED_TO', 'object': 'J147 treatment'}]",484
3883,aducanumab,"[{'article': 'PMC6916654.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Monoclonal antibody targeting Aβ'}, {'article': 'PMC9755275.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early stages of Alzheimer's Disease""}]",146
3884,advanced glycation end products,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",165
3885,agitation,"[{'article': 'PMC4431827.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction in agitation levels after exercise intervention'}]",282
3886,albumin + IVIG,"[{'article': 'PMC9606044.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'better treatment response in AD patients'}]",363
3887,aminotransferase elevations,"[{'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Liver toxicity'}]",85
3888,amygdala,"[{'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}]",182
3889,amygdalar volume,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",182
3890,amyloid,"[{'article': 'PMC4027995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4150993.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8502814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6152871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic exercise intervention'}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cerebral amyloid levels in Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",8
3891,amyloid PET,"[{'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection for Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment planning for Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}]",8
3892,amyloid PET SUVr,"[{'article': 'PMC9768996.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Slowing of clinical decline in Alzheimer's Disease""}]",637
3893,amyloid PET imaging,"[{'article': 'PMC10013957.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection: Clinical decision-making in Alzheimer's Disease""}]",8
3894,amyloid Positron Emission Tomography,"[{'article': 'PMC10167601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
3895,amyloid accumulation,"[{'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",8
3896,amyloid beta peptides,"[{'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7662091.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'preservation of neuroplasticity'}]",8
3897,amyloid beta peptides accumulation,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
3898,amyloid beta peptides burden,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Slower gait speed, increased stance time variability, less cadence, and increased double support time'}]",8
3899,amyloid deposition,"[{'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
3900,amyloid pathology,"[{'article': 'PMC6152871.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}]",8
3901,amyloid peptides,"[{'article': 'PMC10917684.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",8
3902,amyloid plaque deposition,"[{'article': 'PMC4202787.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",8
3903,amyloid plaques,"[{'article': 'PMC4052448.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Target of Treatment: Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Structural changes in the brain, including hippocampal volume loss and decreased glucose metabolism'}]",8
3904,amyloid precursor protein,"[{'article': 'PMC9389745.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
3905,amyloid β,"[{'article': 'PMC4493418.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
3906,amyloid-beta,"[{'article': 'PMC10787596.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC10787596.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment with Lecanemab in Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4095696.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7662091.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Amyloid-beta positive subjects with mild cognitive impairment due to AD or mild AD dementia'}, {'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]",8
3907,amyloid-beta deposits,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
3908,amyloid-β,"[{'article': 'PMC2765081.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'interaction effects on tau-WM association patterns'}, {'article': 'PMC8581408.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4876902.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""preclinical Alzheimer's Disease""}, {'article': 'PMC5342482.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'tau accumulation'}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'spread of tau from hippocampus to cortex'}, {'article': 'PMC6201586.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",8
3909,amyloid-β (Aβ),"[{'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid accumulation'}]",8
3910,amyloid-β 42/40 ratio,"[{'article': 'PMC8453354.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
3911,amyloid-β levels,"[{'article': 'PMC6909550.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to gantenerumab treatment'}]",8
3912,amyloid-β plaques,"[{'article': 'PMC6909550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6909550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
3913,amyloid-β1–42,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",8
3914,animals/10 s,"[{'article': 'PMC7662628.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Dementia incidence'}, {'article': 'PMC7662628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dementia conversion'}]",433
3915,animals/10s,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",433
3916,animals/10 s,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early-stage dementia'}, {'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}]",433
3917,anterior cingulate cortex,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease""}]",448
3918,anterior lobe structures,"[{'article': 'PMC5619554.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",409
3919,anterior temporal lobe atrophy,"[{'article': 'PMC6110931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Semantic variant of primary progressive aphasia (svPPA)'}]",444
3920,anti-Aβ antibodies,"[{'article': 'PMC2868024.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
3921,anti-tau antibodies,"[{'article': 'PMC8088704.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Therapeutic development for Alzheimer's Disease""}]",40
3922,anticholinergic burden,"[{'article': 'PMC5442667.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",191
3923,apathy,"[{'article': 'PMC4431827.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced apathy in nursing home residents with dementia'}, {'article': 'PMC4431827.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Apathy in nursing home residents with dementia'}, {'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}]",663
3924,apo B,"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebrovascular inflammation in Alzheimer's Disease""}, {'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cerebral microvascular leakage in Alzheimer's Disease""}]",527
3925,apo B lipoproteins,"[{'article': 'PMC3216294.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",189
3926,apoE genotype,"[{'article': 'PMC3534053.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}]",403
3927,apoE3-R136S,"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",78
3928,apoE3-V236E,"[{'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",78
3929,apoE4,"[{'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of tau phosphorylation'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduced cognitive function and faster disease progression'}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced Aβ deposition and improved cognitive function'}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Therapeutic strategies to modulate apoE levels'}, {'article': 'PMC9644639.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Amyloid-beta plaques and cerebral amyloid angiopathy'}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: HAE-4 antibody injection'}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: AAV-mediated expression of APOE2'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased Aβ and tau aggregation, inflammation, and lipid dysregulation'}, {'article': 'PMC9644639.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Cognitive decline and AD progression'}, {'article': 'PMC9644639.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive function and synaptic loss'}, {'article': 'PMC9644639.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Plasma replacement therapy and albumin replacement'}, {'article': 'PMC9644639.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Isoform-specific therapeutic interventions'}, {'article': 'PMC9644639.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Peripheral apoE modulation'}]",142
3930,apoe4,"[{'article': 'PMC4731943.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased amyloid burden and aggregation'}, {'article': 'PMC4731943.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Response to bexarotene treatment'}, {'article': 'PMC4772335.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'ALZ-801 treatment'}, {'article': 'PMC7822120.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Late-Onset Alzheimer's Disease""}, {'article': 'PMC7822120.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Late-Onset Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9389745.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk for CVD and T2DM'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased prevalence and hazard for metabolic syndrome'}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Disrupted pathways related to synaptic formation and increased synaptic transmission'}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Altered cholesterol metabolism and impaired Aβ uptake'}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Less efficient Aβ clearance and activation of inflammatory genes in microglia'}, {'article': 'PMC9644639.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Vulnerability to bioenergetic deficits'}, {'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced synaptic and mitochondrial function and increased neuroimmune signaling'}]",142
3931,apoe4 carrier status,"[{'article': 'PMC9768996.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Evaluated as a covariate in efficacy endpoints and disease progression models'}]",78
3932,apoe4 genotype,"[{'article': 'PMC8211849.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s Disease'}]",403
3933,apolipoprotein B (apo B),"[{'article': 'PMC3216294.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid beta peptides (Aβ) in brain parenchyma'}]",189
3934,apolipoprotein E (ApoE) genotype,"[{'article': 'PMC8733254.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'dementia'}]",189
3935,apolipoprotein E epsilon 4 allele,"[{'article': 'PMC5389824.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",189
3936,arterial stiffness,"[{'article': 'PMC7934383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitored during treatment'}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced arterial stiffness is associated with improved brain health and cognitive function in older adults with Alzheimer's Disease.""}]",252
3937,asiatic acid,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of asiaticoside'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment with CAW'}]",389
3938,astrocytes,"[{'article': 'PMC6130053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Astrocytes respond to NBM stimulation and play a role in synaptic plasticity, which may be associated with better outcomes.'}]",339
3939,atrophy rate measured from structural MRI,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",651
3940,bFGF,"[{'article': 'PMC8789895.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",192
3941,balance,"[{'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",91
3942,balance function,"[{'article': 'PMC9344717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Motoric impairments in Alzheimer's Disease""}, {'article': 'PMC9344717.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}]",91
3943,bapineuzumab,"[{'article': 'PMC6916654.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Passive immunotherapy targeting Aβ'}]",268
3944,basal forebrain,"[{'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",360
3945,basal forebrain atrophy,"[{'article': 'PMC7203806.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'hippocampal atrophy in typical AD'}]",360
3946,basal forebrain volume,"[{'article': 'PMC7203806.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Longitudinal atrophy rates'}]",360
3947,basal nucleus of Meynert,"[{'article': 'PMC9213384.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Clinical features of Alzheimer's Disease""}]",280
3948,bche gene,"[{'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's disease-related neuropathological features""}]",638
3949,be quiet,"[{'article': 'PMC5237556.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts: Probable Alzheimer's Disease""}]",621
3950,behavioural markers of apathy,"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Apathy in Alzheimer's Disease""}]",663
3951,beta amyloid,"[{'article': 'PMC8351379.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4069047.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease progression""}]",8
3952,beta secretase 1 protein (BACE-1),"[{'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",617
3953,beta secretase I,"[{'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",617
3954,beta-amyloid,"[{'article': 'PMC4615808.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4810525.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""reduced formation in Alzheimer's Disease treatment""}]",8
3955,beta-amyloid levels,"[{'article': 'PMC9635167.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Treatment efficacy in Alzheimer's Disease""}]",8
3956,beta-amyloid1–42 peptide,"[{'article': 'PMC4659639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
3957,beta1 rhythm,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",164
3958,blood biomarkers,"[{'article': 'PMC6052695.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differential diagnosis of Alzheimer’s disease vs frontotemporal dementia'}]",257
3959,blood glucose,"[{'article': 'PMC8857690.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC7407252.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Adherence to dietary intake reporting protocols'}]",586
3960,blood-based biomarkers,"[{'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8549374.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC8549374.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-stage Alzheimer's Disease""}]",257
3961,bone health,"[{'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",51
3962,brain MRI,"[{'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",10
3963,brain amyloid plaque,"[{'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
3964,brain atrophy,"[{'article': 'PMC4936020.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",184
3965,brain atrophy profiles,"[{'article': 'PMC3389343.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",184
3966,brain atrophy rate,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",184
3967,brain derived neurotrophic factor (BDNF),"[{'article': 'PMC3110111.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",234
3968,brain glucose metabolism,"[{'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved synaptic function'}]",539
3969,brain morphology,"[{'article': 'PMC3110111.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",82
3970,brain network characteristics,"[{'article': 'PMC8795741.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",82
3971,brain volume,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Progression""}, {'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognitive function in older adults with mild cognitive impairment'}, {'article': 'PMC5302785.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'slower dementia progression and reduced risk of dementia'}, {'article': 'PMC7808620.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic exercise intervention'}, {'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Structural changes in Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Age-related improvements or attenuated decline in cognition'}]",160
3972,brain-derived neurotrophic factor,"[{'article': 'PMC8857690.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Neuroprotection in Alzheimer's Disease""}]",234
3973,brain-derived neurotrophic factor (BDNF),"[{'article': 'PMC8795741.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive Decline in Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",234
3974,brevican,"[{'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",151
3975,bumetanide,"[{'article': 'PMC10002844.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduced risk of Alzheimer’s Disease'}]",151
3976,c-Fos-stained neurons,"[{'article': 'PMC4981900.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",280
3977,c-fos,"[{'article': 'PMC5520675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neural activation in the hippocampus'}, {'article': 'PMC5520675.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal activation in the dentate gyrus after hippocampus stimulation'}]",343
3978,c-kit-positive cells,"[{'article': 'PMC4707222.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Neuroprotection and repair mechanisms in Alzheimer's Disease""}]",72
3979,cAMP,"[{'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Impaired cognition and neurodegeneration in Alzheimer's Disease""}]",114
3980,cVEMP,"[{'article': 'PMC9344717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",49
3981,cadence,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'microbleed presence'}]",110
3982,cardiorespiratory fitness,"[{'article': 'PMC5302785.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'improved memory performance and reduced hippocampal atrophy'}]",69
3983,cardiovascular biomarkers,"[{'article': 'PMC7934383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitored during treatment'}]",257
3984,caspase pathways,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Apoptosis'}]",86
3985,catalase,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",14
3986,cathepsin B,"[{'article': 'PMC5445077.txt', 'relationship': 'ASSOCIATED_WITH_AMYLOID_PLAQUES_IN', 'object': 'AD brains'}]",14
3987,cathepsin L,"[{'article': 'PMC5445077.txt', 'relationship': 'INCREASES_α-SECRETASE-MEDIATED_NON-AMYLOIDOGENIC_PATHWAY', 'object': 'In AD development'}]",14
3988,ccl2,"[{'article': 'PMC11274940.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",465
3989,cellular oxygen consumption rate (OCR),"[{'article': 'PMC3467226.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",232
3990,cerebellum,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",93
3991,cerebral amyloid,"[{'article': 'PMC7808620.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",8
3992,cerebral blood flow (CBF),"[{'article': 'PMC3467226.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""tACS treatment in Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'tACS treatment effects'}, {'article': 'PMC8690894.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'treatment effects'}]",511
3993,cerebral glucose hypometabolism,"[{'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",539
3994,cerebral glucose metabolic rate,"[{'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}, {'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease progression""}]",539
3995,cerebral glucose metabolism,"[{'article': 'PMC7489025.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",539
3996,cerebral metabolic rate of oxygen (CMRO2),"[{'article': 'PMC3467226.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better outcome in Alzheimer's Disease""}]",539
3997,cerebral perfusion,"[{'article': 'PMC6023430.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",311
3998,cerebral small vessel disease (CSVD),"[{'article': 'PMC8733254.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'cognitive impairment'}]",107
3999,cerebral spinal fluid (CSF) cholinergic markers,"[{'article': 'PMC4936020.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'NGF-ECB treatment'}]",155
4000,cerebral spinal fluid (CSF) clearance,"[{'article': 'PMC4493418.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",155
4001,cerebral spinal fluid AD biomarkers,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease severity in Alzheimer's Disease patients""}]",155
4002,cerebral spinal fluid Aβ,"[{'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",140
4003,cerebral spinal fluid Aβ1–40,"[{'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Reduction in levels consistent with atabecestat's inhibitory effect""}]",140
4004,cerebral spinal fluid Aβ1–42,"[{'article': 'PMC6945608.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6945608.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Amyloid positivity in Alzheimer's Disease""}]",140
4005,cerebral spinal fluid Aβ42,"[{'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC3695013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Clinical diagnosis of AD'}, {'article': 'PMC4746584.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid pathology'}]",140
4006,cerebral spinal fluid Aβ42 levels,"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'β-amyloidopathy in cognitively impaired subjects'}]",140
4007,cerebral spinal fluid Aβ42/40,"[{'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in Alzheimer's Disease""}]",140
4008,cerebral spinal fluid Aβ42/Aβ40,"[{'article': 'PMC10075195.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",140
4009,cerebral spinal fluid Aβ42/p-tau,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment due to Alzheimer's Disease""}]",140
4010,cerebral spinal fluid Aβ42/t-tau,"[{'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild cognitive impairment due to Alzheimer's Disease""}]",140
4011,cerebral spinal fluid BACE,"[{'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No relevant changes in levels'}]",155
4012,cerebral spinal fluid DJ-1,"[{'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Oxidative stress response'}]",155
4013,cerebral spinal fluid F2-isoprostane levels,"[{'article': 'PMC4202787.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to E/C/ALA treatment'}]",155
4014,cerebral spinal fluid Mid‐p‐tau231,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Preclinical Alzheimer's Disease""}]",98
4015,cerebral spinal fluid NPY,"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Diabetes and low plasma cholesterol levels'}]",155
4016,cerebral spinal fluid NSE,"[{'article': 'PMC5008228.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cell death after brain trauma'}]",155
4017,cerebral spinal fluid NfL levels,"[{'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower levels in African Americans without cognitive impairment'}]",155
4018,cerebral spinal fluid N‐p‐tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",98
4019,cerebral spinal fluid P-tau,"[{'article': 'PMC5089525.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'High diagnostic accuracy for AD'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No relevant changes in levels'}, {'article': 'PMC6945608.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}]",98
4020,cerebral spinal fluid P-tau217,"[{'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Higher levels associated with worse prognosis in Alzheimer's Disease""}]",98
4021,cerebral spinal fluid S100B,"[{'article': 'PMC5008228.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Glial death in the brain'}]",155
4022,cerebral spinal fluid SOM,"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ1–42 concentrations and blood total cholesterol levels'}]",155
4023,cerebral spinal fluid T-tau,"[{'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'High diagnostic accuracy for AD'}, {'article': 'PMC6945608.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease prognosis""}]",98
4024,cerebral spinal fluid amyloid (Aβ42),"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",140
4025,cerebral spinal fluid amyloid-β1–42,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",140
4026,cerebral spinal fluid biomarker,"[{'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Pharmacological activity of neflamapimod in Alzheimer's Disease""}]",155
4027,cerebral spinal fluid biomarkers,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Determine preclinical AD pathology in APOEε4 carriers'}, {'article': 'PMC7648990.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",155
4028,cerebral spinal fluid homovanillic acid (HVA),"[{'article': 'PMC5008228.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Nilotinib treatment'}]",155
4029,cerebral spinal fluid p-tau,"[{'article': 'PMC4866415.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Progression""}, {'article': 'PMC4866415.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4866415.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Treatment'}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'PD and DLB progression'}]",98
4030,cerebral spinal fluid p-tau181,"[{'article': 'PMC8157623.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Decreased levels indicate better prognosis in Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""synaptic dysfunction in Alzheimer's Disease""}]",98
4031,cerebral spinal fluid p-tau181 levels,"[{'article': 'PMC5668981.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Lower levels in African Americans may indicate less neurodegeneration'}]",98
4032,cerebral spinal fluid phospho-Tau,"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuronal damage early in Alzheimer's Disease""}]",98
4033,cerebral spinal fluid phosphorylated tau,"[{'article': 'PMC4132648.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts presence of: Alzheimer's Disease""}]",98
4034,cerebral spinal fluid phosphorylated tau (P-tau),"[{'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",98
4035,cerebral spinal fluid phosphorylated tau (p-tau),"[{'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decrease in cerebral spinal fluid phosphorylated tau (p-tau) in response to semagacestat treatment'}]",98
4036,cerebral spinal fluid protein markers,"[{'article': 'PMC8157623.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment: Decrease in synaptic dysfunction markers'}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}]",155
4037,cerebral spinal fluid p‐tau,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Progression from cognitively unimpaired to mild cognitive impairment and eventually to AD dementia'}, {'article': 'PMC7721364.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Cognitive impairment'}, {'article': 'PMC7721364.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease progression""}]",98
4038,cerebral spinal fluid p‐tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ pathology'}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",98
4039,cerebral spinal fluid p‐tau217,"[{'article': 'PMC7721364.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Aβ pathology'}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early stages of autosomal‐dominant AD'}]",98
4040,cerebral spinal fluid p‐tau231,"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early changes in tau metabolism in preclinical Alzheimer's""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Preclinical Alzheimer's Disease""}]",98
4041,cerebral spinal fluid sAPPα,"[{'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Dose-related increase in levels'}]",155
4042,cerebral spinal fluid sAPPβ,"[{'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decrease in levels consistent with β-secretase inhibition'}]",155
4043,cerebral spinal fluid sVCAM-1 levels,"[{'article': 'PMC5668981.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Correlated with vascular risk factors and white matter hyperintensity (WMH) volume in Caucasians'}]",155
4044,cerebral spinal fluid t-Tau/Aβ42 ratio,"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",140
4045,cerebral spinal fluid t-tau,"[{'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to MAPTRx treatment'}]",98
4046,cerebral spinal fluid t-tau/Aβ42 ratio,"[{'article': 'PMC5668981.txt', 'relationship': 'DIAGNOSITC_OF', 'object': 'Cognitive impairment in African Americans and Caucasians'}]",140
4047,cerebral spinal fluid tau,"[{'article': 'PMC3695013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal injury and neurodegeneration'}, {'article': 'PMC3695013.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Severity of cognitive impairment'}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",98
4048,cerebral spinal fluid tau/Aβ42 ratio,"[{'article': 'PMC3523068.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early AD marker'}]",140
4049,cerebral spinal fluid total sAPP,"[{'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Dose-dependent decrease in levels'}]",155
4050,cerebral spinal fluid total tau,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts presence of: Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Decreased levels indicate better prognosis in Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'PD and DLB progression'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No relevant changes in levels'}]",98
4051,cerebral spinal fluid total tau (T-tau),"[{'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",98
4052,cerebral spinal fluid total-Tau,"[{'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neuronal damage early in Alzheimer's Disease""}]",98
4053,cerebral spinal fluid tracer (FITC-Dextran-3kD),"[{'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cerebral spinal fluid dynamics in Alzheimer's Disease""}]",155
4054,cerebral spinal fluid α-synuclein,"[{'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Stabilization of α-synuclein levels in PD'}]",395
4055,cerebrospinal fluid (CSF) GFAP levels,"[{'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""presence of Alzheimer's Disease through association with p-tau181 levels""}]",13
4056,cholesterol,"[{'article': 'PMC8857690.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",413
4057,choline,"[{'article': 'PMC4862247.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",529
4058,cholinergic pathways,"[{'article': 'PMC5326769.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognostic evaluation""}]",191
4059,cholinesterase inhibitors,"[{'article': 'PMC3481364.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Symptom relief in AD'}]",191
4060,chronic inflammatory mechanisms,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",289
4061,circRNAs,"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aging and Alzheimer's Disease""}]",161
4062,circadian rhythms,"[{'article': 'PMC8317398.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Bright Light Therapy (BLT)'}]",164
4063,circuitousness,"[{'article': 'PMC4465490.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",70
4064,classical monocytes,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'age-related immune changes'}]",385
4065,cleaved caspase-3,"[{'article': 'PMC5520675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lack of apoptotic cells after TI stimulation'}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",86
4066,cleaved-caspase 3,"[{'article': 'PMC3520904.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",86
4067,cognitive assessments,"[{'article': 'PMC7808620.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive decline in Alzheimer's Disease""}]",41
4068,cognitive deficits,"[{'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",516
4069,cognitive function,"[{'article': 'PMC3110111.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4981900.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Reduced risk of hospitalization due to Alzheimer's Disease and vascular dementia""}, {'article': 'PMC4981900.txt', 'relationship': 'RESPONDED_TO', 'object': 'EMF treatment in AD patients resulted in significant improvement in cognitive measures'}]",104
4070,cognitive impairment,"[{'article': 'PMC3978714.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",516
4071,cognitive measures,"[{'article': 'PMC4876902.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",41
4072,cognitive performance,"[{'article': 'PMC4876902.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",41
4073,completion time,"[{'article': 'PMC4465490.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",168
4074,composite-cerebellum SUVR,"[{'article': 'PMC4003513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",93
4075,content density,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",47
4076,cortical and limbic atrophy,"[{'article': 'PMC9213384.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",184
4077,cortical tau,"[{'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive impairment in Alzheimer's Disease""}]",44
4078,cortical thickness,"[{'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",197
4079,cortical thickness in medial temporal lobe (MTL),"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",197
4080,cortical thickness in parietal lobe,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",197
4081,cortical thickness in temporal lobe,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",197
4082,cortical thickness of the entorhinal cortex,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",36
4083,cortisol,"[{'article': 'PMC3110111.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3110199.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'oxidative DNA and RNA damage'}, {'article': 'PMC3652205.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Stress'}, {'article': 'PMC3652205.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to yoga and compassion meditation program'}, {'article': 'PMC3652205.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Risk of Alzheimer's Disease""}, {'article': 'PMC6162846.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognition'}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",132
4084,curcumin,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Neuroprotection in AD'}]",344
4085,cyclin D1,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",241
4086,cytokine levels,"[{'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduced cytokine levels in Alzheimer's Disease mice treated with GV-971""}, {'article': 'PMC9108275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9108275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",666
4087,cytokines,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""neuroinflammation in Alzheimer's Disease""}]",666
4088,cytoplasmic DNA,"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aseptic inflammation and immune senescence'}]",472
4089,daytime activity,"[{'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}]",130
4090,daytime activity level,"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}]",130
4091,delta band functional connectivity,"[{'article': 'PMC6370863.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease therapy with Souvenaid""}]",58
4092,dendritic cells,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'age-related immune changes'}]",72
4093,dietary changes,"[{'article': 'PMC9755275.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'cognition'}]",145
4094,digital biomarkers,"[{'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early-onset Alzheimer's Disease""}, {'article': 'PMC9203627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease stages including mild cognitive impairment and dementia""}, {'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease in different clinical stages""}]",257
4095,dipeptides,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4694064.txt', 'relationship': 'RESPONDED_TO', 'object': 'J147 treatment'}]",105
4096,donepezil,"[{'article': 'PMC3481364.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",272
4097,dopamine receptors,"[{'article': 'PMC4150993.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",491
4098,double support percentage,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'increased number of microbleeds'}]",7
4099,double support time,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'silent infarcts and microbleeds'}]",7
4100,dual-task gait cost,"[{'article': 'PMC4197903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""aMCI (a subtype of Alzheimer's Disease)""}]",446
4101,dura mater lymphatic vessels,"[{'article': 'PMC4493418.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Impaired macromolecule clearance from the brain'}, {'article': 'PMC4493418.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",154
4102,dwell time,"[{'article': 'PMC10916999.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",168
4103,eCarb,"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes in Alzheimer's Disease prevention""}, {'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""cognitive decline in Alzheimer's Disease""}]",48
4104,eCarb (digestible carbohydrates),"[{'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline in older adults at risk for dementia'}]",48
4105,eFat,"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes in Alzheimer's Disease prevention""}, {'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""slower cognitive processing speed in Alzheimer's Disease""}]",54
4106,eFat (total fat),"[{'article': 'PMC10236460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline in older adults at risk for dementia'}]",54
4107,eIF2α,"[{'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Protein homeostasis and Alzheimer's Disease""}]",88
4108,eNOS,"[{'article': 'PMC10917684.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",12
4109,eProt,"[{'article': 'PMC10236460.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better cognitive outcomes in Alzheimer's Disease prevention""}]",163
4110,eea1,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",63
4111,efficiency,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",565
4112,eicosapentaenoic acid (EPA),"[{'article': 'PMC7145106.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Non-elderly subarachnoid hemorrhage patients'}]",317
4113,emotional arousal,"[{'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}]",328
4114,endosome number,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",427
4115,endosome volume,"[{'article': 'PMC5068716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",427
4116,endostatin,"[{'article': 'PMC8645072.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Changes in MoCA scores over 2 weeks'}]",242
4117,energy expenditure,"[{'article': 'PMC4849800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",27
4118,enlarged endosomes,"[{'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5068716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",427
4119,entorhinal cortex,"[{'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}]",36
4120,entorhinal cortex thickness,"[{'article': 'PMC4846650.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Advanced clinical symptoms of Pre-AD'}]",36
4121,entorhinal volume,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",36
4122,eotaxin,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",48
4123,eotaxin-3,"[{'article': 'PMC8789895.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8789895.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'reduced loss of hippocampal gray matter volume'}]",48
4124,epichaperome probes,"[{'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",665
4125,errors in language production,"[{'article': 'PMC6261049.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",254
4126,estradiol to follicle-stimulating hormone ratio,"[{'article': 'PMC8060832.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""presence of improved cognitive function in women with Alzheimer's Disease""}]",299
4127,fALFF,"[{'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease-related neurodegeneration""}, {'article': 'PMC6306691.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Disease progression in Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6306691.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Dementia of Alzheimer’s disease'}, {'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Dementia of Alzheimer’s disease'}, {'article': 'PMC9309357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9309357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",95
4128,fMRI,"[{'article': 'PMC4846650.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC8760674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased activation and functional connectivity in brain regions specific for mnestic functions'}, {'article': 'PMC9246122.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Default mode network connectivity predictive of clinical progression to dementia'}]",329
4129,fNIRS,"[{'article': 'PMC8154928.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}, {'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}]",243
4130,fasting insulin,"[{'article': 'PMC6679855.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",200
4131,fasudil hydrochloride,"[{'article': 'PMC7145106.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Non-elderly subarachnoid hemorrhage patients'}]",95
4132,ferritin,"[{'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'AD biomarker'}]",366
4133,filled pauses,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",621
4134,flavonoids,"[{'article': 'PMC6616509.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved mood in participants, which may relate to Alzheimer's Disease outcomes""}]",249
4135,florbenazine,"[{'article': 'PMC4027995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function in Dementia with Lewy Bodies (DLB)'}]",4
4136,florbenazine SUVr,"[{'article': 'PMC4027995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",4
4137,florbetapir,"[{'article': 'PMC4027995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4027995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid deposition in Alzheimer's Disease""}, {'article': 'PMC4027995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive decline in Dementia with Lewy Bodies (DLB)'}, {'article': 'PMC4027995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4027995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4027995.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Treatment Eligibility: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Longitudinal cognitive deterioration'}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid-β (Aβ) pathology in Alzheimer's Disease""}, {'article': 'PMC6937673.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",362
4138,florbetapir F 18,"[{'article': 'PMC4027995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",689
4139,florbetapir PET,"[{'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Brain amyloid burden in Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Change in brain amyloid burden'}, {'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",362
4140,florbetapir SUVr,"[{'article': 'PMC4027995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",362
4141,flortaucipir,"[{'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Tau pathology beyond the mesial temporal lobe'}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Tau pathology in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Longitudinal cognitive deterioration'}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Age-related decrease in SUVr in Aβ+ subjects'}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive performance on MMSE and ADAS'}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease-related tau deposition""}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Monitoring effects of Alzheimer's Disease therapies""}, {'article': 'PMC7295920.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Ptau burden'}, {'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",4
4142,flortaucipir SUVr,"[{'article': 'PMC7295920.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",4
4143,flutemetamol,"[{'article': 'PMC4526582.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",393
4144,flutemetamol (18F),"[{'article': 'PMC4526582.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",393
4145,foetal tau,"[{'article': 'PMC4255368.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",213
4146,frontal cortical thickness,"[{'article': 'PMC6167961.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Change in SDMT and exercise load'}]",197
4147,frontal-posterior theta coherence,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Behavioral improvements after cognitive training'}]",210
4148,frontostriatal structural connectivity,"[{'article': 'PMC9972804.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Verbal episode memory improvements in APP mutation carriers'}]",172
4149,functional connectivity,"[{'article': 'PMC4846650.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Pre-AD'}, {'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved cognitive function in older adults with mild cognitive impairment'}]",175
4150,functional connectivity (FC),"[{'article': 'PMC5399035.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",175
4151,functional connectivity (FC) of the caudate-rMFG tract,"[{'article': 'PMC9972804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early identification of preclinical Alzheimer’s disease'}]",498
4152,functional independence,"[{'article': 'PMC3110111.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",681
4153,functional magnetic resonance imaging (fMRI),"[{'article': 'PMC8795741.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Changes in functional brain networks in people with mild cognitive impairment or early-stage dementia'}]",329
4154,functional skills,"[{'article': 'PMC4876902.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cognitive decline in Alzheimer's Disease""}]",104
4155,fusiform volume,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",6
4156,gait,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved balance and reduced fall risk in older adults'}, {'article': 'PMC7505369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9344717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Motoric impairments in Alzheimer's Disease""}]",159
4157,gait speed,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid beta peptides burden'}, {'article': 'PMC7106668.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline'}, {'article': 'PMC7106668.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased risk of falls'}, {'article': 'PMC7106668.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""cognitive decline and adverse outcomes such as falls in Alzheimer's Disease""}, {'article': 'PMC7106668.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression and outcomes""}, {'article': 'PMC7106668.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""increased risk of falls and cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7106668.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Increased risk of falls'}]",703
4158,gait variability,"[{'article': 'PMC3898226.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Alzheimer’s disease and related disorders (ADRD)'}]",159
4159,gait velocity,"[{'article': 'PMC4197903.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amnestic mild cognitive impairment'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'silent infarcts'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'reduced fractional anisotropy (FA) and increased mean diffusivity (MD)'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities (WMH) burden'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities (WMH) volume'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'White matter hyperintensities (WMH) severity'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'ventricular enlargement, WMH volume, and brain infarcts'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'corpus callosum volume at baseline'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'high total and periventricular white matter hyperintensities'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'amyloid beta peptides burden'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'large total WMH volume'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'total white matter volume and cerebral spinal fluid volume'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced grey matter volume in frontal cortex'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced grey matter volume in occipital cortex'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced hippocampal volume'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cerebellar atrophy'}]",703
4160,gamma activity,"[{'article': 'PMC8690894.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Transcranial alternating current stimulation (tACS)'}]",9
4161,gamma oscillations,"[{'article': 'PMC8690894.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'tACS treatment effects'}, {'article': 'PMC8690894.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'treatment effects'}]",9
4162,generalization,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",149
4163,genetic variations in drug metabolism enzymes,"[{'article': 'PMC3764973.txt', 'relationship': 'RELATED_TOLERABILITY_AND_RESPONSE', 'object': 'Inter-individual variability in efficacy and tolerability of Alzheimer’s drugs'}]",85
4164,genistein,"[{'article': 'PMC9635167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]",64
4165,ghrelin,"[{'article': 'PMC5445077.txt', 'relationship': 'COUNTERACTS_MEMORY_DEFICITS_AND_SYNAPTIC_DEGENERATION_IN', 'object': ""Alzheimer's Disease animal models""}]",68
4166,gingipains,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",587
4167,girl is,"[{'article': 'PMC5237556.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts: Probable Alzheimer's Disease""}]",57
4168,global cognitive status,"[{'article': 'PMC3110111.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",41
4169,global efficiency,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",565
4170,glucose metabolism,"[{'article': 'PMC7814451.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",586
4171,glucose uptake,"[{'article': 'PMC3467226.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'spatial memory deterioration'}]",586
4172,glutamate,"[{'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]",321
4173,glycated hemoglobin,"[{'article': 'PMC9755275.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'cognition'}]",124
4174,glycine recognition sites (GlyRS),"[{'article': 'PMC9213384.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""chronic anxiety in Alzheimer's Disease""}]",165
4175,glymphatic system,"[{'article': 'PMC4493418.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",165
4176,granulovacuolar degeneration (GVD),"[{'article': 'PMC6679484.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuronal loss and cognitive decline in Alzheimer's Disease""}]",125
4177,graphic markers,"[{'article': 'PMC9092839.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",181
4178,grey matter atrophy,"[{'article': 'PMC6615169.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",23
4179,gut microbiota,"[{'article': 'PMC8843023.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Therapeutic strategies for AD-related cognitive decline'}, {'article': 'PMC8873004.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6530014.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Alzheimer’s Disease treatment'}, {'article': 'PMC7592675.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': ""Alzheimer's Disease""}]",353
4180,hFABP,"[{'article': 'PMC6966425.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Progression from mild cognitive impairment to AD'}, {'article': 'PMC6966425.txt', 'relationship': 'CORRELATES_WITH', 'object': 'Brain atrophy among individuals with low cerebral spinal fluid Aβ42'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis in Alzheimer's Disease""}]",0
4181,hand movement analysis,"[{'article': 'PMC9289357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}]",435
4182,high-sensitivity C-reactive protein,"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}]",38
4183,higher strychnine-sensitive glycine receptor (GlyRS) functioning,"[{'article': 'PMC9213384.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",165
4184,higher t-tau and p-tau levels,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4185,hilar GABAergic interneurons,"[{'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Learning performance in female apoe4-KI mice'}]",673
4186,hippocampal atrophy,"[{'article': 'PMC6110931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Semantic memory deficits in svPPA'}]",391
4187,hippocampal atrophy rate,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",391
4188,hippocampal binding memory task,"[{'article': 'PMC8325256.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Evaluate the effect of levetiracetam on cognitive function in Alzheimer's Disease""}]",229
4189,hippocampal subfield morphometry and volumetry,"[{'article': 'PMC10710152.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",648
4190,hippocampal volume,"[{'article': 'PMC2764863.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3110111.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4150993.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8530186.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""cognitive decline in Alzheimer's Disease""}, {'article': 'PMC5302785.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'reduced atrophy and improved memory performance'}, {'article': 'PMC5399035.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No evidence of reverse relationship with exercise load'}, {'article': 'PMC6565843.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Shorter stride length and smaller hippocampal volume'}, {'article': 'PMC7808620.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to aerobic exercise intervention'}, {'article': 'PMC9972804.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",648
4191,hippocampal-sparing AD,"[{'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Better response to cholinergic treatment'}]",229
4192,hippocampal-sparing atrophy,"[{'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Better response to cholinergic treatment compared to AD patients'}]",391
4193,hippocampus,"[{'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC5619554.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",229
4194,hippocampus atrophy,"[{'article': 'PMC7203806.txt', 'relationship': 'RESPONDED_TO', 'object': 'NGF treatment in hippocampal-sparing AD'}]",391
4195,hippocampus volume,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8733254.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'cognitive impairment'}]",648
4196,"hippocampus, ventro-medial prefrontal, fronto-insular, and lateral temporal cortex","[{'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}]",229
4197,hippocampus-PCC circuit,"[{'article': 'PMC6961388.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression in FAD'}]",457
4198,hippocampus-PCC structural connectivity,"[{'article': 'PMC9972804.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",457
4199,hmuY gene,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",638
4200,hs-CRP,"[{'article': 'PMC3110111.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4179179.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive impairment in elderly subjects'}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation and Alzheimer's Disease""}, {'article': 'PMC4153084.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Inflammation in Alzheimer's Disease""}, {'article': 'PMC5105117.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Inflammation in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to probiotic treatment in Alzheimer's Disease patients""}, {'article': 'PMC5105117.txt', 'relationship': 'RESPONDED_TO', 'object': 'Probiotic supplementation'}]",112
4201,hsCRP,"[{'article': 'PMC8201462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",495
4202,hyperphosphorylated tau,"[{'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10787596.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3978916.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4877513.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8581408.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4203,hyperphosphorylated tau protein,"[{'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4204,hyperproduction of reactive oxygen species,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Central Nervous System Dysfunction'}]",232
4205,hypocretin-1,"[{'article': 'PMC4052448.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Early detection of Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early stage Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Brain accumulation of β-amyloid peptides in Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': ""Biomarker Dynamics: Monitoring during treatment of Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': ""Therapy Choice: Alzheimer's Disease""}]",241
4206,iNOS,"[{'article': 'PMC3116821.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3237323.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Inflammatory response: Not significantly reduced due to variability'}, {'article': 'PMC3237323.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction of toxic microglial enzyme in AD mice'}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Oxidative stress in Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6921051.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation in Alzheimer's Disease""}, {'article': 'PMC9321013.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}]",12
4207,idea density,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",47
4208,immune cytokines,"[{'article': 'PMC2241592.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2241592.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",666
4209,inaccuracy score,"[{'article': 'PMC10916999.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",1
4210,induced second slow-wave peak,"[{'article': 'PMC11493878.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ42/Aβ40 ratio improvement'}]",421
4211,inferior parietal lobule (IPL),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",657
4212,inflammatory biomarkers,"[{'article': 'PMC7934383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitored during treatment'}]",289
4213,inflammatory cytokines,"[{'article': 'PMC3110111.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",666
4214,inflammatory markers,"[{'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Lower levels of inflammatory markers are associated with improved physical fitness and function in older adults with dementia.'}]",289
4215,insulin,"[{'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease: cognitive decline""}, {'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease: cognitive protection""}, {'article': 'PMC10001958.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10001958.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3761088.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early cognitive decline in Alzheimer's Disease""}, {'article': 'PMC3761088.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Preservation of metabolic integrity of the brain in Alzheimer's Disease""}, {'article': 'PMC3761088.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Intranasal administration for cognitive improvement in Alzheimer's Disease""}, {'article': 'PMC3761088.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Eligibility: Cognitive improvement in amnestic mild cognitive impairment or mild to moderate Alzheimer's Disease""}, {'article': 'PMC4979550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis and treatment of Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",73
4216,insulin sensitivity,"[{'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'cognitive deficits'}]",73
4217,insulin-like growth factor 1 (IGF-1),"[{'article': 'PMC7067577.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive Decline in Alzheimer's Disease""}]",227
4218,insulin-like growth factor-1 (IGF-1),"[{'article': 'PMC3110111.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",227
4219,insulin/IGF signaling,"[{'article': 'PMC4979550.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",202
4220,interleukin-6,"[{'article': 'PMC8857690.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Inflammation associated with Alzheimer's Disease""}]",115
4221,intermediate monocytes,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'age-related immune changes'}]",385
4222,ioflupane (123I),"[{'article': 'PMC4091455.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",640
4223,k3,"[{'article': 'PMC5478550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",223
4224,lacunes,"[{'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Cognitive impairment related to Alzheimer's Disease""}, {'article': 'PMC7477392.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD progression'}]",605
4225,lamin B1,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neural stem cell division and neurogenesis'}]",120
4226,language comprehension,"[{'article': 'PMC6261049.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",568
4227,language production,"[{'article': 'PMC6261049.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",568
4228,left fusiform gyrus (L FFG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",52
4229,left inferior frontal gyrus (IFG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",284
4230,left inferior parietal gyrus,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",284
4231,left inferior temporal gyrus,"[{'article': 'PMC9309357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive improvement in Alzheimer's Disease""}, {'article': 'PMC9309357.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Acupuncture combined with Donepezil treatment'}]",284
4232,left inferior temporal gyrus (ITG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",284
4233,left middle temporal gyrus (MTG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",52
4234,left precuneus fALFF,"[{'article': 'PMC9309357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",95
4235,left superior temporal gyrus (STG),"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",284
4236,leptin,"[{'article': 'PMC5445077.txt', 'relationship': 'ACTS_AS_NEUROTROPHIC_FACTOR_AND_EXERTS_NEUROPROTECTIVE_EFFECTS_AGAINST', 'object': 'Aβ oligomer-induced toxicity'}]",134
4237,let-7,"[{'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",620
4238,locus coeruleus (LC),"[{'article': 'PMC9213384.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Presence of depression in Alzheimer's Disease""}]",33
4239,lowSWA,"[{'article': 'PMC9053232.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Strong responders to auditory stimulation'}, {'article': 'PMC9053232.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to auditory stimulation during sleep'}, {'article': 'PMC9053232.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Enhancement of slow-wave activity due to stimulation'}, {'article': 'PMC9053232.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Auditory deep sleep stimulation'}, {'article': 'PMC9053232.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Slow-wave enhancement for patients with Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Consideration of stimulation approaches in clinical trials for Alzheimer's Disease""}]",38
4240,lowSWA (low-frequency slow wave activity),"[{'article': 'PMC9053232.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Auditory slow wave stimulation'}, {'article': 'PMC9053232.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Auditory slow wave stimulation'}]",421
4241,lowSWE,"[{'article': 'PMC9053232.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9053232.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",38
4242,lower cerebral spinal fluid Aβ42,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",140
4243,lower resting cortical metabolism,"[{'article': 'PMC9213384.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",27
4244,lvPPA,"[{'article': 'PMC8615710.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",258
4245,mALFF values,"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",397
4246,mALFF values in the left hippocampus,"[{'article': 'PMC6306691.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive performance'}]",229
4247,mALFF values in the precuneus,"[{'article': 'PMC6306691.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Global cognition decline'}]",397
4248,mALFF/mfALFF values in the precuneus,"[{'article': 'PMC6306691.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",397
4249,mI/Cr,"[{'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'APOE ε4 carriership'}]",112
4250,mSOA,"[{'article': 'PMC4407573.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",31
4251,mTOR,"[{'article': 'PMC4485995.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease therapy""}, {'article': 'PMC8470960.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target for autophagy modulation in VCP disease'}, {'article': 'PMC7805132.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment pathway""}]",652
4252,mTOR kinase,"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",652
4253,mTORC1,"[{'article': 'PMC9962062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Neurodegenerative Disorders'}]",219
4254,mTORC1 activation,"[{'article': 'PMC9962062.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Neuroprotection'}]",652
4255,madecassic acid,"[{'article': 'PMC8868383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of madecassoside'}, {'article': 'PMC8868383.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to treatment with CAW'}]",696
4256,markers of angiogenesis,"[{'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",257
4257,markers of neurogenesis,"[{'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",464
4258,markers of oxidative stress,"[{'article': 'PMC8645072.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",517
4259,mature NGF,"[{'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",116
4260,medial temporal lobe atrophy,"[{'article': 'PMC7203806.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Poorer response to pharmacologic cholinergic treatment'}]",444
4261,medial temporal lobe network,"[{'article': 'PMC4846650.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}]",409
4262,medial temporal lobe structures,"[{'article': 'PMC5619554.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",409
4263,medial temporal lobe volumes,"[{'article': 'PMC4750048.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased risk of developing dementia'}]",409
4264,melatonin,"[{'article': 'PMC8336239.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Diurnal neuroendocrine activity'}]",536
4265,memantine,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Advanced AD'}]",96
4266,metabolism intensity,"[{'article': 'PMC9606044.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'PE treatment in AD patients'}]",27
4267,miR-124,"[{'article': 'PMC7674923.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4268,miR-155,"[{'article': 'PMC11274940.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Limiting AD pathology and maintaining cognitive function'}, {'article': 'PMC11274940.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'MGnD-induced phenotypic reversion and cognitive function'}]",24
4269,miR-16,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Neuronal differentiation'}, {'article': 'PMC4908397.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Trophic factors in hBM-MSCs dynamic conditioned media'}]",24
4270,miR-16-5p,"[{'article': 'PMC4908397.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4271,miR-19a-5p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4272,miR-2467-3p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4273,miR-25802,"[{'article': 'PMC11274940.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': 'Survival: AD-related pathology'}]",24
4274,miR-301a-3p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4275,miR-3132,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4276,miR-411-5p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4277,miR-4303,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4278,miR-4513,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4279,miR-4649-5p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4280,miR-4761-3p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4281,miR-495-3p,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4282,miR-543,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4283,miR-5682,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4284,miR-623,"[{'article': 'PMC9100641.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",24
4285,miRNA-146a,"[{'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Immune responses in AD'}]",24
4286,miRNA-33,"[{'article': 'PMC9644639.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ metabolism in AD'}]",24
4287,miRNAs,"[{'article': 'PMC9755275.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Aging and Alzheimer's Disease""}]",24
4288,microRNA-130a,"[{'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",161
4289,microRNAs,"[{'article': 'PMC9644639.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Disease progression in LOAD'}]",161
4290,microbleeds,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""lower Aβ42 levels in vascular dementia and higher tau levels in participants with subjective memory complaints, associated with Alzheimer's Disease""}]",600
4291,microglia,"[{'article': 'PMC8258160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",423
4292,microglial activation,"[{'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduced microglial activation in Alzheimer's Disease mice treated with GV-971""}]",423
4293,mid temporal volume,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",28
4294,middle and inferior frontal gyri,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",284
4295,midline frontal theta power,"[{'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Behavioral improvements after cognitive training'}]",210
4296,mitochondrial Aβ1–40 levels,"[{'article': 'PMC4981900.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",8
4297,mitochondrial bioenergetics,"[{'article': 'PMC9527145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Improved mitochondrial function and neuroprotection in Alzheimer's Disease""}]",295
4298,mitochondrial biogenesis,"[{'article': 'PMC9527145.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Impaired mitochondrial biogenesis in Alzheimer's Disease""}]",295
4299,mitochondrial complex I–III activity,"[{'article': 'PMC3467226.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",295
4300,mitochondrial dysfunction,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",295
4301,mitochondrial dysfunctions,"[{'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Central Nervous System Dysfunction'}]",295
4302,mitochondrial function,"[{'article': 'PMC8797052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improved mitochondrial function'}]",295
4303,mitochondrial quality control,"[{'article': 'PMC9527145.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Improved mitochondrial quality control after exercise training in Alzheimer's Disease""}]",295
4304,mitofusin-2,"[{'article': 'PMC9962062.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Restoration of mitochondrial dynamics and weakening of apoptosis'}]",632
4305,modularity,"[{'article': 'PMC8795741.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",141
4306,monocytes,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",385
4307,months/10s,"[{'article': 'PMC7392684.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",103
4308,months/10 s,"[{'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early-stage dementia'}, {'article': 'PMC7392684.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}]",103
4309,myo-inositol (mI),"[{'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid pathology in preclinical Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",382
4310,myo-inositol (mI)/creatine (Cr),"[{'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid plaques'}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",382
4311,n-3 PUFA,"[{'article': 'PMC6521224.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': 'Eligibility for study participation based on plasma levels'}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnosis: Cognitive decline'}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Cognitive decline'}, {'article': 'PMC6521224.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Better cognitive function'}]",559
4312,n-3 PUFAs,"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cognitive function in the elderly'}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced cognitive decline'}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Better cognitive performance in Alzheimer's Disease""}, {'article': 'PMC4179179.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline and Alzheimer's Disease""}]",559
4313,"n-3 PUFAs (22:6n-3, total n-3)","[{'article': 'PMC4179179.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Cognitive performance in Alzheimer's Disease""}]",559
4314,n-3 Polyunsaturated Fatty Acids (n-3 PUFA),"[{'article': 'PMC6521224.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Cerebral Small Vessel Disease'}, {'article': 'PMC6521224.txt', 'relationship': 'IS_BASIS_FOR_THERAPY_CHOICE', 'object': 'Cognitive Decline Prevention'}]",259
4315,n-3 fatty acids,"[{'article': 'PMC5223628.txt', 'relationship': 'PREDICTS_RESPONSE_TO', 'object': ""Response to aerobic exercise treatment in Alzheimer's Disease""}, {'article': 'PMC5223628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment in Alzheimer's Disease""}, {'article': 'PMC5223628.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive response to exercise treatment in Alzheimer's Disease""}, {'article': 'PMC5223628.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Favourable changes in cognition at 12 months'}, {'article': 'PMC5223628.txt', 'relationship': 'PREDICTS_BETTER_OUTCOME', 'object': 'Predicts improved or stabilised ADAS-Cog at 12 months'}]",259
4316,n-6/n-3 ratio,"[{'article': 'PMC4179179.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive decline in Alzheimer's Disease""}]",179
4317,n-gram features,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",167
4318,n3-PUFAs,"[{'article': 'PMC7698404.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Lower incidence of Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Promotes amyloid-beta clearance in Alzheimer's Disease""}]",559
4319,neocortex,"[{'article': 'PMC5619554.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",64
4320,network failure quotient (NFQ),"[{'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",288
4321,neuritic plaques,"[{'article': 'PMC9213384.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""presence of depression in Alzheimer's Disease""}]",548
4322,neurocan,"[{'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",64
4323,neurocognitive measures,"[{'article': 'PMC4876902.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease progression""}]",41
4324,neurofilament light,"[{'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9297091.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC9297091.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",415
4325,neurofilament light (NfL),"[{'article': 'PMC7223540.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",415
4326,neurofilament light chain,"[{'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",415
4327,neurofilament light chain (NFL),"[{'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",415
4328,neurogranin,"[{'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8157623.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ pathology in cognitively unimpaired individuals'}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Synaptic dysfunction in early Alzheimer's Disease continuum""}, {'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""synaptic toxicity in Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""synaptic toxicity in Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_TREATMENT_ELIGIBILITY', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's disease-related neuropathological features""}, {'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Visceral adipose tissue area'}, {'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Visceral adipose tissue area'}]",685
4329,neurogranin levels,"[{'article': 'PMC8381483.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduced neurogranin levels'}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",685
4330,neuronal viability,"[{'article': 'PMC8797052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improved neuronal viability'}]",70
4331,neurotrophic biomarkers,"[{'article': 'PMC7934383.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitored during treatment'}]",464
4332,neurotrophic blood-based biomarkers,"[{'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Enhanced neurotrophic blood-based biomarkers are associated with improved cognitive function in individuals with dementia.'}]",464
4333,neutrophils,"[{'article': 'PMC8258160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",598
4334,non-classical monocytes,"[{'article': 'PMC8258160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'age-related immune changes'}]",385
4335,norepinephrine,"[{'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",520
4336,oVEMP,"[{'article': 'PMC9344717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",31
4337,oligodendrocytes,"[{'article': 'PMC4979550.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",339
4338,omnibus scores,"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",1
4339,oxidative stress,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",517
4340,oxidative stress markers,"[{'article': 'PMC8797052.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in oxidative stress markers'}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",517
4341,ozagrel sodium,"[{'article': 'PMC7145106.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Non-elderly subarachnoid hemorrhage patients'}]",105
4342,p-AMPK,"[{'article': 'PMC9389745.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Acupuncture increases p-AMPK levels in the hippocampus.'}]",676
4343,p-H2A.X Ser139,"[{'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",99
4344,p-NMDAR2A,"[{'article': 'PMC3712995.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Increased levels linked to improved cognitive function in Alzheimer's Disease""}, {'article': 'PMC3712995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Spatial memory deficits in Alzheimer's Disease""}]",492
4345,p-Tau,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease neuropathology""}, {'article': 'PMC10013957.txt', 'relationship': 'PREDICTS_PROGRESSION', 'object': ""Progression: Mild Cognitive Impairment to Alzheimer's Disease dementia""}, {'article': 'PMC4247762.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Neurodegeneration and cognitive decline'}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4247762.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'RESPONDED_TO', 'object': 'Nilotinib treatment'}, {'article': 'PMC4396171.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Cerebral spinal fluid biomarker levels'}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4928349.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cortical dysfunction in Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4346,p-Tau (Ser396),"[{'article': 'PMC4247762.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4247762.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",40
4347,p-Tau (Thr181),"[{'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",40
4348,p-Tau Ser 396,"[{'article': 'PMC4247762.txt', 'relationship': 'RESPONDED_TO', 'object': 'Nilotinib treatment'}]",40
4349,p-Tau levels,"[{'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4350,p-Tau ser396,"[{'article': 'PMC4247762.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4351,p-Tau181,"[{'article': 'PMC4961391.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4961391.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Faster progression of Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4352,p-tau,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of AD pathology'}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'MEDIATES', 'object': 'The relationship between CA1 volume and retroactive interference (RI)'}, {'article': 'PMC10115176.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Alzheimer’s disease'}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC10294511.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC10294511.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC3523068.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau-related pathology progression in Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}, {'article': 'PMC4461930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction in p-tau related to cognitive decline'}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4822297.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC4918115.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment effect in Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Treatment response in Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ pathology in cognitively unimpaired individuals'}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology in early Alzheimer's Disease continuum""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC5648830.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'No significant treatment effect observed'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No treatment effect'}, {'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to aducanumab treatment in Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to gantenerumab treatment in Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Tau pathology and cognitive decline in Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depression in Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Lecanemab treatment response'}]",40
4353,p-tau (phosphorylated tau proteins),"[{'article': 'PMC9289357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]",40
4354,p-tau depositions,"[{'article': 'PMC8690894.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8690894.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]",40
4355,p-tau in CSF,"[{'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4356,p-tau levels,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4357,p-tau pathology,"[{'article': 'PMC10075195.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Memory performance and RI'}]",40
4358,p-tau(181),"[{'article': 'PMC8866346.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8866346.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Pathological cerebral spinal fluid profile'}, {'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",40
4359,p-tau(217),"[{'article': 'PMC8866346.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4360,p-tau(231),"[{'article': 'PMC8866346.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}]",40
4361,p-tau181,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Abnormal brain amyloid-β status'}, {'article': 'PMC10115176.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Alzheimer’s disease'}, {'article': 'PMC10115176.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Dose-dependent decreases in p-tau181 concentration in cerebral spinal fluid'}, {'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to MAPTRx treatment'}, {'article': 'PMC3580400.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapeutic interventions in Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Disease progression and cognitive decline'}, {'article': 'PMC8157623.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""synaptic dysfunction in Alzheimer's Disease""}, {'article': 'PMC8157623.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in adults with Down syndrome""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease pathology""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease progression""}, {'article': 'PMC8280160.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Predicts Alzheimer's Disease pathology""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease in adults with Down syndrome""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Higher levels associated with worse cognitive outcomes in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reflects: Disease progression and prognosis'}, {'article': 'PMC8280160.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Associated with: Cortical atrophy and brain hypometabolism'}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Tau pathology in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'PREDICTS_DISEASE_PROGRESSION', 'object': ""Predict: Disease progression in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Guide treatment selection: Anti-tau compounds in Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease in individuals with Down syndrome""}, {'article': 'PMC8280160.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Monitor drug effects on tau pathology in clinical trials'}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease in individuals with Down syndrome""}, {'article': 'PMC8280160.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease in individuals with Down syndrome""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ pathology'}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Confirm AD diagnosis'}, {'article': 'PMC8416781.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'AD diagnosis and patient recruitment into clinical trials'}, {'article': 'PMC8416781.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'AD neurodegeneration as measured by FDG-PET and grey matter volume'}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Amyloid and tau pathology in Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Differential diagnosis of Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Therapy response in Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Intermediate to high Consortium to Establish a Registry for Alzheimer's Disease neuritic plaques and Braak tau stages""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Pathology-confirmed AD from non-AD dementia'}, {'article': 'PMC8480485.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of AD pathology'}, {'article': 'PMC8480485.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Pathology-confirmed Alzheimer's Disease dementia""}, {'article': 'PMC8480485.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease neuropathologic changes""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Aβ status in Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5576287.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower levels in African Americans compared to Caucasians'}, {'article': 'PMC5668981.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive impairment in African Americans'}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No change during treatment'}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Preclinical Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Early detection of AD'}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'PET amyloid and tau pathology, predicts AD dementia progression'}, {'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Higher levels in married participants compared to non-married participants'}, {'article': 'PMC9716660.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Changes in levels over time during intervention'}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Plasma biomarker measured using a commercially validated single molecule array (Simoa) assay developed by Quanterix'}, {'article': 'PMC9768996.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Slower cognitive decline in Alzheimer's Disease""}, {'article': 'PMC9768996.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Lecanemab treatment response'}, {'article': 'PMC9768996.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment effects and disease state'}]",40
4362,p-tau181 (CSF),"[{'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4363,p-tau181 (plasma),"[{'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",239
4364,p-tau181/Aβ1-42 ratio,"[{'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",473
4365,p-tau181ADx,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Abnormal Aβ status in Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4366,p-tau181Fuji,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4367,p-tau181P,"[{'article': 'PMC6106931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",40
4368,p-tau181WashU,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4369,p-tau181p,"[{'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4370,p-tau217,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Indicates presence of: Abnormal brain amyloid-β status'}, {'article': 'PMC10115176.txt', 'relationship': 'PREDICTS', 'object': 'Future conversion to Alzheimer’s disease dementia (ADD)'}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'DIAGNOSTIC', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'PREDICTS_COGNITIVE_DECLINE', 'object': 'Preclinical cases of AD'}, {'article': 'PMC8416781.txt', 'relationship': 'DIFFERENTIATE', 'object': 'AD from controls and other tauopathies and neurodegenerative disorders'}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Aβ pathology'}, {'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Progression to Alzheimer's Disease dementia""}, {'article': 'PMC8966264.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Greater risk of progression to AD dementia in mild cognitive impairment patients'}, {'article': 'PMC8966264.txt', 'relationship': 'PREDICTS_CONVERSION_TO', 'object': ""Alzheimer's Disease dementia""}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8966264.txt', 'relationship': 'PREDICTS_CONVERSION_TO_AD', 'object': 'Conversion to AD dementia'}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_AD_PROGRESSION', 'object': 'Progression to AD dementia'}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Predictive marker for clinical progression to Alzheimer's Disease dementia""}, {'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Conversion to AD dementia'}, {'article': 'PMC8966264.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: AD progression'}, {'article': 'PMC8966264.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Risk of conversion to AD dementia within 3 years'}, {'article': 'PMC8966264.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Predict future decline in AD'}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4371,p-tau217Janss,"[{'article': 'PMC10115176.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Progression to Alzheimer's Disease Dementia""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4372,p-tau217Lilly,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4373,p-tau217WashU,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Abnormal Aβ status in Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Progression to Alzheimer's Disease Dementia""}, {'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10115176.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",40
4374,p-tau231,"[{'article': 'PMC10115176.txt', 'relationship': 'PREDICTS', 'object': 'Future progression from mild cognitive impairment to ADD'}, {'article': 'PMC10115176.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10710152.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease neuropathology""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Longitudinal cognitive decline and hippocampal volume changes'}, {'article': 'PMC8043944.txt', 'relationship': 'PREDICTS_MORTALITY', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease diagnosis""}, {'article': 'PMC8043944.txt', 'relationship': 'PREDICTS_SURVIVAL', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC8043944.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease treatment monitoring""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Cognitive decline and neurodegeneration'}, {'article': 'PMC8043944.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': '1-year decrease in hippocampal volume and worsening MMSE scores'}, {'article': 'PMC8043944.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment selection for Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Therapy for Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Early tau deposition and disease progression'}, {'article': 'PMC8043944.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early tau deposition in Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early stages of Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Therapeutic trials targeting early Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Individuals at higher risk of Alzheimer's Disease progression""}, {'article': 'PMC8043944.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Early Aβ deposition'}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Neurofibrillary tangles deposition in the entorhinal cortex'}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Early Aβ pathology before amyloid PET positivity'}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4375,p-tau231UGOT,"[{'article': 'PMC10115176.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4376,p11,"[{'article': 'PMC3835777.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",507
4377,p27,"[{'article': 'PMC5445077.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Poor prognosis in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuronal apoptosis in Alzheimer's Disease""}]",507
4378,p38 MAPK,"[{'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",414
4379,p3E,"[{'article': 'PMC4888851.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Target for Aβ immunotherapy'}]",466
4380,p53,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neuronal apoptosis in Alzheimer's Disease""}, {'article': 'PMC5445077.txt', 'relationship': 'LEVELS_DIMINISHED_UPON', 'object': 'SLAB51 treatment in AD mice'}]",245
4381,p62,"[{'article': 'PMC5445077.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5445077.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Autophagy activation and reduced levels in Alzheimer's Disease""}]",507
4382,p62/SQSTM1,"[{'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4489713.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Autophagic dysfunction in VCPR155H/+ mice'}, {'article': 'PMC4489713.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'VCP-associated disease'}, {'article': 'PMC4489713.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4489713.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Muscle pathology and autophagy dysfunction'}, {'article': 'PMC5456028.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Autophagy dysfunction in VCP disease'}, {'article': 'PMC5456028.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'VCP disease pathology'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC5456028.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'VCP disease pathology in patient myoblasts'}, {'article': 'PMC5456028.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to Rapamycin treatment in VCP disease'}]",99
4383,p70S6 kinase,"[{'article': 'PMC7805132.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment""}, {'article': 'PMC7805132.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to NNI-362 treatment in Alzheimer's Disease models""}, {'article': 'PMC7805132.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Improved memory function and increased adult-born neural cells'}, {'article': 'PMC7805132.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Alzheimer's Disease treatment with NNI-362""}]",399
4384,p70S6 kinase (p70S6K),"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",399
4385,p75,"[{'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",660
4386,p75NTR,"[{'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurotrophin receptor activity in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",660
4387,pGlu-Aβ,"[{'article': 'PMC6182869.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Synaptic impairment and neurotoxicity in Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Reduction in pGlu-Aβ levels associated with improved learning and memory deficits in AD-like mice.'}]",8
4388,pGlu-CCL2,"[{'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",562
4389,pGluAB42,"[{'article': 'PMC8381483.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Development of Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC8381483.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",562
4390,pNN50,"[{'article': 'PMC8154928.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Mild Cognitive Impairment'}]",507
4391,pSer202/pThr205,"[{'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",502
4392,pT181 tau protein,"[{'article': 'PMC6201586.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4393,pTau,"[{'article': 'PMC8381483.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment effects""}, {'article': 'PMC6764494.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Amyloid'}, {'article': 'PMC6764494.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Tau pathology'}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",490
4394,pTau Ser396,"[{'article': 'PMC4694064.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",40
4395,pTau/Aβ1-42 ratio,"[{'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",675
4396,pTau/Aβ42,"[{'article': 'PMC6429814.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",675
4397,pTau181,"[{'article': 'PMC9373273.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",502
4398,pThr181,"[{'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",502
4399,pThr217,"[{'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",502
4400,pThr231,"[{'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",502
4401,pan-tyrosine phosphorylated Abl,"[{'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib administration'}]",267
4402,parafoveal and peripapillary densities,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]",154
4403,parahippocampal atrophy,"[{'article': 'PMC5348543.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early-onset Alzheimer's Disease""}]",391
4404,parahippocampal gyrus,"[{'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",229
4405,parietal lobule,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease""}]",151
4406,parvalbumin,"[{'article': 'PMC3534053.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",53
4407,peak VO2,"[{'article': 'PMC5302785.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Better memory performance and reduced hippocampal atrophy in early-stage Alzheimer's Disease""}, {'article': 'PMC5302785.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Functional ability and cognitive decline in Alzheimer's Disease""}]",521
4408,perilesional areas,"[{'article': 'PMC5253356.txt', 'relationship': 'PREDICTS_TREATMENT_RESPONSE', 'object': 'treatment response in chronic aphasia'}]",280
4409,pharmacogenomic characteristics,"[{'article': 'PMC3764973.txt', 'relationship': 'PREDICTS_TOLERABILITY', 'object': 'Tolerability to acetylcholinesterase inhibitors (ChEIs)'}]",85
4410,phospho-AKT,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",613
4411,phospho-ERK,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",613
4412,phospho-GSK-3 beta S9 (S9-GSK-3β),"[{'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",333
4413,phospho-JNK,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",613
4414,phospho-PI3K,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",29
4415,phospho-PKA,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",613
4416,phospho-PKCα,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",613
4417,phospho-Tau181,"[{'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease (increased levels considered pathological)""}]",40
4418,phospho-p38,"[{'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",613
4419,phospho-tau,"[{'article': 'PMC4255368.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Selection of immunotherapy approaches'}, {'article': 'PMC4410460.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4410460.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease progression""}, {'article': 'PMC5496518.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}]",40
4420,phospho-tau concentrations,"[{'article': 'PMC4866415.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}]",40
4421,phosphorylated tau,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}]",40
4422,phosphorylated tau (p-tau),"[{'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4423,phosphorylated tau (p-tau181),"[{'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}]",40
4424,phosphorylated tau (ptau),"[{'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",40
4425,phosphorylated-tau,"[{'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6167961.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4426,physiological micro tremors (7–8 Hz amplitude),"[{'article': 'PMC9203627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Male sex in the context of Alzheimer's Disease""}]",218
4427,planum temporale in STG,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",28
4428,plasma Aβ,"[{'article': 'PMC8530186.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8843023.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-onset Alzheimer's Disease""}]",551
4429,plasma GFAP levels,"[{'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""presence of Alzheimer's Disease through association with p-tau181 levels""}]",13
4430,plasma P-tau217,"[{'article': 'PMC7653537.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early preclinical Alzheimer's Disease""}, {'article': 'PMC7653537.txt', 'relationship': 'PREDICTS', 'object': 'Higher future increase in tau-PET signal in the entorhinal ROI'}, {'article': 'PMC7653537.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Drug responses in clinical trials including individuals with preclinical AD'}]",239
4431,plasma amyloid-β (Aβ) peptides,"[{'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in plasma Aβ peptides in response to semagacestat treatment'}]",8
4432,plasma n-3 fatty acids,"[{'article': 'PMC5223628.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'cognitive responses to exercise treatment among patients with AD'}, {'article': 'PMC5223628.txt', 'relationship': 'PREDICTS', 'object': 'cognitive responses to aerobic exercise interventions in AD'}, {'article': 'PMC5223628.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'recommendations for n-3 supplementation to enhance pro-cognitive effects of exercise'}]",259
4433,plasma neurofilament light chain,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",415
4434,plasma p-tau181,"[{'article': 'PMC9289357.txt', 'relationship': 'PREDICTS_COGNITIVE_DECLINE', 'object': ""Cognitive decline in preclinical Alzheimer's Disease""}, {'article': 'PMC9289357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease pathology""}]",239
4435,plasma p-tau217,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",239
4436,plasma p-tau231,"[{'article': 'PMC10710152.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",239
4437,plasma p‐tau181,"[{'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Preclinical AD'}]",239
4438,plasma tau,"[{'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Accelerated decline of MMSE score'}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'High baseline ADAS-cog and accelerated increase'}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Large baseline ventricular volume and accelerated increase'}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Accelerated decrease of hippocampal volume'}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Accelerated decline of FDG-PET'}, {'article': 'PMC5089525.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Poor cognition at baseline and accelerated worsening of cognition'}, {'article': 'PMC5089525.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Accelerated worsening of cognition, large ventricular volumes at baseline and accelerated atrophy, and accelerated decrease in cortical glucose metabolism'}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'High plasma tau associated with low cerebral spinal fluid Aβ42'}, {'article': 'PMC5089525.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'High plasma tau associated with high cerebral spinal fluid T-tau and P-tau'}]",239
4439,posterior cingulate cortex,"[{'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",448
4440,precuneus,"[{'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depressive symptoms in Alzheimer's Disease""}]",677
4441,precuneus atrophy,"[{'article': 'PMC7203806.txt', 'relationship': 'RESPONDED_TO', 'object': 'NGF treatment in hippocampal-sparing AD'}]",286
4442,precuneus/posterior cingulate cortex,"[{'article': 'PMC8110716.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",448
4443,presenilin-1,"[{'article': 'PMC9389745.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",487
4444,primacy/recency ratio,"[{'article': 'PMC5226952.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'No significant difference from Experiment 1'}]",149
4445,primary somatosensory cortex (PSC),"[{'article': 'PMC7203806.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",162
4446,proNGF,"[{'article': 'PMC3706879.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",56
4447,propionate,"[{'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC7831739.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7831739.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",500
4448,proportion of word counts,"[{'article': 'PMC4526336.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild Cognitive Impairment'}, {'article': 'PMC4526336.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Mild Cognitive Impairment'}]",417
4449,proportions of pronouns,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",47
4450,proportions of verbs,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",47
4451,ptau,"[{'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-positive individuals'}]",490
4452,ptau/Aβ1–42,"[{'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}]",675
4453,ptau181,"[{'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",502
4454,pulse wave velocity,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""cerebral Aβ accumulation in Alzheimer's Disease""}]",97
4455,pupil dilation,"[{'article': 'PMC6943370.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6943370.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6943370.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6943370.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6943370.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",208
4456,p‐tau (AT8),"[{'article': 'PMC4774258.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",40
4457,p‐tau (PHF),"[{'article': 'PMC4774258.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4774258.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}]",40
4458,p‐tau181,"[{'article': 'PMC10075195.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Predicts progression to cognitive impairment'}]",40
4459,p‐tau217,"[{'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4460,p‐tau231,"[{'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Early preclinical stage of Alzheimer's Disease""}]",40
4461,quality of sleep,"[{'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Apathy in Alzheimer's Disease""}, {'article': 'PMC8345445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Apathy in Alzheimer's Disease""}]",479
4462,rCBF,"[{'article': 'PMC3338462.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Reduction in rCBF in Tg mice during ON periods'}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Monitoring Alzheimer's Disease progression""}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6668217.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early Alzheimer's Disease""}]",303
4463,rCBF in IPL,"[{'article': 'PMC6668217.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",303
4464,rMT,"[{'article': 'PMC7360860.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC7360860.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Severity of cognitive dysfunction in Alzheimer's Disease""}]",462
4465,recall-ratio z-scores,"[{'article': 'PMC5226952.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5226952.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Changes in cognitive function across trials'}]",157
4466,"references to objects, subjects and actions","[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",332
4467,right hippocampus volume,"[{'article': 'PMC4846650.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Advanced clinical symptoms of Pre-AD'}]",648
4468,right inferior temporal gyrus fALFF,"[{'article': 'PMC9309357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",284
4469,right middle temporal gyrus,"[{'article': 'PMC9309357.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}]",52
4470,right precuneus,"[{'article': 'PMC9309357.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease treatment response""}]",677
4471,rivastigmine,"[{'article': 'PMC5075013.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",595
4472,rs2143466,"[{'article': 'PMC6158742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Age of onset in Alzheimer's Disease""}]",144
4473,sAPP,"[{'article': 'PMC8901176.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease-related APP cleavage""}, {'article': 'PMC6106931.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Treatment: Atabecestat'}]",214
4474,sAPP-α,"[{'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",214
4475,sAPP-β,"[{'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",214
4476,sAPPα,"[{'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Increase in cerebral spinal fluid levels compared to placebo'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Treatment with atabecestat'}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6174237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}]",214
4477,sAPPβ,"[{'article': 'PMC6106931.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Decline in cerebral spinal fluid levels in response to atabecestat treatment'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to atabecestat treatment'}]",214
4478,sCTX,"[{'article': 'PMC4396171.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to AZD0530 treatment'}, {'article': 'PMC4396171.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Marker of Src family kinase target inhibition'}, {'article': 'PMC4396171.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}]",187
4479,sICAM-1,"[{'article': 'PMC8439008.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduction of Aβ levels in AD mouse models'}, {'article': 'PMC8439008.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'hUCB-MSC treatment'}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'n-3 PUFA supplementation effects'}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",75
4480,sICAM-1 (Soluble intercellular adhesion molecule 1),"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",447
4481,sLRP1,"[{'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive function in Alzheimer's Disease""}, {'article': 'PMC9393528.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Blood-brain barrier (BBB) integrity in Alzheimer's Disease (AD)""}, {'article': 'PMC9393528.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline in AD'}, {'article': 'PMC9393528.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Differentiate AD from mixed dementia phenotypes'}]",258
4482,sMRI,"[{'article': 'PMC4846650.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]",31
4483,sTNFR1,"[{'article': 'PMC3206445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'CORRELATES_WITH', 'object': ""TACE activity in Alzheimer's Disease""}]",596
4484,sTNFR2,"[{'article': 'PMC3206445.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3206445.txt', 'relationship': 'CORRELATES_WITH', 'object': ""TACE activity in Alzheimer's Disease""}]",596
4485,sTREM2,"[{'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cortical thinning in Alzheimer's Disease""}, {'article': 'PMC6879435.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's disease-related neuropathological features""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",596
4486,sVCAM-1,"[{'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC6521224.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7934383.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",127
4487,sVCAM-1 (Soluble vascular cell adhesion molecule 1),"[{'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",447
4488,salivary cortisol,"[{'article': 'PMC8336239.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Diurnal neuroendocrine activity'}]",132
4489,scFv D10,"[{'article': 'PMC4857621.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Targeting α-syn for Alzheimer's Disease treatment""}]",66
4490,scFv D5,"[{'article': 'PMC4857621.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Targeting α-syn for Alzheimer's Disease treatment""}]",66
4491,selective reduction of N-methyl-d-aspartate (NMDA) receptor NR2A density,"[{'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",449
4492,sensor-based Frailty Measurement (FM),"[{'article': 'PMC7996628.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}]",218
4493,sleep disturbances,"[{'article': 'PMC8317398.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Bright Light Therapy (BLT)'}]",283
4494,sleep quality,"[{'article': 'PMC8345445.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""apathy in Alzheimer's Disease""}]",479
4495,slow waves,"[{'article': 'PMC9053232.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""lower amyloid burden in older adults, which is associated with Alzheimer's Disease""}]",421
4496,sodium benzoate,"[{'article': 'PMC8060832.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment""}]",105
4497,solanezumab,"[{'article': 'PMC6916654.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Passive immunotherapy targeting soluble monomeric Aβ'}]",268
4498,speech production,"[{'article': 'PMC6261049.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",74
4499,speech rate,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",74
4500,speech timing,"[{'article': 'PMC8110716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment and Alzheimer's Disease""}]",74
4501,speech-based classifiers,"[{'article': 'PMC8110716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive deficits in Alzheimer's Disease""}]",167
4502,speech/language alterations,"[{'article': 'PMC9171270.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early diagnosis of Alzheimer's Disease""}]",568
4503,statin,"[{'article': 'PMC7145106.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Non-elderly subarachnoid hemorrhage patients'}]",134
4504,step count,"[{'article': 'PMC4849800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",305
4505,step length,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced grey matter volume in hippocampus'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Reduced grey matter volume in prefrontal cortex'}]",305
4506,stride length,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'white matter lesions (WML) in the right centrum semiovale'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'reduced fractional anisotropy (FA) and increased mean diffusivity (MD)'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'reduction in white matter volume'}]",246
4507,stride length variability,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'increased mean diffusivity (MD) in normal appearing white matter'}]",246
4508,stride time variability,"[{'article': 'PMC4197903.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Episodic memory deficits in mild cognitive impairment'}]",246
4509,stride width,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'global silent infarct presence'}, {'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'reduced fractional anisotropy (FA) and increased mean diffusivity (MD)'}]",246
4510,stride width variability,"[{'article': 'PMC6565843.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'reduced mean diffusivity (MD) in white matter lesions'}]",246
4511,substantia nigra (SN),"[{'article': 'PMC9213384.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neurodegenerative changes in Alzheimer's Disease""}]",79
4512,superficial parafoveal vessel density,"[{'article': 'PMC6445433.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Early Alzheimer's Disease""}]",154
4513,synaptic density,"[{'article': 'PMC3110111.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",616
4514,synaptic dysfunction,"[{'article': 'PMC4970664.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Alzheimer's Disease""}]",616
4515,synaptic proteins and BDNF,"[{'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of: Cognitive Dysfunctions'}, {'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved Cognitive Functions'}]",616
4516,synaptic toxicity,"[{'article': 'PMC8381483.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduced synaptic toxicity'}]",616
4517,synaptopathy,"[{'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",129
4518,synaptophysin,"[{'article': 'PMC5520675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'No change in synapse density after TI stimulation'}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",129
4519,synaptotagmin,"[{'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Patient selection'}]",129
4520,syntactic errors,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",254
4521,t-PrP,"[{'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differentiate AD from CJD'}]",61
4522,t-Tau,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease neuropathology""}, {'article': 'PMC10013957.txt', 'relationship': 'PREDICTS_PROGRESSION', 'object': ""Progression: Mild Cognitive Impairment to Alzheimer's Disease dementia""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Cortical dysfunction in Alzheimer's Disease""}, {'article': 'PMC4868930.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive impairment in African Americans'}, {'article': 'PMC6236893.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'DIAGNOSITC_OF', 'object': 'Diagnose: Differential diagnosis between AD and DLB'}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease (increased levels considered pathological)""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",213
4523,t-Tau and p-tau181,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",40
4524,"t-Tau, Phospho-Tau, and Aβ42 combination","[{'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",473
4525,t-tau,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10013957.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of AD pathology'}, {'article': 'PMC10075195.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10233712.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC10287562.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to MAPTRx treatment'}, {'article': 'PMC10287562.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Reduction in t-tau concentration in cerebral spinal fluid'}, {'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3580400.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC4822297.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4936020.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8053280.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease via increased levels""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Indicates presence of Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ pathology in cognitively unimpaired individuals'}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in early Alzheimer's Disease continuum""}, {'article': 'PMC8314554.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8416781.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Pathology-confirmed AD dementia'}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Pathology-confirmed Alzheimer's Disease dementia""}, {'article': 'PMC8480485.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease neuropathologic changes""}, {'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Higher levels associated with poor outcomes in Alzheimer's Disease""}, {'article': 'PMC8480485.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response to treatment in Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8524356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Early-stage Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive impairment associated with Alzheimer's Disease""}, {'article': 'PMC5668981.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Lower levels in African Americans compared to Caucasians'}, {'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6106931.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6146627.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'No significant treatment effect observed'}, {'article': 'PMC6146627.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'No treatment effect'}, {'article': 'PMC7084863.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Atabecestat treatment'}, {'article': 'PMC7227237.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'No change during treatment'}, {'article': 'PMC7424995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7721364.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7830228.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9213384.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Depression in Alzheimer's Disease""}, {'article': 'PMC9327167.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Tau pathology in Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Reflects neuronal injury and Aβ-induced tau secretion in AD'}, {'article': 'PMC9716660.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9716660.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'Lower levels in APOE ε2/ε4 genotype compared to APOE ε3/ε4 genotype'}, {'article': 'PMC9716660.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Changes in levels over time during intervention'}]",213
4526,t-tau in CSF,"[{'article': 'PMC7424995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7424995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4527,t-tau/Aβ1-42 ratio,"[{'article': 'PMC8480485.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",473
4528,t-α-synuclein,"[{'article': 'PMC7523311.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",395
4529,tDCS stimulation,"[{'article': 'PMC4804486.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",310
4530,tPA,"[{'article': 'PMC3835777.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",201
4531,tTau,"[{'article': 'PMC6429814.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Amyloid'}, {'article': 'PMC6764494.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Tau pathology'}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",94
4532,tTau levels,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4533,tTau/Aβ1-42,"[{'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6764494.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence of Amyloid'}]",675
4534,tTau/Aβ1-42 ratio,"[{'article': 'PMC6764494.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",675
4535,tTau/Aβ42,"[{'article': 'PMC6429814.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",675
4536,tapping frequency,"[{'article': 'PMC10916999.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",76
4537,tapping variability,"[{'article': 'PMC10916999.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",76
4538,tau,"[{'article': 'PMC10013957.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'MAPTRx treatment'}, {'article': 'PMC11274940.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4052448.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to AADvac1 vaccine treatment'}, {'article': 'PMC4255368.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target of AADvac1 vaccine'}, {'article': 'PMC4255368.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis of Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline and memory impairment in Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4346122.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neurodegeneration and cognitive decline in Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4690296.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4772335.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""White-matter (WM) degeneration in Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease using tau PET imaging""}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Cognitive decline in mild cognitive impairment'}, {'article': 'PMC8364310.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Higher tau levels correlated with increased mean diffusivity (MD) in brain pathways'}, {'article': 'PMC8364310.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ' Tau deposition patterns in brain regions for diagnostic purposes'}, {'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'tau pathology in spatially selective pathways'}, {'article': 'PMC8364310.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'WM degeneration associated with tau deposition'}, {'article': 'PMC8480485.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8733254.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Early detection and diagnosis of cognitive impairment'}, {'article': 'PMC8905724.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC4471648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC4679337.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4774258.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Worse cognitive symptoms'}, {'article': 'PMC5067556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased cognitive impairment'}, {'article': 'PMC5382945.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5382945.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'posterior cortical flortaucipir SUVr'}, {'article': 'PMC5496518.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease pathology""}, {'article': 'PMC5516350.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""treatment of Alzheimer's Disease by targeting pathological tau phosphorylation and aggregation""}, {'article': 'PMC6110931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6182869.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Disease-Modifying Therapies (DMTs) in AD'}, {'article': 'PMC7223540.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Anti-tau therapies for Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Cerebrospinal fluid tau biomarkers'}, {'article': 'PMC9327167.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Mild cognitive impairment due to AD or mild AD dementia'}, {'article': 'PMC9327167.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment selection: Clinical trials of anti-amyloid monoclonal antibody'}, {'article': 'PMC9327167.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Early stages of tau deposition and cognitive decline in AD'}, {'article': 'PMC9527145.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC9527145.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}]",213
4539,tau biomarkers,"[{'article': 'PMC7223540.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression and prognosis in Alzheimer's Disease""}, {'article': 'PMC9202553.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4540,tau hyperphosphorylation,"[{'article': 'PMC4485995.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurofibrillary tangles in Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neurodegeneration and cell death in Alzheimer's Disease""}]",40
4541,tau oligomers,"[{'article': 'PMC4255368.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255368.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Disease progression in Alzheimer's Disease""}]",40
4542,tau pathology,"[{'article': 'PMC4255368.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Therapeutic target for Alzheimer's Disease""}]",40
4543,tau peptide fragments,"[{'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4544,tau phosphorylated at threonine 181 (p-tau),"[{'article': 'PMC6966425.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4545,tau phosphorylation,"[{'article': 'PMC4255368.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive and functional decline in Alzheimer's Disease""}, {'article': 'PMC4615808.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6796854.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Response: Reduced tau phosphorylation in Alzheimer's Disease mice treated with GV-971""}]",40
4546,tau protein,"[{'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC10287562.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4150993.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: Target for tau immunotherapy'}, {'article': 'PMC4255369.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Neurofibrillary tangles and tau oligomers'}, {'article': 'PMC4255369.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Prognosis: Disease progression and severity'}, {'article': 'PMC4255369.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Outcome: Increased tau oligomers and tangles'}, {'article': 'PMC4255369.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment: DC8E8 immunotherapy'}, {'article': 'PMC4255369.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': 'Treatment selection: Targeting tau protein forms'}, {'article': 'PMC4255369.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target: Tau protein forms for immunotherapy'}, {'article': 'PMC4255369.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Reduction in insoluble tau oligomers'}, {'article': 'PMC4255369.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Dynamics: Decreased levels of insoluble tau oligomers'}, {'article': 'PMC4255369.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4255369.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4485995.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Autophagic dysfunction in Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4810525.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4810525.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""reduced hyperphosphorylation in Alzheimer's Disease treatment""}, {'article': 'PMC4936020.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC8690894.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5372260.txt', 'relationship': 'REDUCES', 'object': 'tau protein or its abnormal phosphorylation'}, {'article': 'PMC5372260.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6110931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6201586.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'AADvac1 immunotherapy'}, {'article': 'PMC6201586.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: AADvac1 active vaccine'}, {'article': 'PMC6679484.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Neurofibrillary tangles correlate with cognitive impairment and disease severity in Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Hyperphosphorylated and abnormally folded tau protein contributes to neuronal death and cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Development of Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9755275.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9755275.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: Anti-tau drugs'}, {'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",40
4547,tau protein phosphorylation,"[{'article': 'PMC9962062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Outcome: Improved Cognitive Functions'}]",40
4548,tau proteins,"[{'article': 'PMC7662091.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7698404.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",40
4549,tau tangles,"[{'article': 'PMC8325256.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4550,tau-441,"[{'article': 'PMC6357742.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",40
4551,tau-PET,"[{'article': 'PMC8364310.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Early diagnosis and tracking of disease progression in Alzheimer's Disease""}]",213
4552,tau-p181,"[{'article': 'PMC9202553.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",40
4553,tau-phosphorylated,"[{'article': 'PMC4979550.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4554,tau-positive neuropil threads,"[{'article': 'PMC6679484.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis of Alzheimer's Disease""}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Neuronal loss and cognitive decline in Alzheimer's Disease""}]",40
4555,tau/Aβ42 ratio,"[{'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6429814.txt', 'relationship': 'PREDICTS_PRESENCE_OF', 'object': 'Early AD pathology'}]",473
4556,tau/cerebral spinal fluid Aβ42 ratios,"[{'article': 'PMC6429814.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Amyloid PET Centiloids'}]",140
4557,taurine levels,"[{'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'astrocytic activity'}, {'article': 'PMC4847010.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4847010.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",213
4558,telomerase,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Aging-related diseases and cancer'}]",513
4559,telomeres,"[{'article': 'PMC9755275.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Organismal aging and DNA damage response'}]",513
4560,temporal meta-regions of interest (ROI) cortical thickness,"[{'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",197
4561,temporal pole,"[{'article': 'PMC10310693.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",28
4562,temporal speech features,"[{'article': 'PMC8110716.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8110716.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence of: Cognitive deficits in Alzheimer's Disease""}]",167
4563,the mother,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Probable Alzheimer's Disease""}]",113
4564,the window,"[{'article': 'PMC5237556.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Probable Alzheimer's Disease""}]",113
4565,theobromine,"[{'article': 'PMC6893800.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved cognitive function related to Alzheimer's Disease""}]",105
4566,theta rhythm,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",210
4567,thioflavin S,"[{'article': 'PMC4003513.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",2
4568,total alpha-synuclein,"[{'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Differential diagnosis between Alzheimer's Disease and Dementia with Lewy Bodies""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",395
4569,total sAPP,"[{'article': 'PMC6106931.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}]",214
4570,total semantic units,"[{'article': 'PMC3859216.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease progression""}]",167
4571,total tau,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC8043944.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8280160.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4862247.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5008228.txt', 'relationship': 'ASSOCIATED_WITH', 'object': 'neurodegeneration'}, {'article': 'PMC5008228.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}, {'article': 'PMC6371616.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Prodromal Alzheimer's Disease""}, {'article': 'PMC6646979.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Alzheimer's Disease treatment effects""}, {'article': 'PMC7067750.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7067750.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",40
4572,total tau (t-tau),"[{'article': 'PMC6966425.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC7223540.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7227237.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Response to atabecestat treatment'}]",40
4573,total tau protein,"[{'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4574,total-tau,"[{'article': 'PMC8439008.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",40
4575,total-tau (t-tau),"[{'article': 'PMC8043944.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",40
4576,triglycerides,"[{'article': 'PMC8857690.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",264
4577,ttau,"[{'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4683859.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Amyloid-positive individuals'}, {'article': 'PMC4683859.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Preclinical Alzheimer's Disease""}]",94
4578,typical word usage,"[{'article': 'PMC5147824.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5147824.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Predicts conversion from mild cognitive impairment to Alzheimer's Disease""}]",17
4579,t‐tau,"[{'article': 'PMC8416781.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Incident neurodegeneration in Alzheimer's Disease""}]",213
4580,ubiquitin,"[{'article': 'PMC5456028.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC6679855.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}]",650
4581,vAChT,"[{'article': 'PMC4890804.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",49
4582,vAβ,"[{'article': 'PMC4519341.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline associated with Alzheimer's Disease""}]",49
4583,vMRI,"[{'article': 'PMC6146627.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response to crenezumab treatment'}]",336
4584,valeric acid,"[{'article': 'PMC8873004.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Cognitive dysfunction'}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8873004.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Impaired learning and memory dysfunction'}, {'article': 'PMC8873004.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]",563
4585,valproate,"[{'article': 'PMC7831739.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased risk of developing dementia'}, {'article': 'PMC7831739.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Treatment of agitation in dementia'}]",309
4586,various other experimental biomarkers,"[{'article': 'PMC8381483.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Response: Improvements on various other experimental biomarkers'}]",257
4587,velocity,"[{'article': 'PMC4465490.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",97
4588,ventricles volume,"[{'article': 'PMC4132648.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",410
4589,ventricular volume,"[{'article': 'PMC4461930.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': 'Increase in ventricular volume in response to semagacestat treatment'}]",410
4590,verbal episodic memory performance,"[{'article': 'PMC4750048.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Increased risk of developing dementia'}]",463
4591,vestibular function,"[{'article': 'PMC9344717.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Motoric impairments in Alzheimer's Disease""}]",50
4592,vocal markers,"[{'article': 'PMC9092839.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",181
4593,waist circumference,"[{'article': 'PMC10310693.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease""}]",510
4594,walking speed,"[{'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'cognitive impairment and senile dementia'}]",97
4595,weight loss,"[{'article': 'PMC7890889.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'AD-related cognitive decline'}]",19
4596,white matter hyperintensities,"[{'article': 'PMC4835514.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""reduced Aβ42 levels in cerebral spinal fluid, associated with Alzheimer's Disease""}]",89
4597,white matter hyperintensity (WMH) volume,"[{'article': 'PMC8530186.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",89
4598,xenon washout parameter,"[{'article': 'PMC6023430.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC6023430.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}, {'article': 'PMC6023430.txt', 'relationship': 'GUIDES_TREATMENT_SELECTION', 'object': ""Treatment: Alzheimer's Disease""}]",461
4599,α-Syn,"[{'article': 'PMC5067556.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}]",501
4600,α-Tocopherol (AT),"[{'article': 'PMC9321013.txt', 'relationship': 'RESPONDED_TO', 'object': 'Reduction of IL-1β, IL-6, and TNF-α release in BV-2 cells'}]",249
4601,α-ketoglutarate,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4694064.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Treatment response in Alzheimer's Disease""}]",373
4602,α-sAPP,"[{'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",214
4603,α-syn,"[{'article': 'PMC4857621.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Alzheimer’s Disease'}, {'article': 'PMC4857621.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Neurodegeneration in Alzheimer's Disease""}, {'article': 'PMC7171193.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Absence of significant reactivity in Alzheimer's Disease""}, {'article': 'PMC7171193.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Low LED scores (<1000 mg/day)'}, {'article': 'PMC7171193.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': 'Age (≥70 years)'}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease (significant differences in levels between AD and DLB groups)""}, {'article': 'PMC7523311.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Cognitive deficits in Alzheimer's Disease""}, {'article': 'PMC7523311.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",501
4604,α-syn-specific T cell reactivity,"[{'article': 'PMC7171193.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",139
4605,α-synuclein,"[{'article': 'PMC8314554.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Alzheimer's Disease Diagnosis""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8314554.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4857621.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Target for small molecule inhibitors to prevent amyloidogenesis'}, {'article': 'PMC4857621.txt', 'relationship': 'BIOMARKER_DYNAMICS_UNDER_TREATMENT', 'object': 'Dynamics and intra-molecular binding properties under treatment with inhibitors'}, {'article': 'PMC5008228.txt', 'relationship': 'MONITORED_DURING_TREATMENT', 'object': 'Nilotinib treatment'}, {'article': 'PMC5067556.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5496518.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC5565643.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Diagnose: Differential diagnosis from AD'}, {'article': 'PMC6679484.txt', 'relationship': 'ASSOCIATED_WITH', 'object': ""Lewy-related pathology in Alzheimer's Disease""}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': 'Lewy body pathology among AD patients'}, {'article': 'PMC6966425.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Patient selection in Alzheimer's Disease""}]",395
4606,α-synuclein pathology biomarkers,"[{'article': 'PMC6966425.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Alzheimer's Disease""}]",395
4607,α7 nicotinic acetylcholine receptor (α7nAChR),"[{'article': 'PMC5516350.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}]",355
4608,α7 nicotinic acetylcholine receptors (α7 nAChRs),"[{'article': 'PMC4174765.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4174765.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Presence: Aβ oligomers binding and synaptic plasticity changes'}, {'article': 'PMC4174765.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease progression""}]",355
4609,β amyloid,"[{'article': 'PMC4826954.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Associated with better outcomes in Alzheimer's Disease through potential prevention, interruption, or elimination of β amyloid accumulation.""}]",8
4610,β-NGF,"[{'article': 'PMC6406356.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Cognitive decline in Alzheimer's Disease""}, {'article': 'PMC6406356.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': ""Alzheimer's Disease""}]",275
4611,β-OHB,"[{'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Improved paragraph recall with MCT administration'}]",275
4612,β-Sitosterol (BS),"[{'article': 'PMC9321013.txt', 'relationship': 'RESPONDED_TO', 'object': 'Reduction of IL-1β, IL-6, and TNF-α release in BV-2 cells'}]",275
4613,β-actin,"[{'article': 'PMC8333062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",275
4614,β-amyloid,"[{'article': 'PMC2880593.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC2880593.txt', 'relationship': 'RELATED_TREATMENT', 'object': 'Cognitive deficits in Down Syndrome mice'}, {'article': 'PMC4526582.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4707222.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4810525.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease""}, {'article': 'PMC8225898.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC8905724.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': 'Treatment: Aducanumab'}, {'article': 'PMC8905724.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnosis: Alzheimer's Disease""}, {'article': 'PMC4774258.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4970664.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Early-onset Alzheimer's Disease""}, {'article': 'PMC5352784.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': 'Diagnose: Alzheimer’s Disease'}, {'article': 'PMC5352784.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Probable Alzheimer's Disease""}, {'article': 'PMC6357742.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC6448216.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC6910674.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': ""Outcome: Hippocampal Atrophy in Alzheimer's Disease""}, {'article': 'PMC6910674.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Hippocampal atrophy in Alzheimer's Disease""}, {'article': 'PMC7648990.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'Boosted clearance from the brain, potentially delaying neuropathological progression'}, {'article': 'PMC7995588.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9962062.txt', 'relationship': 'DIAGNOSITC_OF', 'object': ""Alzheimer's Disease""}]",8
4615,β-amyloid (1-42),"[{'article': 'PMC10287562.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",8
4616,β-amyloid (Aβ),"[{'article': 'PMC3338462.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC3338462.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}, {'article': 'PMC4607601.txt', 'relationship': 'DIAGNOSTIC_OF', 'object': ""Diagnose: Early-stage Alzheimer's Disease""}, {'article': 'PMC6145937.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': 'Synapse loss and further Aβ production'}, {'article': 'PMC6145937.txt', 'relationship': 'ASSOCIATED_WITH_POOR_OUTCOME', 'object': 'Increased Aβ production and synapse loss'}, {'article': 'PMC7995588.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}, {'article': 'PMC9389745.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}, {'article': 'PMC9972756.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",8
4617,β-amyloid aggregates,"[{'article': 'PMC4707222.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Decreased β-amyloid aggregates in Alzheimer's Disease""}]",8
4618,β-amyloid plaques,"[{'article': 'PMC4707222.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Prognosis: Decreased β-amyloid plaques in Alzheimer's Disease""}]",8
4619,β-amyloid protein,"[{'article': 'PMC5372260.txt', 'relationship': 'REDUCES', 'object': 'β-amyloid protein or its toxicity'}]",8
4620,β-amyloid proteins,"[{'article': 'PMC9962062.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Presence: Alzheimer's Disease""}]",8
4621,β-catenin,"[{'article': 'PMC6211704.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease progression""}, {'article': 'PMC7067577.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Alzheimer's Disease""}]",275
4622,β-hydroxybutyrate,"[{'article': 'PMC2731764.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Therapeutic response to AC-1202 in Alzheimer's Disease patients""}, {'article': 'PMC3213220.txt', 'relationship': 'LEVELS_REFLECT_RESPONSE', 'object': ""Cognitive performance changes in Alzheimer's Disease treatment""}, {'article': 'PMC4202787.txt', 'relationship': 'INDICATES_PRESENCE_OF', 'object': ""Improved cognitive function in Alzheimer's Disease""}]",361
4623,β-sAPP,"[{'article': 'PMC2876785.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",214
4624,β-secretase,"[{'article': 'PMC3741576.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Alzheimer's Disease""}]",617
4625,β-wrapin AS69,"[{'article': 'PMC4857621.txt', 'relationship': 'RELATED_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]",275
4626,β1−γ,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI) related to Alzheimer's Disease""}]",275
4627,β2−γ,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI) related to Alzheimer's Disease""}]",275
4628,γ-glutamyl amino acids,"[{'article': 'PMC4694064.txt', 'relationship': 'RELATED_PROGNOSIS', 'object': ""Alzheimer's Disease prognosis""}, {'article': 'PMC4694064.txt', 'relationship': 'RESPONDED_TO', 'object': 'J147 treatment'}, {'article': 'PMC4694064.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Impaired GSH homeostasis in Alzheimer's Disease""}]",321
4629,γ-secretase complex,"[{'article': 'PMC7389451.txt', 'relationship': 'IS_TARGET_OF_TREATMENT', 'object': ""Treatment: Alzheimer's Disease""}]",617
4630,γH2AX,"[{'article': 'PMC5520675.txt', 'relationship': 'ASSOCIATED_WITH_BETTER_OUTCOME', 'object': 'No DNA damage after TI stimulation'}]",26
4631,δ−α2,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI) related to Alzheimer's Disease""}]",285
4632,θ−α2,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI) related to Alzheimer's Disease""}]",639
4633,θ−β1,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI) related to Alzheimer's Disease""}]",639
4634,θ−γ,"[{'article': 'PMC4611062.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Mild Cognitive Impairment (MCI) related to Alzheimer's Disease""}]",639
4635,λk3,"[{'article': 'PMC5478550.txt', 'relationship': 'USED_TO_DIAGNOSE', 'object': ""Diagnose: Alzheimer's Disease""}]",29
